id	sid	tid	token	lemma	pos
admet-1883	1	1	infections	infection	NOUN
admet-1883	1	2	associated	associate	VERB
admet-1883	1	3	with	with	ADP
admet-1883	1	4	sars	sar	NOUN
admet-1883	1	5	-	-	PUNCT
admet-1883	1	6	cov-2	cov-2	PART
admet-1883	1	7	exploited	exploit	VERB
admet-1883	1	8	via	via	ADP
admet-1883	1	9	nanoformulated	nanoformulate	VERB
admet-1883	1	10	photodynamic	photodynamic	ADJ
admet-1883	1	11	therapy	therapy	NOUN
admet-1883	1	12	doi	doi	NOUN
admet-1883	1	13	:	:	PUNCT
admet-1883	1	14	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	PROPN
admet-1883	1	15	t.1883	t.1883	NOUN
admet-1883	1	16	513	513	NUM
admet-1883	1	17	admet	admet	PROPN
admet-1883	1	18	&	&	CCONJ
admet-1883	1	19	dmpk	dmpk	PROPN
admet-1883	1	20	11(4	11(4	NUM
admet-1883	1	21	)	)	PUNCT
admet-1883	1	22	(	(	PUNCT
admet-1883	1	23	2023	2023	NUM
admet-1883	1	24	)	)	PUNCT
admet-1883	1	25	513	513	NUM
admet-1883	1	26	-	-	SYM
admet-1883	1	27	531	531	NUM
admet-1883	1	28	;	;	PUNCT
admet-1883	1	29	doi	doi	NOUN
admet-1883	1	30	:	:	PUNCT
admet-1883	1	31	https://doi.org/10.5599/admet.1883	https://doi.org/10.5599/admet.1883	ADJ
admet-1883	1	32	open	open	ADJ
admet-1883	1	33	access	access	NOUN
admet-1883	1	34	:	:	PUNCT
admet-1883	1	35	issn	issn	PROPN
admet-1883	1	36	:	:	PUNCT
admet-1883	1	37	1848	1848	NUM
admet-1883	1	38	-	-	SYM
admet-1883	1	39	7718	7718	NUM
admet-1883	1	40	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-1883	1	41	review	review	NOUN
admet-1883	1	42	infections	infection	NOUN
admet-1883	1	43	associated	associate	VERB
admet-1883	1	44	with	with	ADP
admet-1883	1	45	sars	sar	NOUN
admet-1883	1	46	-	-	PUNCT
admet-1883	1	47	cov-2	cov-2	PART
admet-1883	1	48	exploited	exploit	VERB
admet-1883	1	49	via	via	ADP
admet-1883	1	50	nanoformulated	nanoformulate	VERB
admet-1883	1	51	photodynamic	photodynamic	ADJ
admet-1883	1	52	therapy	therapy	NOUN
admet-1883	1	53	pragya	pragya	PROPN
admet-1883	1	54	pallavi1,†	pallavi1,†	PROPN
admet-1883	1	55	,	,	PUNCT
admet-1883	1	56	karthick	karthick	PROPN
admet-1883	1	57	harini1,†	harini1,†	PROPN
admet-1883	1	58	,	,	PUNCT
admet-1883	1	59	noureddine	noureddine	ADP
admet-1883	1	60	elboughdiri2,3	elboughdiri2,3	PROPN
admet-1883	1	61	,	,	PUNCT
admet-1883	1	62	pemula	pemula	NOUN
admet-1883	1	63	gowtham1	gowtham1	PROPN
admet-1883	1	64	,	,	PUNCT
admet-1883	1	65	koyeli	koyeli	PROPN
admet-1883	1	66	girigoswami1	girigoswami1	PROPN
admet-1883	1	67	and	and	CCONJ
admet-1883	1	68	agnishwar	agnishwar	PROPN
admet-1883	1	69	girigoswami1	girigoswami1	PROPN
admet-1883	1	70	,	,	PUNCT
admet-1883	1	71	*	*	PROPN
admet-1883	1	72	1medical	1medical	NUM
admet-1883	1	73	bionanotechnology	bionanotechnology	NOUN
admet-1883	1	74	,	,	PUNCT
admet-1883	1	75	faculty	faculty	NOUN
admet-1883	1	76	of	of	ADP
admet-1883	1	77	allied	ally	VERB
admet-1883	1	78	health	health	NOUN
admet-1883	1	79	sciences	science	NOUN
admet-1883	1	80	,	,	PUNCT
admet-1883	1	81	chettinad	chettinad	PROPN
admet-1883	1	82	hospital	hospital	PROPN
admet-1883	1	83	and	and	CCONJ
admet-1883	1	84	research	research	PROPN
admet-1883	1	85	institute	institute	PROPN
admet-1883	1	86	(	(	PUNCT
admet-1883	1	87	chri	chri	PROPN
admet-1883	1	88	)	)	PUNCT
admet-1883	1	89	,	,	PUNCT
admet-1883	1	90	chettinad	chettinad	PROPN
admet-1883	1	91	academy	academy	PROPN
admet-1883	1	92	of	of	ADP
admet-1883	1	93	research	research	NOUN
admet-1883	1	94	and	and	CCONJ
admet-1883	1	95	education	education	NOUN
admet-1883	1	96	(	(	PUNCT
admet-1883	1	97	care	care	NOUN
admet-1883	1	98	)	)	PUNCT
admet-1883	1	99	,	,	PUNCT
admet-1883	1	100	kelambakkam	kelambakkam	PROPN
admet-1883	1	101	,	,	PUNCT
admet-1883	1	102	chennai	chennai	PROPN
admet-1883	1	103	,	,	PUNCT
admet-1883	1	104	tn-603103	tn-603103	PROPN
admet-1883	1	105	,	,	PUNCT
admet-1883	1	106	india	india	PROPN
admet-1883	1	107	2chemical	2chemical	PROPN
admet-1883	1	108	engineering	engineering	PROPN
admet-1883	1	109	department	department	NOUN
admet-1883	1	110	,	,	PUNCT
admet-1883	1	111	college	college	NOUN
admet-1883	1	112	of	of	ADP
admet-1883	1	113	engineering	engineering	NOUN
admet-1883	1	114	,	,	PUNCT
admet-1883	1	115	university	university	NOUN
admet-1883	1	116	of	of	ADP
admet-1883	1	117	ha'il	ha'il	PROPN
admet-1883	1	118	,	,	PUNCT
admet-1883	1	119	p.o	p.o	PROPN
admet-1883	1	120	.	.	PROPN
admet-1883	1	121	box	box	PROPN
admet-1883	1	122	2440	2440	NUM
admet-1883	1	123	,	,	PUNCT
admet-1883	1	124	ha'il	ha'il	NOUN
admet-1883	1	125	81441	81441	NUM
admet-1883	1	126	,	,	PUNCT
admet-1883	1	127	saudi	saudi	PROPN
admet-1883	1	128	arabia	arabia	PROPN
admet-1883	1	129	3chemical	3chemical	NUM
admet-1883	1	130	engineering	engineering	NOUN
admet-1883	1	131	process	process	NOUN
admet-1883	1	132	department	department	NOUN
admet-1883	1	133	,	,	PUNCT
admet-1883	1	134	national	national	ADJ
admet-1883	1	135	school	school	NOUN
admet-1883	1	136	of	of	ADP
admet-1883	1	137	engineers	engineer	NOUN
admet-1883	1	138	gabes	gabes	PROPN
admet-1883	1	139	,	,	PUNCT
admet-1883	1	140	university	university	PROPN
admet-1883	1	141	of	of	ADP
admet-1883	1	142	gabes	gabes	PROPN
admet-1883	1	143	,	,	PUNCT
admet-1883	1	144	gabes	gabes	PROPN
admet-1883	1	145	6029	6029	NUM
admet-1883	1	146	,	,	PUNCT
admet-1883	1	147	tunisia	tunisia	PROPN
admet-1883	1	148	†equal	†equal	ADJ
admet-1883	1	149	contribution	contribution	NOUN
admet-1883	1	150	*	*	PUNCT
admet-1883	1	151	corresponding	correspond	VERB
admet-1883	1	152	author	author	NOUN
admet-1883	1	153	:	:	PUNCT
admet-1883	1	154	e	e	NOUN
admet-1883	1	155	-	-	NOUN
admet-1883	1	156	mail	mail	NOUN
admet-1883	1	157	:	:	PUNCT
admet-1883	1	158	agnishwarg@gmail.com	agnishwarg@gmail.com	X
admet-1883	1	159	;	;	PUNCT
admet-1883	1	160	tel	tel	PROPN
admet-1883	1	161	.	.	PROPN
admet-1883	1	162	+91	+91	PROPN
admet-1883	1	163	-	-	PUNCT
admet-1883	1	164	9445	9445	NUM
admet-1883	1	165	268	268	NUM
admet-1883	1	166	615	615	NUM
admet-1883	1	167	received	receive	VERB
admet-1883	1	168	:	:	PUNCT
admet-1883	1	169	may	may	PROPN
admet-1883	1	170	08	08	NUM
admet-1883	1	171	,	,	PUNCT
admet-1883	1	172	2023	2023	NUM
admet-1883	1	173	;	;	PUNCT
admet-1883	1	174	revised	revise	VERB
admet-1883	1	175	:	:	PUNCT
admet-1883	1	176	june	june	PROPN
admet-1883	1	177	30	30	NUM
admet-1883	1	178	,	,	PUNCT
admet-1883	1	179	2023	2023	NUM
admet-1883	1	180	;	;	PUNCT
admet-1883	1	181	published	publish	VERB
admet-1883	1	182	:	:	PUNCT
admet-1883	1	183	july	july	PROPN
admet-1883	1	184	1,2023	1,2023	NUM
admet-1883	1	185	abstract	abstract	ADJ
admet-1883	1	186	background	background	NOUN
admet-1883	1	187	and	and	CCONJ
admet-1883	1	188	purpose	purpose	NOUN
admet-1883	1	189	:	:	PUNCT
admet-1883	1	190	the	the	DET
admet-1883	1	191	pandemic	pandemic	NOUN
admet-1883	1	192	of	of	ADP
admet-1883	1	193	covid-19	covid-19	PROPN
admet-1883	1	194	has	have	AUX
admet-1883	1	195	highlighted	highlight	VERB
admet-1883	1	196	the	the	DET
admet-1883	1	197	need	need	NOUN
admet-1883	1	198	for	for	ADP
admet-1883	1	199	managing	manage	VERB
admet-1883	1	200	infectious	infectious	ADJ
admet-1883	1	201	diseases	disease	NOUN
admet-1883	1	202	,	,	PUNCT
admet-1883	1	203	which	which	PRON
admet-1883	1	204	spreads	spread	VERB
admet-1883	1	205	by	by	ADP
admet-1883	1	206	airborne	airborne	ADJ
admet-1883	1	207	transmission	transmission	NOUN
admet-1883	1	208	leading	lead	VERB
admet-1883	1	209	to	to	ADP
admet-1883	1	210	serious	serious	ADJ
admet-1883	1	211	health	health	NOUN
admet-1883	1	212	,	,	PUNCT
admet-1883	1	213	social	social	ADJ
admet-1883	1	214	,	,	PUNCT
admet-1883	1	215	and	and	CCONJ
admet-1883	1	216	economic	economic	ADJ
admet-1883	1	217	issues	issue	NOUN
admet-1883	1	218	.	.	PUNCT
admet-1883	2	1	sars	sar	NOUN
admet-1883	2	2	-	-	PUNCT
admet-1883	2	3	cov-2	cov-2	PART
admet-1883	2	4	is	be	AUX
admet-1883	2	5	an	an	DET
admet-1883	2	6	enveloped	envelop	VERB
admet-1883	2	7	virus	virus	NOUN
admet-1883	2	8	with	with	ADP
admet-1883	2	9	a	a	DET
admet-1883	2	10	60–140	60–140	PROPN
admet-1883	2	11	nm	nm	ADJ
admet-1883	2	12	diameter	diameter	NOUN
admet-1883	2	13	and	and	CCONJ
admet-1883	2	14	particle	particle	NOUN
admet-1883	2	15	-	-	PUNCT
admet-1883	2	16	like	like	ADJ
admet-1883	2	17	features	feature	NOUN
admet-1883	2	18	,	,	PUNCT
admet-1883	2	19	which	which	PRON
admet-1883	2	20	majorly	majorly	ADV
admet-1883	2	21	accounts	account	VERB
admet-1883	2	22	for	for	ADP
admet-1883	2	23	this	this	DET
admet-1883	2	24	disease	disease	NOUN
admet-1883	2	25	.	.	PUNCT
admet-1883	3	1	expanding	expand	VERB
admet-1883	3	2	diagnostic	diagnostic	ADJ
admet-1883	3	3	capabilities	capability	NOUN
admet-1883	3	4	,	,	PUNCT
admet-1883	3	5	developing	develop	VERB
admet-1883	3	6	safe	safe	ADJ
admet-1883	3	7	vaccinations	vaccination	NOUN
admet-1883	3	8	with	with	ADP
admet-1883	3	9	longlasting	longlaste	VERB
admet-1883	3	10	immunity	immunity	NOUN
admet-1883	3	11	,	,	PUNCT
admet-1883	3	12	and	and	CCONJ
admet-1883	3	13	formulating	formulate	VERB
admet-1883	3	14	effective	effective	ADJ
admet-1883	3	15	medications	medication	NOUN
admet-1883	3	16	are	be	AUX
admet-1883	3	17	the	the	DET
admet-1883	3	18	strategies	strategy	NOUN
admet-1883	3	19	to	to	PART
admet-1883	3	20	be	be	AUX
admet-1883	3	21	investigated	investigate	VERB
admet-1883	3	22	.	.	PUNCT
admet-1883	4	1	experimental	experimental	ADJ
admet-1883	4	2	approach	approach	NOUN
admet-1883	4	3	:	:	PUNCT
admet-1883	4	4	for	for	ADP
admet-1883	4	5	the	the	DET
admet-1883	4	6	literature	literature	NOUN
admet-1883	4	7	search	search	NOUN
admet-1883	4	8	,	,	PUNCT
admet-1883	4	9	electronic	electronic	ADJ
admet-1883	4	10	databases	database	NOUN
admet-1883	4	11	such	such	ADJ
admet-1883	4	12	as	as	ADP
admet-1883	4	13	scopus	scopus	NOUN
admet-1883	4	14	,	,	PUNCT
admet-1883	4	15	google	google	NOUN
admet-1883	4	16	scholar	scholar	NOUN
admet-1883	4	17	,	,	PUNCT
admet-1883	4	18	medline	medline	NOUN
admet-1883	4	19	,	,	PUNCT
admet-1883	4	20	embase	embase	PROPN
admet-1883	4	21	,	,	PUNCT
admet-1883	4	22	pubmed	pubmed	PROPN
admet-1883	4	23	,	,	PUNCT
admet-1883	4	24	and	and	CCONJ
admet-1883	4	25	web	web	NOUN
admet-1883	4	26	of	of	ADP
admet-1883	4	27	science	science	NOUN
admet-1883	4	28	were	be	AUX
admet-1883	4	29	used	use	VERB
admet-1883	4	30	as	as	ADP
admet-1883	4	31	the	the	DET
admet-1883	4	32	source	source	NOUN
admet-1883	4	33	.	.	PUNCT
admet-1883	5	1	search	search	NOUN
admet-1883	5	2	terms	term	NOUN
admet-1883	5	3	like	like	ADP
admet-1883	5	4	'	'	PUNCT
admet-1883	5	5	nanomediated	nanomediate	VERB
admet-1883	5	6	pdt	pdt	NOUN
admet-1883	5	7	,	,	PUNCT
admet-1883	5	8	'	'	PUNCT
admet-1883	5	9	'	'	PUNCT
admet-1883	5	10	pdt	pdt	NOUN
admet-1883	5	11	for	for	ADP
admet-1883	5	12	sars	sar	NOUN
admet-1883	5	13	-	-	PUNCT
admet-1883	5	14	cov-2	cov-2	NOUN
admet-1883	5	15	'	'	PUNCT
admet-1883	5	16	,	,	PUNCT
admet-1883	5	17	and	and	CCONJ
admet-1883	5	18	'	'	PUNCT
admet-1883	5	19	nanotechnology	nanotechnology	NOUN
admet-1883	5	20	in	in	ADP
admet-1883	5	21	treatment	treatment	NOUN
admet-1883	5	22	for	for	ADP
admet-1883	5	23	sars	sar	NOUN
admet-1883	5	24	-	-	PUNCT
admet-1883	5	25	cov-2	cov-2	NOUN
admet-1883	5	26	'	'	PUNCT
admet-1883	5	27	were	be	AUX
admet-1883	5	28	used	use	VERB
admet-1883	5	29	.	.	PUNCT
admet-1883	6	1	out	out	ADP
admet-1883	6	2	of	of	ADP
admet-1883	6	3	275	275	NUM
admet-1883	6	4	initially	initially	ADV
admet-1883	6	5	selected	select	VERB
admet-1883	6	6	articles	article	NOUN
admet-1883	6	7	,	,	PUNCT
admet-1883	6	8	198	198	NUM
admet-1883	6	9	were	be	AUX
admet-1883	6	10	chosen	choose	VERB
admet-1883	6	11	after	after	ADP
admet-1883	6	12	the	the	DET
admet-1883	6	13	abstract	abstract	ADJ
admet-1883	6	14	screening	screening	NOUN
admet-1883	6	15	.	.	PUNCT
admet-1883	7	1	during	during	ADP
admet-1883	7	2	the	the	DET
admet-1883	7	3	full	full	ADJ
admet-1883	7	4	-	-	PUNCT
admet-1883	7	5	text	text	NOUN
admet-1883	7	6	screening	screening	NOUN
admet-1883	7	7	,	,	PUNCT
admet-1883	7	8	80	80	NUM
admet-1883	7	9	papers	paper	NOUN
admet-1883	7	10	were	be	AUX
admet-1883	7	11	excluded	exclude	VERB
admet-1883	7	12	,	,	PUNCT
admet-1883	7	13	and	and	CCONJ
admet-1883	7	14	18	18	NUM
admet-1883	7	15	were	be	AUX
admet-1883	7	16	eliminated	eliminate	VERB
admet-1883	7	17	during	during	ADP
admet-1883	7	18	data	data	NOUN
admet-1883	7	19	extraction	extraction	NOUN
admet-1883	7	20	.	.	PUNCT
admet-1883	8	1	preference	preference	NOUN
admet-1883	8	2	was	be	AUX
admet-1883	8	3	given	give	VERB
admet-1883	8	4	to	to	ADP
admet-1883	8	5	articles	article	NOUN
admet-1883	8	6	published	publish	VERB
admet-1883	8	7	from	from	ADP
admet-1883	8	8	2018	2018	NUM
admet-1883	8	9	onwards	onward	NOUN
admet-1883	8	10	,	,	PUNCT
admet-1883	8	11	but	but	CCONJ
admet-1883	8	12	a	a	DET
admet-1883	8	13	few	few	ADJ
admet-1883	8	14	older	old	ADJ
admet-1883	8	15	references	reference	NOUN
admet-1883	8	16	were	be	AUX
admet-1883	8	17	cited	cite	VERB
admet-1883	8	18	for	for	ADP
admet-1883	8	19	their	their	PRON
admet-1883	8	20	valuable	valuable	ADJ
admet-1883	8	21	information	information	NOUN
admet-1883	8	22	.	.	PUNCT
admet-1883	9	1	key	key	ADJ
admet-1883	9	2	results	result	NOUN
admet-1883	9	3	:	:	PUNCT
admet-1883	9	4	synthetic	synthetic	ADJ
admet-1883	9	5	nanoparticles	nanoparticle	NOUN
admet-1883	9	6	(	(	PUNCT
admet-1883	9	7	nps	nps	PROPN
admet-1883	9	8	)	)	PUNCT
admet-1883	9	9	have	have	VERB
admet-1883	9	10	a	a	DET
admet-1883	9	11	close	close	ADJ
admet-1883	9	12	structural	structural	ADJ
admet-1883	9	13	resemblance	resemblance	NOUN
admet-1883	9	14	to	to	ADP
admet-1883	9	15	viruses	virus	NOUN
admet-1883	9	16	and	and	CCONJ
admet-1883	9	17	interact	interact	VERB
admet-1883	9	18	greatly	greatly	ADV
admet-1883	9	19	with	with	ADP
admet-1883	9	20	their	their	PRON
admet-1883	9	21	proteins	protein	NOUN
admet-1883	9	22	due	due	ADP
admet-1883	9	23	to	to	ADP
admet-1883	9	24	their	their	PRON
admet-1883	9	25	similarities	similarity	NOUN
admet-1883	9	26	in	in	ADP
admet-1883	9	27	the	the	DET
admet-1883	9	28	configurations	configuration	NOUN
admet-1883	9	29	.	.	PUNCT
admet-1883	10	1	nps	nps	PROPN
admet-1883	10	2	had	have	AUX
admet-1883	10	3	previously	previously	ADV
admet-1883	10	4	been	be	AUX
admet-1883	10	5	reported	report	VERB
admet-1883	10	6	to	to	PART
admet-1883	10	7	be	be	AUX
admet-1883	10	8	effective	effective	ADJ
admet-1883	10	9	against	against	ADP
admet-1883	10	10	a	a	DET
admet-1883	10	11	variety	variety	NOUN
admet-1883	10	12	of	of	ADP
admet-1883	10	13	viruses	virus	NOUN
admet-1883	10	14	.	.	PUNCT
admet-1883	11	1	in	in	ADP
admet-1883	11	2	this	this	DET
admet-1883	11	3	way	way	NOUN
admet-1883	11	4	,	,	PUNCT
admet-1883	11	5	with	with	ADP
admet-1883	11	6	nanoparticles	nanoparticle	NOUN
admet-1883	11	7	,	,	PUNCT
admet-1883	11	8	photodynamic	photodynamic	ADJ
admet-1883	11	9	therapy	therapy	NOUN
admet-1883	11	10	(	(	PUNCT
admet-1883	11	11	pdt	pdt	PROPN
admet-1883	11	12	)	)	PUNCT
admet-1883	11	13	can	can	AUX
admet-1883	11	14	be	be	AUX
admet-1883	11	15	a	a	DET
admet-1883	11	16	viable	viable	ADJ
admet-1883	11	17	alternative	alternative	NOUN
admet-1883	11	18	to	to	ADP
admet-1883	11	19	antibiotics	antibiotic	NOUN
admet-1883	11	20	in	in	ADP
admet-1883	11	21	fighting	fight	VERB
admet-1883	11	22	against	against	ADP
admet-1883	11	23	microbial	microbial	ADJ
admet-1883	11	24	infections	infection	NOUN
admet-1883	11	25	.	.	PUNCT
admet-1883	12	1	the	the	DET
admet-1883	12	2	protocol	protocol	NOUN
admet-1883	12	3	of	of	ADP
admet-1883	12	4	pdt	pdt	PROPN
admet-1883	12	5	includes	include	VERB
admet-1883	12	6	the	the	DET
admet-1883	12	7	activation	activation	NOUN
admet-1883	12	8	of	of	ADP
admet-1883	12	9	photosensitizers	photosensitizer	NOUN
admet-1883	12	10	using	use	VERB
admet-1883	12	11	specific	specific	ADJ
admet-1883	12	12	light	light	NOUN
admet-1883	12	13	to	to	PART
admet-1883	12	14	destroy	destroy	VERB
admet-1883	12	15	microorganisms	microorganism	NOUN
admet-1883	12	16	in	in	ADP
admet-1883	12	17	the	the	DET
admet-1883	12	18	presence	presence	NOUN
admet-1883	12	19	of	of	ADP
admet-1883	12	20	oxygen	oxygen	NOUN
admet-1883	12	21	,	,	PUNCT
admet-1883	12	22	treating	treat	VERB
admet-1883	12	23	several	several	ADJ
admet-1883	12	24	respiratory	respiratory	ADJ
admet-1883	12	25	diseases	disease	NOUN
admet-1883	12	26	.	.	PUNCT
admet-1883	13	1	conclusion	conclusion	NOUN
admet-1883	13	2	:	:	PUNCT
admet-1883	13	3	the	the	DET
admet-1883	13	4	use	use	NOUN
admet-1883	13	5	of	of	ADP
admet-1883	13	6	pdt	pdt	NOUN
admet-1883	13	7	in	in	ADP
admet-1883	13	8	treating	treat	VERB
admet-1883	13	9	covid-19	covid-19	PROPN
admet-1883	13	10	requires	require	VERB
admet-1883	13	11	intensive	intensive	ADJ
admet-1883	13	12	investigations	investigation	NOUN
admet-1883	13	13	,	,	PUNCT
admet-1883	13	14	which	which	PRON
admet-1883	13	15	has	have	AUX
admet-1883	13	16	been	be	AUX
admet-1883	13	17	reviewed	review	VERB
admet-1883	13	18	in	in	ADP
admet-1883	13	19	this	this	DET
admet-1883	13	20	manuscript	manuscript	NOUN
admet-1883	13	21	,	,	PUNCT
admet-1883	13	22	including	include	VERB
admet-1883	13	23	a	a	DET
admet-1883	13	24	computational	computational	ADJ
admet-1883	13	25	approach	approach	NOUN
admet-1883	13	26	to	to	ADP
admet-1883	13	27	formulating	formulate	VERB
admet-1883	13	28	effective	effective	ADJ
admet-1883	13	29	photosensitizers	photosensitizer	NOUN
admet-1883	13	30	.	.	PUNCT
admet-1883	14	1	©	©	ADP
admet-1883	14	2	2023	2023	NUM
admet-1883	14	3	by	by	ADP
admet-1883	14	4	the	the	DET
admet-1883	14	5	authors	author	NOUN
admet-1883	14	6	.	.	PUNCT
admet-1883	15	1	this	this	DET
admet-1883	15	2	article	article	NOUN
admet-1883	15	3	is	be	AUX
admet-1883	15	4	an	an	DET
admet-1883	15	5	open	open	ADJ
admet-1883	15	6	-	-	PUNCT
admet-1883	15	7	access	access	NOUN
admet-1883	15	8	article	article	NOUN
admet-1883	15	9	distributed	distribute	VERB
admet-1883	15	10	under	under	ADP
admet-1883	15	11	the	the	DET
admet-1883	15	12	terms	term	NOUN
admet-1883	15	13	and	and	CCONJ
admet-1883	15	14	conditions	condition	NOUN
admet-1883	15	15	of	of	ADP
admet-1883	15	16	the	the	DET
admet-1883	15	17	creative	creative	ADJ
admet-1883	15	18	commons	common	NOUN
admet-1883	15	19	attribution	attribution	NOUN
admet-1883	15	20	license	license	NOUN
admet-1883	15	21	(	(	PUNCT
admet-1883	15	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-1883	15	23	)	)	PUNCT
admet-1883	15	24	.	.	PUNCT
admet-1883	16	1	keywords	keyword	VERB
admet-1883	16	2	pdt	pdt	PROPN
admet-1883	16	3	;	;	PUNCT
admet-1883	16	4	covid-19	covid-19	PROPN
admet-1883	16	5	;	;	PUNCT
admet-1883	16	6	photosensitizers	photosensitizer	NOUN
admet-1883	16	7	;	;	PUNCT
admet-1883	16	8	vaccines	vaccine	NOUN
admet-1883	16	9	;	;	PUNCT
admet-1883	16	10	drug	drug	NOUN
admet-1883	16	11	delivery	delivery	NOUN
admet-1883	16	12	introduction	introduction	NOUN
admet-1883	16	13	sars	sar	NOUN
admet-1883	16	14	is	be	AUX
admet-1883	16	15	an	an	DET
admet-1883	16	16	airborne	airborne	ADJ
admet-1883	16	17	viral	viral	ADJ
admet-1883	16	18	infection	infection	NOUN
admet-1883	16	19	that	that	PRON
admet-1883	16	20	spreads	spread	VERB
admet-1883	16	21	through	through	ADP
admet-1883	16	22	mild	mild	ADJ
admet-1883	16	23	droplets	droplet	NOUN
admet-1883	16	24	of	of	ADP
admet-1883	16	25	saliva	saliva	NOUN
admet-1883	16	26	,	,	PUNCT
admet-1883	16	27	much	much	ADJ
admet-1883	16	28	like	like	ADP
admet-1883	16	29	the	the	DET
admet-1883	16	30	influenza	influenza	NOUN
admet-1883	16	31	virus	virus	NOUN
admet-1883	16	32	and	and	CCONJ
admet-1883	16	33	the	the	DET
admet-1883	16	34	common	common	ADJ
admet-1883	16	35	cold	cold	ADJ
admet-1883	17	1	[	[	X
admet-1883	17	2	1,2	1,2	NUM
admet-1883	17	3	]	]	PUNCT
admet-1883	17	4	.	.	PUNCT
admet-1883	18	1	the	the	DET
admet-1883	18	2	outbreak	outbreak	NOUN
admet-1883	18	3	of	of	ADP
admet-1883	18	4	covid-19	covid-19	PROPN
admet-1883	18	5	(	(	PUNCT
admet-1883	18	6	coronavirus	coronavirus	NOUN
admet-1883	18	7	disease-2019	disease-2019	ADJ
admet-1883	18	8	)	)	PUNCT
admet-1883	18	9	has	have	AUX
admet-1883	18	10	transformed	transform	VERB
admet-1883	18	11	into	into	ADP
admet-1883	18	12	a	a	DET
admet-1883	18	13	global	global	ADJ
admet-1883	18	14	https://doi.org/10.5599/admet.1883	https://doi.org/10.5599/admet.1883	ADJ
admet-1883	18	15	https://doi.org/10.5599/admet.1883	https://doi.org/10.5599/admet.1883	ADJ
admet-1883	18	16	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-1883	18	17	mailto:agnishwarg@gmail.com	mailto:agnishwarg@gmail.com	X
admet-1883	19	1	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-1883	19	2	p.	p.	PROPN
admet-1883	19	3	pallavi	pallavi	VERB
admet-1883	19	4	et	et	PROPN
admet-1883	19	5	al	al	PROPN
admet-1883	19	6	.	.	PROPN
admet-1883	19	7	admet	admet	PROPN
admet-1883	19	8	&	&	CCONJ
admet-1883	19	9	dmpk	dmpk	PROPN
admet-1883	19	10	11(4	11(4	NUM
admet-1883	19	11	)	)	PUNCT
admet-1883	19	12	(	(	PUNCT
admet-1883	19	13	2023	2023	NUM
admet-1883	19	14	)	)	PUNCT
admet-1883	19	15	513	513	NUM
admet-1883	19	16	-	-	SYM
admet-1883	19	17	531	531	NUM
admet-1883	19	18	514	514	NUM
admet-1883	20	1	pandemic	pandemic	ADJ
admet-1883	20	2	[	[	X
admet-1883	20	3	3	3	NUM
admet-1883	20	4	]	]	PUNCT
admet-1883	20	5	.	.	PUNCT
admet-1883	21	1	the	the	DET
admet-1883	21	2	name	name	NOUN
admet-1883	21	3	of	of	ADP
admet-1883	21	4	the	the	DET
admet-1883	21	5	virus	virus	NOUN
admet-1883	21	6	causing	cause	VERB
admet-1883	21	7	covid-19	covid-19	PROPN
admet-1883	21	8	is	be	AUX
admet-1883	21	9	given	give	VERB
admet-1883	21	10	by	by	ADP
admet-1883	21	11	the	the	DET
admet-1883	21	12	international	international	ADJ
admet-1883	21	13	committee	committee	NOUN
admet-1883	21	14	on	on	ADP
admet-1883	21	15	taxonomy	taxonomy	NOUN
admet-1883	21	16	of	of	ADP
admet-1883	21	17	viruses	virus	NOUN
admet-1883	21	18	(	(	PUNCT
admet-1883	21	19	ictv	ictv	NOUN
admet-1883	21	20	)	)	PUNCT
admet-1883	22	1	[	[	X
admet-1883	22	2	4,5	4,5	NUM
admet-1883	22	3	]	]	PUNCT
admet-1883	22	4	.	.	PUNCT
admet-1883	23	1	this	this	PRON
admet-1883	23	2	became	become	VERB
admet-1883	23	3	the	the	DET
admet-1883	23	4	first	first	ADJ
admet-1883	23	5	novel	novel	ADJ
admet-1883	23	6	virus	virus	NOUN
admet-1883	23	7	to	to	PART
admet-1883	23	8	emerge	emerge	VERB
admet-1883	23	9	in	in	ADP
admet-1883	23	10	the	the	DET
admet-1883	23	11	twenty	twenty	NUM
admet-1883	23	12	-	-	PUNCT
admet-1883	23	13	first	first	ADJ
admet-1883	23	14	century	century	NOUN
admet-1883	23	15	as	as	ADP
admet-1883	23	16	both	both	CCONJ
admet-1883	23	17	a	a	DET
admet-1883	23	18	severe	severe	ADJ
admet-1883	23	19	and	and	CCONJ
admet-1883	23	20	easily	easily	ADV
admet-1883	23	21	transmissible	transmissible	ADJ
admet-1883	23	22	infection	infection	NOUN
admet-1883	23	23	.	.	PUNCT
admet-1883	24	1	the	the	DET
admet-1883	24	2	sars	sar	NOUN
admet-1883	24	3	-	-	PUNCT
admet-1883	24	4	cov-2	cov-2	PART
admet-1883	24	5	(	(	PUNCT
admet-1883	24	6	severe	severe	ADJ
admet-1883	24	7	acute	acute	ADJ
admet-1883	24	8	respiratory	respiratory	ADJ
admet-1883	24	9	syndrome	syndrome	NOUN
admet-1883	24	10	coronavirus	coronavirus	NOUN
admet-1883	24	11	2	2	NUM
admet-1883	24	12	)	)	PUNCT
admet-1883	24	13	virus	virus	NOUN
admet-1883	24	14	is	be	AUX
admet-1883	24	15	a	a	DET
admet-1883	24	16	single	single	ADJ
admet-1883	24	17	-	-	PUNCT
admet-1883	24	18	stranded	strand	VERB
admet-1883	24	19	rna	rna	NOUN
admet-1883	24	20	virus	virus	NOUN
admet-1883	24	21	that	that	PRON
admet-1883	24	22	contains	contain	VERB
admet-1883	24	23	29,903	29,903	NUM
admet-1883	24	24	nucleotides	nucleotide	NOUN
admet-1883	24	25	with	with	ADP
admet-1883	24	26	a	a	DET
admet-1883	24	27	positive	positive	ADJ
admet-1883	24	28	sense	sense	NOUN
admet-1883	24	29	[	[	X
admet-1883	24	30	6,7	6,7	NUM
admet-1883	24	31	]	]	PUNCT
admet-1883	24	32	.	.	PUNCT
admet-1883	25	1	the	the	DET
admet-1883	25	2	transmission	transmission	NOUN
admet-1883	25	3	of	of	ADP
admet-1883	25	4	these	these	DET
admet-1883	25	5	viruses	virus	NOUN
admet-1883	25	6	was	be	AUX
admet-1883	25	7	within	within	ADP
admet-1883	25	8	animals	animal	NOUN
admet-1883	25	9	until	until	ADP
admet-1883	25	10	the	the	DET
admet-1883	25	11	end	end	NOUN
admet-1883	25	12	of	of	ADP
admet-1883	25	13	2019	2019	NUM
admet-1883	25	14	.	.	PUNCT
admet-1883	26	1	as	as	SCONJ
admet-1883	26	2	the	the	DET
admet-1883	26	3	seafood	seafood	NOUN
admet-1883	26	4	market	market	NOUN
admet-1883	26	5	in	in	ADP
admet-1883	26	6	wuhan	wuhan	PROPN
admet-1883	26	7	(	(	PUNCT
admet-1883	26	8	china	china	PROPN
admet-1883	26	9	)	)	PUNCT
admet-1883	26	10	,	,	PUNCT
admet-1883	26	11	known	know	VERB
admet-1883	26	12	for	for	ADP
admet-1883	26	13	selling	sell	VERB
admet-1883	26	14	live	live	ADJ
admet-1883	26	15	animals	animal	NOUN
admet-1883	26	16	like	like	ADP
admet-1883	26	17	frogs	frog	NOUN
admet-1883	26	18	,	,	PUNCT
admet-1883	26	19	bats	bat	NOUN
admet-1883	26	20	,	,	PUNCT
admet-1883	26	21	birds	bird	NOUN
admet-1883	26	22	,	,	PUNCT
admet-1883	26	23	and	and	CCONJ
admet-1883	26	24	snakes	snake	NOUN
admet-1883	26	25	,	,	PUNCT
admet-1883	26	26	has	have	AUX
admet-1883	26	27	sold	sell	VERB
admet-1883	26	28	a	a	DET
admet-1883	26	29	virally	virally	ADV
admet-1883	26	30	infected	infect	VERB
admet-1883	26	31	organism	organism	NOUN
admet-1883	26	32	,	,	PUNCT
admet-1883	26	33	the	the	DET
admet-1883	26	34	infection	infection	NOUN
admet-1883	26	35	of	of	ADP
admet-1883	26	36	covid19	covid19	NOUN
admet-1883	26	37	was	be	AUX
admet-1883	26	38	transmitted	transmit	VERB
admet-1883	26	39	to	to	ADP
admet-1883	26	40	humans	human	NOUN
admet-1883	26	41	[	[	X
admet-1883	26	42	8	8	NUM
admet-1883	26	43	]	]	PUNCT
admet-1883	26	44	.	.	PUNCT
admet-1883	27	1	several	several	ADJ
admet-1883	27	2	terrible	terrible	ADJ
admet-1883	27	3	disasters	disaster	NOUN
admet-1883	27	4	occurred	occur	VERB
admet-1883	27	5	throughout	throughout	ADP
admet-1883	27	6	this	this	DET
admet-1883	27	7	phase	phase	NOUN
admet-1883	27	8	.	.	PUNCT
admet-1883	28	1	china	china	PROPN
admet-1883	28	2	's	's	PART
admet-1883	28	3	national	national	PROPN
admet-1883	28	4	health	health	PROPN
admet-1883	28	5	commission	commission	PROPN
admet-1883	28	6	has	have	AUX
admet-1883	28	7	provided	provide	VERB
admet-1883	28	8	information	information	NOUN
admet-1883	28	9	about	about	ADP
admet-1883	28	10	the	the	DET
admet-1883	28	11	pandemic	pandemic	NOUN
admet-1883	28	12	,	,	PUNCT
admet-1883	28	13	which	which	PRON
admet-1883	28	14	has	have	AUX
admet-1883	28	15	been	be	AUX
admet-1883	28	16	linked	link	VERB
admet-1883	28	17	to	to	ADP
admet-1883	28	18	viral	viral	ADJ
admet-1883	28	19	pneumonia	pneumonia	NOUN
admet-1883	28	20	.	.	PUNCT
admet-1883	29	1	eventually	eventually	ADV
admet-1883	29	2	,	,	PUNCT
admet-1883	29	3	a	a	DET
admet-1883	29	4	new	new	ADJ
admet-1883	29	5	coronavirus	coronavirus	NOUN
admet-1883	29	6	(	(	PUNCT
admet-1883	29	7	sars	sar	NOUN
admet-1883	29	8	-	-	PUNCT
admet-1883	29	9	cov2	cov2	PROPN
admet-1883	29	10	)	)	PUNCT
admet-1883	29	11	was	be	AUX
admet-1883	29	12	discovered	discover	VERB
admet-1883	29	13	following	follow	VERB
admet-1883	29	14	on	on	ADP
admet-1883	29	15	study	study	NOUN
admet-1883	29	16	based	base	VERB
admet-1883	29	17	on	on	ADP
admet-1883	29	18	affected	affect	VERB
admet-1883	29	19	individuals	individual	NOUN
admet-1883	29	20	and	and	CCONJ
admet-1883	29	21	genetic	genetic	ADJ
admet-1883	29	22	sequence	sequence	NOUN
admet-1883	29	23	research	research	NOUN
admet-1883	29	24	.	.	PUNCT
admet-1883	30	1	furthermore	furthermore	ADV
admet-1883	30	2	,	,	PUNCT
admet-1883	30	3	with	with	ADP
admet-1883	30	4	the	the	DET
admet-1883	30	5	discovery	discovery	NOUN
admet-1883	30	6	of	of	ADP
admet-1883	30	7	genetic	genetic	ADJ
admet-1883	30	8	similarities	similarity	NOUN
admet-1883	30	9	between	between	ADP
admet-1883	30	10	a	a	DET
admet-1883	30	11	new	new	ADJ
admet-1883	30	12	coronavirus	coronavirus	NOUN
admet-1883	30	13	and	and	CCONJ
admet-1883	30	14	sars	sar	NOUN
admet-1883	30	15	-	-	PUNCT
admet-1883	30	16	like	like	ADJ
admet-1883	30	17	bat	bat	NOUN
admet-1883	30	18	viruses	virus	NOUN
admet-1883	30	19	,	,	PUNCT
admet-1883	30	20	researchers	researcher	NOUN
admet-1883	30	21	hypothesized	hypothesize	VERB
admet-1883	30	22	that	that	SCONJ
admet-1883	30	23	bats	bat	NOUN
admet-1883	30	24	might	might	AUX
admet-1883	30	25	be	be	AUX
admet-1883	30	26	the	the	DET
admet-1883	30	27	sole	sole	ADJ
admet-1883	30	28	reservoirs	reservoir	NOUN
admet-1883	31	1	[	[	X
admet-1883	31	2	9	9	NUM
admet-1883	31	3	-	-	SYM
admet-1883	31	4	11	11	NUM
admet-1883	31	5	]	]	PUNCT
admet-1883	31	6	.	.	PUNCT
admet-1883	32	1	in	in	ADP
admet-1883	32	2	order	order	NOUN
admet-1883	32	3	to	to	PART
admet-1883	32	4	design	design	VERB
admet-1883	32	5	preventive	preventive	ADJ
admet-1883	32	6	tactics	tactic	NOUN
admet-1883	32	7	to	to	PART
admet-1883	32	8	fight	fight	VERB
admet-1883	32	9	an	an	DET
admet-1883	32	10	infection	infection	NOUN
admet-1883	32	11	,	,	PUNCT
admet-1883	32	12	the	the	DET
admet-1883	32	13	origin	origin	NOUN
admet-1883	32	14	and	and	CCONJ
admet-1883	32	15	transmission	transmission	NOUN
admet-1883	32	16	channels	channel	NOUN
admet-1883	32	17	must	must	AUX
admet-1883	32	18	b	b	PROPN
admet-1883	32	19	e	e	NOUN
admet-1883	32	20	recognized	recognize	VERB
admet-1883	32	21	.	.	PUNCT
admet-1883	33	1	the	the	DET
admet-1883	33	2	majorities	majority	NOUN
admet-1883	33	3	of	of	ADP
admet-1883	33	4	infected	infected	ADJ
admet-1883	33	5	people	people	NOUN
admet-1883	33	6	who	who	PRON
admet-1883	33	7	are	be	AUX
admet-1883	33	8	identified	identify	VERB
admet-1883	33	9	with	with	ADP
admet-1883	33	10	covid-19	covid-19	PROPN
admet-1883	33	11	begin	begin	VERB
admet-1883	33	12	the	the	DET
admet-1883	33	13	viral	viral	ADJ
admet-1883	33	14	process	process	NOUN
admet-1883	33	15	three	three	NUM
admet-1883	33	16	days	day	NOUN
admet-1883	33	17	before	before	ADP
admet-1883	33	18	the	the	DET
admet-1883	33	19	beginning	beginning	NOUN
admet-1883	33	20	of	of	ADP
admet-1883	33	21	the	the	DET
admet-1883	33	22	symptoms	symptom	NOUN
admet-1883	33	23	and	and	CCONJ
admet-1883	33	24	can	can	AUX
admet-1883	33	25	last	last	VERB
admet-1883	33	26	up	up	ADP
admet-1883	33	27	to	to	ADP
admet-1883	33	28	a	a	DET
admet-1883	33	29	week	week	NOUN
admet-1883	33	30	after	after	ADP
admet-1883	33	31	the	the	DET
admet-1883	33	32	onset	onset	NOUN
admet-1883	33	33	of	of	ADP
admet-1883	33	34	symptoms	symptom	NOUN
admet-1883	33	35	.	.	PUNCT
admet-1883	34	1	incubation	incubation	NOUN
admet-1883	34	2	time	time	NOUN
admet-1883	34	3	varies	vary	VERB
admet-1883	34	4	from	from	ADP
admet-1883	34	5	2	2	NUM
admet-1883	34	6	-	-	SYM
admet-1883	34	7	14	14	NUM
admet-1883	34	8	days	day	NOUN
admet-1883	34	9	in	in	ADP
admet-1883	34	10	individuals	individual	NOUN
admet-1883	34	11	who	who	PRON
admet-1883	34	12	become	become	VERB
admet-1883	34	13	symptomatic	symptomatic	ADJ
admet-1883	34	14	[	[	X
admet-1883	34	15	12	12	NUM
admet-1883	34	16	]	]	PUNCT
admet-1883	34	17	.	.	PUNCT
admet-1883	35	1	the	the	DET
admet-1883	35	2	overall	overall	ADJ
admet-1883	35	3	symptoms	symptom	NOUN
admet-1883	35	4	,	,	PUNCT
admet-1883	35	5	means	mean	NOUN
admet-1883	35	6	of	of	ADP
admet-1883	35	7	communication	communication	NOUN
admet-1883	35	8	,	,	PUNCT
admet-1883	35	9	diagnosis	diagnosis	NOUN
admet-1883	35	10	,	,	PUNCT
admet-1883	35	11	and	and	CCONJ
admet-1883	35	12	therapy	therapy	NOUN
admet-1883	35	13	,	,	PUNCT
admet-1883	35	14	including	include	VERB
admet-1883	35	15	prevention	prevention	NOUN
admet-1883	35	16	,	,	PUNCT
admet-1883	35	17	are	be	AUX
admet-1883	35	18	represented	represent	VERB
admet-1883	35	19	in	in	ADP
admet-1883	35	20	figure	figure	NOUN
admet-1883	35	21	1	1	NUM
admet-1883	35	22	.	.	PUNCT
admet-1883	36	1	figure	figure	NOUN
admet-1883	36	2	1	1	NUM
admet-1883	36	3	.	.	PUNCT
admet-1883	36	4	overview	overview	NOUN
admet-1883	36	5	of	of	ADP
admet-1883	36	6	the	the	DET
admet-1883	36	7	infection	infection	NOUN
admet-1883	36	8	and	and	CCONJ
admet-1883	36	9	theranostic	theranostic	ADJ
admet-1883	36	10	approach	approach	NOUN
admet-1883	36	11	against	against	ADP
admet-1883	36	12	covid-19	covid-19	PROPN
admet-1883	36	13	.	.	PUNCT
admet-1883	36	14	fever	fever	NOUN
admet-1883	36	15	or	or	CCONJ
admet-1883	36	16	chills	chill	NOUN
admet-1883	36	17	,	,	PUNCT
admet-1883	36	18	cough	cough	NOUN
admet-1883	36	19	,	,	PUNCT
admet-1883	36	20	sore	sore	ADJ
admet-1883	36	21	throat	throat	NOUN
admet-1883	36	22	,	,	PUNCT
admet-1883	36	23	nausea	nausea	NOUN
admet-1883	36	24	,	,	PUNCT
admet-1883	36	25	rhinorrhea	rhinorrhea	PROPN
admet-1883	36	26	,	,	PUNCT
admet-1883	36	27	diarrhea	diarrhea	PROPN
admet-1883	36	28	,	,	PUNCT
admet-1883	36	29	weariness	weariness	NOUN
admet-1883	36	30	,	,	PUNCT
admet-1883	36	31	exhaustion	exhaustion	NOUN
admet-1883	36	32	,	,	PUNCT
admet-1883	36	33	headache	headache	NOUN
admet-1883	36	34	,	,	PUNCT
admet-1883	36	35	dyspnea	dyspnea	NOUN
admet-1883	36	36	,	,	PUNCT
admet-1883	36	37	myalgia	myalgia	NOUN
admet-1883	36	38	,	,	PUNCT
admet-1883	36	39	dysgeusia	dysgeusia	PROPN
admet-1883	36	40	,	,	PUNCT
admet-1883	36	41	or	or	CCONJ
admet-1883	36	42	anosmia	anosmia	NOUN
admet-1883	36	43	are	be	AUX
admet-1883	36	44	the	the	DET
admet-1883	36	45	prevalent	prevalent	ADJ
admet-1883	36	46	symptoms	symptom	NOUN
admet-1883	36	47	,	,	PUNCT
admet-1883	36	48	especially	especially	ADV
admet-1883	36	49	if	if	SCONJ
admet-1883	36	50	the	the	DET
admet-1883	36	51	patients	patient	NOUN
admet-1883	36	52	have	have	AUX
admet-1883	36	53	been	be	AUX
admet-1883	36	54	exposed	expose	VERB
admet-1883	36	55	recently	recently	ADV
admet-1883	36	56	[	[	X
admet-1883	36	57	13,14	13,14	NUM
admet-1883	36	58	]	]	PUNCT
admet-1883	36	59	.	.	PUNCT
admet-1883	37	1	in	in	ADP
admet-1883	37	2	the	the	DET
admet-1883	37	3	majority	majority	NOUN
admet-1883	37	4	of	of	ADP
admet-1883	37	5	patients	patient	NOUN
admet-1883	37	6	,	,	PUNCT
admet-1883	37	7	the	the	DET
admet-1883	37	8	sickness	sickness	NOUN
admet-1883	37	9	is	be	AUX
admet-1883	37	10	self	self	NOUN
admet-1883	37	11	-	-	PUNCT
admet-1883	37	12	limiting	limit	VERB
admet-1883	37	13	,	,	PUNCT
admet-1883	37	14	but	but	CCONJ
admet-1883	37	15	in	in	ADP
admet-1883	37	16	some	some	DET
admet-1883	37	17	cases	case	NOUN
admet-1883	37	18	,	,	PUNCT
admet-1883	37	19	patients	patient	NOUN
admet-1883	37	20	require	require	VERB
admet-1883	37	21	hospitalization	hospitalization	NOUN
admet-1883	37	22	due	due	ADP
admet-1883	37	23	to	to	ADP
admet-1883	37	24	hypoxia	hypoxia	NOUN
admet-1883	37	25	,	,	PUNCT
admet-1883	37	26	which	which	PRON
admet-1883	37	27	is	be	AUX
admet-1883	37	28	more	more	ADV
admet-1883	37	29	common	common	ADJ
admet-1883	37	30	among	among	ADP
admet-1883	37	31	those	those	PRON
admet-1883	37	32	with	with	ADP
admet-1883	37	33	concurrent	concurrent	ADJ
admet-1883	37	34	conditions	condition	NOUN
admet-1883	37	35	.	.	PUNCT
admet-1883	38	1	acute	acute	ADJ
admet-1883	38	2	respiratory	respiratory	ADJ
admet-1883	38	3	distress	distress	NOUN
admet-1883	38	4	syndrome	syndrome	NOUN
admet-1883	38	5	affects	affect	VERB
admet-1883	38	6	around	around	ADV
admet-1883	38	7	5	5	NUM
admet-1883	38	8	%	%	NOUN
admet-1883	38	9	of	of	ADP
admet-1883	38	10	the	the	DET
admet-1883	38	11	population	population	NOUN
admet-1883	38	12	,	,	PUNCT
admet-1883	38	13	and	and	CCONJ
admet-1883	38	14	the	the	DET
admet-1883	38	15	infected	infect	VERB
admet-1883	38	16	symptomatic	symptomatic	ADJ
admet-1883	38	17	patient	patient	NOUN
admet-1883	38	18	requires	require	VERB
admet-1883	38	19	oxygen	oxygen	NOUN
admet-1883	38	20	supplement	supplement	NOUN
admet-1883	38	21	intubation	intubation	NOUN
admet-1883	38	22	and	and	CCONJ
admet-1883	38	23	other	other	ADJ
admet-1883	38	24	invasive	invasive	ADJ
admet-1883	38	25	treatment	treatment	NOUN
admet-1883	38	26	.	.	PUNCT
admet-1883	39	1	currently	currently	ADV
admet-1883	39	2	,	,	PUNCT
admet-1883	39	3	there	there	PRON
admet-1883	39	4	are	be	VERB
admet-1883	39	5	many	many	ADJ
admet-1883	39	6	studies	study	NOUN
admet-1883	39	7	aiming	aim	VERB
admet-1883	39	8	at	at	ADP
admet-1883	39	9	the	the	DET
admet-1883	39	10	development	development	NOUN
admet-1883	39	11	of	of	ADP
admet-1883	39	12	vaccines	vaccine	NOUN
admet-1883	39	13	and	and	CCONJ
admet-1883	39	14	antiviral	antiviral	ADJ
admet-1883	39	15	medicines	medicine	NOUN
admet-1883	39	16	for	for	ADP
admet-1883	39	17	covid-19	covid-19	PROPN
admet-1883	39	18	.	.	PUNCT
admet-1883	40	1	there	there	PRON
admet-1883	40	2	are	be	VERB
admet-1883	40	3	some	some	DET
admet-1883	40	4	antiviral	antiviral	ADJ
admet-1883	40	5	drugs	drug	NOUN
admet-1883	40	6	being	be	AUX
admet-1883	40	7	prescribed	prescribe	VERB
admet-1883	40	8	for	for	ADP
admet-1883	40	9	treating	treat	VERB
admet-1883	40	10	the	the	DET
admet-1883	40	11	covid-19	covid-19	PROPN
admet-1883	40	12	infection	infection	NOUN
admet-1883	40	13	,	,	PUNCT
admet-1883	40	14	including	include	VERB
admet-1883	40	15	remdesivir	remdesivir	NOUN
admet-1883	40	16	,	,	PUNCT
admet-1883	40	17	steroids	steroid	NOUN
admet-1883	40	18	,	,	PUNCT
admet-1883	40	19	tocilizumab	tocilizumab	NOUN
admet-1883	40	20	,	,	PUNCT
admet-1883	40	21	favipiravir	favipiravir	PROPN
admet-1883	40	22	,	,	PUNCT
admet-1883	40	23	ivermectin	ivermectin	PROPN
admet-1883	40	24	,	,	PUNCT
admet-1883	40	25	lopinavir	lopinavir	NOUN
admet-1883	40	26	/ritonavir	/ritonavir	PUNCT
admet-1883	41	1	[	[	X
admet-1883	41	2	15	15	NUM
admet-1883	41	3	-	-	SYM
admet-1883	41	4	17	17	NUM
admet-1883	41	5	]	]	PUNCT
admet-1883	41	6	.	.	PUNCT
admet-1883	42	1	studies	study	NOUN
admet-1883	42	2	revealed	reveal	VERB
admet-1883	42	3	that	that	SCONJ
admet-1883	42	4	in	in	ADP
admet-1883	42	5	comparison	comparison	NOUN
admet-1883	42	6	to	to	ADP
admet-1883	42	7	other	other	ADJ
admet-1883	42	8	antiviral	antiviral	ADJ
admet-1883	42	9	drugs	drug	NOUN
admet-1883	42	10	,	,	PUNCT
admet-1883	42	11	remdesivir	remdesivir	NOUN
admet-1883	42	12	showed	show	VERB
admet-1883	42	13	a	a	DET
admet-1883	42	14	better	well	ADJ
admet-1883	42	15	therapeutic	therapeutic	ADJ
admet-1883	42	16	effect	effect	NOUN
admet-1883	42	17	.	.	PUNCT
admet-1883	43	1	a	a	DET
admet-1883	43	2	summary	summary	NOUN
admet-1883	43	3	of	of	ADP
admet-1883	43	4	the	the	DET
admet-1883	43	5	current	current	ADJ
admet-1883	43	6	treatment	treatment	NOUN
admet-1883	43	7	options	option	NOUN
admet-1883	43	8	and	and	CCONJ
admet-1883	43	9	clinical	clinical	ADJ
admet-1883	43	10	features	feature	NOUN
admet-1883	43	11	of	of	ADP
admet-1883	43	12	covid-19	covid-19	PROPN
admet-1883	43	13	is	be	AUX
admet-1883	43	14	provided	provide	VERB
admet-1883	43	15	here	here	ADV
admet-1883	43	16	,	,	PUNCT
admet-1883	43	17	along	along	ADP
admet-1883	43	18	with	with	ADP
admet-1883	43	19	the	the	DET
admet-1883	43	20	role	role	NOUN
admet-1883	43	21	and	and	CCONJ
admet-1883	43	22	progress	progress	NOUN
admet-1883	43	23	of	of	ADP
admet-1883	43	24	nanotechnology	nanotechnology	NOUN
admet-1883	43	25	-	-	PUNCT
admet-1883	43	26	based	base	VERB
admet-1883	43	27	photodynamic	photodynamic	ADJ
admet-1883	43	28	therapy	therapy	NOUN
admet-1883	43	29	in	in	ADP
admet-1883	43	30	treating	treat	VERB
admet-1883	43	31	infections	infection	NOUN
admet-1883	43	32	.	.	PUNCT
admet-1883	44	1	admet	admet	PROPN
admet-1883	44	2	&	&	CCONJ
admet-1883	44	3	dmpk	dmpk	PROPN
admet-1883	44	4	11(4	11(4	NUM
admet-1883	44	5	)	)	PUNCT
admet-1883	44	6	(	(	PUNCT
admet-1883	44	7	2023	2023	NUM
admet-1883	44	8	)	)	PUNCT
admet-1883	44	9	513	513	NUM
admet-1883	44	10	-	-	SYM
admet-1883	44	11	531	531	NUM
admet-1883	44	12	infections	infection	NOUN
admet-1883	44	13	associated	associate	VERB
admet-1883	44	14	with	with	ADP
admet-1883	44	15	sars	sar	NOUN
admet-1883	44	16	-	-	PUNCT
admet-1883	44	17	cov-2	cov-2	PART
admet-1883	44	18	exploited	exploit	VERB
admet-1883	44	19	via	via	ADP
admet-1883	44	20	photodynamic	photodynamic	ADJ
admet-1883	44	21	therapy	therapy	NOUN
admet-1883	44	22	doi	doi	NOUN
admet-1883	44	23	:	:	PUNCT
admet-1883	44	24	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-1883	44	25	t.1883	t.1883	VERB
admet-1883	44	26	515	515	NUM
admet-1883	44	27	methods	method	NOUN
admet-1883	44	28	a	a	DET
admet-1883	44	29	comprehensive	comprehensive	ADJ
admet-1883	44	30	search	search	NOUN
admet-1883	44	31	initially	initially	ADV
admet-1883	44	32	yielded	yield	VERB
admet-1883	44	33	a	a	DET
admet-1883	44	34	total	total	ADJ
admet-1883	44	35	number	number	NOUN
admet-1883	44	36	of	of	ADP
admet-1883	44	37	275	275	NUM
admet-1883	44	38	research	research	NOUN
admet-1883	44	39	articles	article	NOUN
admet-1883	44	40	related	relate	VERB
admet-1883	44	41	to	to	ADP
admet-1883	44	42	the	the	DET
admet-1883	44	43	topic	topic	NOUN
admet-1883	44	44	,	,	PUNCT
admet-1883	44	45	while	while	SCONJ
admet-1883	44	46	some	some	DET
admet-1883	44	47	specific	specific	ADJ
admet-1883	44	48	keywords	keyword	NOUN
admet-1883	44	49	like	like	ADP
admet-1883	44	50	'	'	PUNCT
admet-1883	44	51	nano	nano	NOUN
admet-1883	44	52	-	-	PUNCT
admet-1883	44	53	mediated	mediate	VERB
admet-1883	44	54	pdt	pdt	NOUN
admet-1883	44	55	'	'	PUNCT
admet-1883	44	56	,	,	PUNCT
admet-1883	44	57	'	'	PUNCT
admet-1883	44	58	pdt	pdt	NOUN
admet-1883	44	59	for	for	ADP
admet-1883	44	60	sars	sar	NOUN
admet-1883	44	61	-	-	PUNCT
admet-1883	44	62	cov-2	cov-2	NOUN
admet-1883	44	63	'	'	PUNCT
admet-1883	44	64	,	,	PUNCT
admet-1883	44	65	and	and	CCONJ
admet-1883	44	66	'	'	PUNCT
admet-1883	44	67	nanotechnology	nanotechnology	NOUN
admet-1883	44	68	in	in	ADP
admet-1883	44	69	treatment	treatment	NOUN
admet-1883	44	70	for	for	ADP
admet-1883	44	71	sars	sar	NOUN
admet-1883	44	72	-	-	PUNCT
admet-1883	44	73	cov-2	cov-2	NOUN
admet-1883	44	74	'	'	PUNCT
admet-1883	44	75	were	be	AUX
admet-1883	44	76	placed	place	VERB
admet-1883	44	77	in	in	ADP
admet-1883	44	78	the	the	DET
admet-1883	44	79	online	online	ADJ
admet-1883	44	80	database	database	NOUN
admet-1883	44	81	search	search	NOUN
admet-1883	44	82	.	.	PUNCT
admet-1883	45	1	popular	popular	ADJ
admet-1883	45	2	electronic	electronic	ADJ
admet-1883	45	3	databases	database	NOUN
admet-1883	45	4	such	such	ADJ
admet-1883	45	5	as	as	ADP
admet-1883	45	6	scopus	scopus	NOUN
admet-1883	45	7	,	,	PUNCT
admet-1883	45	8	google	google	NOUN
admet-1883	45	9	scholar	scholar	NOUN
admet-1883	45	10	,	,	PUNCT
admet-1883	45	11	medline	medline	NOUN
admet-1883	45	12	,	,	PUNCT
admet-1883	45	13	embase	embase	PROPN
admet-1883	45	14	,	,	PUNCT
admet-1883	45	15	pubmed	pubmed	PROPN
admet-1883	45	16	,	,	PUNCT
admet-1883	45	17	and	and	CCONJ
admet-1883	45	18	web	web	NOUN
admet-1883	45	19	of	of	ADP
admet-1883	45	20	science	science	NOUN
admet-1883	45	21	were	be	AUX
admet-1883	45	22	used	use	VERB
admet-1883	45	23	to	to	PART
admet-1883	45	24	collect	collect	VERB
admet-1883	45	25	the	the	DET
admet-1883	45	26	articles	article	NOUN
admet-1883	45	27	.	.	PUNCT
admet-1883	46	1	instead	instead	ADV
admet-1883	46	2	of	of	ADP
admet-1883	46	3	merely	merely	ADV
admet-1883	46	4	using	use	VERB
admet-1883	46	5	pdt	pdt	NOUN
admet-1883	46	6	as	as	ADP
admet-1883	46	7	a	a	DET
admet-1883	46	8	keyword	keyword	NOUN
admet-1883	46	9	,	,	PUNCT
admet-1883	46	10	pdt	pdt	PROPN
admet-1883	46	11	was	be	AUX
admet-1883	46	12	sometimes	sometimes	ADV
admet-1883	46	13	referred	refer	VERB
admet-1883	46	14	to	to	ADP
admet-1883	46	15	as	as	ADP
admet-1883	46	16	'	'	PUNCT
admet-1883	46	17	photodynamic	photodynamic	ADJ
admet-1883	46	18	therapy	therapy	NOUN
admet-1883	46	19	'	'	PUNCT
admet-1883	46	20	.	.	PUNCT
admet-1883	47	1	after	after	ADP
admet-1883	47	2	conducting	conduct	VERB
admet-1883	47	3	an	an	DET
admet-1883	47	4	abstract	abstract	ADJ
admet-1883	47	5	screening	screening	NOUN
admet-1883	47	6	,	,	PUNCT
admet-1883	47	7	198	198	NUM
admet-1883	47	8	articles	article	NOUN
admet-1883	47	9	were	be	AUX
admet-1883	47	10	selected	select	VERB
admet-1883	47	11	for	for	ADP
admet-1883	47	12	further	further	ADJ
admet-1883	47	13	consideration	consideration	NOUN
admet-1883	47	14	.	.	PUNCT
admet-1883	48	1	during	during	ADP
admet-1883	48	2	the	the	DET
admet-1883	48	3	full	full	ADJ
admet-1883	48	4	-	-	PUNCT
admet-1883	48	5	text	text	NOUN
admet-1883	48	6	screening	screening	NOUN
admet-1883	48	7	,	,	PUNCT
admet-1883	48	8	80	80	NUM
admet-1883	48	9	articles	article	NOUN
admet-1883	48	10	were	be	AUX
admet-1883	48	11	excludeed	exclude	VERB
admet-1883	48	12	leaving	leave	VERB
admet-1883	48	13	a	a	DET
admet-1883	48	14	subset	subset	NOUN
admet-1883	48	15	of	of	ADP
admet-1883	48	16	relevant	relevant	ADJ
admet-1883	48	17	articles	article	NOUN
admet-1883	48	18	.	.	PUNCT
admet-1883	49	1	additionally	additionally	ADV
admet-1883	49	2	,	,	PUNCT
admet-1883	49	3	18	18	NUM
admet-1883	49	4	more	more	ADJ
admet-1883	49	5	papers	paper	NOUN
admet-1883	49	6	were	be	AUX
admet-1883	49	7	deemed	deem	VERB
admet-1883	49	8	unsuitable	unsuitable	ADJ
admet-1883	49	9	for	for	ADP
admet-1883	49	10	inclusion	inclusion	NOUN
admet-1883	49	11	in	in	ADP
admet-1883	49	12	the	the	DET
admet-1883	49	13	manuscript	manuscript	NOUN
admet-1883	49	14	during	during	ADP
admet-1883	49	15	the	the	DET
admet-1883	49	16	data	data	NOUN
admet-1883	49	17	extraction	extraction	NOUN
admet-1883	49	18	process	process	NOUN
admet-1883	49	19	.	.	PUNCT
admet-1883	50	1	while	while	SCONJ
admet-1883	50	2	prioritizing	prioritize	VERB
admet-1883	50	3	articles	article	NOUN
admet-1883	50	4	published	publish	VERB
admet-1883	50	5	from	from	ADP
admet-1883	50	6	2018	2018	NUM
admet-1883	50	7	onwards	onward	NOUN
admet-1883	50	8	,	,	PUNCT
admet-1883	50	9	a	a	DET
admet-1883	50	10	few	few	ADJ
admet-1883	50	11	older	old	ADJ
admet-1883	50	12	references	reference	NOUN
admet-1883	50	13	were	be	AUX
admet-1883	50	14	included	include	VERB
admet-1883	50	15	to	to	PART
admet-1883	50	16	furnish	furnish	VERB
admet-1883	50	17	the	the	DET
admet-1883	50	18	basic	basic	ADJ
admet-1883	50	19	concepts	concept	NOUN
admet-1883	50	20	utilizing	utilize	VERB
admet-1883	50	21	their	their	PRON
admet-1883	50	22	valuable	valuable	ADJ
admet-1883	50	23	and	and	CCONJ
admet-1883	50	24	unchanging	unchanging	ADJ
admet-1883	50	25	particulars	particular	NOUN
admet-1883	50	26	.	.	PUNCT
admet-1883	51	1	vaccines	vaccine	NOUN
admet-1883	51	2	vaccine	vaccine	NOUN
admet-1883	51	3	development	development	NOUN
admet-1883	51	4	is	be	AUX
admet-1883	51	5	a	a	DET
admet-1883	51	6	difficult	difficult	ADJ
admet-1883	51	7	,	,	PUNCT
admet-1883	51	8	time	time	NOUN
admet-1883	51	9	-	-	PUNCT
admet-1883	51	10	consuming	consume	VERB
admet-1883	51	11	,	,	PUNCT
admet-1883	51	12	and	and	CCONJ
admet-1883	51	13	expensive	expensive	ADJ
admet-1883	51	14	procedure	procedure	NOUN
admet-1883	51	15	.	.	PUNCT
admet-1883	52	1	trained	train	VERB
admet-1883	52	2	professionals	professional	NOUN
admet-1883	52	3	are	be	AUX
admet-1883	52	4	required	require	VERB
admet-1883	52	5	with	with	ADP
admet-1883	52	6	multiple	multiple	ADJ
admet-1883	52	7	procedures	procedure	NOUN
admet-1883	52	8	,	,	PUNCT
admet-1883	52	9	pauses	pause	VERB
admet-1883	52	10	for	for	ADP
admet-1883	52	11	inspections	inspection	NOUN
admet-1883	52	12	,	,	PUNCT
admet-1883	52	13	and	and	CCONJ
admet-1883	52	14	data	datum	NOUN
admet-1883	52	15	analysis	analysis	NOUN
admet-1883	52	16	to	to	PART
admet-1883	52	17	develop	develop	VERB
admet-1883	52	18	licensed	licensed	ADJ
admet-1883	52	19	work	work	NOUN
admet-1883	52	20	.	.	PUNCT
admet-1883	53	1	the	the	DET
admet-1883	53	2	development	development	NOUN
admet-1883	53	3	of	of	ADP
admet-1883	53	4	an	an	DET
admet-1883	53	5	ideal	ideal	ADJ
admet-1883	53	6	vaccine	vaccine	NOUN
admet-1883	53	7	needs	need	VERB
admet-1883	53	8	technical	technical	ADJ
admet-1883	53	9	flexibility	flexibility	NOUN
admet-1883	53	10	and	and	CCONJ
admet-1883	53	11	adaptability	adaptability	NOUN
admet-1883	53	12	with	with	ADP
admet-1883	53	13	large	large	ADJ
admet-1883	53	14	-	-	PUNCT
admet-1883	53	15	scale	scale	NOUN
admet-1883	53	16	manufacturing	manufacturing	NOUN
admet-1883	53	17	,	,	PUNCT
admet-1883	53	18	high	high	ADJ
admet-1883	53	19	purity	purity	NOUN
admet-1883	53	20	,	,	PUNCT
admet-1883	53	21	easy	easy	ADJ
admet-1883	53	22	transportation	transportation	NOUN
admet-1883	53	23	,	,	PUNCT
admet-1883	53	24	and	and	CCONJ
admet-1883	53	25	storage	storage	NOUN
admet-1883	53	26	.	.	PUNCT
admet-1883	54	1	the	the	DET
admet-1883	54	2	foremost	foremost	ADJ
admet-1883	54	3	considerations	consideration	NOUN
admet-1883	54	4	while	while	SCONJ
admet-1883	54	5	designing	design	VERB
admet-1883	54	6	a	a	DET
admet-1883	54	7	vaccine	vaccine	NOUN
admet-1883	54	8	are	be	AUX
admet-1883	54	9	the	the	DET
admet-1883	54	10	stability	stability	NOUN
admet-1883	54	11	,	,	PUNCT
admet-1883	54	12	route	route	NOUN
admet-1883	54	13	of	of	ADP
admet-1883	54	14	administration	administration	NOUN
admet-1883	54	15	,	,	PUNCT
admet-1883	54	16	and	and	CCONJ
admet-1883	54	17	adverse	adverse	ADJ
admet-1883	54	18	effects	effect	NOUN
admet-1883	54	19	.	.	PUNCT
admet-1883	55	1	the	the	DET
admet-1883	55	2	present	present	ADJ
admet-1883	55	3	efforts	effort	NOUN
admet-1883	55	4	are	be	AUX
admet-1883	55	5	to	to	PART
admet-1883	55	6	create	create	VERB
admet-1883	55	7	a	a	DET
admet-1883	55	8	vaccination	vaccination	NOUN
admet-1883	55	9	against	against	ADP
admet-1883	55	10	covid-19	covid-19	PROPN
admet-1883	55	11	as	as	ADV
admet-1883	55	12	quickly	quickly	ADV
admet-1883	55	13	as	as	ADP
admet-1883	55	14	possible	possible	ADJ
admet-1883	55	15	.	.	PUNCT
admet-1883	56	1	the	the	DET
admet-1883	56	2	most	most	ADV
admet-1883	56	3	challenging	challenging	ADJ
admet-1883	56	4	aspect	aspect	NOUN
admet-1883	56	5	of	of	ADP
admet-1883	56	6	vaccine	vaccine	NOUN
admet-1883	56	7	designing	design	VERB
admet-1883	56	8	is	be	AUX
admet-1883	56	9	identifying	identify	VERB
admet-1883	56	10	the	the	DET
admet-1883	56	11	causative	causative	ADJ
admet-1883	56	12	agent	agent	NOUN
admet-1883	56	13	,	,	PUNCT
admet-1883	56	14	wherein	wherein	SCONJ
admet-1883	56	15	the	the	DET
admet-1883	56	16	incidence	incidence	NOUN
admet-1883	56	17	of	of	ADP
admet-1883	56	18	covid-19	covid-19	PROPN
admet-1883	56	19	was	be	AUX
admet-1883	56	20	not	not	PART
admet-1883	56	21	found	find	VERB
admet-1883	56	22	quickly	quickly	ADV
admet-1883	56	23	after	after	SCONJ
admet-1883	56	24	the	the	DET
admet-1883	56	25	outbreak	outbreak	NOUN
admet-1883	56	26	began	begin	VERB
admet-1883	56	27	[	[	X
admet-1883	56	28	18	18	NUM
admet-1883	56	29	]	]	PUNCT
admet-1883	56	30	.	.	PUNCT
admet-1883	57	1	based	base	VERB
admet-1883	57	2	on	on	ADP
admet-1883	57	3	the	the	DET
admet-1883	57	4	knowledge	knowledge	NOUN
admet-1883	57	5	gathered	gather	VERB
admet-1883	57	6	from	from	ADP
admet-1883	57	7	past	past	ADJ
admet-1883	57	8	epidemics	epidemic	NOUN
admet-1883	57	9	of	of	ADP
admet-1883	57	10	corona	corona	NOUN
admet-1883	57	11	-	-	PUNCT
admet-1883	57	12	mediated	mediate	VERB
admet-1883	57	13	viral	viral	ADJ
admet-1883	57	14	infections	infection	NOUN
admet-1883	57	15	,	,	PUNCT
admet-1883	57	16	specifically	specifically	ADV
admet-1883	57	17	from	from	ADP
admet-1883	57	18	sars	sar	NOUN
admet-1883	57	19	-	-	PUNCT
admet-1883	57	20	cov	cov	PROPN
admet-1883	57	21	and	and	CCONJ
admet-1883	57	22	mers	mer	NOUN
admet-1883	57	23	-	-	PUNCT
admet-1883	57	24	cov	cov	NOUN
admet-1883	57	25	,	,	PUNCT
admet-1883	57	26	many	many	ADJ
admet-1883	57	27	international	international	ADJ
admet-1883	57	28	funding	funding	NOUN
admet-1883	57	29	organizations	organization	NOUN
admet-1883	57	30	for	for	ADP
admet-1883	57	31	vaccines	vaccine	NOUN
admet-1883	57	32	and	and	CCONJ
admet-1883	57	33	immunization	immunization	NOUN
admet-1883	57	34	are	be	AUX
admet-1883	57	35	sponsoring	sponsor	VERB
admet-1883	57	36	to	to	PART
admet-1883	57	37	support	support	VERB
admet-1883	57	38	and	and	CCONJ
admet-1883	57	39	continue	continue	VERB
admet-1883	57	40	the	the	DET
admet-1883	57	41	creative	creative	ADJ
admet-1883	57	42	attempts	attempt	NOUN
admet-1883	57	43	to	to	PART
admet-1883	57	44	design	design	VERB
admet-1883	57	45	a	a	DET
admet-1883	57	46	vaccine	vaccine	NOUN
admet-1883	57	47	.	.	PUNCT
admet-1883	58	1	the	the	DET
admet-1883	58	2	protein	protein	NOUN
admet-1883	58	3	contents	content	NOUN
admet-1883	58	4	of	of	ADP
admet-1883	58	5	sars	sar	NOUN
admet-1883	58	6	-	-	PUNCT
admet-1883	58	7	cov-2	cov-2	NOUN
admet-1883	58	8	,	,	PUNCT
admet-1883	58	9	as	as	ADV
admet-1883	58	10	well	well	ADV
admet-1883	58	11	as	as	ADP
admet-1883	58	12	their	their	PRON
admet-1883	58	13	mode	mode	NOUN
admet-1883	58	14	of	of	ADP
admet-1883	58	15	action	action	NOUN
admet-1883	58	16	,	,	PUNCT
admet-1883	58	17	had	have	AUX
admet-1883	58	18	already	already	ADV
admet-1883	58	19	been	be	AUX
admet-1883	58	20	recognized	recognize	VERB
admet-1883	58	21	.	.	PUNCT
admet-1883	59	1	sars	sar	NOUN
admet-1883	59	2	-	-	PUNCT
admet-1883	59	3	cov-2	cov-2	PART
admet-1883	59	4	is	be	AUX
admet-1883	59	5	a	a	DET
admet-1883	59	6	positive	positive	ADJ
admet-1883	59	7	sensed	sensed	ADJ
admet-1883	59	8	and	and	CCONJ
admet-1883	59	9	single	single	ADJ
admet-1883	59	10	-	-	PUNCT
admet-1883	59	11	stranded	strand	VERB
admet-1883	59	12	rna	rna	NOUN
admet-1883	59	13	virus	virus	NOUN
admet-1883	59	14	[	[	X
admet-1883	59	15	19	19	NUM
admet-1883	59	16	]	]	PUNCT
admet-1883	59	17	.	.	PUNCT
admet-1883	60	1	proteins	protein	NOUN
admet-1883	60	2	e	e	NOUN
admet-1883	60	3	,	,	PUNCT
admet-1883	60	4	s	s	X
admet-1883	60	5	,	,	PUNCT
admet-1883	60	6	m	m	PROPN
admet-1883	60	7	,	,	PUNCT
admet-1883	60	8	and	and	CCONJ
admet-1883	60	9	n	n	PRON
admet-1883	60	10	are	be	AUX
admet-1883	60	11	some	some	DET
admet-1883	60	12	structural	structural	ADJ
admet-1883	60	13	and	and	CCONJ
admet-1883	60	14	functional	functional	ADJ
admet-1883	60	15	protein	protein	NOUN
admet-1883	60	16	that	that	PRON
admet-1883	60	17	surrounds	surround	VERB
admet-1883	60	18	the	the	DET
admet-1883	60	19	sars	sar	NOUN
admet-1883	60	20	-	-	PUNCT
admet-1883	60	21	cov-2	cov-2	PART
admet-1883	60	22	virus	virus	NOUN
admet-1883	60	23	[	[	X
admet-1883	60	24	20,21	20,21	NUM
admet-1883	60	25	]	]	PUNCT
admet-1883	60	26	.	.	PUNCT
admet-1883	61	1	the	the	DET
admet-1883	61	2	current	current	ADJ
admet-1883	61	3	approaches	approach	NOUN
admet-1883	61	4	for	for	ADP
admet-1883	61	5	designing	design	VERB
admet-1883	61	6	vaccines	vaccine	NOUN
admet-1883	61	7	constitute	constitute	VERB
admet-1883	61	8	viral	viral	ADJ
admet-1883	61	9	vector	vector	NOUN
admet-1883	61	10	-	-	PUNCT
admet-1883	61	11	based	base	VERB
admet-1883	61	12	vaccines	vaccine	NOUN
admet-1883	61	13	,	,	PUNCT
admet-1883	61	14	virus	virus	NOUN
admet-1883	61	15	-	-	PUNCT
admet-1883	61	16	like	like	ADJ
admet-1883	61	17	protein	protein	NOUN
admet-1883	61	18	particles	particle	NOUN
admet-1883	61	19	(	(	PUNCT
admet-1883	61	20	vlp	vlp	PROPN
admet-1883	61	21	)	)	PUNCT
admet-1883	61	22	,	,	PUNCT
admet-1883	61	23	viral	viral	ADJ
admet-1883	61	24	protein	protein	NOUN
admet-1883	61	25	s	s	PART
admet-1883	61	26	subunit	subunit	NOUN
admet-1883	61	27	,	,	PUNCT
admet-1883	61	28	and	and	CCONJ
admet-1883	61	29	novel	novel	ADJ
admet-1883	61	30	non	non	ADJ
admet-1883	61	31	-	-	ADJ
admet-1883	61	32	viral	viral	ADJ
admet-1883	61	33	nucleic	nucleic	ADJ
admet-1883	61	34	acid	acid	NOUN
admet-1883	61	35	(	(	PUNCT
admet-1883	61	36	rna	rna	NOUN
admet-1883	61	37	and	and	CCONJ
admet-1883	61	38	dna	dna	PROPN
admet-1883	61	39	)	)	PUNCT
admet-1883	61	40	based	base	VERB
admet-1883	61	41	vaccines	vaccine	NOUN
admet-1883	61	42	[	[	X
admet-1883	61	43	22,23	22,23	NOUN
admet-1883	61	44	]	]	PUNCT
admet-1883	61	45	.	.	PUNCT
admet-1883	62	1	due	due	ADP
admet-1883	62	2	to	to	ADP
admet-1883	62	3	the	the	DET
admet-1883	62	4	previous	previous	ADJ
admet-1883	62	5	research	research	NOUN
admet-1883	62	6	in	in	ADP
admet-1883	62	7	2003	2003	NUM
admet-1883	62	8	for	for	ADP
admet-1883	62	9	developing	develop	VERB
admet-1883	62	10	a	a	DET
admet-1883	62	11	vaccine	vaccine	NOUN
admet-1883	62	12	against	against	ADP
admet-1883	62	13	sars	sar	NOUN
admet-1883	62	14	-	-	PUNCT
admet-1883	62	15	cov	cov	NOUN
admet-1883	62	16	by	by	ADP
admet-1883	62	17	targeting	target	VERB
admet-1883	62	18	the	the	DET
admet-1883	62	19	s	s	NOUN
admet-1883	62	20	subunit	subunit	NOUN
admet-1883	62	21	,	,	PUNCT
admet-1883	62	22	vaccination	vaccination	NOUN
admet-1883	62	23	against	against	ADP
admet-1883	62	24	sars	sar	NOUN
admet-1883	62	25	-	-	PUNCT
admet-1883	62	26	cov-2	cov-2	PART
admet-1883	62	27	went	go	VERB
admet-1883	62	28	straight	straight	ADV
admet-1883	62	29	into	into	ADP
admet-1883	62	30	clinical	clinical	ADJ
admet-1883	62	31	researchhuman	researchhuman	NOUN
admet-1883	62	32	trial	trial	NOUN
admet-1883	62	33	with	with	ADP
admet-1883	62	34	the	the	DET
admet-1883	62	35	previous	previous	ADJ
admet-1883	62	36	results	result	NOUN
admet-1883	62	37	[	[	X
admet-1883	62	38	24,25	24,25	NUM
admet-1883	62	39	]	]	PUNCT
admet-1883	62	40	.	.	PUNCT
admet-1883	63	1	sars	sars	PROPN
admet-1883	63	2	-	-	PUNCT
admet-1883	63	3	coronavirus	coronavirus	PROPN
admet-1883	63	4	possess	possess	NOUN
admet-1883	63	5	unique	unique	ADJ
admet-1883	63	6	rna	rna	NOUN
admet-1883	63	7	proofreading	proofreading	NOUN
admet-1883	63	8	capabilities	capability	NOUN
admet-1883	63	9	by	by	ADP
admet-1883	63	10	3'5	3'5	NUM
admet-1883	63	11	'	'	PUNCT
admet-1883	63	12	exonuclease	exonuclease	NOUN
admet-1883	63	13	activities	activity	NOUN
admet-1883	63	14	of	of	ADP
admet-1883	63	15	nsp12	nsp12	NOUN
admet-1883	63	16	and	and	CCONJ
admet-1883	63	17	nsp14	nsp14	NOUN
admet-1883	63	18	[	[	X
admet-1883	63	19	26	26	NUM
admet-1883	63	20	]	]	PUNCT
admet-1883	63	21	.	.	PUNCT
admet-1883	64	1	this	this	PRON
admet-1883	64	2	decides	decide	VERB
admet-1883	64	3	the	the	DET
admet-1883	64	4	two	two	NUM
admet-1883	64	5	major	major	ADJ
admet-1883	64	6	characteristics	characteristic	NOUN
admet-1883	64	7	of	of	ADP
admet-1883	64	8	the	the	DET
admet-1883	64	9	virus	virus	NOUN
admet-1883	64	10	:	:	PUNCT
admet-1883	64	11	(	(	PUNCT
admet-1883	64	12	1	1	X
admet-1883	64	13	)	)	PUNCT
admet-1883	64	14	high	high	ADJ
admet-1883	64	15	replication	replication	NOUN
admet-1883	64	16	efficiency	efficiency	NOUN
admet-1883	64	17	and	and	CCONJ
admet-1883	64	18	(	(	PUNCT
admet-1883	64	19	2	2	X
admet-1883	64	20	)	)	PUNCT
admet-1883	64	21	minimal	minimal	ADJ
admet-1883	64	22	new	new	ADJ
admet-1883	64	23	mutation	mutation	NOUN
admet-1883	64	24	rate	rate	NOUN
admet-1883	64	25	and	and	CCONJ
admet-1883	64	26	estimated	estimate	VERB
admet-1883	64	27	to	to	PART
admet-1883	64	28	be	be	AUX
admet-1883	64	29	around	around	ADP
admet-1883	64	30	2x105	2x105	NUM
admet-1883	64	31	.	.	PUNCT
admet-1883	65	1	due	due	ADP
admet-1883	65	2	to	to	ADP
admet-1883	65	3	the	the	DET
admet-1883	65	4	unusual	unusual	ADJ
admet-1883	65	5	faults	fault	NOUN
admet-1883	65	6	during	during	ADP
admet-1883	65	7	viral	viral	ADJ
admet-1883	65	8	genome	genome	NOUN
admet-1883	65	9	replication	replication	NOUN
admet-1883	65	10	,	,	PUNCT
admet-1883	65	11	it	it	PRON
admet-1883	65	12	may	may	AUX
admet-1883	65	13	sometimes	sometimes	ADV
admet-1883	65	14	result	result	VERB
admet-1883	65	15	in	in	ADP
admet-1883	65	16	the	the	DET
admet-1883	65	17	formation	formation	NOUN
admet-1883	65	18	of	of	ADP
admet-1883	65	19	variations	variation	NOUN
admet-1883	65	20	,	,	PUNCT
admet-1883	65	21	which	which	PRON
admet-1883	65	22	greatly	greatly	ADV
admet-1883	65	23	impacts	impact	VERB
admet-1883	65	24	the	the	DET
admet-1883	65	25	virus	virus	NOUN
admet-1883	65	26	infectivity	infectivity	NOUN
admet-1883	65	27	,	,	PUNCT
admet-1883	65	28	causes	cause	VERB
admet-1883	65	29	antigenic	antigenic	ADJ
admet-1883	65	30	drift	drift	NOUN
admet-1883	65	31	,	,	PUNCT
admet-1883	65	32	and	and	CCONJ
admet-1883	65	33	alters	alter	VERB
admet-1883	65	34	the	the	DET
admet-1883	65	35	host	host	NOUN
admet-1883	65	36	's	's	PART
admet-1883	65	37	response	response	NOUN
admet-1883	65	38	towards	towards	ADP
admet-1883	65	39	the	the	DET
admet-1883	65	40	viral	viral	ADJ
admet-1883	65	41	antigen	antigen	NOUN
admet-1883	65	42	.	.	PUNCT
admet-1883	66	1	this	this	DET
admet-1883	66	2	antigen	antigen	ADJ
admet-1883	66	3	drift	drift	NOUN
admet-1883	66	4	could	could	AUX
admet-1883	66	5	hinder	hinder	VERB
admet-1883	66	6	the	the	DET
admet-1883	66	7	construction	construction	NOUN
admet-1883	66	8	of	of	ADP
admet-1883	66	9	a	a	DET
admet-1883	66	10	vaccine	vaccine	NOUN
admet-1883	66	11	that	that	PRON
admet-1883	66	12	is	be	AUX
admet-1883	66	13	active	active	ADJ
admet-1883	66	14	for	for	ADP
admet-1883	66	15	a	a	DET
admet-1883	66	16	longer	long	ADJ
admet-1883	66	17	duration	duration	NOUN
admet-1883	66	18	.	.	PUNCT
admet-1883	67	1	single	single	ADJ
admet-1883	67	2	amino	amino	NOUN
admet-1883	67	3	acid	acid	NOUN
admet-1883	67	4	mutation	mutation	NOUN
admet-1883	67	5	in	in	ADP
admet-1883	67	6	the	the	DET
admet-1883	67	7	s	s	NOUN
admet-1883	67	8	protein	protein	NOUN
admet-1883	67	9	,	,	PUNCT
admet-1883	67	10	like	like	ADP
admet-1883	67	11	d614	d614	NUM
admet-1883	67	12	g	g	NOUN
admet-1883	67	13	,	,	PUNCT
admet-1883	67	14	has	have	AUX
admet-1883	67	15	emerged	emerge	VERB
admet-1883	67	16	as	as	ADP
admet-1883	67	17	the	the	DET
admet-1883	67	18	widespread	widespread	ADJ
admet-1883	67	19	genotype	genotype	NOUN
admet-1883	67	20	in	in	ADP
admet-1883	67	21	the	the	DET
admet-1883	67	22	present	present	ADJ
admet-1883	67	23	pandemic	pandemic	NOUN
admet-1883	67	24	.	.	PUNCT
admet-1883	68	1	according	accord	VERB
admet-1883	68	2	to	to	ADP
admet-1883	68	3	preliminary	preliminary	ADJ
admet-1883	68	4	studies	study	NOUN
admet-1883	68	5	,	,	PUNCT
admet-1883	68	6	the	the	DET
admet-1883	68	7	d614	d614	PROPN
admet-1883	68	8	g	g	NOUN
admet-1883	68	9	variation	variation	NOUN
admet-1883	68	10	does	do	AUX
admet-1883	68	11	not	not	PART
admet-1883	68	12	affect	affect	VERB
admet-1883	68	13	the	the	DET
admet-1883	68	14	effectiveness	effectiveness	NOUN
admet-1883	68	15	of	of	ADP
admet-1883	68	16	vaccines	vaccine	NOUN
admet-1883	68	17	targeting	target	VERB
admet-1883	68	18	the	the	DET
admet-1883	68	19	s	s	NOUN
admet-1883	68	20	protein	protein	NOUN
admet-1883	68	21	,	,	PUNCT
admet-1883	68	22	as	as	SCONJ
admet-1883	68	23	this	this	DET
admet-1883	68	24	variation	variation	NOUN
admet-1883	68	25	has	have	VERB
admet-1883	68	26	no	no	DET
admet-1883	68	27	impact	impact	NOUN
admet-1883	68	28	on	on	ADP
admet-1883	68	29	the	the	DET
admet-1883	68	30	antigenic	antigenic	ADJ
admet-1883	68	31	characteristics	characteristic	NOUN
admet-1883	68	32	of	of	ADP
admet-1883	68	33	the	the	DET
admet-1883	68	34	s	s	X
admet-1883	68	35	protein	protein	NOUN
admet-1883	68	36	[	[	X
admet-1883	68	37	27,28	27,28	NOUN
admet-1883	68	38	]	]	X
admet-1883	68	39	.	.	PUNCT
admet-1883	69	1	dna	dna	PROPN
admet-1883	69	2	-	-	PUNCT
admet-1883	69	3	based	base	VERB
admet-1883	69	4	vaccine	vaccine	NOUN
admet-1883	69	5	dna	dna	NOUN
admet-1883	69	6	-	-	PUNCT
admet-1883	69	7	based	base	VERB
admet-1883	69	8	covid-19	covid-19	PROPN
admet-1883	69	9	vaccine	vaccine	NOUN
admet-1883	69	10	is	be	AUX
admet-1883	69	11	a	a	DET
admet-1883	69	12	defining	define	VERB
admet-1883	69	13	attempt	attempt	NOUN
admet-1883	69	14	for	for	ADP
admet-1883	69	15	nucleic	nucleic	ADJ
admet-1883	69	16	acid	acid	NOUN
admet-1883	69	17	technology	technology	NOUN
admet-1883	69	18	,	,	PUNCT
admet-1883	69	19	mostly	mostly	ADV
admet-1883	69	20	disregarded	disregard	VERB
admet-1883	69	21	throughout	throughout	ADP
admet-1883	69	22	the	the	DET
admet-1883	69	23	pandemic	pandemic	NOUN
admet-1883	69	24	.	.	PUNCT
admet-1883	70	1	a	a	DET
admet-1883	70	2	novel	novel	ADJ
admet-1883	70	3	covid-19	covid-19	PROPN
admet-1883	70	4	vaccine	vaccine	NOUN
admet-1883	70	5	entices	entice	VERB
admet-1883	70	6	the	the	DET
admet-1883	70	7	immune	immune	ADJ
admet-1883	70	8	system	system	NOUN
admet-1883	70	9	against	against	ADP
admet-1883	70	10	the	the	DET
admet-1883	70	11	sars	sar	NOUN
admet-1883	70	12	-	-	PUNCT
admet-1883	70	13	cov-2	cov-2	NOUN
admet-1883	70	14	virus	virus	NOUN
admet-1883	70	15	by	by	ADP
admet-1883	70	16	using	use	VERB
admet-1883	70	17	circular	circular	ADJ
admet-1883	70	18	strands	strand	NOUN
admet-1883	70	19	of	of	ADP
admet-1883	70	20	dna	dna	PROPN
admet-1883	70	21	[	[	X
admet-1883	70	22	29	29	NUM
admet-1883	70	23	]	]	PUNCT
admet-1883	70	24	.	.	PUNCT
admet-1883	71	1	researchers	researcher	NOUN
admet-1883	71	2	have	have	AUX
admet-1883	71	3	hailed	hail	VERB
admet-1883	71	4	the	the	DET
admet-1883	71	5	clearance	clearance	NOUN
admet-1883	71	6	of	of	ADP
admet-1883	71	7	dna	dna	PROPN
admet-1883	71	8	vaccines	vaccine	NOUN
admet-1883	71	9	for	for	ADP
admet-1883	71	10	humans	human	NOUN
admet-1883	71	11	.	.	PUNCT
admet-1883	72	1	dna	dna	PROPN
admet-1883	72	2	vaccines	vaccine	NOUN
admet-1883	72	3	have	have	VERB
admet-1883	72	4	a	a	DET
admet-1883	72	5	number	number	NOUN
admet-1883	72	6	of	of	ADP
admet-1883	72	7	attractive	attractive	ADJ
admet-1883	72	8	properties	property	NOUN
admet-1883	72	9	that	that	PRON
admet-1883	72	10	include	include	VERB
admet-1883	72	11	easy	easy	ADJ
admet-1883	72	12	production	production	NOUN
admet-1883	72	13	with	with	ADP
admet-1883	72	14	excellent	excellent	ADJ
admet-1883	72	15	quality	quality	NOUN
admet-1883	72	16	,	,	PUNCT
admet-1883	72	17	cost	cost	NOUN
admet-1883	72	18	-	-	PUNCT
admet-1883	72	19	effectiveness	effectiveness	NOUN
admet-1883	72	20	,	,	PUNCT
admet-1883	72	21	high	high	ADJ
admet-1883	72	22	safety	safety	NOUN
admet-1883	72	23	concerns	concern	NOUN
admet-1883	72	24	,	,	PUNCT
admet-1883	72	25	and	and	CCONJ
admet-1883	72	26	stability	stability	NOUN
admet-1883	72	27	[	[	X
admet-1883	72	28	30	30	NUM
admet-1883	72	29	]	]	PUNCT
admet-1883	72	30	.	.	PUNCT
admet-1883	73	1	dna	dna	PROPN
admet-1883	73	2	vaccines	vaccine	NOUN
admet-1883	73	3	can	can	AUX
admet-1883	73	4	be	be	AUX
admet-1883	73	5	delivered	deliver	VERB
admet-1883	73	6	via	via	ADP
admet-1883	73	7	https://doi.org/10.5599/admet.1883	https://doi.org/10.5599/admet.1883	ADJ
admet-1883	73	8	p.	p.	PROPN
admet-1883	74	1	pallavi	pallavi	VERB
admet-1883	74	2	et	et	PROPN
admet-1883	74	3	al	al	PROPN
admet-1883	74	4	.	.	PROPN
admet-1883	74	5	admet	admet	PROPN
admet-1883	74	6	&	&	CCONJ
admet-1883	74	7	dmpk	dmpk	PROPN
admet-1883	74	8	11(4	11(4	NUM
admet-1883	74	9	)	)	PUNCT
admet-1883	74	10	(	(	PUNCT
admet-1883	74	11	2023	2023	NUM
admet-1883	74	12	)	)	PUNCT
admet-1883	74	13	513	513	NUM
admet-1883	74	14	-	-	SYM
admet-1883	74	15	531	531	NUM
admet-1883	74	16	516	516	NUM
admet-1883	74	17	intramuscular	intramuscular	ADJ
admet-1883	74	18	or	or	CCONJ
admet-1883	74	19	intradermal	intradermal	ADJ
admet-1883	74	20	inoculation	inoculation	NOUN
admet-1883	74	21	,	,	PUNCT
admet-1883	74	22	as	as	ADV
admet-1883	74	23	well	well	ADV
admet-1883	74	24	as	as	ADP
admet-1883	74	25	electroporation	electroporation	NOUN
admet-1883	74	26	.	.	PUNCT
admet-1883	75	1	the	the	DET
admet-1883	75	2	immunogenicity	immunogenicity	NOUN
admet-1883	75	3	and	and	CCONJ
admet-1883	75	4	tolerance	tolerance	NOUN
admet-1883	75	5	rate	rate	NOUN
admet-1883	75	6	of	of	ADP
admet-1883	75	7	dna	dna	PROPN
admet-1883	75	8	vaccines	vaccine	NOUN
admet-1883	75	9	were	be	AUX
admet-1883	75	10	found	find	VERB
admet-1883	75	11	to	to	PART
admet-1883	75	12	be	be	AUX
admet-1883	75	13	huge	huge	ADJ
admet-1883	75	14	;	;	PUNCT
admet-1883	75	15	thus	thus	ADV
admet-1883	75	16	,	,	PUNCT
admet-1883	75	17	they	they	PRON
admet-1883	75	18	are	be	AUX
admet-1883	75	19	being	be	AUX
admet-1883	75	20	developed	develop	VERB
admet-1883	75	21	to	to	PART
admet-1883	75	22	combat	combat	VERB
admet-1883	75	23	various	various	ADJ
admet-1883	75	24	infections	infection	NOUN
admet-1883	75	25	.	.	PUNCT
admet-1883	76	1	researchers	researcher	NOUN
admet-1883	76	2	developed	develop	VERB
admet-1883	76	3	a	a	DET
admet-1883	76	4	dna	dna	NOUN
admet-1883	76	5	vaccine	vaccine	NOUN
admet-1883	76	6	in	in	ADP
admet-1883	76	7	order	order	NOUN
admet-1883	76	8	to	to	PART
admet-1883	76	9	decrease	decrease	VERB
admet-1883	76	10	the	the	DET
admet-1883	76	11	level	level	NOUN
admet-1883	76	12	of	of	ADP
admet-1883	76	13	viral	viral	ADJ
admet-1883	76	14	rna	rna	NOUN
admet-1883	76	15	,	,	PUNCT
admet-1883	76	16	which	which	PRON
admet-1883	76	17	was	be	AUX
admet-1883	76	18	tested	test	VERB
admet-1883	76	19	against	against	ADP
admet-1883	76	20	a	a	DET
admet-1883	76	21	sars	sar	NOUN
admet-1883	76	22	-	-	PUNCT
admet-1883	76	23	cov-2	cov-2	NOUN
admet-1883	76	24	immunized	immunize	VERB
admet-1883	76	25	monkey	monkey	NOUN
admet-1883	76	26	model	model	NOUN
admet-1883	76	27	and	and	CCONJ
admet-1883	76	28	shown	show	VERB
admet-1883	76	29	to	to	PART
admet-1883	76	30	exhibit	exhibit	VERB
admet-1883	76	31	an	an	DET
admet-1883	76	32	effective	effective	ADJ
admet-1883	76	33	immune	immune	ADJ
admet-1883	76	34	response	response	NOUN
admet-1883	76	35	[	[	X
admet-1883	76	36	31,32	31,32	NUM
admet-1883	76	37	]	]	X
admet-1883	76	38	.	.	PUNCT
admet-1883	77	1	similarly	similarly	ADV
admet-1883	77	2	,	,	PUNCT
admet-1883	77	3	recombinant	recombinant	ADJ
admet-1883	77	4	adenovirus	adenovirus	NOUN
admet-1883	77	5	expressing	express	VERB
admet-1883	77	6	whole	whole	ADJ
admet-1883	77	7	spike	spike	ADJ
admet-1883	77	8	protein	protein	NOUN
admet-1883	77	9	vaccine	vaccine	NOUN
admet-1883	77	10	was	be	AUX
admet-1883	77	11	developed	develop	VERB
admet-1883	77	12	and	and	CCONJ
admet-1883	77	13	tested	test	VERB
admet-1883	77	14	.	.	PUNCT
admet-1883	78	1	many	many	ADJ
admet-1883	78	2	vaccinated	vaccinated	ADJ
admet-1883	78	3	candidates	candidate	NOUN
admet-1883	78	4	displayed	display	VERB
admet-1883	78	5	t	t	NOUN
admet-1883	78	6	-	-	PUNCT
admet-1883	78	7	cell	cell	NOUN
admet-1883	78	8	responses	response	NOUN
admet-1883	78	9	and	and	CCONJ
admet-1883	78	10	dose	dose	NOUN
admet-1883	78	11	-	-	PUNCT
admet-1883	78	12	dependent	dependent	ADJ
admet-1883	78	13	antibody	antibody	NOUN
admet-1883	78	14	activity	activity	NOUN
admet-1883	78	15	.	.	PUNCT
admet-1883	79	1	the	the	DET
admet-1883	79	2	adverse	adverse	ADJ
admet-1883	79	3	effects	effect	NOUN
admet-1883	79	4	were	be	AUX
admet-1883	79	5	moderate	moderate	ADJ
admet-1883	79	6	,	,	PUNCT
admet-1883	79	7	and	and	CCONJ
admet-1883	79	8	no	no	DET
admet-1883	79	9	severe	severe	ADJ
admet-1883	79	10	complications	complication	NOUN
admet-1883	79	11	were	be	AUX
admet-1883	79	12	reported	report	VERB
admet-1883	79	13	[	[	X
admet-1883	79	14	33,34	33,34	NOUN
admet-1883	79	15	]	]	PUNCT
admet-1883	79	16	.	.	PUNCT
admet-1883	80	1	mrna	mrna	PROPN
admet-1883	80	2	-	-	PUNCT
admet-1883	80	3	based	base	VERB
admet-1883	80	4	vaccine	vaccine	NOUN
admet-1883	80	5	the	the	DET
admet-1883	80	6	mrna	mrna	PROPN
admet-1883	80	7	vaccine	vaccine	NOUN
admet-1883	80	8	largely	largely	ADV
admet-1883	80	9	varies	vary	VERB
admet-1883	80	10	from	from	ADP
admet-1883	80	11	conventional	conventional	ADJ
admet-1883	80	12	vaccines	vaccine	NOUN
admet-1883	80	13	,	,	PUNCT
admet-1883	80	14	where	where	SCONJ
admet-1883	80	15	it	it	PRON
admet-1883	80	16	stimulates	stimulate	VERB
admet-1883	80	17	the	the	DET
admet-1883	80	18	host	host	NOUN
admet-1883	80	19	immune	immune	ADJ
admet-1883	80	20	system	system	NOUN
admet-1883	80	21	by	by	ADP
admet-1883	80	22	using	use	VERB
admet-1883	80	23	any	any	DET
admet-1883	80	24	one	one	NUM
admet-1883	80	25	of	of	ADP
admet-1883	80	26	two	two	NUM
admet-1883	80	27	major	major	ADJ
admet-1883	80	28	components	component	NOUN
admet-1883	80	29	:	:	PUNCT
admet-1883	80	30	an	an	DET
admet-1883	80	31	inactivated	inactivated	ADJ
admet-1883	80	32	organism	organism	NOUN
admet-1883	80	33	or	or	CCONJ
admet-1883	80	34	an	an	DET
admet-1883	80	35	antigen	antigen	NOUN
admet-1883	80	36	,	,	PUNCT
admet-1883	80	37	which	which	PRON
admet-1883	80	38	is	be	AUX
admet-1883	80	39	the	the	DET
admet-1883	80	40	protein	protein	NOUN
admet-1883	80	41	of	of	ADP
admet-1883	80	42	that	that	DET
admet-1883	80	43	organism	organism	NOUN
admet-1883	80	44	[	[	X
admet-1883	80	45	35	35	NUM
admet-1883	80	46	]	]	PUNCT
admet-1883	80	47	.	.	PUNCT
admet-1883	81	1	an	an	DET
admet-1883	81	2	rna	rna	NOUN
admet-1883	81	3	polymerase	polymerase	NOUN
admet-1883	81	4	was	be	AUX
admet-1883	81	5	used	use	VERB
admet-1883	81	6	to	to	PART
admet-1883	81	7	transcribe	transcribe	VERB
admet-1883	81	8	an	an	DET
admet-1883	81	9	orf	orf	ADV
admet-1883	81	10	-	-	PUNCT
admet-1883	81	11	containing	contain	VERB
admet-1883	81	12	mrna	mrna	NOUN
admet-1883	81	13	from	from	ADP
admet-1883	81	14	a	a	DET
admet-1883	81	15	dna	dna	PROPN
admet-1883	81	16	template	template	NOUN
admet-1883	81	17	.	.	PUNCT
admet-1883	82	1	the	the	DET
admet-1883	82	2	advantages	advantage	NOUN
admet-1883	82	3	of	of	ADP
admet-1883	82	4	mrna	mrna	NOUN
admet-1883	82	5	-	-	PUNCT
admet-1883	82	6	based	base	VERB
admet-1883	82	7	vaccinations	vaccination	NOUN
admet-1883	82	8	include	include	VERB
admet-1883	82	9	simplicity	simplicity	NOUN
admet-1883	82	10	,	,	PUNCT
admet-1883	82	11	safety	safety	NOUN
admet-1883	82	12	,	,	PUNCT
admet-1883	82	13	and	and	CCONJ
admet-1883	82	14	scalability	scalability	NOUN
admet-1883	82	15	of	of	ADP
admet-1883	82	16	laboratory	laboratory	NOUN
admet-1883	82	17	manufacturing	manufacturing	NOUN
admet-1883	82	18	,	,	PUNCT
admet-1883	82	19	depending	depend	VERB
admet-1883	82	20	on	on	ADP
admet-1883	82	21	the	the	DET
admet-1883	82	22	translational	translational	ADJ
admet-1883	82	23	machinery	machinery	NOUN
admet-1883	82	24	of	of	ADP
admet-1883	82	25	the	the	DET
admet-1883	82	26	host	host	NOUN
admet-1883	82	27	,	,	PUNCT
admet-1883	82	28	and	and	CCONJ
admet-1883	82	29	loss	loss	NOUN
admet-1883	82	30	of	of	ADP
admet-1883	82	31	integration	integration	NOUN
admet-1883	82	32	in	in	ADP
admet-1883	82	33	the	the	DET
admet-1883	82	34	genome	genome	NOUN
admet-1883	82	35	[	[	X
admet-1883	82	36	36	36	NUM
admet-1883	82	37	]	]	PUNCT
admet-1883	82	38	.	.	PUNCT
admet-1883	83	1	however	however	ADV
admet-1883	83	2	,	,	PUNCT
admet-1883	83	3	there	there	PRON
admet-1883	83	4	is	be	VERB
admet-1883	83	5	a	a	DET
admet-1883	83	6	significant	significant	ADJ
admet-1883	83	7	barrier	barrier	NOUN
admet-1883	83	8	to	to	ADP
admet-1883	83	9	successful	successful	ADJ
admet-1883	83	10	delivery	delivery	NOUN
admet-1883	83	11	,	,	PUNCT
admet-1883	83	12	including	include	VERB
admet-1883	83	13	the	the	DET
admet-1883	83	14	stability	stability	NOUN
admet-1883	83	15	of	of	ADP
admet-1883	83	16	mrna	mrna	PROPN
admet-1883	83	17	during	during	ADP
admet-1883	83	18	storage	storage	NOUN
admet-1883	83	19	,	,	PUNCT
admet-1883	83	20	the	the	DET
admet-1883	83	21	stability	stability	NOUN
admet-1883	83	22	inside	inside	ADP
admet-1883	83	23	the	the	DET
admet-1883	83	24	host	host	NOUN
admet-1883	83	25	,	,	PUNCT
admet-1883	83	26	an	an	DET
admet-1883	83	27	unpredictable	unpredictable	ADJ
admet-1883	83	28	immune	immune	ADJ
admet-1883	83	29	response	response	NOUN
admet-1883	83	30	,	,	PUNCT
admet-1883	83	31	and	and	CCONJ
admet-1883	83	32	storage	storage	NOUN
admet-1883	83	33	instability	instability	NOUN
admet-1883	83	34	until	until	ADP
admet-1883	83	35	frozen	freeze	VERB
admet-1883	83	36	.	.	PUNCT
admet-1883	84	1	vaccination	vaccination	NOUN
admet-1883	84	2	with	with	ADP
admet-1883	84	3	mrna	mrna	PROPN
admet-1883	84	4	is	be	AUX
admet-1883	84	5	considered	consider	VERB
admet-1883	84	6	a	a	DET
admet-1883	84	7	relatively	relatively	ADV
admet-1883	84	8	productive	productive	ADJ
admet-1883	84	9	and	and	CCONJ
admet-1883	84	10	time	time	NOUN
admet-1883	84	11	-	-	PUNCT
admet-1883	84	12	saving	save	VERB
admet-1883	84	13	option	option	NOUN
admet-1883	84	14	against	against	ADP
admet-1883	84	15	covid-19	covid-19	PROPN
admet-1883	84	16	.	.	PUNCT
admet-1883	85	1	as	as	ADP
admet-1883	85	2	a	a	DET
admet-1883	85	3	result	result	NOUN
admet-1883	85	4	,	,	PUNCT
admet-1883	85	5	rna	rna	PROPN
admet-1883	85	6	has	have	AUX
admet-1883	85	7	emerged	emerge	VERB
admet-1883	85	8	as	as	ADP
admet-1883	85	9	the	the	DET
admet-1883	85	10	key	key	ADJ
admet-1883	85	11	component	component	NOUN
admet-1883	85	12	in	in	ADP
admet-1883	85	13	the	the	DET
admet-1883	85	14	development	development	NOUN
admet-1883	85	15	of	of	ADP
admet-1883	85	16	vaccines	vaccine	NOUN
admet-1883	85	17	against	against	ADP
admet-1883	85	18	covid-19	covid-19	PROPN
admet-1883	85	19	.	.	PUNCT
admet-1883	86	1	spike	spike	ADJ
admet-1883	86	2	protein	protein	NOUN
admet-1883	86	3	is	be	AUX
admet-1883	86	4	the	the	DET
admet-1883	86	5	prime	prime	ADJ
admet-1883	86	6	target	target	NOUN
admet-1883	86	7	for	for	ADP
admet-1883	86	8	mrna	mrna	PROPN
admet-1883	86	9	vaccines	vaccine	NOUN
admet-1883	86	10	,	,	PUNCT
admet-1883	86	11	as	as	SCONJ
admet-1883	86	12	the	the	DET
admet-1883	86	13	structural	structural	ADJ
admet-1883	86	14	aspect	aspect	NOUN
admet-1883	86	15	is	be	AUX
admet-1883	86	16	similar	similar	ADJ
admet-1883	86	17	to	to	ADP
admet-1883	86	18	sars	sars	PROPN
admet-1883	86	19	-	-	PUNCT
admet-1883	86	20	cov	cov	PROPN
admet-1883	86	21	and	and	CCONJ
admet-1883	86	22	sars	sar	NOUN
admet-1883	86	23	-	-	PUNCT
admet-1883	86	24	cov-2	cov-2	PART
admet-1883	86	25	[	[	X
admet-1883	86	26	37,38	37,38	NOUN
admet-1883	86	27	]	]	PUNCT
admet-1883	86	28	.	.	PUNCT
admet-1883	87	1	neutralizing	neutralize	VERB
admet-1883	87	2	activity	activity	NOUN
admet-1883	87	3	of	of	ADP
admet-1883	87	4	antibodies	antibody	NOUN
admet-1883	87	5	against	against	ADP
admet-1883	87	6	the	the	DET
admet-1883	87	7	n	n	CCONJ
admet-1883	87	8	-	-	PUNCT
admet-1883	87	9	terminal	terminal	ADJ
admet-1883	87	10	and	and	CCONJ
admet-1883	87	11	receptor	receptor	NOUN
admet-1883	87	12	binding	bind	VERB
admet-1883	87	13	domain	domain	NOUN
admet-1883	87	14	(	(	PUNCT
admet-1883	87	15	rbd	rbd	NOUN
admet-1883	87	16	)	)	PUNCT
admet-1883	87	17	of	of	ADP
admet-1883	87	18	s	s	NOUN
admet-1883	87	19	protein	protein	NOUN
admet-1883	87	20	was	be	AUX
admet-1883	87	21	studied	study	VERB
admet-1883	87	22	in	in	ADP
admet-1883	87	23	covid-19	covid-19	PROPN
admet-1883	87	24	patients	patient	NOUN
admet-1883	87	25	and	and	CCONJ
admet-1883	87	26	proved	prove	VERB
admet-1883	87	27	that	that	SCONJ
admet-1883	87	28	these	these	PRON
admet-1883	87	29	are	be	AUX
admet-1883	87	30	the	the	DET
admet-1883	87	31	components	component	NOUN
admet-1883	87	32	that	that	PRON
admet-1883	87	33	hinder	hinder	VERB
admet-1883	87	34	their	their	PRON
admet-1883	87	35	use	use	NOUN
admet-1883	87	36	as	as	ADP
admet-1883	87	37	the	the	DET
admet-1883	87	38	target	target	NOUN
admet-1883	87	39	for	for	ADP
admet-1883	87	40	vaccine	vaccine	NOUN
admet-1883	87	41	development	development	NOUN
admet-1883	87	42	[	[	X
admet-1883	87	43	39,40	39,40	NUM
admet-1883	87	44	]	]	PUNCT
admet-1883	87	45	.	.	PUNCT
admet-1883	88	1	the	the	DET
admet-1883	88	2	major	major	ADJ
admet-1883	88	3	problem	problem	NOUN
admet-1883	88	4	is	be	AUX
admet-1883	88	5	the	the	DET
admet-1883	88	6	entry	entry	NOUN
admet-1883	88	7	route	route	NOUN
admet-1883	88	8	of	of	ADP
admet-1883	88	9	sars	sar	NOUN
admet-1883	88	10	-	-	PUNCT
admet-1883	88	11	cov-2	cov-2	NOUN
admet-1883	88	12	into	into	ADP
admet-1883	88	13	the	the	DET
admet-1883	88	14	cell	cell	NOUN
admet-1883	88	15	with	with	ADP
admet-1883	88	16	a	a	DET
admet-1883	88	17	mechanism	mechanism	NOUN
admet-1883	88	18	that	that	PRON
admet-1883	88	19	is	be	AUX
admet-1883	88	20	not	not	PART
admet-1883	88	21	dependent	dependent	ADJ
admet-1883	88	22	on	on	ADP
admet-1883	88	23	ace2	ace2	PROPN
admet-1883	88	24	.	.	PUNCT
admet-1883	89	1	rna	rna	NOUN
admet-1883	89	2	vaccine	vaccine	NOUN
admet-1883	89	3	has	have	VERB
admet-1883	89	4	some	some	PRON
admet-1883	89	5	more	more	ADJ
admet-1883	89	6	challenges	challenge	NOUN
admet-1883	89	7	like	like	ADP
admet-1883	89	8	the	the	DET
admet-1883	89	9	stability	stability	NOUN
admet-1883	89	10	of	of	ADP
admet-1883	89	11	mrna	mrna	PROPN
admet-1883	89	12	,	,	PUNCT
admet-1883	89	13	absorption	absorption	NOUN
admet-1883	89	14	efficiency	efficiency	NOUN
admet-1883	89	15	by	by	ADP
admet-1883	89	16	the	the	DET
admet-1883	89	17	host	host	NOUN
admet-1883	89	18	cells	cell	NOUN
admet-1883	89	19	,	,	PUNCT
admet-1883	89	20	and	and	CCONJ
admet-1883	89	21	release	release	VERB
admet-1883	89	22	rate	rate	NOUN
admet-1883	89	23	into	into	ADP
admet-1883	89	24	the	the	DET
admet-1883	89	25	cell	cell	NOUN
admet-1883	89	26	cytoplasm	cytoplasm	NOUN
admet-1883	89	27	to	to	PART
admet-1883	89	28	target	target	VERB
admet-1883	89	29	the	the	DET
admet-1883	89	30	protein	protein	NOUN
admet-1883	89	31	[	[	X
admet-1883	89	32	41	41	NUM
admet-1883	89	33	]	]	PUNCT
admet-1883	89	34	.	.	PUNCT
admet-1883	90	1	nanoparticle	nanoparticle	NOUN
admet-1883	90	2	used	use	VERB
admet-1883	90	3	for	for	ADP
admet-1883	90	4	vaccine	vaccine	NOUN
admet-1883	90	5	rna	rna	NOUN
admet-1883	90	6	and	and	CCONJ
admet-1883	90	7	dna	dna	PROPN
admet-1883	90	8	vaccines	vaccine	NOUN
admet-1883	90	9	can	can	AUX
admet-1883	90	10	generate	generate	VERB
admet-1883	90	11	immunity	immunity	NOUN
admet-1883	90	12	against	against	ADP
admet-1883	90	13	a	a	DET
admet-1883	90	14	specific	specific	ADJ
admet-1883	90	15	disease	disease	NOUN
admet-1883	90	16	while	while	SCONJ
admet-1883	90	17	reducing	reduce	VERB
admet-1883	90	18	the	the	DET
admet-1883	90	19	risk	risk	NOUN
admet-1883	90	20	of	of	ADP
admet-1883	90	21	infection	infection	NOUN
admet-1883	90	22	.	.	PUNCT
admet-1883	91	1	the	the	DET
admet-1883	91	2	delivery	delivery	NOUN
admet-1883	91	3	of	of	ADP
admet-1883	91	4	these	these	DET
admet-1883	91	5	immunogens	immunogen	NOUN
admet-1883	91	6	to	to	ADP
admet-1883	91	7	the	the	DET
admet-1883	91	8	site	site	NOUN
admet-1883	91	9	of	of	ADP
admet-1883	91	10	action	action	NOUN
admet-1883	91	11	,	,	PUNCT
admet-1883	91	12	together	together	ADV
admet-1883	91	13	with	with	ADP
admet-1883	91	14	other	other	ADJ
admet-1883	91	15	immunogens	immunogen	NOUN
admet-1883	91	16	,	,	PUNCT
admet-1883	91	17	as	as	ADP
admet-1883	91	18	part	part	NOUN
admet-1883	91	19	of	of	ADP
admet-1883	91	20	a	a	DET
admet-1883	91	21	vaccination	vaccination	NOUN
admet-1883	91	22	regimen	regimen	NOUN
admet-1883	91	23	is	be	AUX
admet-1883	91	24	a	a	DET
admet-1883	91	25	major	major	ADJ
admet-1883	91	26	difficulty	difficulty	NOUN
admet-1883	91	27	.	.	PUNCT
admet-1883	92	1	the	the	DET
admet-1883	92	2	limitations	limitation	NOUN
admet-1883	92	3	can	can	AUX
admet-1883	92	4	be	be	AUX
admet-1883	92	5	resolved	resolve	VERB
admet-1883	92	6	by	by	ADP
admet-1883	92	7	employing	employ	VERB
admet-1883	92	8	an	an	DET
admet-1883	92	9	efficient	efficient	ADJ
admet-1883	92	10	delivery	delivery	NOUN
admet-1883	92	11	method	method	NOUN
admet-1883	92	12	to	to	PART
admet-1883	92	13	deliver	deliver	VERB
admet-1883	92	14	the	the	DET
admet-1883	92	15	vaccine	vaccine	NOUN
admet-1883	92	16	to	to	ADP
admet-1883	92	17	the	the	DET
admet-1883	92	18	target	target	NOUN
admet-1883	92	19	location	location	NOUN
admet-1883	92	20	and	and	CCONJ
admet-1883	92	21	the	the	DET
admet-1883	92	22	adjuvant	adjuvant	NOUN
admet-1883	92	23	while	while	SCONJ
admet-1883	92	24	preserving	preserve	VERB
admet-1883	92	25	it	it	PRON
admet-1883	92	26	against	against	ADP
admet-1883	92	27	deterioration	deterioration	NOUN
admet-1883	92	28	in	in	ADP
admet-1883	92	29	a	a	DET
admet-1883	92	30	hostile	hostile	ADJ
admet-1883	92	31	environment	environment	NOUN
admet-1883	92	32	.	.	PUNCT
admet-1883	93	1	the	the	DET
admet-1883	93	2	delivery	delivery	NOUN
admet-1883	93	3	mechanism	mechanism	NOUN
admet-1883	93	4	should	should	AUX
admet-1883	93	5	have	have	VERB
admet-1883	93	6	an	an	DET
admet-1883	93	7	immunogenic	immunogenic	ADJ
admet-1883	93	8	effect	effect	NOUN
admet-1883	93	9	that	that	PRON
admet-1883	93	10	lasts	last	VERB
admet-1883	93	11	without	without	ADP
admet-1883	93	12	causing	cause	VERB
admet-1883	93	13	any	any	DET
admet-1883	93	14	negative	negative	ADJ
admet-1883	93	15	effects	effect	NOUN
admet-1883	93	16	.	.	PUNCT
admet-1883	94	1	nanoparticles	nanoparticle	NOUN
admet-1883	94	2	based	base	VERB
admet-1883	94	3	delivery	delivery	NOUN
admet-1883	94	4	systems	system	NOUN
admet-1883	94	5	are	be	AUX
admet-1883	94	6	popular	popular	ADJ
admet-1883	94	7	nowadays	nowadays	ADV
admet-1883	94	8	for	for	ADP
admet-1883	94	9	theranostic	theranostic	ADJ
admet-1883	94	10	applications	application	NOUN
admet-1883	94	11	[	[	X
admet-1883	94	12	42	42	NUM
admet-1883	94	13	-	-	SYM
admet-1883	94	14	45	45	NUM
admet-1883	94	15	]	]	PUNCT
admet-1883	94	16	.	.	PUNCT
admet-1883	95	1	nano	nano	NOUN
admet-1883	95	2	-	-	PUNCT
admet-1883	95	3	delivery	delivery	NOUN
admet-1883	95	4	methods	method	NOUN
admet-1883	95	5	might	might	AUX
admet-1883	95	6	meet	meet	VERB
admet-1883	95	7	the	the	DET
admet-1883	95	8	criteria	criterion	NOUN
admet-1883	95	9	and	and	CCONJ
admet-1883	95	10	allow	allow	VERB
admet-1883	95	11	for	for	ADP
admet-1883	95	12	the	the	DET
admet-1883	95	13	long	long	ADJ
admet-1883	95	14	-	-	PUNCT
admet-1883	95	15	term	term	NOUN
admet-1883	95	16	sustained	sustained	ADJ
admet-1883	95	17	release	release	NOUN
admet-1883	95	18	of	of	ADP
admet-1883	95	19	vaccine	vaccine	NOUN
admet-1883	95	20	molecules	molecule	NOUN
admet-1883	95	21	without	without	ADP
admet-1883	95	22	being	be	AUX
admet-1883	95	23	damaged	damage	VERB
admet-1883	95	24	by	by	ADP
admet-1883	95	25	proteases	protease	NOUN
admet-1883	95	26	[	[	X
admet-1883	95	27	46,47	46,47	NUM
admet-1883	95	28	]	]	X
admet-1883	95	29	.	.	PUNCT
admet-1883	96	1	the	the	DET
admet-1883	96	2	use	use	NOUN
admet-1883	96	3	of	of	ADP
admet-1883	96	4	nanocarriers	nanocarrier	NOUN
admet-1883	96	5	for	for	ADP
admet-1883	96	6	vaccine	vaccine	NOUN
admet-1883	96	7	components	component	NOUN
admet-1883	96	8	improves	improve	VERB
admet-1883	96	9	cellular	cellular	ADJ
admet-1883	96	10	absorption	absorption	NOUN
admet-1883	96	11	,	,	PUNCT
admet-1883	96	12	resulting	result	VERB
admet-1883	96	13	in	in	ADP
admet-1883	96	14	enhanced	enhanced	ADJ
admet-1883	96	15	innate	innate	NOUN
admet-1883	96	16	,	,	PUNCT
admet-1883	96	17	humoral	humoral	ADJ
admet-1883	96	18	,	,	PUNCT
admet-1883	96	19	cellular	cellular	ADJ
admet-1883	96	20	,	,	PUNCT
admet-1883	96	21	and	and	CCONJ
admet-1883	96	22	mucosal	mucosal	ADJ
admet-1883	96	23	immune	immune	ADJ
admet-1883	96	24	responses	response	NOUN
admet-1883	96	25	[	[	X
admet-1883	96	26	48,49	48,49	X
admet-1883	96	27	]	]	PUNCT
admet-1883	96	28	.	.	PUNCT
admet-1883	97	1	nanoparticle	nanoparticle	NOUN
admet-1883	97	2	vaccines	vaccine	NOUN
admet-1883	97	3	are	be	AUX
admet-1883	97	4	powerful	powerful	ADJ
admet-1883	97	5	,	,	PUNCT
admet-1883	97	6	safe	safe	ADJ
admet-1883	97	7	,	,	PUNCT
admet-1883	97	8	and	and	CCONJ
admet-1883	97	9	simple	simple	ADJ
admet-1883	97	10	to	to	PART
admet-1883	97	11	make	make	VERB
admet-1883	97	12	.	.	PUNCT
admet-1883	98	1	in	in	ADP
admet-1883	98	2	comparison	comparison	NOUN
admet-1883	98	3	to	to	ADP
admet-1883	98	4	vaccinations	vaccination	NOUN
admet-1883	98	5	that	that	PRON
admet-1883	98	6	retain	retain	VERB
admet-1883	98	7	parts	part	NOUN
admet-1883	98	8	of	of	ADP
admet-1883	98	9	the	the	DET
admet-1883	98	10	virus	virus	NOUN
admet-1883	98	11	,	,	PUNCT
admet-1883	98	12	attenuated	attenuate	VERB
admet-1883	98	13	viral	viral	ADJ
admet-1883	98	14	vaccines	vaccine	NOUN
admet-1883	98	15	are	be	AUX
admet-1883	98	16	more	more	ADV
admet-1883	98	17	effective	effective	ADJ
admet-1883	98	18	,	,	PUNCT
admet-1883	98	19	but	but	CCONJ
admet-1883	98	20	they	they	PRON
admet-1883	98	21	take	take	VERB
admet-1883	98	22	a	a	DET
admet-1883	98	23	longer	long	ADJ
admet-1883	98	24	time	time	NOUN
admet-1883	98	25	to	to	PART
admet-1883	98	26	reach	reach	VERB
admet-1883	98	27	the	the	DET
admet-1883	98	28	site	site	NOUN
admet-1883	98	29	,	,	PUNCT
admet-1883	98	30	have	have	VERB
admet-1883	98	31	special	special	ADJ
admet-1883	98	32	storage	storage	NOUN
admet-1883	98	33	conditions	condition	NOUN
admet-1883	98	34	(	(	PUNCT
admet-1883	98	35	subzero	subzero	NOUN
admet-1883	98	36	temperatures	temperature	NOUN
admet-1883	98	37	)	)	PUNCT
admet-1883	98	38	,	,	PUNCT
admet-1883	98	39	and	and	CCONJ
admet-1883	98	40	might	might	AUX
admet-1883	98	41	carry	carry	VERB
admet-1883	98	42	the	the	DET
admet-1883	98	43	risk	risk	NOUN
admet-1883	98	44	of	of	ADP
admet-1883	98	45	adverse	adverse	ADJ
admet-1883	98	46	effects	effect	NOUN
admet-1883	98	47	.	.	PUNCT
admet-1883	99	1	vaccines	vaccine	NOUN
admet-1883	99	2	containing	contain	VERB
admet-1883	99	3	nucleic	nucleic	ADJ
admet-1883	99	4	acids	acid	NOUN
admet-1883	99	5	(	(	PUNCT
admet-1883	99	6	rna	rna	NOUN
admet-1883	99	7	and	and	CCONJ
admet-1883	99	8	dna	dna	PROPN
admet-1883	99	9	)	)	PUNCT
admet-1883	99	10	are	be	AUX
admet-1883	99	11	easy	easy	ADJ
admet-1883	99	12	to	to	PART
admet-1883	99	13	make	make	VERB
admet-1883	99	14	,	,	PUNCT
admet-1883	99	15	but	but	CCONJ
admet-1883	99	16	they	they	PRON
admet-1883	99	17	are	be	AUX
admet-1883	99	18	expensive	expensive	ADJ
admet-1883	99	19	and	and	CCONJ
admet-1883	99	20	may	may	AUX
admet-1883	99	21	require	require	VERB
admet-1883	99	22	many	many	ADJ
admet-1883	99	23	doses	dose	NOUN
admet-1883	99	24	.	.	PUNCT
admet-1883	100	1	there	there	PRON
admet-1883	100	2	have	have	AUX
admet-1883	100	3	been	be	AUX
admet-1883	100	4	reports	report	NOUN
admet-1883	100	5	of	of	ADP
admet-1883	100	6	nanoparticle	nanoparticle	NOUN
admet-1883	100	7	vaccinations	vaccination	NOUN
admet-1883	100	8	for	for	ADP
admet-1883	100	9	covid-19	covid-19	PROPN
admet-1883	100	10	eliciting	elicit	VERB
admet-1883	100	11	an	an	DET
admet-1883	100	12	effective	effective	ADJ
admet-1883	100	13	immunological	immunological	ADJ
admet-1883	100	14	response	response	NOUN
admet-1883	100	15	in	in	ADP
admet-1883	100	16	mice	mouse	NOUN
admet-1883	100	17	after	after	ADP
admet-1883	100	18	a	a	DET
admet-1883	100	19	single	single	ADJ
admet-1883	100	20	dosage	dosage	NOUN
admet-1883	100	21	.	.	PUNCT
admet-1883	101	1	the	the	DET
admet-1883	101	2	mrna	mrna	PROPN
admet-1883	101	3	is	be	AUX
admet-1883	101	4	encapsulated	encapsulate	VERB
admet-1883	101	5	in	in	ADP
admet-1883	101	6	lipid	lipid	NOUN
admet-1883	101	7	-	-	PUNCT
admet-1883	101	8	based	base	VERB
admet-1883	101	9	nanoparticles	nanoparticle	NOUN
admet-1883	101	10	or	or	CCONJ
admet-1883	101	11	other	other	ADJ
admet-1883	101	12	substances	substance	NOUN
admet-1883	101	13	and	and	CCONJ
admet-1883	101	14	can	can	AUX
admet-1883	101	15	be	be	AUX
admet-1883	101	16	injected	inject	VERB
admet-1883	101	17	into	into	ADP
admet-1883	101	18	the	the	DET
admet-1883	101	19	host	host	NOUN
admet-1883	101	20	via	via	ADP
admet-1883	101	21	i	i	PRON
admet-1883	101	22	m	m	VERB
admet-1883	101	23	(	(	PUNCT
admet-1883	101	24	intramuscular	intramuscular	ADJ
admet-1883	101	25	)	)	PUNCT
admet-1883	101	26	route	route	NOUN
admet-1883	101	27	to	to	PART
admet-1883	101	28	increase	increase	VERB
admet-1883	101	29	its	its	PRON
admet-1883	101	30	stability	stability	NOUN
admet-1883	101	31	and	and	CCONJ
admet-1883	101	32	prevent	prevent	VERB
admet-1883	101	33	it	it	PRON
admet-1883	101	34	from	from	ADP
admet-1883	101	35	rapid	rapid	ADJ
admet-1883	101	36	degradation	degradation	NOUN
admet-1883	101	37	by	by	ADP
admet-1883	101	38	host	host	NOUN
admet-1883	101	39	ribonucleases	ribonuclease	NOUN
admet-1883	102	1	[	[	X
admet-1883	102	2	50	50	NUM
admet-1883	102	3	]	]	PUNCT
admet-1883	102	4	.	.	PUNCT
admet-1883	103	1	the	the	DET
admet-1883	103	2	mrna-1273	mrna-1273	ADJ
admet-1883	103	3	vaccine	vaccine	NOUN
admet-1883	103	4	is	be	AUX
admet-1883	103	5	the	the	DET
admet-1883	103	6	first	first	ADJ
admet-1883	103	7	mrna	mrna	PROPN
admet-1883	103	8	vaccine	vaccine	NOUN
admet-1883	103	9	with	with	ADP
admet-1883	103	10	lipid	lipid	PROPN
admet-1883	103	11	microparticle	microparticle	PROPN
admet-1883	103	12	capsule	capsule	PROPN
admet-1883	103	13	-	-	PUNCT
admet-1883	103	14	based	base	VERB
admet-1883	103	15	modified	modified	ADJ
admet-1883	103	16	viral	viral	ADJ
admet-1883	103	17	rna	rna	NOUN
admet-1883	103	18	against	against	ADP
admet-1883	103	19	covid-19	covid-19	PROPN
admet-1883	104	1	[	[	X
admet-1883	104	2	51	51	NUM
admet-1883	104	3	]	]	PUNCT
admet-1883	104	4	.	.	PUNCT
admet-1883	105	1	admet	admet	PROPN
admet-1883	105	2	&	&	CCONJ
admet-1883	105	3	dmpk	dmpk	PROPN
admet-1883	105	4	11(4	11(4	NUM
admet-1883	105	5	)	)	PUNCT
admet-1883	105	6	(	(	PUNCT
admet-1883	105	7	2023	2023	NUM
admet-1883	105	8	)	)	PUNCT
admet-1883	105	9	513	513	NUM
admet-1883	105	10	-	-	SYM
admet-1883	105	11	531	531	NUM
admet-1883	105	12	infections	infection	NOUN
admet-1883	105	13	associated	associate	VERB
admet-1883	105	14	with	with	ADP
admet-1883	105	15	sars	sar	NOUN
admet-1883	105	16	-	-	PUNCT
admet-1883	105	17	cov-2	cov-2	PART
admet-1883	105	18	exploited	exploit	VERB
admet-1883	105	19	via	via	ADP
admet-1883	105	20	photodynamic	photodynamic	ADJ
admet-1883	105	21	therapy	therapy	NOUN
admet-1883	105	22	doi	doi	NOUN
admet-1883	105	23	:	:	PUNCT
admet-1883	105	24	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-1883	105	25	t.1883	t.1883	VERB
admet-1883	105	26	517	517	NUM
admet-1883	105	27	diagnosis	diagnosis	NOUN
admet-1883	105	28	the	the	DET
admet-1883	105	29	diagnosis	diagnosis	NOUN
admet-1883	105	30	is	be	AUX
admet-1883	105	31	made	make	VERB
admet-1883	105	32	depending	depend	VERB
admet-1883	105	33	on	on	ADP
admet-1883	105	34	a	a	DET
admet-1883	105	35	range	range	NOUN
admet-1883	105	36	of	of	ADP
admet-1883	105	37	factors	factor	NOUN
admet-1883	105	38	,	,	PUNCT
admet-1883	105	39	including	include	VERB
admet-1883	105	40	epidemiology	epidemiology	NOUN
admet-1883	105	41	,	,	PUNCT
admet-1883	105	42	clinical	clinical	ADJ
admet-1883	105	43	findings	finding	NOUN
admet-1883	105	44	,	,	PUNCT
admet-1883	105	45	in	in	ADP
admet-1883	105	46	vitro	vitro	X
admet-1883	105	47	assays	assay	NOUN
admet-1883	105	48	,	,	PUNCT
admet-1883	105	49	and	and	CCONJ
admet-1883	105	50	the	the	DET
admet-1883	105	51	nucleic	nucleic	ADJ
admet-1883	105	52	acid	acid	NOUN
admet-1883	105	53	amplification	amplification	NOUN
admet-1883	105	54	test	test	NOUN
admet-1883	105	55	.	.	PUNCT
admet-1883	106	1	the	the	DET
admet-1883	106	2	most	most	ADV
admet-1883	106	3	accurate	accurate	ADJ
admet-1883	106	4	assay	assay	NOUN
admet-1883	106	5	for	for	ADP
admet-1883	106	6	detecting	detect	VERB
admet-1883	106	7	sars	sar	NOUN
admet-1883	106	8	-	-	PUNCT
admet-1883	106	9	cov-2	cov-2	NUM
admet-1883	106	10	is	be	AUX
admet-1883	106	11	presently	presently	ADV
admet-1883	106	12	being	be	AUX
admet-1883	106	13	reliably	reliably	ADV
admet-1883	106	14	detected	detect	VERB
admet-1883	106	15	by	by	ADP
admet-1883	106	16	real	real	ADJ
admet-1883	106	17	-	-	PUNCT
admet-1883	106	18	time	time	NOUN
admet-1883	106	19	reverse	reverse	ADJ
admet-1883	106	20	transcriptase	transcriptase	NOUN
admet-1883	106	21	-	-	PUNCT
admet-1883	106	22	pcr	pcr	ADJ
admet-1883	106	23	(	(	PUNCT
admet-1883	106	24	rrt	rrt	NOUN
admet-1883	106	25	-	-	ADJ
admet-1883	106	26	pcr	pcr	NOUN
admet-1883	106	27	)	)	PUNCT
admet-1883	106	28	,	,	PUNCT
admet-1883	106	29	which	which	PRON
admet-1883	106	30	is	be	AUX
admet-1883	106	31	reinforced	reinforce	VERB
admet-1883	106	32	by	by	ADP
admet-1883	106	33	other	other	ADJ
admet-1883	106	34	auxiliary	auxiliary	ADJ
admet-1883	106	35	assays	assay	NOUN
admet-1883	106	36	like	like	ADP
admet-1883	106	37	serology	serology	NOUN
admet-1883	106	38	and	and	CCONJ
admet-1883	106	39	radiography	radiography	NOUN
admet-1883	107	1	[	[	X
admet-1883	107	2	52	52	NUM
admet-1883	107	3	]	]	PUNCT
admet-1883	107	4	.	.	PUNCT
admet-1883	108	1	commercial	commercial	ADJ
admet-1883	108	2	kits	kit	NOUN
admet-1883	108	3	have	have	AUX
admet-1883	108	4	been	be	AUX
admet-1883	108	5	brought	bring	VERB
admet-1883	108	6	into	into	ADP
admet-1883	108	7	the	the	DET
admet-1883	108	8	field	field	NOUN
admet-1883	108	9	by	by	ADP
admet-1883	108	10	validating	validate	VERB
admet-1883	108	11	numerous	numerous	ADJ
admet-1883	108	12	molecular	molecular	ADJ
admet-1883	108	13	and	and	CCONJ
admet-1883	108	14	immunological	immunological	ADJ
admet-1883	108	15	aspects	aspect	NOUN
admet-1883	108	16	by	by	ADP
admet-1883	108	17	the	the	DET
admet-1883	108	18	fda	fda	PROPN
admet-1883	108	19	(	(	PUNCT
admet-1883	108	20	food	food	NOUN
admet-1883	108	21	and	and	CCONJ
admet-1883	108	22	drug	drug	NOUN
admet-1883	108	23	administration	administration	NOUN
admet-1883	108	24	)	)	PUNCT
admet-1883	108	25	and	and	CCONJ
admet-1883	108	26	icmr	icmr	PROPN
admet-1883	108	27	(	(	PUNCT
admet-1883	108	28	indian	indian	ADJ
admet-1883	108	29	council	council	PROPN
admet-1883	108	30	of	of	ADP
admet-1883	108	31	medical	medical	ADJ
admet-1883	108	32	research	research	NOUN
admet-1883	108	33	)	)	PUNCT
admet-1883	109	1	[	[	X
admet-1883	109	2	53,54	53,54	NUM
admet-1883	109	3	]	]	X
admet-1883	109	4	.	.	PUNCT
admet-1883	110	1	however	however	ADV
admet-1883	110	2	,	,	PUNCT
admet-1883	110	3	given	give	VERB
admet-1883	110	4	the	the	DET
admet-1883	110	5	drawbacks	drawback	NOUN
admet-1883	110	6	in	in	ADP
admet-1883	110	7	terms	term	NOUN
admet-1883	110	8	of	of	ADP
admet-1883	110	9	sensitivity	sensitivity	NOUN
admet-1883	110	10	and	and	CCONJ
admet-1883	110	11	specificity	specificity	NOUN
admet-1883	110	12	,	,	PUNCT
admet-1883	110	13	as	as	ADV
admet-1883	110	14	well	well	ADV
admet-1883	110	15	as	as	ADP
admet-1883	110	16	the	the	DET
admet-1883	110	17	gaps	gap	NOUN
admet-1883	110	18	in	in	ADP
admet-1883	110	19	monitoring	monitor	VERB
admet-1883	110	20	the	the	DET
admet-1883	110	21	virus	virus	NOUN
admet-1883	110	22	spread	spread	VERB
admet-1883	110	23	,	,	PUNCT
admet-1883	110	24	there	there	PRON
admet-1883	110	25	is	be	VERB
admet-1883	110	26	an	an	DET
admet-1883	110	27	urgent	urgent	ADJ
admet-1883	110	28	need	need	NOUN
admet-1883	110	29	to	to	PART
admet-1883	110	30	develop	develop	VERB
admet-1883	110	31	a	a	DET
admet-1883	110	32	novel	novel	ADJ
admet-1883	110	33	diagnostic	diagnostic	ADJ
admet-1883	110	34	technique	technique	NOUN
admet-1883	110	35	that	that	PRON
admet-1883	110	36	is	be	AUX
admet-1883	110	37	both	both	CCONJ
admet-1883	110	38	rapid	rapid	ADJ
admet-1883	110	39	and	and	CCONJ
admet-1883	110	40	accurate	accurate	ADJ
admet-1883	110	41	with	with	ADP
admet-1883	110	42	high	high	ADJ
admet-1883	110	43	safety	safety	NOUN
admet-1883	110	44	concerns	concern	NOUN
admet-1883	110	45	to	to	PART
admet-1883	110	46	deploy	deploy	VERB
admet-1883	110	47	them	they	PRON
admet-1883	110	48	on	on	ADP
admet-1883	110	49	a	a	DET
admet-1883	110	50	wide	wide	ADJ
admet-1883	110	51	scale	scale	NOUN
admet-1883	110	52	in	in	ADP
admet-1883	110	53	order	order	NOUN
admet-1883	110	54	to	to	PART
admet-1883	110	55	halt	halt	VERB
admet-1883	110	56	the	the	DET
admet-1883	110	57	global	global	ADJ
admet-1883	110	58	outbreak	outbreak	NOUN
admet-1883	110	59	.	.	PUNCT
admet-1883	111	1	nanoparticle	nanoparticle	NOUN
admet-1883	111	2	-	-	PUNCT
admet-1883	111	3	based	base	VERB
admet-1883	111	4	diagnosis	diagnosis	NOUN
admet-1883	111	5	because	because	SCONJ
admet-1883	111	6	of	of	ADP
admet-1883	111	7	its	its	PRON
admet-1883	111	8	simplicity	simplicity	NOUN
admet-1883	111	9	,	,	PUNCT
admet-1883	111	10	high	high	ADJ
admet-1883	111	11	sensitivity	sensitivity	NOUN
admet-1883	111	12	,	,	PUNCT
admet-1883	111	13	and	and	CCONJ
admet-1883	111	14	high	high	ADJ
admet-1883	111	15	specificity	specificity	NOUN
admet-1883	111	16	based	base	VERB
admet-1883	111	17	on	on	ADP
admet-1883	111	18	exponential	exponential	ADJ
admet-1883	111	19	growth	growth	NOUN
admet-1883	111	20	in	in	ADP
admet-1883	111	21	rna	rna	NOUN
admet-1883	111	22	generated	generate	VERB
admet-1883	111	23	throughout	throughout	ADP
admet-1883	111	24	the	the	DET
admet-1883	111	25	operation	operation	NOUN
admet-1883	111	26	,	,	PUNCT
admet-1883	111	27	rt	rt	PROPN
admet-1883	111	28	-	-	PUNCT
admet-1883	111	29	pcr	pcr	PROPN
admet-1883	111	30	was	be	AUX
admet-1883	111	31	used	use	VERB
admet-1883	111	32	in	in	ADP
admet-1883	111	33	most	most	ADJ
admet-1883	111	34	viral	viral	ADJ
admet-1883	111	35	rna	rna	NOUN
admet-1883	111	36	detection	detection	NOUN
admet-1883	111	37	procedures	procedure	NOUN
admet-1883	111	38	[	[	X
admet-1883	111	39	55	55	NUM
admet-1883	111	40	]	]	PUNCT
admet-1883	111	41	.	.	PUNCT
admet-1883	112	1	although	although	SCONJ
admet-1883	112	2	rt	rt	PROPN
admet-1883	112	3	-	-	PUNCT
admet-1883	112	4	pcr	pcr	NOUN
admet-1883	112	5	techniques	technique	NOUN
admet-1883	112	6	are	be	AUX
admet-1883	112	7	commonly	commonly	ADV
admet-1883	112	8	accepted	accept	VERB
admet-1883	112	9	as	as	ADP
admet-1883	112	10	the	the	DET
admet-1883	112	11	gold	gold	ADJ
admet-1883	112	12	standard	standard	NOUN
admet-1883	112	13	for	for	ADP
admet-1883	112	14	coronavirus	coronavirus	NOUN
admet-1883	112	15	detection	detection	NOUN
admet-1883	112	16	,	,	PUNCT
admet-1883	112	17	they	they	PRON
admet-1883	112	18	do	do	AUX
admet-1883	112	19	have	have	VERB
admet-1883	112	20	certain	certain	ADJ
admet-1883	112	21	drawbacks	drawback	NOUN
admet-1883	112	22	,	,	PUNCT
admet-1883	112	23	such	such	ADJ
admet-1883	112	24	as	as	ADP
admet-1883	112	25	limited	limited	ADJ
admet-1883	112	26	extraction	extraction	NOUN
admet-1883	112	27	efficiency	efficiency	NOUN
admet-1883	112	28	,	,	PUNCT
admet-1883	112	29	time	time	NOUN
admet-1883	112	30	-	-	PUNCT
admet-1883	112	31	consuming	consume	VERB
admet-1883	112	32	procedure	procedure	NOUN
admet-1883	112	33	,	,	PUNCT
admet-1883	112	34	and	and	CCONJ
admet-1883	112	35	false	false	ADJ
admet-1883	112	36	-	-	PUNCT
admet-1883	112	37	positive	positive	ADJ
admet-1883	112	38	result	result	NOUN
admet-1883	112	39	due	due	ADP
admet-1883	112	40	to	to	ADP
admet-1883	112	41	contamination	contamination	NOUN
admet-1883	112	42	.	.	PUNCT
admet-1883	113	1	to	to	PART
admet-1883	113	2	improve	improve	VERB
admet-1883	113	3	the	the	DET
admet-1883	113	4	method	method	NOUN
admet-1883	113	5	of	of	ADP
admet-1883	113	6	detection	detection	NOUN
admet-1883	113	7	of	of	ADP
admet-1883	113	8	virus	virus	NOUN
admet-1883	113	9	efficacy	efficacy	NOUN
admet-1883	113	10	,	,	PUNCT
admet-1883	113	11	ultra	ultra	ADJ
admet-1883	113	12	-	-	ADJ
admet-1883	113	13	small	small	ADJ
admet-1883	113	14	nanoparticles	nanoparticle	NOUN
admet-1883	113	15	have	have	AUX
admet-1883	113	16	been	be	AUX
admet-1883	113	17	used	use	VERB
admet-1883	113	18	not	not	PART
admet-1883	113	19	only	only	ADV
admet-1883	113	20	in	in	ADP
admet-1883	113	21	rt	rt	ADJ
admet-1883	113	22	-	-	PUNCT
admet-1883	113	23	pcr	pcr	PROPN
admet-1883	113	24	but	but	CCONJ
admet-1883	113	25	also	also	ADV
admet-1883	113	26	in	in	ADP
admet-1883	113	27	other	other	ADJ
admet-1883	113	28	viral	viral	ADJ
admet-1883	113	29	detection	detection	NOUN
admet-1883	113	30	techniques	technique	NOUN
admet-1883	113	31	such	such	ADJ
admet-1883	113	32	as	as	ADP
admet-1883	113	33	an	an	DET
admet-1883	113	34	enzyme	enzyme	NOUN
admet-1883	113	35	-	-	PUNCT
admet-1883	113	36	linked	link	VERB
admet-1883	113	37	immunosorbent	immunosorbent	NOUN
admet-1883	113	38	assay	assay	PROPN
admet-1883	113	39	(	(	PUNCT
admet-1883	113	40	elisa	elisa	NOUN
admet-1883	113	41	)	)	PUNCT
admet-1883	113	42	and	and	CCONJ
admet-1883	113	43	rt	rt	NOUN
admet-1883	113	44	-	-	PUNCT
admet-1883	113	45	lamp	lamp	NOUN
admet-1883	113	46	(	(	PUNCT
admet-1883	113	47	reverse	reverse	VERB
admet-1883	113	48	transcription	transcription	NOUN
admet-1883	113	49	loop	loop	NOUN
admet-1883	113	50	-	-	PUNCT
admet-1883	113	51	mediated	mediate	VERB
admet-1883	113	52	isothermal	isothermal	ADJ
admet-1883	113	53	amplification	amplification	NOUN
admet-1883	113	54	)	)	PUNCT
admet-1883	114	1	[	[	X
admet-1883	114	2	56,57	56,57	NOUN
admet-1883	114	3	]	]	X
admet-1883	114	4	.	.	PUNCT
admet-1883	115	1	metal	metal	NOUN
admet-1883	115	2	nanoparticles	nanoparticle	NOUN
admet-1883	115	3	,	,	PUNCT
admet-1883	115	4	carbon	carbon	NOUN
admet-1883	115	5	nanotubes	nanotube	NOUN
admet-1883	115	6	,	,	PUNCT
admet-1883	115	7	silica	silica	NOUN
admet-1883	115	8	nanoparticles	nanoparticle	NOUN
admet-1883	115	9	,	,	PUNCT
admet-1883	115	10	quantum	quantum	ADJ
admet-1883	115	11	dots	dot	NOUN
admet-1883	115	12	(	(	PUNCT
admet-1883	115	13	qds	qds	PROPN
admet-1883	115	14	)	)	PUNCT
admet-1883	115	15	,	,	PUNCT
admet-1883	115	16	and	and	CCONJ
admet-1883	115	17	polymeric	polymeric	ADJ
admet-1883	115	18	nanoparticles	nanoparticle	NOUN
admet-1883	115	19	have	have	AUX
admet-1883	115	20	been	be	AUX
admet-1883	115	21	examined	examine	VERB
admet-1883	115	22	in	in	ADP
admet-1883	115	23	the	the	DET
admet-1883	115	24	context	context	NOUN
admet-1883	115	25	of	of	ADP
admet-1883	115	26	viral	viral	ADJ
admet-1883	115	27	detection	detection	NOUN
admet-1883	115	28	.	.	PUNCT
admet-1883	116	1	colorimetric	colorimetric	ADJ
admet-1883	116	2	,	,	PUNCT
admet-1883	116	3	fluorescent	fluorescent	NOUN
admet-1883	116	4	,	,	PUNCT
admet-1883	116	5	electrochemical	electrochemical	ADJ
admet-1883	116	6	,	,	PUNCT
admet-1883	116	7	and	and	CCONJ
admet-1883	116	8	optical	optical	ADJ
admet-1883	116	9	imaging	imaging	NOUN
admet-1883	116	10	techniques	technique	NOUN
admet-1883	116	11	are	be	AUX
admet-1883	116	12	used	use	VERB
admet-1883	116	13	as	as	ADP
admet-1883	116	14	most	most	ADJ
admet-1883	116	15	diagnostic	diagnostic	ADJ
admet-1883	116	16	methods	method	NOUN
admet-1883	116	17	.	.	PUNCT
admet-1883	117	1	metal	metal	NOUN
admet-1883	117	2	nanoparticles	nanoparticle	NOUN
admet-1883	117	3	and	and	CCONJ
admet-1883	117	4	qds	qds	PROPN
admet-1883	117	5	with	with	ADP
admet-1883	117	6	distinct	distinct	ADJ
admet-1883	117	7	optical	optical	ADJ
admet-1883	117	8	characteristics	characteristic	NOUN
admet-1883	117	9	offer	offer	VERB
admet-1883	117	10	increased	increase	VERB
admet-1883	117	11	sensitivity	sensitivity	NOUN
admet-1883	117	12	for	for	ADP
admet-1883	117	13	optical	optical	ADJ
admet-1883	117	14	biosensing	biosensing	NOUN
admet-1883	117	15	,	,	PUNCT
admet-1883	117	16	and	and	CCONJ
admet-1883	117	17	magnetic	magnetic	ADJ
admet-1883	117	18	properties	property	NOUN
admet-1883	117	19	are	be	AUX
admet-1883	117	20	used	use	VERB
admet-1883	117	21	in	in	ADP
admet-1883	117	22	the	the	DET
admet-1883	117	23	extraction	extraction	NOUN
admet-1883	117	24	process	process	NOUN
admet-1883	117	25	of	of	ADP
admet-1883	117	26	the	the	DET
admet-1883	117	27	virus	virus	NOUN
admet-1883	118	1	[	[	X
admet-1883	118	2	58	58	NUM
admet-1883	118	3	-	-	SYM
admet-1883	118	4	61	61	NUM
admet-1883	118	5	]	]	PUNCT
admet-1883	118	6	.	.	PUNCT
admet-1883	119	1	nanoparticle	nanoparticle	NOUN
admet-1883	119	2	-	-	PUNCT
admet-1883	119	3	based	base	VERB
admet-1883	119	4	viral	viral	ADJ
admet-1883	119	5	detection	detection	NOUN
admet-1883	119	6	method	method	NOUN
admet-1883	119	7	has	have	AUX
admet-1883	119	8	been	be	AUX
admet-1883	119	9	identified	identify	VERB
admet-1883	119	10	as	as	ADP
admet-1883	119	11	a	a	DET
admet-1883	119	12	suitable	suitable	ADJ
admet-1883	119	13	target	target	NOUN
admet-1883	119	14	for	for	ADP
admet-1883	119	15	sars	sar	NOUN
admet-1883	119	16	-	-	PUNCT
admet-1883	119	17	cov-2	cov-2	NOUN
admet-1883	119	18	.	.	PUNCT
admet-1883	119	19	nanoparticles	nanoparticle	NOUN
admet-1883	119	20	will	will	AUX
admet-1883	119	21	play	play	VERB
admet-1883	119	22	a	a	DET
admet-1883	119	23	major	major	ADJ
admet-1883	119	24	role	role	NOUN
admet-1883	119	25	in	in	ADP
admet-1883	119	26	enhancing	enhance	VERB
admet-1883	119	27	not	not	PART
admet-1883	119	28	only	only	ADV
admet-1883	119	29	coronavirus	coronavirus	NOUN
admet-1883	119	30	detection	detection	NOUN
admet-1883	119	31	efficiency	efficiency	NOUN
admet-1883	119	32	but	but	CCONJ
admet-1883	119	33	also	also	ADV
admet-1883	119	34	biological	biological	ADJ
admet-1883	119	35	pathogen	pathogen	NOUN
admet-1883	119	36	diagnoses	diagnosis	NOUN
admet-1883	119	37	,	,	PUNCT
admet-1883	119	38	with	with	ADP
admet-1883	119	39	improvement	improvement	NOUN
admet-1883	119	40	in	in	ADP
admet-1883	119	41	study	study	NOUN
admet-1883	119	42	and	and	CCONJ
admet-1883	119	43	development	development	NOUN
admet-1883	119	44	(	(	PUNCT
admet-1883	119	45	figure	figure	NOUN
admet-1883	119	46	2	2	NUM
admet-1883	119	47	)	)	PUNCT
admet-1883	120	1	[	[	X
admet-1883	120	2	62,63	62,63	NOUN
admet-1883	120	3	]	]	PUNCT
admet-1883	120	4	.	.	PUNCT
admet-1883	121	1	figure	figure	NOUN
admet-1883	121	2	2	2	NUM
admet-1883	121	3	.	.	PUNCT
admet-1883	122	1	nanoparticles	nanoparticle	NOUN
admet-1883	122	2	used	use	VERB
admet-1883	122	3	for	for	ADP
admet-1883	122	4	prevention	prevention	NOUN
admet-1883	122	5	to	to	ADP
admet-1883	122	6	treatment	treatment	NOUN
admet-1883	122	7	against	against	ADP
admet-1883	122	8	sars	sar	NOUN
admet-1883	122	9	-	-	PUNCT
admet-1883	122	10	cov-2	cov-2	NOUN
admet-1883	122	11	https://doi.org/10.5599/admet.1883	https://doi.org/10.5599/admet.1883	ADJ
admet-1883	122	12	p.	p.	PROPN
admet-1883	122	13	pallavi	pallavi	VERB
admet-1883	122	14	et	et	PROPN
admet-1883	122	15	al	al	PROPN
admet-1883	122	16	.	.	PROPN
admet-1883	122	17	admet	admet	PROPN
admet-1883	122	18	&	&	CCONJ
admet-1883	122	19	dmpk	dmpk	PROPN
admet-1883	122	20	11(4	11(4	NUM
admet-1883	122	21	)	)	PUNCT
admet-1883	122	22	(	(	PUNCT
admet-1883	122	23	2023	2023	NUM
admet-1883	122	24	)	)	PUNCT
admet-1883	122	25	513	513	NUM
admet-1883	122	26	-	-	SYM
admet-1883	122	27	531	531	NUM
admet-1883	122	28	518	518	NUM
admet-1883	122	29	treatment	treatment	NOUN
admet-1883	122	30	researchers	researcher	NOUN
admet-1883	122	31	are	be	AUX
admet-1883	122	32	already	already	ADV
admet-1883	122	33	into	into	ADP
admet-1883	122	34	the	the	DET
admet-1883	122	35	development	development	NOUN
admet-1883	122	36	of	of	ADP
admet-1883	122	37	a	a	DET
admet-1883	122	38	variety	variety	NOUN
admet-1883	122	39	of	of	ADP
admet-1883	122	40	pharmaceuticals	pharmaceutical	NOUN
admet-1883	122	41	to	to	PART
admet-1883	122	42	combat	combat	VERB
admet-1883	122	43	covid-19	covid-19	PROPN
admet-1883	122	44	.	.	PUNCT
admet-1883	123	1	drugs	drug	NOUN
admet-1883	123	2	being	be	AUX
admet-1883	123	3	investigated	investigate	VERB
admet-1883	123	4	for	for	ADP
admet-1883	123	5	the	the	DET
admet-1883	123	6	treatment	treatment	NOUN
admet-1883	123	7	against	against	ADP
admet-1883	123	8	covid-19	covid-19	PROPN
admet-1883	123	9	follow	follow	VERB
admet-1883	123	10	either	either	DET
admet-1883	123	11	one	one	NUM
admet-1883	123	12	of	of	ADP
admet-1883	123	13	the	the	DET
admet-1883	123	14	two	two	NUM
admet-1883	123	15	mechanisms	mechanism	NOUN
admet-1883	123	16	:	:	PUNCT
admet-1883	123	17	(	(	PUNCT
admet-1883	123	18	1	1	X
admet-1883	123	19	)	)	PUNCT
admet-1883	123	20	to	to	PART
admet-1883	123	21	control	control	VERB
admet-1883	123	22	the	the	DET
admet-1883	123	23	symptoms	symptom	NOUN
admet-1883	123	24	caused	cause	VERB
admet-1883	123	25	or	or	CCONJ
admet-1883	123	26	(	(	PUNCT
admet-1883	123	27	2	2	NUM
admet-1883	123	28	)	)	PUNCT
admet-1883	123	29	to	to	PART
admet-1883	123	30	inactivate	inactivate	VERB
admet-1883	123	31	by	by	ADP
admet-1883	123	32	targeting	target	VERB
admet-1883	123	33	the	the	DET
admet-1883	123	34	replication	replication	NOUN
admet-1883	123	35	cycle	cycle	NOUN
admet-1883	123	36	of	of	ADP
admet-1883	123	37	the	the	DET
admet-1883	123	38	virus	virus	NOUN
admet-1883	124	1	[	[	X
admet-1883	124	2	64,65	64,65	NOUN
admet-1883	124	3	]	]	X
admet-1883	124	4	.	.	PUNCT
admet-1883	125	1	since	since	SCONJ
admet-1883	125	2	no	no	DET
admet-1883	125	3	proper	proper	ADJ
admet-1883	125	4	drug	drug	NOUN
admet-1883	125	5	is	be	AUX
admet-1883	125	6	developed	develop	VERB
admet-1883	125	7	,	,	PUNCT
admet-1883	125	8	many	many	ADJ
admet-1883	125	9	antimicrobial	antimicrobial	ADJ
admet-1883	125	10	drugs	drug	NOUN
admet-1883	125	11	are	be	AUX
admet-1883	125	12	being	be	AUX
admet-1883	125	13	provided	provide	VERB
admet-1883	125	14	to	to	ADP
admet-1883	125	15	the	the	DET
admet-1883	125	16	patients	patient	NOUN
admet-1883	125	17	as	as	ADP
admet-1883	125	18	a	a	DET
admet-1883	125	19	first	first	ADJ
admet-1883	125	20	-line	-line	NOUN
admet-1883	125	21	treatment	treatment	NOUN
admet-1883	125	22	is	be	AUX
admet-1883	125	23	tabulated	tabulate	VERB
admet-1883	125	24	below	below	ADP
admet-1883	125	25	(	(	PUNCT
admet-1883	125	26	table	table	NOUN
admet-1883	125	27	1	1	NUM
admet-1883	125	28	)	)	PUNCT
admet-1883	125	29	.	.	PUNCT
admet-1883	126	1	table	table	NOUN
admet-1883	127	1	1	1	NUM
admet-1883	127	2	.	.	PUNCT
admet-1883	128	1	summary	summary	NOUN
admet-1883	128	2	of	of	ADP
admet-1883	128	3	antiviral	antiviral	ADJ
admet-1883	128	4	drugs	drug	NOUN
admet-1883	128	5	being	be	AUX
admet-1883	128	6	used	use	VERB
admet-1883	128	7	for	for	SCONJ
admet-1883	128	8	covid-19	covid-19	PROPN
admet-1883	128	9	to	to	PART
admet-1883	128	10	suppress	suppress	VERB
admet-1883	128	11	aggressiveness	aggressiveness	NOUN
admet-1883	128	12	.	.	PUNCT
admet-1883	129	1	no	no	DET
admet-1883	129	2	name	name	NOUN
admet-1883	129	3	of	of	ADP
admet-1883	129	4	the	the	DET
admet-1883	129	5	drugs	drug	NOUN
admet-1883	129	6	class	class	NOUN
admet-1883	129	7	of	of	ADP
admet-1883	129	8	the	the	DET
admet-1883	129	9	drug	drug	NOUN
admet-1883	129	10	route	route	NOUN
admet-1883	129	11	of	of	ADP
admet-1883	129	12	administration	administration	NOUN
admet-1883	129	13	mechanism	mechanism	NOUN
admet-1883	129	14	of	of	ADP
admet-1883	129	15	action	action	NOUN
admet-1883	129	16	adverse	adverse	ADJ
admet-1883	129	17	effect	effect	NOUN
admet-1883	129	18	1	1	NUM
admet-1883	129	19	.	.	PUNCT
admet-1883	130	1	remdesivir	remdesivir	PROPN
admet-1883	130	2	antiviral	antiviral	ADJ
admet-1883	130	3	drug	drug	PROPN
admet-1883	130	4	intravenous	intravenous	ADJ
admet-1883	130	5	(	(	PUNCT
admet-1883	130	6	iv	iv	X
admet-1883	130	7	)	)	PUNCT
admet-1883	130	8	injection	injection	NOUN
admet-1883	130	9	possess	possess	VERB
admet-1883	130	10	inhibitory	inhibitory	ADJ
admet-1883	130	11	activity	activity	NOUN
admet-1883	130	12	by	by	ADP
admet-1883	130	13	inhibiting	inhibit	VERB
admet-1883	130	14	viral	viral	ADJ
admet-1883	130	15	rna	rna	NOUN
admet-1883	130	16	-	-	PUNCT
admet-1883	130	17	dependent	dependent	ADJ
admet-1883	130	18	polymerase	polymerase	NOUN
admet-1883	130	19	.	.	PUNCT
admet-1883	131	1	chest	chest	NOUN
admet-1883	131	2	tightness	tightness	NOUN
admet-1883	131	3	,	,	PUNCT
admet-1883	131	4	back	back	NOUN
admet-1883	131	5	pain	pain	NOUN
admet-1883	131	6	,	,	PUNCT
admet-1883	131	7	dark	dark	ADJ
admet-1883	131	8	-	-	PUNCT
admet-1883	131	9	colored	colored	ADJ
admet-1883	131	10	urine	urine	NOUN
admet-1883	131	11	,	,	PUNCT
admet-1883	131	12	light	light	ADJ
admet-1883	131	13	-	-	PUNCT
admet-1883	131	14	colored	colored	ADJ
admet-1883	131	15	stools	stool	NOUN
admet-1883	131	16	,	,	PUNCT
admet-1883	131	17	flushing	flush	VERB
admet-1883	131	18	,	,	PUNCT
admet-1883	131	19	headache	headache	NOUN
admet-1883	131	20	,	,	PUNCT
admet-1883	131	21	nausea	nausea	NOUN
admet-1883	131	22	,	,	PUNCT
admet-1883	131	23	and	and	CCONJ
admet-1883	131	24	vomiting	vomiting	NOUN
admet-1883	131	25	.	.	PUNCT
admet-1883	132	1	2	2	X
admet-1883	132	2	.	.	X
admet-1883	132	3	dexamethasone	dexamethasone	NOUN
admet-1883	132	4	corticosteroid	corticosteroid	ADJ
admet-1883	132	5	oral	oral	ADJ
admet-1883	132	6	/	/	SYM
admet-1883	132	7	intravenous	intravenous	ADJ
admet-1883	132	8	/	/	SYM
admet-1883	132	9	intramuscular	intramuscular	PROPN
admet-1883	132	10	(	(	PUNCT
admet-1883	132	11	i	i	NOUN
admet-1883	132	12	m	m	PROPN
admet-1883	132	13	)	)	PUNCT
admet-1883	132	14	/	/	SYM
admet-1883	132	15	intraarticular	intraarticular	NOUN
admet-1883	132	16	inhibit	inhibit	VERB
admet-1883	132	17	a	a	DET
admet-1883	132	18	proinflammatory	proinflammatory	ADJ
admet-1883	132	19	gene	gene	NOUN
admet-1883	132	20	encoding	encoding	NOUN
admet-1883	132	21	cell	cell	NOUN
admet-1883	132	22	adhesion	adhesion	NOUN
admet-1883	132	23	molecules	molecule	NOUN
admet-1883	132	24	(	(	PUNCT
admet-1883	132	25	cam	cam	NOUN
admet-1883	132	26	)	)	PUNCT
admet-1883	132	27	.	.	PUNCT
admet-1883	133	1	glaucoma	glaucoma	NOUN
admet-1883	133	2	,	,	PUNCT
admet-1883	133	3	cataracts	cataract	NOUN
admet-1883	133	4	,	,	PUNCT
admet-1883	133	5	fluid	fluid	ADJ
admet-1883	133	6	retention	retention	NOUN
admet-1883	133	7	,	,	PUNCT
admet-1883	133	8	hypertension	hypertension	NOUN
admet-1883	133	9	,	,	PUNCT
admet-1883	133	10	osteoporosis	osteoporosis	NOUN
admet-1883	133	11	,	,	PUNCT
admet-1883	133	12	mood	mood	NOUN
admet-1883	133	13	swings	swing	NOUN
admet-1883	133	14	,	,	PUNCT
admet-1883	133	15	confusion	confusion	NOUN
admet-1883	133	16	,	,	PUNCT
admet-1883	133	17	and	and	CCONJ
admet-1883	133	18	irritation	irritation	NOUN
admet-1883	133	19	.	.	PUNCT
admet-1883	134	1	3	3	X
admet-1883	134	2	.	.	X
admet-1883	134	3	tocilizumab	tocilizumab	NOUN
admet-1883	134	4	antiviral	antiviral	ADJ
admet-1883	134	5	drug	drug	PROPN
admet-1883	134	6	iv	iv	NUM
admet-1883	134	7	infusion	infusion	NOUN
admet-1883	134	8	binds	bind	VERB
admet-1883	134	9	to	to	ADP
admet-1883	134	10	both	both	DET
admet-1883	134	11	sil-6r	sil-6r	VERB
admet-1883	134	12	and	and	CCONJ
admet-1883	134	13	mil-6r	mil-6r	PROPN
admet-1883	134	14	to	to	PART
admet-1883	134	15	inhibit	inhibit	VERB
admet-1883	134	16	the	the	DET
admet-1883	134	17	action	action	NOUN
admet-1883	134	18	.	.	PUNCT
admet-1883	135	1	stuffy	stuffy	ADJ
admet-1883	135	2	nose	nose	NOUN
admet-1883	135	3	,	,	PUNCT
admet-1883	135	4	sore	sore	ADJ
admet-1883	135	5	throat	throat	NOUN
admet-1883	135	6	,	,	PUNCT
admet-1883	135	7	headache	headache	NOUN
admet-1883	135	8	,	,	PUNCT
admet-1883	135	9	hypertension	hypertension	NOUN
admet-1883	135	10	,	,	PUNCT
admet-1883	135	11	and	and	CCONJ
admet-1883	135	12	injection	injection	NOUN
admet-1883	135	13	site	site	NOUN
admet-1883	135	14	reactions	reaction	NOUN
admet-1883	135	15	.	.	PUNCT
admet-1883	136	1	the	the	DET
admet-1883	136	2	rare	rare	ADJ
admet-1883	136	3	,	,	PUNCT
admet-1883	136	4	more	more	ADV
admet-1883	136	5	serious	serious	ADJ
admet-1883	136	6	side	side	NOUN
admet-1883	136	7	effects	effect	NOUN
admet-1883	136	8	include	include	VERB
admet-1883	136	9	gastrointestinal	gastrointestinal	ADJ
admet-1883	136	10	perforations	perforation	NOUN
admet-1883	136	11	.	.	PUNCT
admet-1883	137	1	4	4	X
admet-1883	137	2	.	.	X
admet-1883	137	3	favipiravir	favipiravir	PROPN
admet-1883	137	4	antiviral	antiviral	PROPN
admet-1883	137	5	drug	drug	PROPN
admet-1883	137	6	oral	oral	ADJ
admet-1883	137	7	inhibit	inhibit	NOUN
admet-1883	137	8	replication	replication	NOUN
admet-1883	137	9	of	of	ADP
admet-1883	137	10	influenza	influenza	NOUN
admet-1883	137	11	a	a	PRON
admet-1883	137	12	and	and	CCONJ
admet-1883	137	13	b	b	NOUN
admet-1883	137	14	,	,	PUNCT
admet-1883	137	15	ebola	ebola	NOUN
admet-1883	137	16	,	,	PUNCT
admet-1883	137	17	and	and	CCONJ
admet-1883	137	18	other	other	ADJ
admet-1883	137	19	pathogenic	pathogenic	ADJ
admet-1883	137	20	viral	viral	ADJ
admet-1883	137	21	infections	infection	NOUN
admet-1883	137	22	,	,	PUNCT
admet-1883	137	23	but	but	CCONJ
admet-1883	137	24	the	the	DET
admet-1883	137	25	drug	drug	NOUN
admet-1883	137	26	has	have	AUX
admet-1883	137	27	shown	show	VERB
admet-1883	137	28	promise	promise	NOUN
admet-1883	137	29	in	in	ADP
admet-1883	137	30	the	the	DET
admet-1883	137	31	treatment	treatment	NOUN
admet-1883	137	32	of	of	ADP
admet-1883	137	33	avian	avian	ADJ
admet-1883	137	34	influenza	influenza	NOUN
admet-1883	137	35	.	.	PUNCT
admet-1883	138	1	diarrhea	diarrhea	PROPN
admet-1883	138	2	,	,	PUNCT
admet-1883	138	3	hyperuricemia	hyperuricemia	ADV
admet-1883	138	4	,	,	PUNCT
admet-1883	138	5	reduced	reduce	VERB
admet-1883	138	6	neutrophil	neutrophil	ADJ
admet-1883	138	7	count	count	NOUN
admet-1883	138	8	,	,	PUNCT
admet-1883	138	9	abdominal	abdominal	ADJ
admet-1883	138	10	pain	pain	NOUN
admet-1883	138	11	,	,	PUNCT
admet-1883	138	12	nausea	nausea	NOUN
admet-1883	138	13	,	,	PUNCT
admet-1883	138	14	and	and	CCONJ
admet-1883	138	15	vomiting	vomiting	NOUN
admet-1883	138	16	.	.	PUNCT
admet-1883	139	1	5	5	X
admet-1883	139	2	.	.	X
admet-1883	139	3	ivermectin	ivermectin	NOUN
admet-1883	139	4	antiparasitic	antiparasitic	ADJ
admet-1883	139	5	drug	drug	NOUN
admet-1883	139	6	subcutaneous	subcutaneous	ADJ
admet-1883	139	7	/	/	SYM
admet-1883	139	8	oral	oral	NOUN
admet-1883	139	9	it	it	PRON
admet-1883	139	10	targets	target	VERB
admet-1883	139	11	the	the	DET
admet-1883	139	12	impα	impα	NOUN
admet-1883	139	13	component	component	NOUN
admet-1883	139	14	and	and	CCONJ
admet-1883	139	15	blocks	block	VERB
admet-1883	139	16	the	the	DET
admet-1883	139	17	nuclear	nuclear	ADJ
admet-1883	139	18	transport	transport	NOUN
admet-1883	139	19	of	of	ADP
admet-1883	139	20	viral	viral	ADJ
admet-1883	139	21	proteins	protein	NOUN
admet-1883	139	22	.	.	PUNCT
admet-1883	140	1	headache	headache	NOUN
admet-1883	140	2	,	,	PUNCT
admet-1883	140	3	dizziness	dizziness	NOUN
admet-1883	140	4	,	,	PUNCT
admet-1883	140	5	muscle	muscle	NOUN
admet-1883	140	6	pain	pain	NOUN
admet-1883	140	7	,	,	PUNCT
admet-1883	140	8	nausea	nausea	NOUN
admet-1883	140	9	,	,	PUNCT
admet-1883	140	10	swollen	swollen	ADJ
admet-1883	140	11	lymph	lymph	NOUN
admet-1883	140	12	nodes	node	NOUN
admet-1883	140	13	,	,	PUNCT
admet-1883	140	14	eye	eye	NOUN
admet-1883	140	15	swelling	swelling	NOUN
admet-1883	140	16	,	,	PUNCT
admet-1883	140	17	weakness	weakness	NOUN
admet-1883	140	18	,	,	PUNCT
admet-1883	140	19	vision	vision	NOUN
admet-1883	140	20	changes	change	NOUN
admet-1883	140	21	,	,	PUNCT
admet-1883	140	22	and	and	CCONJ
admet-1883	140	23	itching	itching	NOUN
admet-1883	140	24	.	.	PUNCT
admet-1883	141	1	6	6	X
admet-1883	141	2	.	.	X
admet-1883	141	3	lopinavir	lopinavir	NOUN
admet-1883	141	4	/ritonavir	/ritonavir	PUNCT
admet-1883	142	1	antiretroviral	antiretroviral	ADJ
admet-1883	142	2	oral	oral	ADJ
admet-1883	142	3	inhibit	inhibit	VERB
admet-1883	142	4	the	the	DET
admet-1883	142	5	action	action	NOUN
admet-1883	142	6	of	of	ADP
admet-1883	142	7	3clpro	3clpro	NUM
admet-1883	142	8	therapy	therapy	NOUN
admet-1883	142	9	to	to	PART
admet-1883	142	10	disrupt	disrupt	VERB
admet-1883	142	11	viral	viral	ADJ
admet-1883	142	12	replication	replication	NOUN
admet-1883	142	13	.	.	PUNCT
admet-1883	143	1	muscle	muscle	NOUN
admet-1883	143	2	weakness	weakness	NOUN
admet-1883	143	3	,	,	PUNCT
admet-1883	143	4	diarrhea	diarrhea	NOUN
admet-1883	143	5	,	,	PUNCT
admet-1883	143	6	heart	heart	NOUN
admet-1883	143	7	burning	burning	NOUN
admet-1883	143	8	,	,	PUNCT
admet-1883	143	9	difficulty	difficulty	NOUN
admet-1883	143	10	in	in	ADP
admet-1883	143	11	sleep	sleep	NOUN
admet-1883	143	12	,	,	PUNCT
admet-1883	143	13	muscle	muscle	NOUN
admet-1883	143	14	pain	pain	NOUN
admet-1883	143	15	,	,	PUNCT
admet-1883	143	16	nausea	nausea	NOUN
admet-1883	143	17	loss	loss	NOUN
admet-1883	143	18	of	of	ADP
admet-1883	143	19	appetite	appetite	PROPN
admet-1883	143	20	.7	.7	PROPN
admet-1883	143	21	.	.	PUNCT
admet-1883	144	1	baricitinib	baricitinib	NOUN
admet-1883	144	2	antirheumatic	antirheumatic	ADJ
admet-1883	144	3	drug	drug	NOUN
admet-1883	144	4	oral	oral	ADJ
admet-1883	144	5	inhibit	inhibit	NOUN
admet-1883	144	6	jak1	jak1	PROPN
admet-1883	144	7	/	/	SYM
admet-1883	144	8	jak2	jak2	PROPN
admet-1883	144	9	to	to	PART
admet-1883	144	10	modulate	modulate	VERB
admet-1883	144	11	downstream	downstream	ADJ
admet-1883	144	12	inflammatory	inflammatory	ADJ
admet-1883	144	13	responses	response	NOUN
admet-1883	144	14	.	.	PUNCT
admet-1883	145	1	anemia	anemia	NOUN
admet-1883	145	2	,	,	PUNCT
admet-1883	145	3	liver	liver	NOUN
admet-1883	145	4	disease	disease	NOUN
admet-1883	145	5	,	,	PUNCT
admet-1883	145	6	nausea	nausea	NOUN
admet-1883	145	7	,	,	PUNCT
admet-1883	145	8	loss	loss	NOUN
admet-1883	145	9	of	of	ADP
admet-1883	145	10	appetite	appetite	NOUN
admet-1883	145	11	,	,	PUNCT
admet-1883	145	12	abdominal	abdominal	ADJ
admet-1883	145	13	pain	pain	NOUN
admet-1883	145	14	,	,	PUNCT
admet-1883	145	15	yellowing	yellow	VERB
admet-1883	145	16	eyes	eye	NOUN
admet-1883	145	17	/	/	SYM
admet-1883	145	18	skin	skin	NOUN
admet-1883	145	19	,	,	PUNCT
admet-1883	145	20	dark	dark	ADJ
admet-1883	145	21	urine	urine	NOUN
admet-1883	145	22	,	,	PUNCT
admet-1883	145	23	fever	fever	NOUN
admet-1883	145	24	,	,	PUNCT
admet-1883	145	25	fainting	fainting	NOUN
admet-1883	145	26	.	.	PUNCT
admet-1883	146	1	8	8	X
admet-1883	146	2	.	.	X
admet-1883	146	3	chloroquine	chloroquine	NOUN
admet-1883	146	4	and	and	CCONJ
admet-1883	146	5	hydroxychloroquine	hydroxychloroquine	ADJ
admet-1883	146	6	antimalarial	antimalarial	ADJ
admet-1883	146	7	drug	drug	NOUN
admet-1883	146	8	subcutaneous	subcutaneous	ADJ
admet-1883	146	9	/	/	SYM
admet-1883	146	10	intramuscular	intramuscular	ADJ
admet-1883	146	11	inhibit	inhibit	VERB
admet-1883	146	12	endosomal	endosomal	ADJ
admet-1883	146	13	acidification	acidification	NOUN
admet-1883	146	14	to	to	PART
admet-1883	146	15	block	block	VERB
admet-1883	146	16	glycosylation	glycosylation	NOUN
admet-1883	146	17	and	and	CCONJ
admet-1883	146	18	break	break	VERB
admet-1883	146	19	down	down	ADP
admet-1883	146	20	the	the	DET
admet-1883	146	21	production	production	NOUN
admet-1883	146	22	of	of	ADP
admet-1883	146	23	viral	viral	ADJ
admet-1883	146	24	proteins	protein	NOUN
admet-1883	146	25	.	.	PUNCT
admet-1883	147	1	dizziness	dizziness	NOUN
admet-1883	147	2	,	,	PUNCT
admet-1883	147	3	loss	loss	NOUN
admet-1883	147	4	of	of	ADP
admet-1883	147	5	appetite	appetite	NOUN
admet-1883	147	6	,	,	PUNCT
admet-1883	147	7	diarrhea	diarrhea	PROPN
admet-1883	147	8	,	,	PUNCT
admet-1883	147	9	blurred	blurred	ADJ
admet-1883	147	10	vision	vision	NOUN
admet-1883	147	11	,	,	PUNCT
admet-1883	147	12	sensitivity	sensitivity	NOUN
admet-1883	147	13	to	to	ADP
admet-1883	147	14	light	light	NOUN
admet-1883	147	15	,	,	PUNCT
admet-1883	147	16	ringing	ring	VERB
admet-1883	147	17	in	in	ADP
admet-1883	147	18	ears	ear	NOUN
admet-1883	147	19	,	,	PUNCT
admet-1883	147	20	muscle	muscle	NOUN
admet-1883	147	21	weakness	weakness	NOUN
admet-1883	147	22	,	,	PUNCT
admet-1883	147	23	and	and	CCONJ
admet-1883	147	24	mental	mental	ADJ
admet-1883	147	25	change	change	NOUN
admet-1883	147	26	.	.	PUNCT
admet-1883	148	1	admet	admet	PROPN
admet-1883	148	2	&	&	CCONJ
admet-1883	148	3	dmpk	dmpk	PROPN
admet-1883	148	4	11(4	11(4	NUM
admet-1883	148	5	)	)	PUNCT
admet-1883	148	6	(	(	PUNCT
admet-1883	148	7	2023	2023	NUM
admet-1883	148	8	)	)	PUNCT
admet-1883	148	9	513	513	NUM
admet-1883	148	10	-	-	SYM
admet-1883	148	11	531	531	NUM
admet-1883	148	12	infections	infection	NOUN
admet-1883	148	13	associated	associate	VERB
admet-1883	148	14	with	with	ADP
admet-1883	148	15	sars	sar	NOUN
admet-1883	148	16	-	-	PUNCT
admet-1883	148	17	cov-2	cov-2	PART
admet-1883	148	18	exploited	exploit	VERB
admet-1883	148	19	via	via	ADP
admet-1883	148	20	photodynamic	photodynamic	ADJ
admet-1883	148	21	therapy	therapy	NOUN
admet-1883	148	22	doi	doi	NOUN
admet-1883	148	23	:	:	PUNCT
admet-1883	148	24	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-1883	148	25	t.1883	t.1883	VERB
admet-1883	148	26	519	519	NUM
admet-1883	149	1	no	no	DET
admet-1883	149	2	name	name	NOUN
admet-1883	149	3	of	of	ADP
admet-1883	149	4	the	the	DET
admet-1883	149	5	drugs	drug	NOUN
admet-1883	149	6	class	class	NOUN
admet-1883	149	7	of	of	ADP
admet-1883	149	8	the	the	DET
admet-1883	149	9	drug	drug	NOUN
admet-1883	149	10	route	route	NOUN
admet-1883	149	11	of	of	ADP
admet-1883	149	12	administration	administration	NOUN
admet-1883	149	13	mechanism	mechanism	NOUN
admet-1883	149	14	of	of	ADP
admet-1883	149	15	action	action	NOUN
admet-1883	149	16	adverse	adverse	ADJ
admet-1883	149	17	effect	effect	NOUN
admet-1883	149	18	9	9	NUM
admet-1883	149	19	.	.	X
admet-1883	149	20	nafamostat	nafamostat	NOUN
admet-1883	149	21	and	and	CCONJ
admet-1883	149	22	comostat	comostat	ADJ
admet-1883	149	23	antiviral	antiviral	ADJ
admet-1883	149	24	drug	drug	PROPN
admet-1883	149	25	ora	ora	PROPN
admet-1883	149	26	l/	l/	X
admet-1883	149	27	iv	iv	NUM
admet-1883	149	28	the	the	DET
admet-1883	149	29	antagonist	antagonist	NOUN
admet-1883	149	30	of	of	ADP
admet-1883	149	31	serine	serine	ADJ
admet-1883	149	32	protease	protease	NOUN
admet-1883	149	33	tmprss2	tmprss2	ADV
admet-1883	149	34	and	and	CCONJ
admet-1883	149	35	inhibit	inhibit	VERB
admet-1883	149	36	sars	sar	NOUN
admet-1883	149	37	-	-	PUNCT
admet-1883	149	38	cov	cov	NOUN
admet-1883	149	39	2	2	NUM
admet-1883	149	40	rash	rash	NOUN
admet-1883	149	41	,	,	PUNCT
admet-1883	149	42	pruritus	pruritus	NOUN
admet-1883	149	43	,	,	PUNCT
admet-1883	149	44	nausea	nausea	NOUN
admet-1883	149	45	,	,	PUNCT
admet-1883	149	46	abdominal	abdominal	ADJ
admet-1883	149	47	discomfort	discomfort	NOUN
admet-1883	149	48	,	,	PUNCT
admet-1883	149	49	and	and	CCONJ
admet-1883	149	50	liver	liver	NOUN
admet-1883	149	51	enzyme	enzyme	NOUN
admet-1883	149	52	level	level	NOUN
admet-1883	149	53	elevation	elevation	NOUN
admet-1883	149	54	10	10	NUM
admet-1883	149	55	.	.	PUNCT
admet-1883	150	1	fluvoxamine	fluvoxamine	PROPN
admet-1883	150	2	anti	anti	ADJ
admet-1883	150	3	-	-	ADJ
admet-1883	150	4	inflammatory	inflammatory	ADJ
admet-1883	150	5	,	,	PUNCT
admet-1883	150	6	antiviral	antiviral	ADJ
admet-1883	150	7	,	,	PUNCT
admet-1883	150	8	and	and	CCONJ
admet-1883	150	9	antidepressant	antidepressant	ADJ
admet-1883	150	10	oral	oral	ADJ
admet-1883	150	11	blocks	block	NOUN
admet-1883	150	12	reuptake	reuptake	NOUN
admet-1883	150	13	of	of	ADP
admet-1883	150	14	serotonin	serotonin	NOUN
admet-1883	150	15	enhances	enhance	NOUN
admet-1883	150	16	its	its	PRON
admet-1883	150	17	action	action	NOUN
admet-1883	150	18	difficult	difficult	ADJ
admet-1883	150	19	breathing	breathing	NOUN
admet-1883	150	20	,	,	PUNCT
admet-1883	150	21	skin	skin	NOUN
admet-1883	150	22	rash	rash	NOUN
admet-1883	150	23	,	,	PUNCT
admet-1883	150	24	blisters	blister	NOUN
admet-1883	150	25	,	,	PUNCT
admet-1883	150	26	hives	hive	NOUN
admet-1883	150	27	,	,	PUNCT
admet-1883	150	28	fever	fever	NOUN
admet-1883	150	29	,	,	PUNCT
admet-1883	150	30	joint	joint	ADJ
admet-1883	150	31	pain	pain	NOUN
admet-1883	150	32	,	,	PUNCT
admet-1883	150	33	swelling	swell	VERB
admet-1883	150	34	of	of	ADP
admet-1883	150	35	the	the	DET
admet-1883	150	36	throat	throat	NOUN
admet-1883	150	37	11	11	NUM
admet-1883	150	38	.	.	PUNCT
admet-1883	151	1	umifenovir	umifenovir	ADJ
admet-1883	151	2	antiviral	antiviral	PROPN
admet-1883	151	3	oral	oral	PROPN
admet-1883	151	4	inhibits	inhibit	VERB
admet-1883	151	5	membrane	membrane	NOUN
admet-1883	151	6	fusion	fusion	NOUN
admet-1883	151	7	of	of	ADP
admet-1883	151	8	influenza	influenza	NOUN
admet-1883	151	9	virus	virus	NOUN
admet-1883	151	10	and	and	CCONJ
admet-1883	151	11	prevents	prevent	VERB
admet-1883	151	12	contact	contact	NOUN
admet-1883	151	13	between	between	ADP
admet-1883	151	14	the	the	DET
admet-1883	151	15	virus	virus	NOUN
admet-1883	151	16	and	and	CCONJ
admet-1883	151	17	host	host	NOUN
admet-1883	151	18	tissues	tissue	NOUN
admet-1883	151	19	nausea	nausea	NOUN
admet-1883	151	20	,	,	PUNCT
admet-1883	151	21	vomiting	vomiting	NOUN
admet-1883	151	22	,	,	PUNCT
admet-1883	151	23	diarrhea	diarrhea	NOUN
admet-1883	151	24	12	12	NUM
admet-1883	151	25	.	.	PUNCT
admet-1883	152	1	famotidine	famotidine	NOUN
admet-1883	152	2	histamine	histamine	NOUN
admet-1883	152	3	(	(	PUNCT
admet-1883	152	4	h2	h2	NOUN
admet-1883	152	5	)	)	PUNCT
admet-1883	152	6	receptor	receptor	NOUN
admet-1883	152	7	antagonist	antagonist	NOUN
admet-1883	152	8	oral	oral	NOUN
admet-1883	152	9	activate	activate	VERB
admet-1883	152	10	the	the	DET
admet-1883	152	11	h2	h2	NOUN
admet-1883	152	12	receptor	receptor	NOUN
admet-1883	152	13	and	and	CCONJ
admet-1883	152	14	catalyze	catalyze	NOUN
admet-1883	152	15	proton	proton	NOUN
admet-1883	152	16	pump	pump	NOUN
admet-1883	152	17	action	action	NOUN
admet-1883	152	18	to	to	PART
admet-1883	152	19	secrete	secrete	VERB
admet-1883	152	20	acid	acid	NOUN
admet-1883	152	21	muscle	muscle	NOUN
admet-1883	152	22	cramps	cramp	NOUN
admet-1883	152	23	,	,	PUNCT
admet-1883	152	24	abdominal	abdominal	ADJ
admet-1883	152	25	discomfort	discomfort	NOUN
admet-1883	152	26	,	,	PUNCT
admet-1883	152	27	fatigue	fatigue	NOUN
admet-1883	152	28	,	,	PUNCT
admet-1883	152	29	anorexia	anorexia	ADJ
admet-1883	152	30	,	,	PUNCT
admet-1883	152	31	rash	rash	ADJ
admet-1883	152	32	,	,	PUNCT
admet-1883	152	33	dry	dry	ADJ
admet-1883	152	34	mouth	mouth	NOUN
admet-1883	152	35	photodynamic	photodynamic	ADJ
admet-1883	152	36	therapy	therapy	NOUN
admet-1883	152	37	(	(	PUNCT
admet-1883	152	38	pdt	pdt	PROPN
admet-1883	152	39	)	)	PUNCT
admet-1883	152	40	the	the	DET
admet-1883	152	41	use	use	NOUN
admet-1883	152	42	of	of	ADP
admet-1883	152	43	photosensitizer	photosensitizer	NOUN
admet-1883	152	44	(	(	PUNCT
admet-1883	152	45	ps	ps	NOUN
admet-1883	152	46	)	)	PUNCT
admet-1883	152	47	,	,	PUNCT
admet-1883	152	48	light	light	NOUN
admet-1883	152	49	,	,	PUNCT
admet-1883	152	50	and	and	CCONJ
admet-1883	152	51	molecular	molecular	ADJ
admet-1883	152	52	oxygen	oxygen	NOUN
admet-1883	152	53	(	(	PUNCT
admet-1883	152	54	o2	o2	PROPN
admet-1883	152	55	)	)	PUNCT
admet-1883	152	56	has	have	AUX
admet-1883	152	57	enhanced	enhance	VERB
admet-1883	152	58	through	through	ADP
admet-1883	152	59	time	time	NOUN
admet-1883	152	60	,	,	PUNCT
admet-1883	152	61	and	and	CCONJ
admet-1883	152	62	the	the	DET
admet-1883	152	63	term	term	NOUN
admet-1883	152	64	pdt	pdt	PROPN
admet-1883	152	65	has	have	AUX
admet-1883	152	66	developed	develop	VERB
admet-1883	152	67	[	[	PUNCT
admet-1883	152	68	66,67	66,67	ADP
admet-1883	152	69	]	]	PUNCT
admet-1883	152	70	.	.	PUNCT
admet-1883	153	1	pdt	pdt	PROPN
admet-1883	153	2	is	be	AUX
admet-1883	153	3	a	a	DET
admet-1883	153	4	non	non	ADJ
admet-1883	153	5	-	-	ADJ
admet-1883	153	6	invasive	invasive	ADJ
admet-1883	153	7	emerging	emerge	VERB
admet-1883	153	8	therapeutic	therapeutic	ADJ
admet-1883	153	9	method	method	NOUN
admet-1883	153	10	that	that	PRON
admet-1883	153	11	works	work	VERB
admet-1883	153	12	by	by	ADP
admet-1883	153	13	activating	activate	VERB
admet-1883	153	14	the	the	DET
admet-1883	153	15	photosensitizer	photosensitizer	NOUN
admet-1883	153	16	(	(	PUNCT
admet-1883	153	17	ps	ps	NOUN
admet-1883	153	18	)	)	PUNCT
admet-1883	153	19	with	with	ADP
admet-1883	153	20	a	a	DET
admet-1883	153	21	certain	certain	ADJ
admet-1883	153	22	wavelength	wavelength	NOUN
admet-1883	153	23	of	of	ADP
admet-1883	153	24	light	light	NOUN
admet-1883	153	25	.	.	PUNCT
admet-1883	154	1	in	in	ADP
admet-1883	154	2	the	the	DET
admet-1883	154	3	process	process	NOUN
admet-1883	154	4	of	of	ADP
admet-1883	154	5	illumination	illumination	NOUN
admet-1883	154	6	,	,	PUNCT
admet-1883	154	7	the	the	DET
admet-1883	154	8	ps	ps	NOUN
admet-1883	154	9	transfers	transfer	VERB
admet-1883	154	10	its	its	PRON
admet-1883	154	11	energy	energy	NOUN
admet-1883	154	12	to	to	ADP
admet-1883	154	13	the	the	DET
admet-1883	154	14	molecular	molecular	ADJ
admet-1883	154	15	oxygen	oxygen	NOUN
admet-1883	154	16	when	when	SCONJ
admet-1883	154	17	it	it	PRON
admet-1883	154	18	is	be	AUX
admet-1883	154	19	stimulated	stimulate	VERB
admet-1883	154	20	,	,	PUNCT
admet-1883	154	21	which	which	PRON
admet-1883	154	22	in	in	ADP
admet-1883	154	23	turn	turn	NOUN
admet-1883	154	24	generates	generate	VERB
admet-1883	154	25	cytotoxic	cytotoxic	ADJ
admet-1883	154	26	molecules	molecule	NOUN
admet-1883	154	27	,	,	PUNCT
admet-1883	154	28	namely	namely	ADV
admet-1883	154	29	reactive	reactive	ADJ
admet-1883	154	30	oxygen	oxygen	NOUN
admet-1883	154	31	species	specie	NOUN
admet-1883	154	32	(	(	PUNCT
admet-1883	154	33	ros	ros	PROPN
admet-1883	154	34	)	)	PUNCT
admet-1883	154	35	,	,	PUNCT
admet-1883	154	36	which	which	PRON
admet-1883	154	37	have	have	VERB
admet-1883	154	38	the	the	DET
admet-1883	154	39	ability	ability	NOUN
admet-1883	154	40	to	to	PART
admet-1883	154	41	disrupt	disrupt	VERB
admet-1883	154	42	the	the	DET
admet-1883	154	43	cell	cell	NOUN
admet-1883	154	44	wall	wall	NOUN
admet-1883	154	45	of	of	ADP
admet-1883	154	46	the	the	DET
admet-1883	154	47	microorganisms	microorganism	NOUN
admet-1883	154	48	in	in	ADP
admet-1883	154	49	a	a	DET
admet-1883	154	50	variety	variety	NOUN
admet-1883	154	51	of	of	ADP
admet-1883	154	52	diseases	disease	NOUN
admet-1883	154	53	and	and	CCONJ
admet-1883	154	54	infections	infection	NOUN
admet-1883	154	55	.	.	PUNCT
admet-1883	155	1	the	the	DET
admet-1883	155	2	singlet	singlet	ADJ
admet-1883	155	3	oxygen	oxygen	NOUN
admet-1883	155	4	produced	produce	VERB
admet-1883	155	5	can	can	AUX
admet-1883	155	6	efficiently	efficiently	ADV
admet-1883	155	7	oxidize	oxidize	VERB
admet-1883	155	8	the	the	DET
admet-1883	155	9	main	main	ADJ
admet-1883	155	10	cellular	cellular	ADJ
admet-1883	155	11	macromolecules	macromolecule	NOUN
admet-1883	155	12	that	that	PRON
admet-1883	155	13	destroy	destroy	VERB
admet-1883	155	14	the	the	DET
admet-1883	155	15	microorganisms	microorganism	NOUN
admet-1883	155	16	[	[	X
admet-1883	155	17	67	67	NUM
admet-1883	155	18	]	]	PUNCT
admet-1883	155	19	.	.	PUNCT
admet-1883	156	1	this	this	DET
admet-1883	156	2	therapy	therapy	NOUN
admet-1883	156	3	has	have	AUX
admet-1883	156	4	been	be	AUX
admet-1883	156	5	implemented	implement	VERB
admet-1883	156	6	to	to	PART
admet-1883	156	7	treat	treat	VERB
admet-1883	156	8	cancer	cancer	NOUN
admet-1883	156	9	,	,	PUNCT
admet-1883	156	10	bacterial	bacterial	ADJ
admet-1883	156	11	infection	infection	NOUN
admet-1883	156	12	,	,	PUNCT
admet-1883	156	13	fungal	fungal	ADJ
admet-1883	156	14	and	and	CCONJ
admet-1883	156	15	viral	viral	ADJ
admet-1883	156	16	diseases	disease	NOUN
admet-1883	156	17	,	,	PUNCT
admet-1883	156	18	as	as	ADV
admet-1883	156	19	well	well	ADV
admet-1883	156	20	as	as	ADP
admet-1883	156	21	photodynamic	photodynamic	ADJ
admet-1883	156	22	diagnostics	diagnostic	NOUN
admet-1883	156	23	in	in	ADP
admet-1883	156	24	the	the	DET
admet-1883	156	25	area	area	NOUN
admet-1883	156	26	of	of	ADP
admet-1883	156	27	dentistry	dentistry	NOUN
admet-1883	156	28	.	.	PUNCT
admet-1883	157	1	pdt	pdt	PROPN
admet-1883	157	2	does	do	AUX
admet-1883	157	3	not	not	PART
admet-1883	157	4	pose	pose	VERB
admet-1883	157	5	harmful	harmful	ADJ
admet-1883	157	6	risks	risk	NOUN
admet-1883	157	7	to	to	ADP
admet-1883	157	8	the	the	DET
admet-1883	157	9	biological	biological	ADJ
admet-1883	157	10	system	system	NOUN
admet-1883	157	11	.	.	PUNCT
admet-1883	158	1	it	it	PRON
admet-1883	158	2	is	be	AUX
admet-1883	158	3	clear	clear	ADJ
admet-1883	158	4	that	that	SCONJ
admet-1883	158	5	compared	compare	VERB
admet-1883	158	6	with	with	ADP
admet-1883	158	7	traditional	traditional	ADJ
admet-1883	158	8	treatment	treatment	NOUN
admet-1883	158	9	modalities	modality	NOUN
admet-1883	158	10	,	,	PUNCT
admet-1883	158	11	pdt	pdt	PROPN
admet-1883	158	12	has	have	VERB
admet-1883	158	13	its	its	PRON
admet-1883	158	14	advantages	advantage	NOUN
admet-1883	158	15	due	due	ADP
admet-1883	158	16	to	to	ADP
admet-1883	158	17	its	its	PRON
admet-1883	158	18	limited	limited	ADJ
admet-1883	158	19	invasiveness	invasiveness	ADJ
admet-1883	158	20	and	and	CCONJ
admet-1883	158	21	negligible	negligible	ADJ
admet-1883	158	22	cumulative	cumulative	ADJ
admet-1883	158	23	toxicity	toxicity	NOUN
admet-1883	158	24	.	.	PUNCT
admet-1883	159	1	therefore	therefore	ADV
admet-1883	159	2	,	,	PUNCT
admet-1883	159	3	pdt	pdt	PROPN
admet-1883	159	4	aims	aim	VERB
admet-1883	159	5	to	to	PART
admet-1883	159	6	boost	boost	VERB
admet-1883	159	7	the	the	DET
admet-1883	159	8	quality	quality	NOUN
admet-1883	159	9	of	of	ADP
admet-1883	159	10	life	life	NOUN
admet-1883	159	11	of	of	ADP
admet-1883	159	12	patients	patient	NOUN
admet-1883	159	13	.	.	PUNCT
admet-1883	160	1	jablonski	jablonski	PROPN
admet-1883	160	2	's	's	PART
admet-1883	160	3	schematic	schematic	ADJ
admet-1883	160	4	diagram	diagram	NOUN
admet-1883	160	5	displays	display	VERB
admet-1883	160	6	the	the	DET
admet-1883	160	7	intricacies	intricacy	NOUN
admet-1883	160	8	of	of	ADP
admet-1883	160	9	photodynamic	photodynamic	ADJ
admet-1883	160	10	activity	activity	NOUN
admet-1883	160	11	,	,	PUNCT
admet-1883	160	12	defined	define	VERB
admet-1883	160	13	as	as	ADP
admet-1883	160	14	an	an	DET
admet-1883	160	15	array	array	NOUN
admet-1883	160	16	of	of	ADP
admet-1883	160	17	photophysical	photophysical	ADJ
admet-1883	160	18	and	and	CCONJ
admet-1883	160	19	photochemical	photochemical	ADJ
admet-1883	160	20	reactions	reaction	NOUN
admet-1883	160	21	(	(	PUNCT
admet-1883	160	22	figure	figure	NOUN
admet-1883	160	23	3	3	NUM
admet-1883	160	24	)	)	PUNCT
admet-1883	160	25	.	.	PUNCT
admet-1883	161	1	pdt	pdt	PROPN
admet-1883	161	2	needs	need	VERB
admet-1883	161	3	the	the	DET
admet-1883	161	4	synchronous	synchronous	ADJ
admet-1883	161	5	combination	combination	NOUN
admet-1883	161	6	of	of	ADP
admet-1883	161	7	the	the	DET
admet-1883	161	8	ps	ps	NOUN
admet-1883	161	9	,	,	PUNCT
admet-1883	161	10	proper	proper	ADJ
admet-1883	161	11	wavelength	wavelength	NOUN
admet-1883	161	12	of	of	ADP
admet-1883	161	13	visible	visible	ADJ
admet-1883	161	14	light	light	NOUN
admet-1883	161	15	,	,	PUNCT
admet-1883	161	16	and	and	CCONJ
admet-1883	161	17	molecular	molecular	ADJ
admet-1883	161	18	oxygen	oxygen	NOUN
admet-1883	161	19	.	.	PUNCT
admet-1883	162	1	the	the	DET
admet-1883	162	2	photosensitizing	photosensitize	VERB
admet-1883	162	3	molecule	molecule	NOUN
admet-1883	162	4	possesses	possess	VERB
admet-1883	162	5	two	two	NUM
admet-1883	162	6	electrons	electron	NOUN
admet-1883	162	7	(	(	PUNCT
admet-1883	162	8	opposite	opposite	ADJ
admet-1883	162	9	spins	spin	NOUN
admet-1883	162	10	)	)	PUNCT
admet-1883	162	11	in	in	ADP
admet-1883	162	12	its	its	PRON
admet-1883	162	13	ground	ground	NOUN
admet-1883	162	14	state	state	NOUN
admet-1883	162	15	,	,	PUNCT
admet-1883	162	16	and	and	CCONJ
admet-1883	162	17	the	the	DET
admet-1883	162	18	symbol	symbol	NOUN
admet-1883	162	19	s0	s0	PROPN
admet-1883	162	20	is	be	AUX
admet-1883	162	21	denoted	denote	VERB
admet-1883	162	22	as	as	ADP
admet-1883	162	23	total	total	ADJ
admet-1883	162	24	spin	spin	NOUN
admet-1883	162	25	,	,	PUNCT
admet-1883	162	26	which	which	PRON
admet-1883	162	27	is	be	AUX
admet-1883	162	28	zero	zero	NUM
admet-1883	162	29	.	.	PUNCT
admet-1883	163	1	the	the	DET
admet-1883	163	2	reaction	reaction	NOUN
admet-1883	163	3	includes	include	VERB
admet-1883	163	4	absorption	absorption	NOUN
admet-1883	163	5	of	of	ADP
admet-1883	163	6	light	light	NOUN
admet-1883	163	7	by	by	ADP
admet-1883	163	8	ps	p	NOUN
admet-1883	163	9	and	and	CCONJ
admet-1883	163	10	triggers	trigger	VERB
admet-1883	163	11	an	an	DET
admet-1883	163	12	array	array	NOUN
admet-1883	163	13	of	of	ADP
admet-1883	163	14	photochemical	photochemical	ADJ
admet-1883	163	15	reactions	reaction	NOUN
admet-1883	163	16	leading	lead	VERB
admet-1883	163	17	to	to	ADP
admet-1883	163	18	ros	ros	PROPN
admet-1883	163	19	production	production	NOUN
admet-1883	163	20	.	.	PUNCT
admet-1883	164	1	the	the	DET
admet-1883	164	2	ros	ros	PROPN
admet-1883	164	3	,	,	PUNCT
admet-1883	164	4	also	also	ADV
admet-1883	164	5	termed	term	VERB
admet-1883	164	6	singlet	singlet	ADJ
admet-1883	164	7	oxygen	oxygen	NOUN
admet-1883	164	8	(	(	PUNCT
admet-1883	164	9	1o2	1o2	NUM
admet-1883	164	10	)	)	PUNCT
admet-1883	164	11	in	in	ADP
admet-1883	164	12	the	the	DET
admet-1883	164	13	lowest	low	ADJ
admet-1883	164	14	energy	energy	NOUN
admet-1883	164	15	state	state	NOUN
admet-1883	164	16	,	,	PUNCT
admet-1883	164	17	can	can	AUX
admet-1883	164	18	cause	cause	VERB
admet-1883	164	19	serious	serious	ADJ
admet-1883	164	20	oxidative	oxidative	ADJ
admet-1883	164	21	injury	injury	NOUN
admet-1883	164	22	to	to	ADP
admet-1883	164	23	pathogenic	pathogenic	ADJ
admet-1883	164	24	microorganisms	microorganism	NOUN
admet-1883	164	25	like	like	ADP
admet-1883	164	26	viruses	virus	NOUN
admet-1883	164	27	,	,	PUNCT
admet-1883	164	28	bacteria	bacteria	NOUN
admet-1883	164	29	,	,	PUNCT
admet-1883	164	30	fungi	fungus	NOUN
admet-1883	164	31	,	,	PUNCT
admet-1883	164	32	and	and	CCONJ
admet-1883	164	33	parasites	parasite	NOUN
admet-1883	164	34	.	.	PUNCT
admet-1883	165	1	during	during	ADP
admet-1883	165	2	the	the	DET
admet-1883	165	3	pdt	pdt	NOUN
admet-1883	165	4	process	process	NOUN
admet-1883	165	5	,	,	PUNCT
admet-1883	165	6	it	it	PRON
admet-1883	165	7	produces	produce	VERB
admet-1883	165	8	other	other	ADJ
admet-1883	165	9	1o2	1o2	NUM
admet-1883	165	10	,	,	PUNCT
admet-1883	165	11	such	such	ADJ
admet-1883	165	12	as	as	ADP
admet-1883	165	13	superoxide	superoxide	NOUN
admet-1883	165	14	ions	ion	NOUN
admet-1883	165	15	(	(	PUNCT
admet-1883	165	16	o2-•	o2-•	ADJ
admet-1883	165	17	)	)	PUNCT
admet-1883	165	18	,	,	PUNCT
admet-1883	165	19	hydrogen	hydrogen	NOUN
admet-1883	165	20	peroxide	peroxide	NOUN
admet-1883	165	21	(	(	PUNCT
admet-1883	165	22	h2o2	h2o2	NOUN
admet-1883	165	23	)	)	PUNCT
admet-1883	165	24	,	,	PUNCT
admet-1883	165	25	and	and	CCONJ
admet-1883	165	26	hydroxyl	hydroxyl	NOUN
admet-1883	165	27	radicals	radical	NOUN
admet-1883	165	28	(	(	PUNCT
admet-1883	165	29	oh•	oh•	PROPN
admet-1883	165	30	)	)	PUNCT
admet-1883	166	1	[	[	X
admet-1883	166	2	68,69	68,69	NUM
admet-1883	166	3	]	]	PUNCT
admet-1883	166	4	.	.	PUNCT
admet-1883	167	1	according	accord	VERB
admet-1883	167	2	to	to	ADP
admet-1883	167	3	the	the	DET
admet-1883	167	4	mechanism	mechanism	NOUN
admet-1883	167	5	of	of	ADP
admet-1883	167	6	pdt	pdt	PROPN
admet-1883	167	7	,	,	PUNCT
admet-1883	167	8	the	the	DET
admet-1883	167	9	ps	ps	NOUN
admet-1883	167	10	excites	excite	VERB
admet-1883	167	11	from	from	ADP
admet-1883	167	12	the	the	DET
admet-1883	167	13	low	low	ADJ
admet-1883	167	14	energy	energy	NOUN
admet-1883	167	15	state	state	NOUN
admet-1883	167	16	to	to	ADP
admet-1883	167	17	a	a	DET
admet-1883	167	18	higher	high	ADJ
admet-1883	167	19	energy	energy	NOUN
admet-1883	167	20	state	state	NOUN
admet-1883	167	21	with	with	ADP
admet-1883	167	22	a	a	DET
admet-1883	167	23	limited	limited	ADJ
admet-1883	167	24	life	life	NOUN
admet-1883	167	25	cycle	cycle	NOUN
admet-1883	167	26	ranging	range	VERB
admet-1883	167	27	from	from	ADP
admet-1883	167	28	nanoseconds	nanosecond	NOUN
admet-1883	167	29	to	to	ADP
admet-1883	167	30	less	less	ADV
admet-1883	167	31	after	after	ADP
admet-1883	167	32	the	the	DET
admet-1883	167	33	absorption	absorption	NOUN
admet-1883	167	34	of	of	ADP
admet-1883	167	35	light	light	NOUN
admet-1883	167	36	.	.	PUNCT
admet-1883	168	1	after	after	ADP
admet-1883	168	2	excitation	excitation	NOUN
admet-1883	168	3	,	,	PUNCT
admet-1883	168	4	any	any	DET
admet-1883	168	5	one	one	NUM
admet-1883	168	6	of	of	ADP
admet-1883	168	7	the	the	DET
admet-1883	168	8	two	two	NUM
admet-1883	168	9	mechanisms	mechanism	NOUN
admet-1883	168	10	can	can	AUX
admet-1883	168	11	occur	occur	VERB
admet-1883	168	12	:	:	PUNCT
admet-1883	168	13	(	(	PUNCT
admet-1883	168	14	1	1	X
admet-1883	168	15	)	)	PUNCT
admet-1883	168	16	fall	fall	VERB
admet-1883	168	17	back	back	ADV
admet-1883	168	18	to	to	ADP
admet-1883	168	19	grounds	ground	NOUN
admet-1883	168	20	state	state	NOUN
admet-1883	168	21	and	and	CCONJ
admet-1883	168	22	emits	emit	VERB
admet-1883	168	23	fluorescence	fluorescence	NOUN
admet-1883	168	24	or	or	CCONJ
admet-1883	168	25	(	(	PUNCT
admet-1883	168	26	2	2	X
admet-1883	168	27	)	)	PUNCT
admet-1883	168	28	reach	reach	VERB
admet-1883	168	29	triplet	triplet	NOUN
admet-1883	168	30	state	state	NOUN
admet-1883	168	31	by	by	ADP
admet-1883	168	32	undergoing	undergo	VERB
admet-1883	168	33	the	the	DET
admet-1883	168	34	crossing	crossing	NOUN
admet-1883	168	35	in	in	ADP
admet-1883	168	36	intersystem	intersystem	NOUN
admet-1883	168	37	.	.	PUNCT
admet-1883	169	1	the	the	DET
admet-1883	169	2	triplet	triplet	NOUN
admet-1883	169	3	state	state	NOUN
admet-1883	169	4	lifetime	lifetime	NOUN
admet-1883	169	5	provides	provide	VERB
admet-1883	169	6	adequate	adequate	ADJ
admet-1883	169	7	time	time	NOUN
admet-1883	169	8	for	for	SCONJ
admet-1883	169	9	the	the	DET
admet-1883	169	10	excited	excited	ADJ
admet-1883	169	11	ps	ps	NOUN
admet-1883	169	12	to	to	PART
admet-1883	169	13	interact	interact	VERB
admet-1883	169	14	with	with	ADP
admet-1883	169	15	the	the	DET
admet-1883	169	16	oxygen	oxygen	NOUN
admet-1883	169	17	molecule	molecule	NOUN
admet-1883	169	18	or	or	CCONJ
admet-1883	169	19	other	other	ADJ
admet-1883	169	20	tissue	tissue	NOUN
admet-1883	169	21	substrates	substrate	NOUN
admet-1883	169	22	[	[	X
admet-1883	169	23	70	70	NUM
admet-1883	169	24	]	]	PUNCT
admet-1883	169	25	.	.	PUNCT
admet-1883	170	1	during	during	ADP
admet-1883	170	2	this	this	DET
admet-1883	170	3	mechanism	mechanism	NOUN
admet-1883	170	4	,	,	PUNCT
admet-1883	170	5	the	the	DET
admet-1883	170	6	proton	proton	NOUN
admet-1883	170	7	gets	get	AUX
admet-1883	170	8	transferred	transfer	VERB
admet-1883	170	9	due	due	ADP
admet-1883	170	10	to	to	ADP
admet-1883	170	11	this	this	DET
admet-1883	170	12	direct	direct	ADJ
admet-1883	170	13	interaction	interaction	NOUN
admet-1883	170	14	between	between	ADP
admet-1883	170	15	triplet	triplet	NOUN
admet-1883	170	16	ps	ps	NOUN
admet-1883	170	17	and	and	CCONJ
admet-1883	170	18	substrate	substrate	NOUN
admet-1883	170	19	,	,	PUNCT
admet-1883	170	20	which	which	PRON
admet-1883	170	21	leads	lead	VERB
admet-1883	170	22	to	to	ADP
admet-1883	170	23	the	the	DET
admet-1883	170	24	formation	formation	NOUN
admet-1883	170	25	of	of	ADP
admet-1883	170	26	radical	radical	ADJ
admet-1883	170	27	anion	anion	NOUN
admet-1883	170	28	or	or	CCONJ
admet-1883	170	29	cation	cation	NOUN
admet-1883	170	30	,	,	PUNCT
admet-1883	170	31	which	which	PRON
admet-1883	170	32	in	in	ADP
admet-1883	170	33	turn	turn	NOUN
admet-1883	170	34	tends	tend	VERB
admet-1883	170	35	to	to	PART
admet-1883	170	36	react	react	VERB
admet-1883	170	37	with	with	ADP
admet-1883	170	38	molecular	molecular	ADJ
admet-1883	170	39	oxygen	oxygen	NOUN
admet-1883	170	40	and	and	CCONJ
admet-1883	170	41	produces	produce	VERB
admet-1883	170	42	oxygenated	oxygenate	VERB
admet-1883	170	43	compounds	compound	NOUN
admet-1883	170	44	like	like	ADP
admet-1883	170	45	superoxide	superoxide	NOUN
admet-1883	170	46	anion	anion	NOUN
admet-1883	170	47	radical	radical	ADJ
admet-1883	170	48	,	,	PUNCT
admet-1883	170	49	hydrogen	hydrogen	NOUN
admet-1883	170	50	peroxides	peroxide	NOUN
admet-1883	170	51	,	,	PUNCT
admet-1883	170	52	and	and	CCONJ
admet-1883	170	53	hydroxide	hydroxide	NOUN
admet-1883	170	54	radicals	radical	NOUN
admet-1883	170	55	.	.	PUNCT
admet-1883	171	1	this	this	DET
admet-1883	171	2	method	method	NOUN
admet-1883	171	3	is	be	AUX
admet-1883	171	4	termed	term	VERB
admet-1883	171	5	a	a	DET
admet-1883	171	6	type	type	NOUN
admet-1883	171	7	1	1	NUM
admet-1883	171	8	reaction	reaction	NOUN
admet-1883	171	9	of	of	ADP
admet-1883	171	10	pdt	pdt	PROPN
admet-1883	171	11	.	.	PUNCT
admet-1883	172	1	in	in	ADP
admet-1883	172	2	type	type	NOUN
admet-1883	172	3	ii	ii	NOUN
admet-1883	172	4	reaction	reaction	NOUN
admet-1883	172	5	,	,	PUNCT
admet-1883	172	6	the	the	DET
admet-1883	172	7	direct	direct	ADJ
admet-1883	172	8	energy	energy	NOUN
admet-1883	172	9	transfer	transfer	NOUN
admet-1883	172	10	of	of	ADP
admet-1883	172	11	the	the	DET
admet-1883	172	12	excited	excited	ADJ
admet-1883	172	13	ps	ps	NOUN
admet-1883	172	14	to	to	ADP
admet-1883	172	15	molecular	molecular	ADJ
admet-1883	172	16	oxygen	oxygen	NOUN
admet-1883	172	17	,	,	PUNCT
admet-1883	172	18	in	in	ADP
admet-1883	172	19	turn	turn	NOUN
admet-1883	172	20	,	,	PUNCT
admet-1883	172	21	forms	form	NOUN
admet-1883	172	22	singlet	singlet	ADJ
admet-1883	172	23	oxygen	oxygen	NOUN
admet-1883	172	24	(	(	PUNCT
admet-1883	172	25	1o2	1o2	NUM
admet-1883	172	26	)	)	PUNCT
admet-1883	172	27	.	.	PUNCT
admet-1883	173	1	both	both	CCONJ
admet-1883	173	2	the	the	DET
admet-1883	173	3	type	type	NOUN
admet-1883	173	4	i	i	PRON
admet-1883	173	5	and	and	CCONJ
admet-1883	173	6	type	type	PROPN
admet-1883	173	7	ii	ii	PROPN
admet-1883	173	8	reactions	reaction	NOUN
admet-1883	173	9	involve	involve	VERB
admet-1883	173	10	the	the	DET
admet-1883	173	11	https://doi.org/10.5599/admet.1883	https://doi.org/10.5599/admet.1883	PROPN
admet-1883	173	12	p.	p.	PROPN
admet-1883	173	13	pallavi	pallavi	VERB
admet-1883	173	14	et	et	PROPN
admet-1883	173	15	al	al	PROPN
admet-1883	173	16	.	.	PROPN
admet-1883	173	17	admet	admet	PROPN
admet-1883	173	18	&	&	CCONJ
admet-1883	173	19	dmpk	dmpk	PROPN
admet-1883	173	20	11(4	11(4	NUM
admet-1883	173	21	)	)	PUNCT
admet-1883	173	22	(	(	PUNCT
admet-1883	173	23	2023	2023	NUM
admet-1883	173	24	)	)	PUNCT
admet-1883	173	25	513	513	NUM
admet-1883	173	26	-	-	SYM
admet-1883	173	27	531	531	NUM
admet-1883	173	28	520	520	NUM
admet-1883	173	29	formation	formation	NOUN
admet-1883	173	30	of	of	ADP
admet-1883	173	31	some	some	DET
admet-1883	173	32	final	final	ADJ
admet-1883	173	33	products	product	NOUN
admet-1883	173	34	,	,	PUNCT
admet-1883	173	35	which	which	PRON
admet-1883	173	36	decides	decide	VERB
admet-1883	173	37	the	the	DET
admet-1883	173	38	therapeutic	therapeutic	ADJ
admet-1883	173	39	index	index	NOUN
admet-1883	173	40	of	of	ADP
admet-1883	173	41	the	the	DET
admet-1883	173	42	whole	whole	ADJ
admet-1883	173	43	therapy	therapy	NOUN
admet-1883	173	44	.	.	PUNCT
admet-1883	174	1	in	in	ADP
admet-1883	174	2	a	a	DET
admet-1883	174	3	pdt	pdt	NOUN
admet-1883	174	4	reaction	reaction	NOUN
admet-1883	174	5	,	,	PUNCT
admet-1883	174	6	both	both	CCONJ
admet-1883	174	7	the	the	DET
admet-1883	174	8	types	type	NOUN
admet-1883	174	9	i	i	PRON
admet-1883	174	10	and	and	CCONJ
admet-1883	174	11	ii	ii	PROPN
admet-1883	174	12	reactions	reaction	NOUN
admet-1883	174	13	can	can	AUX
admet-1883	174	14	result	result	VERB
admet-1883	174	15	simultaneously	simultaneously	ADV
admet-1883	174	16	[	[	X
admet-1883	174	17	71,72	71,72	NOUN
admet-1883	174	18	]	]	X
admet-1883	174	19	.	.	PUNCT
admet-1883	175	1	in	in	ADP
admet-1883	175	2	accordance	accordance	NOUN
admet-1883	175	3	with	with	ADP
admet-1883	175	4	the	the	DET
admet-1883	175	5	category	category	NOUN
admet-1883	175	6	of	of	ADP
admet-1883	175	7	ps	ps	PROPN
admet-1883	175	8	,	,	PUNCT
admet-1883	175	9	the	the	DET
admet-1883	175	10	amount	amount	NOUN
admet-1883	175	11	of	of	ADP
admet-1883	175	12	substrate	substrate	NOUN
admet-1883	175	13	in	in	ADP
admet-1883	175	14	tissues	tissue	NOUN
admet-1883	175	15	,	,	PUNCT
admet-1883	175	16	and	and	CCONJ
admet-1883	175	17	the	the	DET
admet-1883	175	18	molecular	molecular	ADJ
admet-1883	175	19	oxygen	oxygen	NOUN
admet-1883	175	20	concentration	concentration	NOUN
admet-1883	175	21	,	,	PUNCT
admet-1883	175	22	the	the	DET
admet-1883	175	23	occurrence	occurrence	NOUN
admet-1883	175	24	rate	rate	NOUN
admet-1883	175	25	of	of	ADP
admet-1883	175	26	type	type	NOUN
admet-1883	175	27	i	i	PRON
admet-1883	175	28	and	and	CCONJ
admet-1883	175	29	type	type	PROPN
admet-1883	175	30	ii	ii	PROPN
admet-1883	175	31	reaction	reaction	NOUN
admet-1883	175	32	differs	differ	VERB
admet-1883	175	33	.	.	PUNCT
admet-1883	176	1	most	most	ADJ
admet-1883	176	2	of	of	ADP
admet-1883	176	3	the	the	DET
admet-1883	176	4	studies	study	NOUN
admet-1883	176	5	suggest	suggest	VERB
admet-1883	176	6	that	that	SCONJ
admet-1883	176	7	1o2	1o2	NUM
admet-1883	176	8	plays	play	VERB
admet-1883	176	9	a	a	DET
admet-1883	176	10	significant	significant	ADJ
admet-1883	176	11	role	role	NOUN
admet-1883	176	12	in	in	ADP
admet-1883	176	13	pdt	pdt	PROPN
admet-1883	177	1	.	.	PUNCT
admet-1883	177	2	figure	figure	NOUN
admet-1883	177	3	3	3	NUM
admet-1883	177	4	.	.	PUNCT
admet-1883	178	1	schematic	schematic	ADJ
admet-1883	178	2	representation	representation	NOUN
admet-1883	178	3	of	of	ADP
admet-1883	178	4	the	the	DET
admet-1883	178	5	mechanism	mechanism	NOUN
admet-1883	178	6	of	of	ADP
admet-1883	178	7	pdt	pdt	NOUN
admet-1883	178	8	against	against	ADP
admet-1883	178	9	viral	viral	ADJ
admet-1883	178	10	infections	infection	NOUN
admet-1883	178	11	pdt	pdt	NOUN
admet-1883	178	12	for	for	ADP
admet-1883	178	13	the	the	DET
admet-1883	178	14	treatment	treatment	NOUN
admet-1883	178	15	of	of	ADP
admet-1883	178	16	viral	viral	ADJ
admet-1883	178	17	infections	infection	NOUN
admet-1883	178	18	infections	infection	NOUN
admet-1883	178	19	are	be	AUX
admet-1883	178	20	one	one	NUM
admet-1883	178	21	of	of	ADP
admet-1883	178	22	the	the	DET
admet-1883	178	23	major	major	ADJ
admet-1883	178	24	public	public	ADJ
admet-1883	178	25	health	health	NOUN
admet-1883	178	26	issues	issue	NOUN
admet-1883	178	27	being	be	AUX
admet-1883	178	28	studied	study	VERB
admet-1883	178	29	by	by	ADP
admet-1883	178	30	diverse	diverse	ADJ
admet-1883	178	31	research	research	NOUN
admet-1883	178	32	teams	team	NOUN
admet-1883	178	33	.	.	PUNCT
admet-1883	179	1	the	the	DET
admet-1883	179	2	number	number	NOUN
admet-1883	179	3	of	of	ADP
admet-1883	179	4	novel	novel	ADJ
admet-1883	179	5	antimicrobials	antimicrobial	NOUN
admet-1883	179	6	and	and	CCONJ
admet-1883	179	7	their	their	PRON
admet-1883	179	8	target	target	NOUN
admet-1883	179	9	structures	structure	NOUN
admet-1883	179	10	has	have	AUX
admet-1883	179	11	steadily	steadily	ADV
admet-1883	179	12	reduced	reduce	VERB
admet-1883	179	13	,	,	PUNCT
admet-1883	179	14	so	so	CCONJ
admet-1883	179	15	there	there	PRON
admet-1883	179	16	is	be	VERB
admet-1883	179	17	a	a	DET
admet-1883	179	18	need	need	NOUN
admet-1883	179	19	for	for	ADP
admet-1883	179	20	alternative	alternative	ADJ
admet-1883	179	21	infection	infection	NOUN
admet-1883	179	22	treatment	treatment	NOUN
admet-1883	179	23	[	[	X
admet-1883	179	24	73,74	73,74	NOUN
admet-1883	179	25	]	]	PUNCT
admet-1883	179	26	.	.	PUNCT
admet-1883	180	1	photodynamic	photodynamic	ADJ
admet-1883	180	2	therapy	therapy	NOUN
admet-1883	180	3	is	be	AUX
admet-1883	180	4	considered	consider	VERB
admet-1883	180	5	an	an	DET
admet-1883	180	6	effective	effective	ADJ
admet-1883	180	7	and	and	CCONJ
admet-1883	180	8	alternative	alternative	ADJ
admet-1883	180	9	treatment	treatment	NOUN
admet-1883	180	10	option	option	NOUN
admet-1883	180	11	that	that	PRON
admet-1883	180	12	has	have	AUX
admet-1883	180	13	been	be	AUX
admet-1883	180	14	shown	show	VERB
admet-1883	180	15	to	to	PART
admet-1883	180	16	have	have	VERB
admet-1883	180	17	great	great	ADJ
admet-1883	180	18	potential	potential	NOUN
admet-1883	180	19	against	against	ADP
admet-1883	180	20	a	a	DET
admet-1883	180	21	variety	variety	NOUN
admet-1883	180	22	of	of	ADP
admet-1883	180	23	disease	disease	NOUN
admet-1883	180	24	states	state	NOUN
admet-1883	180	25	caused	cause	VERB
admet-1883	180	26	by	by	ADP
admet-1883	180	27	an	an	DET
admet-1883	180	28	infectious	infectious	ADJ
admet-1883	180	29	microorganism	microorganism	NOUN
admet-1883	180	30	and	and	CCONJ
admet-1883	180	31	may	may	AUX
admet-1883	180	32	be	be	AUX
admet-1883	180	33	a	a	DET
admet-1883	180	34	viable	viable	ADJ
admet-1883	180	35	option	option	NOUN
admet-1883	180	36	for	for	ADP
admet-1883	180	37	treatment	treatment	NOUN
admet-1883	180	38	against	against	ADP
admet-1883	180	39	sars	sar	NOUN
admet-1883	180	40	-	-	PUNCT
admet-1883	180	41	cov-2	cov-2	NOUN
admet-1883	180	42	infections	infection	NOUN
admet-1883	180	43	,	,	PUNCT
admet-1883	180	44	which	which	PRON
admet-1883	180	45	can	can	AUX
admet-1883	180	46	be	be	AUX
admet-1883	180	47	studied	study	VERB
admet-1883	180	48	further	far	ADV
admet-1883	180	49	to	to	PART
admet-1883	180	50	improve	improve	VERB
admet-1883	180	51	the	the	DET
admet-1883	180	52	treatment	treatment	NOUN
admet-1883	180	53	success	success	NOUN
admet-1883	180	54	rate	rate	NOUN
admet-1883	180	55	.	.	PUNCT
admet-1883	181	1	the	the	DET
admet-1883	181	2	outbreak	outbreak	NOUN
admet-1883	181	3	of	of	ADP
admet-1883	181	4	covid-19	covid-19	PROPN
admet-1883	181	5	has	have	AUX
admet-1883	181	6	expanded	expand	VERB
admet-1883	181	7	enormously	enormously	ADV
admet-1883	181	8	due	due	ADP
admet-1883	181	9	to	to	ADP
admet-1883	181	10	the	the	DET
admet-1883	181	11	insufficiency	insufficiency	NOUN
admet-1883	181	12	of	of	ADP
admet-1883	181	13	immunizations	immunization	NOUN
admet-1883	181	14	also	also	ADV
admet-1883	181	15	therapeutic	therapeutic	ADJ
admet-1883	181	16	interventions	intervention	NOUN
admet-1883	181	17	for	for	ADP
admet-1883	181	18	the	the	DET
admet-1883	181	19	prevention	prevention	NOUN
admet-1883	181	20	and	and	CCONJ
admet-1883	181	21	management	management	NOUN
admet-1883	181	22	of	of	ADP
admet-1883	181	23	viral	viral	ADJ
admet-1883	181	24	infections	infection	NOUN
admet-1883	181	25	.	.	PUNCT
admet-1883	182	1	because	because	SCONJ
admet-1883	182	2	of	of	ADP
admet-1883	182	3	the	the	DET
admet-1883	182	4	severity	severity	NOUN
admet-1883	182	5	and	and	CCONJ
admet-1883	182	6	urgency	urgency	NOUN
admet-1883	182	7	of	of	ADP
admet-1883	182	8	covid-19	covid-19	PROPN
admet-1883	182	9	,	,	PUNCT
admet-1883	182	10	a	a	DET
admet-1883	182	11	new	new	ADJ
admet-1883	182	12	technique	technique	NOUN
admet-1883	182	13	needs	need	VERB
admet-1883	182	14	to	to	PART
admet-1883	182	15	be	be	AUX
admet-1883	182	16	developed	develop	VERB
admet-1883	182	17	for	for	ADP
admet-1883	182	18	the	the	DET
admet-1883	182	19	prevention	prevention	NOUN
admet-1883	182	20	and	and	CCONJ
admet-1883	182	21	treatment	treatment	NOUN
admet-1883	182	22	of	of	ADP
admet-1883	182	23	the	the	DET
admet-1883	182	24	virus	virus	NOUN
admet-1883	183	1	[	[	X
admet-1883	183	2	75,76	75,76	NUM
admet-1883	183	3	]	]	X
admet-1883	183	4	.	.	PUNCT
admet-1883	184	1	antiviral	antiviral	ADJ
admet-1883	184	2	photodynamic	photodynamic	ADJ
admet-1883	184	3	therapy	therapy	NOUN
admet-1883	184	4	(	(	PUNCT
admet-1883	184	5	apdt	apdt	NOUN
admet-1883	184	6	)	)	PUNCT
admet-1883	184	7	is	be	AUX
admet-1883	184	8	likely	likely	ADJ
admet-1883	184	9	to	to	PART
admet-1883	184	10	be	be	AUX
admet-1883	184	11	useful	useful	ADJ
admet-1883	184	12	as	as	ADP
admet-1883	184	13	a	a	DET
admet-1883	184	14	potential	potential	ADJ
admet-1883	184	15	therapy	therapy	NOUN
admet-1883	184	16	for	for	ADP
admet-1883	184	17	coronavirus	coronavirus	NOUN
admet-1883	184	18	inhibition	inhibition	NOUN
admet-1883	184	19	and	and	CCONJ
admet-1883	184	20	reduction	reduction	NOUN
admet-1883	184	21	.	.	PUNCT
admet-1883	185	1	the	the	DET
admet-1883	185	2	effectiveness	effectiveness	NOUN
admet-1883	185	3	of	of	ADP
admet-1883	185	4	apdt	apdt	NOUN
admet-1883	185	5	in	in	ADP
admet-1883	185	6	inactivating	inactivate	VERB
admet-1883	185	7	mammalian	mammalian	ADJ
admet-1883	185	8	viruses	virus	NOUN
admet-1883	185	9	has	have	AUX
admet-1883	185	10	been	be	AUX
admet-1883	185	11	established	establish	VERB
admet-1883	185	12	in	in	ADP
admet-1883	185	13	several	several	ADJ
admet-1883	185	14	research	research	NOUN
admet-1883	185	15	outcomes	outcome	NOUN
admet-1883	185	16	(	(	PUNCT
admet-1883	185	17	table	table	NOUN
admet-1883	185	18	2	2	NUM
admet-1883	185	19	)	)	PUNCT
admet-1883	185	20	.	.	PUNCT
admet-1883	186	1	table	table	NOUN
admet-1883	186	2	2	2	NUM
admet-1883	186	3	.	.	PUNCT
admet-1883	187	1	recent	recent	ADJ
admet-1883	187	2	findings	finding	NOUN
admet-1883	187	3	on	on	ADP
admet-1883	187	4	the	the	DET
admet-1883	187	5	effectiveness	effectiveness	NOUN
admet-1883	187	6	of	of	ADP
admet-1883	187	7	pdt	pdt	NOUN
admet-1883	187	8	against	against	ADP
admet-1883	187	9	viral	viral	ADJ
admet-1883	187	10	infections	infection	NOUN
admet-1883	187	11	no	no	DET
admet-1883	187	12	ps	ps	NOUN
admet-1883	187	13	wavelength	wavelength	NOUN
admet-1883	187	14	,	,	PUNCT
admet-1883	187	15	nm	nm	ADJ
admet-1883	187	16	target	target	NOUN
admet-1883	187	17	finding	finding	NOUN
admet-1883	187	18	remarks	remark	VERB
admet-1883	187	19	1	1	NUM
admet-1883	187	20	.	.	X
admet-1883	188	1	5aminolevulinic	5aminolevulinic	NUM
admet-1883	188	2	acid	acid	NOUN
admet-1883	188	3	(	(	PUNCT
admet-1883	188	4	5	5	NUM
admet-1883	188	5	-	-	PUNCT
admet-1883	188	6	ala	ala	NOUN
admet-1883	188	7	)	)	PUNCT
admet-1883	188	8	635	635	NUM
admet-1883	188	9	juvenile	juvenile	ADJ
admet-1883	188	10	laryngeal	laryngeal	ADJ
admet-1883	188	11	papilloma	papilloma	NOUN
admet-1883	188	12	after	after	ADP
admet-1883	188	13	pdt	pdt	PROPN
admet-1883	188	14	treatment	treatment	PROPN
admet-1883	188	15	,	,	PUNCT
admet-1883	188	16	laryngeal	laryngeal	ADJ
admet-1883	188	17	papilloma	papilloma	NOUN
admet-1883	188	18	was	be	AUX
admet-1883	188	19	almost	almost	ADV
admet-1883	188	20	cured	cure	VERB
admet-1883	188	21	,	,	PUNCT
admet-1883	188	22	and	and	CCONJ
admet-1883	188	23	no	no	DET
admet-1883	188	24	recurrence	recurrence	NOUN
admet-1883	188	25	was	be	AUX
admet-1883	188	26	observed	observe	VERB
admet-1883	188	27	during	during	ADP
admet-1883	188	28	6	6	NUM
admet-1883	188	29	-	-	SYM
admet-1883	188	30	24	24	NUM
admet-1883	188	31	months	month	NOUN
admet-1883	188	32	of	of	ADP
admet-1883	188	33	continuous	continuous	ADJ
admet-1883	188	34	physical	physical	ADJ
admet-1883	188	35	assessment	assessment	NOUN
admet-1883	188	36	.	.	PUNCT
admet-1883	189	1	pdt	pdt	PROPN
admet-1883	189	2	treatment	treatment	NOUN
admet-1883	189	3	with	with	ADP
admet-1883	189	4	the	the	DET
admet-1883	189	5	combination	combination	NOUN
admet-1883	189	6	of	of	ADP
admet-1883	189	7	co2	co2	NOUN
admet-1883	189	8	laser	laser	NOUN
admet-1883	189	9	therapy	therapy	NOUN
admet-1883	189	10	can	can	AUX
admet-1883	189	11	be	be	AUX
admet-1883	189	12	helpful	helpful	ADJ
admet-1883	189	13	for	for	ADP
admet-1883	189	14	the	the	DET
admet-1883	189	15	common	common	ADJ
admet-1883	189	16	benign	benign	ADJ
admet-1883	189	17	tumor	tumor	NOUN
admet-1883	189	18	,	,	PUNCT
admet-1883	189	19	which	which	PRON
admet-1883	189	20	can	can	AUX
admet-1883	189	21	be	be	AUX
admet-1883	189	22	related	relate	VERB
admet-1883	189	23	to	to	ADP
admet-1883	189	24	human	human	ADJ
admet-1883	189	25	papillomavirus	papillomavirus	NOUN
admet-1883	189	26	(	(	PUNCT
admet-1883	189	27	hpv	hpv	NOUN
admet-1883	189	28	)	)	PUNCT
admet-1883	189	29	infections	infection	NOUN
admet-1883	189	30	.	.	PUNCT
admet-1883	190	1	2	2	X
admet-1883	190	2	.	.	X
admet-1883	190	3	curcumin	curcumin	NOUN
admet-1883	190	4	450	450	NUM
admet-1883	190	5	pharyngo	pharyngo	NOUN
admet-1883	190	6	tonsillitis	tonsillitis	PROPN
admet-1883	190	7	ps	ps	PROPN
admet-1883	190	8	was	be	AUX
admet-1883	190	9	able	able	ADJ
admet-1883	190	10	to	to	PART
admet-1883	190	11	get	get	AUX
admet-1883	190	12	delivered	deliver	VERB
admet-1883	190	13	into	into	ADP
admet-1883	190	14	the	the	DET
admet-1883	190	15	pharynx	pharynx	NOUN
admet-1883	190	16	and	and	CCONJ
admet-1883	190	17	tonsils	tonsil	NOUN
admet-1883	190	18	.	.	PUNCT
admet-1883	191	1	the	the	DET
admet-1883	191	2	microbial	microbial	ADJ
admet-1883	191	3	reduction	reduction	NOUN
admet-1883	191	4	in	in	ADP
admet-1883	191	5	1	1	NUM
admet-1883	191	6	log10	log10	NOUN
admet-1883	191	7	of	of	ADP
admet-1883	191	8	the	the	DET
admet-1883	191	9	colonyforming	colonyforme	VERB
admet-1883	191	10	unit	unit	NOUN
admet-1883	191	11	was	be	AUX
admet-1883	191	12	observed	observe	VERB
admet-1883	191	13	after	after	ADP
admet-1883	191	14	therapy	therapy	NOUN
admet-1883	191	15	,	,	PUNCT
admet-1883	191	16	and	and	CCONJ
admet-1883	191	17	also	also	ADV
admet-1883	191	18	recolonization	recolonization	NOUN
admet-1883	191	19	was	be	AUX
admet-1883	191	20	not	not	PART
admet-1883	191	21	observed	observe	VERB
admet-1883	191	22	after	after	ADP
admet-1883	191	23	24	24	NUM
admet-1883	191	24	h.	h.	NOUN
admet-1883	191	25	the	the	DET
admet-1883	191	26	use	use	NOUN
admet-1883	191	27	of	of	ADP
admet-1883	191	28	photodynamic	photodynamic	ADJ
admet-1883	191	29	therapy	therapy	NOUN
admet-1883	191	30	to	to	PART
admet-1883	191	31	treat	treat	VERB
admet-1883	191	32	pharyngo	pharyngo	NOUN
admet-1883	191	33	tonsillitis	tonsillitis	NOUN
admet-1883	191	34	causes	cause	VERB
admet-1883	191	35	only	only	ADV
admet-1883	191	36	minimal	minimal	ADJ
admet-1883	191	37	side	side	NOUN
admet-1883	191	38	effects	effect	NOUN
admet-1883	191	39	.	.	PUNCT
admet-1883	192	1	admet	admet	PROPN
admet-1883	192	2	&	&	CCONJ
admet-1883	192	3	dmpk	dmpk	PROPN
admet-1883	192	4	11(4	11(4	NUM
admet-1883	192	5	)	)	PUNCT
admet-1883	192	6	(	(	PUNCT
admet-1883	192	7	2023	2023	NUM
admet-1883	192	8	)	)	PUNCT
admet-1883	192	9	513	513	NUM
admet-1883	192	10	-	-	SYM
admet-1883	192	11	531	531	NUM
admet-1883	192	12	infections	infection	NOUN
admet-1883	192	13	associated	associate	VERB
admet-1883	192	14	with	with	ADP
admet-1883	192	15	sars	sar	NOUN
admet-1883	192	16	-	-	PUNCT
admet-1883	192	17	cov-2	cov-2	PART
admet-1883	192	18	exploited	exploit	VERB
admet-1883	192	19	via	via	ADP
admet-1883	192	20	photodynamic	photodynamic	ADJ
admet-1883	192	21	therapy	therapy	NOUN
admet-1883	192	22	doi	doi	NOUN
admet-1883	192	23	:	:	PUNCT
admet-1883	192	24	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-1883	192	25	t.1883	t.1883	NOUN
admet-1883	192	26	521	521	NUM
admet-1883	192	27	no	no	DET
admet-1883	192	28	ps	ps	NOUN
admet-1883	192	29	wavelength	wavelength	NOUN
admet-1883	192	30	,	,	PUNCT
admet-1883	192	31	nm	nm	ADJ
admet-1883	192	32	target	target	NOUN
admet-1883	192	33	finding	finding	NOUN
admet-1883	192	34	remarks	remark	VERB
admet-1883	192	35	3	3	NUM
admet-1883	192	36	.	.	PUNCT
admet-1883	192	37	methylene	methylene	ADJ
admet-1883	192	38	blue	blue	NOUN
admet-1883	192	39	(	(	PUNCT
admet-1883	192	40	mb	mb	NOUN
admet-1883	192	41	)	)	PUNCT
admet-1883	192	42	660	660	NUM
admet-1883	192	43	herpes	herpe	NOUN
admet-1883	192	44	simplex	simplex	NOUN
admet-1883	192	45	virus	virus	NOUN
admet-1883	192	46	(	(	PUNCT
admet-1883	192	47	hsv-1	hsv-1	X
admet-1883	192	48	)	)	PUNCT
admet-1883	192	49	after	after	ADP
admet-1883	192	50	pdt	pdt	PROPN
admet-1883	192	51	,	,	PUNCT
admet-1883	192	52	the	the	DET
admet-1883	192	53	first	first	ADJ
admet-1883	192	54	session	session	NOUN
admet-1883	192	55	showed	show	VERB
admet-1883	192	56	betterment	betterment	NOUN
admet-1883	192	57	in	in	ADP
admet-1883	192	58	antiinflammatory	antiinflammatory	NOUN
admet-1883	192	59	activity	activity	NOUN
admet-1883	192	60	and	and	CCONJ
admet-1883	192	61	itching	itching	NOUN
admet-1883	192	62	and	and	CCONJ
admet-1883	192	63	increased	increase	VERB
admet-1883	192	64	the	the	DET
admet-1883	192	65	healing	healing	NOUN
admet-1883	192	66	process	process	NOUN
admet-1883	192	67	of	of	ADP
admet-1883	192	68	wounds	wound	NOUN
admet-1883	192	69	.	.	PUNCT
admet-1883	193	1	treating	treat	VERB
admet-1883	193	2	herpes	herpe	NOUN
admet-1883	193	3	simplex	simplex	NOUN
admet-1883	193	4	infections	infection	NOUN
admet-1883	193	5	in	in	ADP
admet-1883	193	6	the	the	DET
admet-1883	193	7	nasal	nasal	ADJ
admet-1883	193	8	wing	wing	NOUN
admet-1883	193	9	with	with	ADP
admet-1883	193	10	pdt	pdt	PROPN
admet-1883	193	11	and	and	CCONJ
admet-1883	193	12	photobiomodulation	photobiomodulation	NOUN
admet-1883	193	13	was	be	AUX
admet-1883	193	14	beneficial	beneficial	ADJ
admet-1883	193	15	and	and	CCONJ
admet-1883	193	16	delivering	deliver	VERB
admet-1883	193	17	drug	drug	NOUN
admet-1883	193	18	(	(	PUNCT
admet-1883	193	19	ps	ps	NOUN
admet-1883	193	20	)	)	PUNCT
admet-1883	193	21	via	via	ADP
admet-1883	193	22	nebulization	nebulization	NOUN
admet-1883	193	23	can	can	AUX
admet-1883	193	24	overcome	overcome	VERB
admet-1883	193	25	drug	drug	NOUN
admet-1883	193	26	release	release	NOUN
admet-1883	193	27	problems	problem	NOUN
admet-1883	193	28	,	,	PUNCT
admet-1883	193	29	minimizing	minimize	VERB
admet-1883	193	30	side	side	NOUN
admet-1883	193	31	effects	effect	NOUN
admet-1883	193	32	caused	cause	VERB
admet-1883	193	33	due	due	ADP
admet-1883	193	34	to	to	ADP
admet-1883	193	35	iv	iv	NUM
admet-1883	193	36	administration	administration	NOUN
admet-1883	193	37	.	.	PUNCT
admet-1883	194	1	4	4	X
admet-1883	194	2	.	.	X
admet-1883	194	3	methylene	methylene	ADJ
admet-1883	194	4	blue	blue	NOUN
admet-1883	194	5	(	(	PUNCT
admet-1883	194	6	mb	mb	NOUN
admet-1883	194	7	)	)	PUNCT
admet-1883	194	8	and	and	CCONJ
admet-1883	194	9	radahlorin	radahlorin	NOUN
admet-1883	194	10	662	662	NUM
admet-1883	194	11	vero	vero	PROPN
admet-1883	194	12	e6	e6	NOUN
admet-1883	194	13	cells	cell	NOUN
admet-1883	194	14	and	and	CCONJ
admet-1883	194	15	sarscov	sarscov	VERB
admet-1883	194	16	2	2	NUM
admet-1883	194	17	in	in	ADP
admet-1883	194	18	the	the	DET
admet-1883	194	19	presence	presence	NOUN
admet-1883	194	20	of	of	ADP
admet-1883	194	21	mb	mb	PROPN
admet-1883	194	22	and	and	CCONJ
admet-1883	194	23	radahlorin	radahlorin	NOUN
admet-1883	194	24	,	,	PUNCT
admet-1883	194	25	the	the	DET
admet-1883	194	26	ic50	ic50	PROPN
admet-1883	194	27	of	of	ADP
admet-1883	194	28	102	102	NUM
admet-1883	194	29	tcid50	tcid50	NOUN
admet-1883	194	30	of	of	ADP
admet-1883	194	31	sars	sars	PROPN
admet-1883	194	32	cov-2	cov-2	PART
admet-1883	194	33	was	be	AUX
admet-1883	194	34	found	find	VERB
admet-1883	194	35	as	as	ADP
admet-1883	194	36	0.22	0.22	NUM
admet-1883	194	37	µg	µg	ADV
admet-1883	194	38	/	/	SYM
admet-1883	194	39	ml	ml	NOUN
admet-1883	194	40	and	and	CCONJ
admet-1883	194	41	0.33	0.33	NUM
admet-1883	194	42	µg	µg	NOUN
admet-1883	194	43	/	/	SYM
admet-1883	194	44	ml	ml	NOUN
admet-1883	194	45	.	.	PUNCT
admet-1883	194	46	inhibitory	inhibitory	ADJ
admet-1883	194	47	concentration-50	concentration-50	PROPN
admet-1883	194	48	%	%	NOUN
admet-1883	194	49	for	for	ADP
admet-1883	194	50	radahlorin	radahlorin	NOUN
admet-1883	194	51	and	and	CCONJ
admet-1883	194	52	mb	mb	PROPN
admet-1883	194	53	was	be	AUX
admet-1883	194	54	observed	observe	VERB
admet-1883	194	55	at	at	ADP
admet-1883	194	56	0.6	0.6	NUM
admet-1883	194	57	µg	µg	NOUN
admet-1883	194	58	/	/	SYM
admet-1883	194	59	ml	ml	NOUN
admet-1883	194	60	and	and	CCONJ
admet-1883	194	61	2	2	NUM
admet-1883	194	62	µg	µg	NOUN
admet-1883	194	63	/	/	SYM
admet-1883	194	64	ml	ml	NOUN
admet-1883	194	65	.	.	PUNCT
admet-1883	195	1	in	in	ADP
admet-1883	195	2	vitro	vitro	X
admet-1883	195	3	,	,	PUNCT
admet-1883	195	4	when	when	SCONJ
admet-1883	195	5	pdt	pdt	PROPN
admet-1883	195	6	is	be	AUX
admet-1883	195	7	coupled	couple	VERB
admet-1883	195	8	with	with	ADP
admet-1883	195	9	radahlorin	radahlorin	NOUN
admet-1883	195	10	and	and	CCONJ
admet-1883	195	11	mb	mb	ADJ
admet-1883	195	12	,	,	PUNCT
admet-1883	195	13	high	high	ADJ
admet-1883	195	14	antiviral	antiviral	ADJ
admet-1883	195	15	efficacy	efficacy	NOUN
admet-1883	195	16	against	against	ADP
admet-1883	195	17	sars	sar	NOUN
admet-1883	195	18	-	-	PUNCT
admet-1883	195	19	cov-2	cov-2	PART
admet-1883	195	20	was	be	AUX
admet-1883	195	21	observed	observe	VERB
admet-1883	195	22	.	.	PUNCT
admet-1883	196	1	5	5	X
admet-1883	196	2	.	.	X
admet-1883	196	3	phenothiazines	phenothiazine	NOUN
admet-1883	196	4	,	,	PUNCT
admet-1883	196	5	methylene	methylene	NOUN
admet-1883	196	6	blue	blue	NOUN
admet-1883	196	7	(	(	PUNCT
admet-1883	196	8	mb	mb	NOUN
admet-1883	196	9	)	)	PUNCT
admet-1883	196	10	,	,	PUNCT
admet-1883	196	11	porphyrins	porphyrin	NOUN
admet-1883	196	12	,	,	PUNCT
admet-1883	196	13	protoporhphyrineix	protoporhphyrineix	VERB
admet-1883	196	14	(	(	PUNCT
admet-1883	196	15	pp	pp	ADV
admet-1883	196	16	-	-	PUNCT
admet-1883	196	17	ix	ix	ADJ
admet-1883	196	18	)	)	PUNCT
admet-1883	196	19	covid19	covid19	NOUN
admet-1883	196	20	apdt	apdt	ADJ
admet-1883	196	21	treatment	treatment	NOUN
admet-1883	196	22	using	use	VERB
admet-1883	196	23	cost	cost	NOUN
admet-1883	196	24	-	-	PUNCT
admet-1883	196	25	effective	effective	ADJ
admet-1883	196	26	ps	ps	NOUN
admet-1883	196	27	could	could	AUX
admet-1883	196	28	assist	assist	VERB
admet-1883	196	29	in	in	ADP
admet-1883	196	30	mitigating	mitigate	VERB
admet-1883	196	31	covid-19	covid-19	PROPN
admet-1883	196	32	by	by	ADP
admet-1883	196	33	treating	treat	VERB
admet-1883	196	34	infected	infect	VERB
admet-1883	196	35	individuals	individual	NOUN
admet-1883	196	36	by	by	ADP
admet-1883	196	37	developing	develop	VERB
admet-1883	196	38	functional	functional	ADJ
admet-1883	196	39	photoactive	photoactive	ADJ
admet-1883	196	40	textiles	textile	NOUN
admet-1883	196	41	,	,	PUNCT
admet-1883	196	42	auto	auto	NOUN
admet-1883	196	43	-	-	PUNCT
admet-1883	196	44	disinfecting	disinfect	VERB
admet-1883	196	45	surfaces	surface	NOUN
admet-1883	196	46	,	,	PUNCT
admet-1883	196	47	and	and	CCONJ
admet-1883	196	48	disinfecting	disinfecting	NOUN
admet-1883	196	49	water	water	NOUN
admet-1883	196	50	and	and	CCONJ
admet-1883	196	51	air	air	NOUN
admet-1883	196	52	.	.	PUNCT
admet-1883	197	1	photosensitizers	photosensitizer	NOUN
admet-1883	197	2	mb	mb	VERB
admet-1883	197	3	and	and	CCONJ
admet-1883	197	4	ppix	ppix	PROPN
admet-1883	197	5	are	be	AUX
admet-1883	197	6	new	new	ADJ
admet-1883	197	7	technical	technical	ADJ
admet-1883	197	8	methods	method	NOUN
admet-1883	197	9	to	to	PART
admet-1883	197	10	treat	treat	VERB
admet-1883	197	11	covidaffected	covidaffected	ADJ
admet-1883	197	12	patients	patient	NOUN
admet-1883	197	13	in	in	ADP
admet-1883	197	14	a	a	DET
admet-1883	197	15	less	less	ADV
admet-1883	197	16	costly	costly	ADJ
admet-1883	197	17	and	and	CCONJ
admet-1883	197	18	safer	safe	ADJ
admet-1883	197	19	way	way	NOUN
admet-1883	197	20	by	by	ADP
admet-1883	197	21	disinfecting	disinfect	VERB
admet-1883	197	22	infected	infected	ADJ
admet-1883	197	23	water	water	NOUN
admet-1883	197	24	and	and	CCONJ
admet-1883	197	25	water	water	NOUN
admet-1883	197	26	surface	surface	NOUN
admet-1883	197	27	which	which	PRON
admet-1883	197	28	cause	cause	VERB
admet-1883	197	29	the	the	DET
admet-1883	197	30	covid	covid	PROPN
admet-1883	197	31	disease	disease	NOUN
admet-1883	197	32	.	.	PUNCT
admet-1883	198	1	6	6	X
admet-1883	198	2	.	.	X
admet-1883	198	3	methylene	methylene	NOUN
admet-1883	198	4	blue	blue	PROPN
admet-1883	198	5	660	660	NUM
admet-1883	198	6	lip	lip	NOUN
admet-1883	198	7	lesions	lesion	NOUN
admet-1883	198	8	0.1	0.1	NUM
admet-1883	198	9	%	%	NOUN
admet-1883	198	10	methylene	methylene	NOUN
admet-1883	198	11	blue	blue	NOUN
admet-1883	198	12	(	(	PUNCT
admet-1883	198	13	mb	mb	NOUN
admet-1883	198	14	)	)	PUNCT
admet-1883	198	15	photosensitizer	photosensitizer	NOUN
admet-1883	198	16	was	be	AUX
admet-1883	198	17	applied	apply	VERB
admet-1883	198	18	all	all	ADV
admet-1883	198	19	over	over	ADP
admet-1883	198	20	lip	lip	NOUN
admet-1883	198	21	lesions	lesion	NOUN
admet-1883	198	22	and	and	CCONJ
admet-1883	198	23	treated	treat	VERB
admet-1883	198	24	with	with	ADP
admet-1883	198	25	apdt	apdt	NOUN
admet-1883	198	26	and	and	CCONJ
admet-1883	198	27	photomodulation	photomodulation	NOUN
admet-1883	198	28	showed	show	VERB
admet-1883	198	29	complete	complete	ADJ
admet-1883	198	30	healing	healing	NOUN
admet-1883	198	31	in	in	ADP
admet-1883	198	32	4	4	NUM
admet-1883	198	33	days	day	NOUN
admet-1883	198	34	.	.	PUNCT
admet-1883	199	1	covid-19	covid-19	PROPN
admet-1883	199	2	-	-	PUNCT
admet-1883	199	3	related	relate	VERB
admet-1883	199	4	labial	labial	ADJ
admet-1883	199	5	lesions	lesion	NOUN
admet-1883	199	6	can	can	AUX
admet-1883	199	7	be	be	AUX
admet-1883	199	8	efficiently	efficiently	ADV
admet-1883	199	9	treated	treat	VERB
admet-1883	199	10	by	by	ADP
admet-1883	199	11	combining	combine	VERB
admet-1883	199	12	phototherapy	phototherapy	NOUN
admet-1883	199	13	modalities	modality	NOUN
admet-1883	199	14	.	.	PUNCT
admet-1883	200	1	7	7	X
admet-1883	200	2	.	.	X
admet-1883	200	3	curcumin	curcumin	NOUN
admet-1883	200	4	polylactic	polylactic	ADJ
admet-1883	200	5	-	-	PUNCT
admet-1883	200	6	coglycolide	coglycolide	ADJ
admet-1883	200	7	acid	acid	NOUN
admet-1883	200	8	sars	sar	NOUN
admet-1883	200	9	-	-	PUNCT
admet-1883	200	10	cov-2	cov-2	NOUN
admet-1883	200	11	,	,	PUNCT
admet-1883	200	12	vero	vero	PROPN
admet-1883	200	13	cells	cell	NOUN
admet-1883	200	14	apdt	apdt	VERB
admet-1883	200	15	had	have	VERB
admet-1883	200	16	anti	anti	ADJ
admet-1883	200	17	-	-	ADJ
admet-1883	200	18	covid	covid	ADJ
admet-1883	200	19	action	action	NOUN
admet-1883	200	20	in	in	ADP
admet-1883	200	21	vitro	vitro	ADJ
admet-1883	200	22	without	without	ADP
admet-1883	200	23	causing	cause	VERB
admet-1883	200	24	cytotoxicity	cytotoxicity	NOUN
admet-1883	200	25	in	in	ADP
admet-1883	200	26	vero	vero	PROPN
admet-1883	200	27	cells	cell	NOUN
admet-1883	200	28	cultured	cultured	ADJ
admet-1883	200	29	with	with	ADP
admet-1883	200	30	sars	sar	NOUN
admet-1883	200	31	-	-	PUNCT
admet-1883	200	32	cov-2	cov-2	NOUN
admet-1883	200	33	treated	treat	VERB
admet-1883	200	34	plasma	plasma	NOUN
admet-1883	200	35	in	in	ADP
admet-1883	200	36	vitro	vitro	X
admet-1883	200	37	,	,	PUNCT
admet-1883	200	38	covid-19	covid-19	PROPN
admet-1883	200	39	action	action	NOUN
admet-1883	200	40	was	be	AUX
admet-1883	200	41	observed	observe	VERB
admet-1883	200	42	in	in	ADP
admet-1883	200	43	treated	treat	VERB
admet-1883	200	44	plasma	plasma	NOUN
admet-1883	200	45	containing	contain	VERB
admet-1883	200	46	sarscov2	sarscov2	NOUN
admet-1883	200	47	without	without	ADP
admet-1883	200	48	apoptosis	apoptosis	NOUN
admet-1883	200	49	in	in	ADP
admet-1883	200	50	vero	vero	PROPN
admet-1883	200	51	cell	cell	NOUN
admet-1883	200	52	or	or	CCONJ
admet-1883	200	53	any	any	DET
admet-1883	200	54	negative	negative	ADJ
admet-1883	200	55	effect	effect	NOUN
admet-1883	200	56	on	on	ADP
admet-1883	200	57	plasma	plasma	NOUN
admet-1883	200	58	quality	quality	NOUN
admet-1883	200	59	in	in	ADP
admet-1883	200	60	photodynamic	photodynamic	ADJ
admet-1883	200	61	therapy	therapy	NOUN
admet-1883	200	62	.	.	PUNCT
admet-1883	201	1	8	8	NUM
admet-1883	201	2	.	.	X
admet-1883	201	3	5aminolevulinic	5aminolevulinic	NUM
admet-1883	201	4	acid	acid	NOUN
admet-1883	201	5	635	635	NUM
admet-1883	201	6	hsil	hsil	NOUN
admet-1883	201	7	(	(	PUNCT
admet-1883	201	8	high	high	ADJ
admet-1883	201	9	-	-	PUNCT
admet-1883	201	10	grade	grade	NOUN
admet-1883	201	11	intraepithelial	intraepithelial	ADJ
admet-1883	201	12	lesion)/cin2	lesion)/cin2	NOUN
admet-1883	201	13	(	(	PUNCT
admet-1883	201	14	cervical	cervical	ADJ
admet-1883	201	15	squamous	squamous	ADJ
admet-1883	201	16	intraepithelial	intraepithelial	ADJ
admet-1883	201	17	neoplasia	neoplasia	NOUN
admet-1883	201	18	2	2	NUM
admet-1883	201	19	)	)	PUNCT
admet-1883	201	20	with	with	ADP
admet-1883	201	21	high	high	ADJ
admet-1883	201	22	-	-	PUNCT
admet-1883	201	23	risk	risk	NOUN
admet-1883	201	24	human	human	ADJ
admet-1883	201	25	papillomavirus	papillomavirus	NOUN
admet-1883	201	26	(	(	PUNCT
admet-1883	201	27	hhpv	hhpv	NOUN
admet-1883	201	28	)	)	PUNCT
admet-1883	201	29	5	5	NUM
admet-1883	201	30	-	-	PUNCT
admet-1883	201	31	ala	ala	PROPN
admet-1883	201	32	pdt	pdt	PROPN
admet-1883	201	33	possessed	possess	VERB
admet-1883	201	34	higher	high	ADJ
admet-1883	201	35	safety	safety	NOUN
admet-1883	201	36	and	and	CCONJ
admet-1883	201	37	efficacy	efficacy	NOUN
admet-1883	201	38	profile	profile	NOUN
admet-1883	201	39	for	for	ADP
admet-1883	201	40	the	the	DET
admet-1883	201	41	hsil	hsil	NOUN
admet-1883	201	42	/	/	SYM
admet-1883	201	43	cin2	cin2	NOUN
admet-1883	201	44	patients	patient	NOUN
admet-1883	201	45	needing	need	VERB
admet-1883	201	46	reproductive	reproductive	ADJ
admet-1883	201	47	treatment	treatment	NOUN
admet-1883	201	48	.	.	PUNCT
admet-1883	202	1	it	it	PRON
admet-1883	202	2	can	can	AUX
admet-1883	202	3	be	be	AUX
admet-1883	202	4	a	a	DET
admet-1883	202	5	promising	promising	ADJ
admet-1883	202	6	alternative	alternative	ADJ
admet-1883	202	7	surgical	surgical	ADJ
admet-1883	202	8	technique	technique	NOUN
admet-1883	202	9	.	.	PUNCT
admet-1883	203	1	ala	ala	PROPN
admet-1883	203	2	-	-	PUNCT
admet-1883	203	3	pdt	pdt	PROPN
admet-1883	203	4	is	be	AUX
admet-1883	203	5	effective	effective	ADJ
admet-1883	203	6	for	for	ADP
admet-1883	203	7	treating	treat	VERB
admet-1883	203	8	cervical	cervical	ADJ
admet-1883	203	9	hsil	hsil	NOUN
admet-1883	203	10	and	and	CCONJ
admet-1883	203	11	high	high	ADJ
admet-1883	203	12	-	-	PUNCT
admet-1883	203	13	risk	risk	NOUN
admet-1883	203	14	hpv	hpv	NOUN
admet-1883	203	15	infections	infection	NOUN
admet-1883	203	16	,	,	PUNCT
admet-1883	203	17	and	and	CCONJ
admet-1883	203	18	the	the	DET
admet-1883	203	19	effect	effect	NOUN
admet-1883	203	20	may	may	AUX
admet-1883	203	21	be	be	AUX
admet-1883	203	22	maintained	maintain	VERB
admet-1883	203	23	for	for	ADP
admet-1883	203	24	a	a	DET
admet-1883	203	25	long	long	ADJ
admet-1883	203	26	time	time	NOUN
admet-1883	203	27	.	.	PUNCT
admet-1883	204	1	https://doi.org/10.5599/admet.1883	https://doi.org/10.5599/admet.1883	PROPN
admet-1883	204	2	p.	p.	PROPN
admet-1883	204	3	pallavi	pallavi	VERB
admet-1883	204	4	et	et	PROPN
admet-1883	204	5	al	al	PROPN
admet-1883	204	6	.	.	PROPN
admet-1883	204	7	admet	admet	PROPN
admet-1883	204	8	&	&	CCONJ
admet-1883	204	9	dmpk	dmpk	PROPN
admet-1883	204	10	11(4	11(4	NUM
admet-1883	204	11	)	)	PUNCT
admet-1883	204	12	(	(	PUNCT
admet-1883	204	13	2023	2023	NUM
admet-1883	204	14	)	)	PUNCT
admet-1883	205	1	513	513	NUM
admet-1883	205	2	-	-	SYM
admet-1883	205	3	531	531	NUM
admet-1883	205	4	522	522	NUM
admet-1883	205	5	no	no	DET
admet-1883	205	6	ps	ps	NOUN
admet-1883	205	7	wavelength	wavelength	NOUN
admet-1883	205	8	,	,	PUNCT
admet-1883	205	9	nm	nm	ADJ
admet-1883	205	10	target	target	NOUN
admet-1883	205	11	finding	finding	NOUN
admet-1883	205	12	remarks	remark	VERB
admet-1883	205	13	9	9	NUM
admet-1883	205	14	.	.	PUNCT
admet-1883	205	15	porphyrin	porphyrin	NOUN
admet-1883	205	16	sars	sar	NOUN
admet-1883	205	17	-	-	PUNCT
admet-1883	205	18	cov-2	cov-2	NOUN
admet-1883	205	19	coating	coating	NOUN
admet-1883	205	20	of	of	ADP
admet-1883	205	21	siloxane	siloxane	PROPN
admet-1883	205	22	copolymer	copolymer	NOUN
admet-1883	205	23	onto	onto	ADP
admet-1883	205	24	the	the	DET
admet-1883	205	25	textiles	textile	NOUN
admet-1883	205	26	produces	produce	VERB
admet-1883	205	27	excitation	excitation	NOUN
admet-1883	205	28	of	of	ADP
admet-1883	205	29	porphyrin	porphyrin	NOUN
admet-1883	205	30	that	that	PRON
admet-1883	205	31	shows	show	VERB
admet-1883	205	32	1o2	1o2	NUM
admet-1883	205	33	oxidative	oxidative	ADJ
admet-1883	205	34	crosslinking	crosslinking	NOUN
admet-1883	205	35	of	of	ADP
admet-1883	205	36	the	the	DET
admet-1883	205	37	polysiloxane	polysiloxane	NOUN
admet-1883	205	38	with	with	ADP
admet-1883	205	39	amine	amine	ADJ
admet-1883	205	40	links	link	NOUN
admet-1883	205	41	to	to	PART
admet-1883	205	42	create	create	VERB
admet-1883	205	43	hydrophobic	hydrophobic	NOUN
admet-1883	205	44	fabric	fabric	NOUN
admet-1883	205	45	.	.	PUNCT
admet-1883	206	1	the	the	DET
admet-1883	206	2	development	development	NOUN
admet-1883	206	3	of	of	ADP
admet-1883	206	4	a	a	DET
admet-1883	206	5	treated	treat	VERB
admet-1883	206	6	mask	mask	NOUN
admet-1883	206	7	can	can	AUX
admet-1883	206	8	be	be	AUX
admet-1883	206	9	a	a	DET
admet-1883	206	10	barrier	barrier	NOUN
admet-1883	206	11	and	and	CCONJ
admet-1883	206	12	provide	provide	VERB
admet-1883	206	13	better	well	ADJ
admet-1883	206	14	inactivation	inactivation	NOUN
admet-1883	206	15	of	of	ADP
admet-1883	206	16	viral	viral	ADJ
admet-1883	206	17	structures	structure	NOUN
admet-1883	206	18	for	for	ADP
admet-1883	206	19	the	the	DET
admet-1883	206	20	transmission	transmission	NOUN
admet-1883	206	21	of	of	ADP
admet-1883	206	22	sars	sar	NOUN
admet-1883	206	23	-	-	PUNCT
admet-1883	206	24	cov-2	cov-2	PUNCT
admet-1883	206	25	and	and	CCONJ
admet-1883	206	26	also	also	ADV
admet-1883	206	27	have	have	VERB
admet-1883	206	28	broad	broad	ADJ
admet-1883	206	29	-	-	PUNCT
admet-1883	206	30	antiviral	antiviral	ADJ
admet-1883	206	31	activity	activity	NOUN
admet-1883	206	32	application	application	NOUN
admet-1883	206	33	against	against	ADP
admet-1883	206	34	human	human	NOUN
admet-1883	206	35	-	-	PUNCT
admet-1883	206	36	enveloped	envelop	VERB
admet-1883	206	37	viruses	virus	NOUN
admet-1883	206	38	such	such	ADJ
admet-1883	206	39	as	as	ADP
admet-1883	206	40	influenza	influenza	NOUN
admet-1883	206	41	a	a	DET
admet-1883	206	42	virus	virus	NOUN
admet-1883	206	43	and	and	CCONJ
admet-1883	206	44	other	other	ADJ
admet-1883	206	45	coronaviruses	coronaviruse	NOUN
admet-1883	206	46	.	.	PUNCT
admet-1883	207	1	10	10	NUM
admet-1883	207	2	.	.	PUNCT
admet-1883	207	3	methylene	methylene	ADJ
admet-1883	207	4	blue	blue	PROPN
admet-1883	207	5	influenza	influenza	PROPN
admet-1883	207	6	virus	virus	PROPN
admet-1883	207	7	,	,	PUNCT
admet-1883	207	8	sars	sars	PROPN
admet-1883	207	9	-	-	PUNCT
admet-1883	207	10	cov2	cov2	PROPN
admet-1883	207	11	,	,	PUNCT
admet-1883	207	12	and	and	CCONJ
admet-1883	207	13	mers	mer	NOUN
admet-1883	207	14	(	(	PUNCT
admet-1883	207	15	middle	middle	PROPN
admet-1883	207	16	east	east	PROPN
admet-1883	207	17	respiratory	respiratory	ADJ
admet-1883	207	18	syndrome	syndrome	NOUN
admet-1883	207	19	)	)	PUNCT
admet-1883	207	20	as	as	SCONJ
admet-1883	207	21	studies	study	NOUN
admet-1883	207	22	suggest	suggest	VERB
admet-1883	207	23	,	,	PUNCT
admet-1883	207	24	mb	mb	ADJ
admet-1883	207	25	-	-	PUNCT
admet-1883	207	26	mediated	mediate	VERB
admet-1883	207	27	apdt	apdt	NOUN
admet-1883	207	28	can	can	AUX
admet-1883	207	29	minimize	minimize	VERB
admet-1883	207	30	covid-19	covid-19	PROPN
admet-1883	207	31	impact	impact	NOUN
admet-1883	207	32	in	in	ADP
admet-1883	207	33	the	the	DET
admet-1883	207	34	absence	absence	NOUN
admet-1883	207	35	of	of	ADP
admet-1883	207	36	therapy	therapy	NOUN
admet-1883	207	37	for	for	ADP
admet-1883	207	38	covid-19	covid-19	PROPN
admet-1883	207	39	.	.	PUNCT
admet-1883	207	40	methylene	methylene	PROPN
admet-1883	207	41	blue	blue	NOUN
admet-1883	207	42	as	as	ADP
admet-1883	207	43	ps	ps	PROPN
admet-1883	207	44	for	for	ADP
admet-1883	207	45	apdt	apdt	NOUN
admet-1883	207	46	can	can	AUX
admet-1883	207	47	take	take	VERB
admet-1883	207	48	control	control	NOUN
admet-1883	207	49	of	of	ADP
admet-1883	207	50	coronavirus	coronavirus	NOUN
admet-1883	207	51	and	and	CCONJ
admet-1883	207	52	helps	help	VERB
admet-1883	207	53	to	to	PART
admet-1883	207	54	eradicate	eradicate	VERB
admet-1883	207	55	it	it	PRON
admet-1883	207	56	.	.	PUNCT
admet-1883	208	1	more	more	ADJ
admet-1883	208	2	research	research	NOUN
admet-1883	208	3	is	be	AUX
admet-1883	208	4	required	require	VERB
admet-1883	208	5	for	for	ADP
admet-1883	208	6	the	the	DET
admet-1883	208	7	use	use	NOUN
admet-1883	208	8	of	of	ADP
admet-1883	208	9	antiviral	antiviral	ADJ
admet-1883	208	10	pdt	pdt	PROPN
admet-1883	208	11	as	as	ADP
admet-1883	208	12	a	a	DET
admet-1883	208	13	treatment	treatment	NOUN
admet-1883	208	14	against	against	ADP
admet-1883	208	15	covid-19	covid-19	PROPN
admet-1883	208	16	.	.	PUNCT
admet-1883	209	1	examples	example	NOUN
admet-1883	209	2	such	such	ADJ
admet-1883	209	3	as	as	ADP
admet-1883	209	4	adenovirus	adenovirus	NOUN
admet-1883	209	5	,	,	PUNCT
admet-1883	209	6	hepatitis	hepatitis	NOUN
admet-1883	209	7	viruses	viruse	VERB
admet-1883	209	8	a	a	DET
admet-1883	209	9	,	,	PUNCT
admet-1883	209	10	b	b	NOUN
admet-1883	209	11	,	,	PUNCT
admet-1883	209	12	and	and	CCONJ
admet-1883	209	13	c	c	X
admet-1883	209	14	,	,	PUNCT
admet-1883	209	15	hiv	hiv	PROPN
admet-1883	209	16	(	(	PUNCT
admet-1883	209	17	human	human	ADJ
admet-1883	209	18	immunodeficiency	immunodeficiency	NOUN
admet-1883	209	19	virus	virus	NOUN
admet-1883	209	20	)	)	PUNCT
admet-1883	209	21	,	,	PUNCT
admet-1883	209	22	parvovirus	parvovirus	NOUN
admet-1883	209	23	b19	b19	NOUN
admet-1883	209	24	,	,	PUNCT
admet-1883	209	25	herpes	herpe	NOUN
admet-1883	209	26	virus	virus	NOUN
admet-1883	209	27	,	,	PUNCT
admet-1883	209	28	etc	etc	X
admet-1883	209	29	.	.	X
admet-1883	209	30	,	,	PUNCT
admet-1883	209	31	causing	cause	VERB
admet-1883	209	32	infections	infection	NOUN
admet-1883	209	33	have	have	AUX
admet-1883	209	34	been	be	AUX
admet-1883	209	35	studied	study	VERB
admet-1883	209	36	to	to	PART
admet-1883	209	37	get	get	AUX
admet-1883	209	38	treated	treat	VERB
admet-1883	209	39	with	with	ADP
admet-1883	209	40	pdt	pdt	NOUN
admet-1883	209	41	,	,	PUNCT
admet-1883	209	42	and	and	CCONJ
admet-1883	209	43	certain	certain	ADJ
admet-1883	209	44	studies	study	NOUN
admet-1883	209	45	have	have	AUX
admet-1883	209	46	found	find	VERB
admet-1883	209	47	that	that	SCONJ
admet-1883	209	48	the	the	DET
admet-1883	209	49	viruses	virus	NOUN
admet-1883	209	50	with	with	ADP
admet-1883	209	51	the	the	DET
admet-1883	209	52	outer	outer	ADJ
admet-1883	209	53	envelope	envelope	NOUN
admet-1883	209	54	are	be	AUX
admet-1883	209	55	more	more	ADV
admet-1883	209	56	susceptible	susceptible	ADJ
admet-1883	209	57	to	to	PART
admet-1883	209	58	apdt	apdt	VERB
admet-1883	209	59	than	than	ADP
admet-1883	209	60	nonenveloped	nonenvelope	VERB
admet-1883	209	61	viruses	virus	NOUN
admet-1883	209	62	.	.	PUNCT
admet-1883	210	1	apdt	apdt	PROPN
admet-1883	210	2	is	be	AUX
admet-1883	210	3	being	be	AUX
admet-1883	210	4	utilized	utilize	VERB
admet-1883	210	5	for	for	ADP
admet-1883	210	6	inactivating	inactivate	VERB
admet-1883	210	7	multiple	multiple	ADJ
admet-1883	210	8	viruses	virus	NOUN
admet-1883	210	9	in	in	ADP
admet-1883	210	10	a	a	DET
admet-1883	210	11	variety	variety	NOUN
admet-1883	210	12	of	of	ADP
admet-1883	210	13	biological	biological	ADJ
admet-1883	210	14	fluids	fluid	NOUN
admet-1883	210	15	,	,	PUNCT
admet-1883	210	16	including	include	VERB
admet-1883	210	17	blood	blood	NOUN
admet-1883	210	18	.	.	PUNCT
admet-1883	211	1	treating	treat	VERB
admet-1883	211	2	superficial	superficial	ADJ
admet-1883	211	3	viral	viral	ADJ
admet-1883	211	4	lesions	lesion	NOUN
admet-1883	211	5	with	with	ADP
admet-1883	211	6	apdt	apdt	NOUN
admet-1883	211	7	is	be	AUX
admet-1883	211	8	also	also	ADV
admet-1883	211	9	very	very	ADV
admet-1883	211	10	effective	effective	ADJ
admet-1883	211	11	[	[	X
admet-1883	211	12	77	77	NUM
admet-1883	211	13	]	]	PUNCT
admet-1883	211	14	.	.	PUNCT
admet-1883	212	1	the	the	DET
admet-1883	212	2	ros	ros	PROPN
admet-1883	212	3	will	will	AUX
admet-1883	212	4	be	be	AUX
admet-1883	212	5	produced	produce	VERB
admet-1883	212	6	when	when	SCONJ
admet-1883	212	7	a	a	DET
admet-1883	212	8	photoinactivation	photoinactivation	NOUN
admet-1883	212	9	method	method	NOUN
admet-1883	212	10	is	be	AUX
admet-1883	212	11	performed	perform	VERB
admet-1883	212	12	on	on	ADP
admet-1883	212	13	a	a	DET
admet-1883	212	14	variety	variety	NOUN
admet-1883	212	15	of	of	ADP
admet-1883	212	16	significant	significant	ADJ
admet-1883	212	17	biomolecule	biomolecule	NOUN
admet-1883	212	18	targets	target	NOUN
admet-1883	212	19	,	,	PUNCT
admet-1883	212	20	such	such	ADJ
admet-1883	212	21	as	as	ADP
admet-1883	212	22	dna	dna	NOUN
admet-1883	212	23	,	,	PUNCT
admet-1883	212	24	lipids	lipid	NOUN
admet-1883	212	25	,	,	PUNCT
admet-1883	212	26	and	and	CCONJ
admet-1883	212	27	proteins	protein	NOUN
admet-1883	212	28	.	.	PUNCT
admet-1883	213	1	ros	ros	PROPN
admet-1883	213	2	produces	produce	VERB
admet-1883	213	3	oxidative	oxidative	ADJ
admet-1883	213	4	stress	stress	NOUN
admet-1883	213	5	and	and	CCONJ
admet-1883	213	6	causes	cause	VERB
admet-1883	213	7	irreparable	irreparable	ADJ
admet-1883	213	8	damage	damage	NOUN
admet-1883	213	9	to	to	ADP
admet-1883	213	10	the	the	DET
admet-1883	213	11	cellular	cellular	ADJ
admet-1883	213	12	structure	structure	NOUN
admet-1883	213	13	of	of	ADP
admet-1883	213	14	the	the	DET
admet-1883	213	15	virus	virus	NOUN
admet-1883	213	16	.	.	PUNCT
admet-1883	214	1	this	this	DET
admet-1883	214	2	oxidative	oxidative	ADJ
admet-1883	214	3	stress	stress	NOUN
admet-1883	214	4	induces	induce	VERB
admet-1883	214	5	apoptosis	apoptosis	NOUN
admet-1883	214	6	and	and	CCONJ
admet-1883	214	7	necrosis	necrosis	NOUN
admet-1883	214	8	to	to	PART
admet-1883	214	9	kill	kill	VERB
admet-1883	214	10	the	the	DET
admet-1883	214	11	virus	virus	NOUN
admet-1883	214	12	without	without	ADP
admet-1883	214	13	causing	cause	VERB
admet-1883	214	14	damage	damage	NOUN
admet-1883	214	15	to	to	ADP
admet-1883	214	16	the	the	DET
admet-1883	214	17	surrounding	surround	VERB
admet-1883	214	18	healthy	healthy	ADJ
admet-1883	214	19	tissues	tissue	NOUN
admet-1883	214	20	.	.	PUNCT
admet-1883	215	1	both	both	PRON
admet-1883	215	2	intracellular	intracellular	ADJ
admet-1883	215	3	as	as	ADV
admet-1883	215	4	well	well	ADV
admet-1883	215	5	as	as	ADP
admet-1883	215	6	extracellular	extracellular	ADJ
admet-1883	215	7	ros	ros	PROPN
admet-1883	215	8	can	can	AUX
admet-1883	215	9	be	be	AUX
admet-1883	215	10	released	release	VERB
admet-1883	215	11	by	by	ADP
admet-1883	215	12	apdt	apdt	NOUN
admet-1883	215	13	.	.	PUNCT
admet-1883	216	1	ps	ps	PROPN
admet-1883	216	2	is	be	AUX
admet-1883	216	3	considered	consider	VERB
admet-1883	216	4	as	as	ADP
admet-1883	216	5	one	one	NUM
admet-1883	216	6	of	of	ADP
admet-1883	216	7	the	the	DET
admet-1883	216	8	essential	essential	ADJ
admet-1883	216	9	components	component	NOUN
admet-1883	216	10	of	of	ADP
admet-1883	216	11	pdt	pdt	PROPN
admet-1883	216	12	.	.	PUNCT
admet-1883	217	1	colors	color	NOUN
admet-1883	217	2	of	of	ADP
admet-1883	217	3	porphycenes	porphycene	NOUN
admet-1883	217	4	and	and	CCONJ
admet-1883	217	5	phenothiazines	phenothiazine	NOUN
admet-1883	217	6	,	,	PUNCT
admet-1883	217	7	such	such	ADJ
admet-1883	217	8	as	as	ADP
admet-1883	217	9	azure	azure	NOUN
admet-1883	217	10	,	,	PUNCT
admet-1883	217	11	methylene	methylene	ADJ
admet-1883	217	12	blue	blue	NOUN
admet-1883	217	13	(	(	PUNCT
admet-1883	217	14	mb	mb	NOUN
admet-1883	217	15	)	)	PUNCT
admet-1883	217	16	,	,	PUNCT
admet-1883	217	17	toluidine	toluidine	VERB
admet-1883	217	18	blue	blue	ADJ
admet-1883	217	19	o	o	X
admet-1883	217	20	(	(	PUNCT
admet-1883	217	21	tbo	tbo	PROPN
admet-1883	217	22	)	)	PUNCT
admet-1883	217	23	,	,	PUNCT
admet-1883	217	24	chlorine	chlorine	NOUN
admet-1883	217	25	,	,	PUNCT
admet-1883	217	26	porphyrin	porphyrin	NOUN
admet-1883	217	27	,	,	PUNCT
admet-1883	217	28	and	and	CCONJ
admet-1883	217	29	phthalocyanine	phthalocyanine	NOUN
admet-1883	217	30	derivatives	derivative	NOUN
admet-1883	217	31	are	be	AUX
admet-1883	217	32	suitable	suitable	ADJ
admet-1883	217	33	as	as	ADP
admet-1883	217	34	ps	ps	PROPN
admet-1883	217	35	for	for	ADP
admet-1883	217	36	the	the	DET
admet-1883	217	37	apdt	apdt	NOUN
admet-1883	218	1	[	[	X
admet-1883	218	2	78	78	NUM
admet-1883	218	3	]	]	PUNCT
admet-1883	218	4	.	.	PUNCT
admet-1883	219	1	covid-19	covid-19	PROPN
admet-1883	219	2	is	be	AUX
admet-1883	219	3	now	now	ADV
admet-1883	219	4	treated	treat	VERB
admet-1883	219	5	with	with	ADP
admet-1883	219	6	chloroquine	chloroquine	NOUN
admet-1883	219	7	(	(	PUNCT
admet-1883	219	8	c18h26cln3	c18h26cln3	NOUN
admet-1883	219	9	)	)	PUNCT
admet-1883	219	10	,	,	PUNCT
admet-1883	219	11	and	and	CCONJ
admet-1883	219	12	it	it	PRON
admet-1883	219	13	has	have	VERB
admet-1883	219	14	a	a	DET
admet-1883	219	15	structural	structural	ADJ
admet-1883	219	16	similarity	similarity	NOUN
admet-1883	219	17	with	with	ADP
admet-1883	219	18	mb	mb	PROPN
admet-1883	219	19	(	(	PUNCT
admet-1883	219	20	c16h18cln3s	c16h18cln3s	NOUN
admet-1883	219	21	)	)	PUNCT
admet-1883	219	22	.	.	PUNCT
admet-1883	220	1	according	accord	VERB
admet-1883	220	2	to	to	ADP
admet-1883	220	3	the	the	DET
admet-1883	220	4	preliminary	preliminary	ADJ
admet-1883	220	5	data	datum	NOUN
admet-1883	220	6	from	from	ADP
admet-1883	220	7	a	a	DET
admet-1883	220	8	recent	recent	ADJ
admet-1883	220	9	trial	trial	NOUN
admet-1883	220	10	,	,	PUNCT
admet-1883	220	11	mb	mb	ADP
admet-1883	220	12	might	might	AUX
admet-1883	220	13	be	be	AUX
admet-1883	220	14	an	an	DET
admet-1883	220	15	effective	effective	ADJ
admet-1883	220	16	ps	ps	NOUN
admet-1883	220	17	for	for	ADP
admet-1883	220	18	the	the	DET
admet-1883	220	19	therapy	therapy	NOUN
admet-1883	220	20	for	for	ADP
admet-1883	220	21	flu	flu	NOUN
admet-1883	220	22	-	-	PUNCT
admet-1883	220	23	like	like	ADJ
admet-1883	220	24	conditions	condition	NOUN
admet-1883	220	25	like	like	ADP
admet-1883	220	26	covid-19	covid-19	PROPN
admet-1883	220	27	.	.	PUNCT
admet-1883	221	1	studies	study	NOUN
admet-1883	221	2	proved	prove	VERB
admet-1883	221	3	that	that	SCONJ
admet-1883	221	4	mb	mb	ADP
admet-1883	221	5	efficiently	efficiently	ADV
admet-1883	221	6	inhibits	inhibit	VERB
admet-1883	221	7	the	the	DET
admet-1883	221	8	spike	spike	ADJ
admet-1883	221	9	protein	protein	NOUN
admet-1883	221	10	and	and	CCONJ
admet-1883	221	11	ace2	ace2	PROPN
admet-1883	221	12	(	(	PUNCT
admet-1883	221	13	angiotensin	angiotensin	NOUN
admet-1883	221	14	-	-	PUNCT
admet-1883	221	15	converting	convert	VERB
admet-1883	221	16	enzyme	enzyme	NOUN
admet-1883	221	17	2	2	NUM
admet-1883	221	18	)	)	PUNCT
admet-1883	221	19	receptor	receptor	NOUN
admet-1883	221	20	of	of	ADP
admet-1883	221	21	sars	sar	NOUN
admet-1883	221	22	-	-	PUNCT
admet-1883	221	23	cov-2	cov-2	NUM
admet-1883	221	24	to	to	PART
admet-1883	221	25	inactivate	inactivate	VERB
admet-1883	221	26	the	the	DET
admet-1883	221	27	viral	viral	ADJ
admet-1883	221	28	replication	replication	NOUN
admet-1883	221	29	[	[	X
admet-1883	221	30	79	79	NUM
admet-1883	221	31	]	]	PUNCT
admet-1883	221	32	.	.	PUNCT
admet-1883	222	1	nanoformulated	nanoformulate	VERB
admet-1883	222	2	pdt	pdt	PROPN
admet-1883	222	3	management	management	NOUN
admet-1883	222	4	of	of	ADP
admet-1883	222	5	sars	sar	NOUN
admet-1883	222	6	-	-	PUNCT
admet-1883	222	7	cov-2	cov-2	PART
admet-1883	222	8	infections	infection	NOUN
admet-1883	222	9	is	be	AUX
admet-1883	222	10	still	still	ADV
admet-1883	222	11	in	in	ADP
admet-1883	222	12	progress	progress	NOUN
admet-1883	222	13	,	,	PUNCT
admet-1883	222	14	and	and	CCONJ
admet-1883	222	15	some	some	DET
admet-1883	222	16	vaccines	vaccine	NOUN
admet-1883	222	17	are	be	AUX
admet-1883	222	18	in	in	ADP
admet-1883	222	19	use	use	NOUN
admet-1883	222	20	in	in	ADP
admet-1883	222	21	an	an	DET
admet-1883	222	22	emergency	emergency	NOUN
admet-1883	222	23	.	.	PUNCT
admet-1883	223	1	nanotechnology	nanotechnology	NOUN
admet-1883	223	2	has	have	AUX
admet-1883	223	3	been	be	AUX
admet-1883	223	4	employed	employ	VERB
admet-1883	223	5	to	to	PART
admet-1883	223	6	improve	improve	VERB
admet-1883	223	7	the	the	DET
admet-1883	223	8	efficacy	efficacy	NOUN
admet-1883	223	9	of	of	ADP
admet-1883	223	10	those	those	DET
admet-1883	223	11	vaccines	vaccine	NOUN
admet-1883	223	12	to	to	PART
admet-1883	223	13	target	target	VERB
admet-1883	223	14	covid-19	covid-19	PROPN
admet-1883	223	15	(	(	PUNCT
admet-1883	223	16	table	table	NOUN
admet-1883	223	17	3	3	NUM
admet-1883	223	18	)	)	PUNCT
admet-1883	223	19	.	.	PUNCT
admet-1883	224	1	researchers	researcher	NOUN
admet-1883	224	2	currently	currently	ADV
admet-1883	224	3	focus	focus	VERB
admet-1883	224	4	on	on	ADP
admet-1883	224	5	nanomaterials	nanomaterial	NOUN
admet-1883	224	6	-	-	PUNCT
admet-1883	224	7	based	base	VERB
admet-1883	224	8	antiviral	antiviral	ADJ
admet-1883	224	9	photodynamic	photodynamic	ADJ
admet-1883	224	10	therapy	therapy	NOUN
admet-1883	224	11	treatment	treatment	NOUN
admet-1883	224	12	.	.	PUNCT
admet-1883	225	1	that	that	PRON
admet-1883	225	2	has	have	AUX
admet-1883	225	3	been	be	AUX
admet-1883	225	4	proven	prove	VERB
admet-1883	225	5	as	as	ADP
admet-1883	225	6	an	an	DET
admet-1883	225	7	innovative	innovative	ADJ
admet-1883	225	8	strategy	strategy	NOUN
admet-1883	225	9	to	to	PART
admet-1883	225	10	inhibit	inhibit	VERB
admet-1883	225	11	bacterial	bacterial	ADJ
admet-1883	225	12	and	and	CCONJ
admet-1883	225	13	viral	viral	ADJ
admet-1883	225	14	infections	infection	NOUN
admet-1883	225	15	like	like	ADP
admet-1883	225	16	papilloma	papilloma	NOUN
admet-1883	225	17	and	and	CCONJ
admet-1883	225	18	herpes	herpe	NOUN
admet-1883	225	19	.	.	PUNCT
admet-1883	226	1	nanomaterials	nanomaterial	NOUN
admet-1883	226	2	can	can	AUX
admet-1883	226	3	improve	improve	VERB
admet-1883	226	4	solubility	solubility	NOUN
admet-1883	226	5	,	,	PUNCT
admet-1883	226	6	increase	increase	VERB
admet-1883	226	7	blood	blood	NOUN
admet-1883	226	8	circulation	circulation	NOUN
admet-1883	226	9	time	time	NOUN
admet-1883	226	10	,	,	PUNCT
admet-1883	226	11	limit	limit	VERB
admet-1883	226	12	enzymatic	enzymatic	ADJ
admet-1883	226	13	degradation	degradation	NOUN
admet-1883	226	14	,	,	PUNCT
admet-1883	226	15	lesser	less	ADJ
admet-1883	226	16	unwanted	unwanted	ADJ
admet-1883	226	17	side	side	NOUN
admet-1883	226	18	effects	effect	NOUN
admet-1883	226	19	,	,	PUNCT
admet-1883	226	20	and	and	CCONJ
admet-1883	226	21	improve	improve	VERB
admet-1883	226	22	medication	medication	NOUN
admet-1883	226	23	bioavailability	bioavailability	NOUN
admet-1883	226	24	[	[	X
admet-1883	226	25	76	76	NUM
admet-1883	226	26	]	]	PUNCT
admet-1883	226	27	.	.	PUNCT
admet-1883	227	1	in	in	ADP
admet-1883	227	2	antimicrobial	antimicrobial	ADJ
admet-1883	227	3	pdt	pdt	NOUN
admet-1883	227	4	,	,	PUNCT
admet-1883	227	5	employing	employ	VERB
admet-1883	227	6	nanoparticles	nanoparticle	NOUN
admet-1883	227	7	can	can	AUX
admet-1883	227	8	improve	improve	VERB
admet-1883	227	9	the	the	DET
admet-1883	227	10	solubility	solubility	NOUN
admet-1883	227	11	,	,	PUNCT
admet-1883	227	12	photophysics	photophysic	NOUN
admet-1883	227	13	,	,	PUNCT
admet-1883	227	14	and	and	CCONJ
admet-1883	227	15	photochemistry	photochemistry	NOUN
admet-1883	227	16	of	of	ADP
admet-1883	227	17	photosensitizers	photosensitizer	NOUN
admet-1883	227	18	with	with	ADP
admet-1883	227	19	targeting	target	VERB
admet-1883	227	20	features	feature	NOUN
admet-1883	227	21	.	.	PUNCT
admet-1883	228	1	in	in	ADP
admet-1883	228	2	this	this	DET
admet-1883	228	3	process	process	NOUN
admet-1883	228	4	,	,	PUNCT
admet-1883	228	5	ps	ps	PROPN
admet-1883	228	6	can	can	AUX
admet-1883	228	7	be	be	AUX
admet-1883	228	8	encapsulated	encapsulate	VERB
admet-1883	228	9	in	in	ADP
admet-1883	228	10	different	different	ADJ
admet-1883	228	11	nanostructures	nanostructure	NOUN
admet-1883	228	12	or	or	CCONJ
admet-1883	228	13	nanoparticles	nanoparticle	NOUN
admet-1883	228	14	like	like	ADP
admet-1883	228	15	micelles	micelle	NOUN
admet-1883	228	16	,	,	PUNCT
admet-1883	228	17	reverse	reverse	ADJ
admet-1883	228	18	micelles	micelle	NOUN
admet-1883	228	19	,	,	PUNCT
admet-1883	228	20	liposomes	liposome	NOUN
admet-1883	228	21	,	,	PUNCT
admet-1883	228	22	metal	metal	NOUN
admet-1883	228	23	and	and	CCONJ
admet-1883	228	24	metal	metal	NOUN
admet-1883	228	25	-	-	PUNCT
admet-1883	228	26	oxide	oxide	NOUN
admet-1883	228	27	nanoparticles	nanoparticle	NOUN
admet-1883	228	28	,	,	PUNCT
admet-1883	228	29	polymer	polymer	NOUN
admet-1883	228	30	nanoparticles	nanoparticle	NOUN
admet-1883	228	31	,	,	PUNCT
admet-1883	228	32	carbon	carbon	NOUN
admet-1883	228	33	nanotubes	nanotube	NOUN
admet-1883	228	34	,	,	PUNCT
admet-1883	228	35	and	and	CCONJ
admet-1883	228	36	ceramic	ceramic	NOUN
admet-1883	228	37	-	-	PUNCT
admet-1883	228	38	based	base	VERB
admet-1883	228	39	nanoparticles	nanoparticle	NOUN
admet-1883	228	40	.	.	PUNCT
admet-1883	229	1	in	in	ADP
admet-1883	229	2	this	this	DET
admet-1883	229	3	regard	regard	NOUN
admet-1883	229	4	,	,	PUNCT
admet-1883	229	5	the	the	DET
admet-1883	229	6	dendrimers	dendrimer	NOUN
admet-1883	229	7	are	be	AUX
admet-1883	229	8	also	also	ADV
admet-1883	229	9	promising	promise	VERB
admet-1883	229	10	to	to	PART
admet-1883	229	11	conjugate	conjugate	VERB
admet-1883	229	12	or	or	CCONJ
admet-1883	229	13	load	load	VERB
admet-1883	229	14	the	the	DET
admet-1883	229	15	ps	ps	NOUN
admet-1883	229	16	molecules	molecule	NOUN
admet-1883	229	17	for	for	ADP
admet-1883	229	18	better	well	ADJ
admet-1883	229	19	apdt	apdt	NOUN
admet-1883	230	1	[	[	X
admet-1883	230	2	80	80	NUM
admet-1883	230	3	]	]	PUNCT
admet-1883	230	4	.	.	PUNCT
admet-1883	231	1	admet	admet	PROPN
admet-1883	231	2	&	&	CCONJ
admet-1883	231	3	dmpk	dmpk	PROPN
admet-1883	231	4	11(4	11(4	NUM
admet-1883	231	5	)	)	PUNCT
admet-1883	231	6	(	(	PUNCT
admet-1883	231	7	2023	2023	NUM
admet-1883	231	8	)	)	PUNCT
admet-1883	231	9	513	513	NUM
admet-1883	231	10	-	-	SYM
admet-1883	231	11	531	531	NUM
admet-1883	231	12	infections	infection	NOUN
admet-1883	231	13	associated	associate	VERB
admet-1883	231	14	with	with	ADP
admet-1883	231	15	sars	sar	NOUN
admet-1883	231	16	-	-	PUNCT
admet-1883	231	17	cov-2	cov-2	PART
admet-1883	231	18	exploited	exploit	VERB
admet-1883	231	19	via	via	ADP
admet-1883	231	20	photodynamic	photodynamic	ADJ
admet-1883	231	21	therapy	therapy	NOUN
admet-1883	231	22	doi	doi	NOUN
admet-1883	231	23	:	:	PUNCT
admet-1883	231	24	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-1883	231	25	t.1883	t.1883	NOUN
admet-1883	231	26	523	523	NUM
admet-1883	231	27	table	table	NOUN
admet-1883	231	28	3	3	NUM
admet-1883	231	29	.	.	PUNCT
admet-1883	231	30	nanoenabled	nanoenable	VERB
admet-1883	231	31	immunization	immunization	NOUN
admet-1883	231	32	against	against	ADP
admet-1883	231	33	covid-19	covid-19	PROPN
admet-1883	231	34	no	no	PROPN
admet-1883	231	35	.	.	PUNCT
admet-1883	232	1	vaccine	vaccine	NOUN
admet-1883	232	2	vaccine	vaccine	NOUN
admet-1883	232	3	type	type	NOUN
admet-1883	232	4	administrat	administrat	NOUN
admet-1883	232	5	ion	ion	NOUN
admet-1883	232	6	regimen	regimen	NOUN
admet-1883	232	7	target	target	NOUN
admet-1883	232	8	virus	virus	NOUN
admet-1883	232	9	target	target	NOUN
admet-1883	232	10	disease	disease	NOUN
admet-1883	232	11	nanoformulation	nanoformulation	NOUN
admet-1883	232	12	mode	mode	NOUN
admet-1883	232	13	of	of	ADP
admet-1883	232	14	action	action	NOUN
admet-1883	232	15	company	company	NOUN
admet-1883	232	16	1	1	NUM
admet-1883	232	17	.	.	PUNCT
admet-1883	233	1	bnt162	bnt162	PROPN
admet-1883	233	2	bnt162a1	bnt162a1	NOUN
admet-1883	233	3	uridine	uridine	NOUN
admet-1883	233	4	mrna	mrna	PROPN
admet-1883	233	5	(	(	PUNCT
admet-1883	233	6	urna	urna	PROPN
admet-1883	233	7	)	)	PUNCT
admet-1883	233	8	vaccine	vaccine	NOUN
admet-1883	233	9	prime/	prime/	NUM
admet-1883	233	10	boost	boost	NOUN
admet-1883	233	11	(	(	PUNCT
admet-1883	233	12	p	p	NOUN
admet-1883	233	13	/	/	SYM
admet-1883	233	14	b	b	NOUN
admet-1883	233	15	)	)	PUNCT
admet-1883	233	16	regimen	regiman	NOUN
admet-1883	233	17	sarscov-2	sarscov-2	NUM
admet-1883	233	18	covid-19	covid-19	PROPN
admet-1883	233	19	lipid	lipid	NOUN
admet-1883	233	20	nanoparticles	nanoparticle	NOUN
admet-1883	233	21	(	(	PUNCT
admet-1883	233	22	lnp	lnp	PROPN
admet-1883	233	23	)	)	PUNCT
admet-1883	233	24	na	na	PART
admet-1883	233	25	biontech	biontech	NOUN
admet-1883	233	26	and	and	CCONJ
admet-1883	233	27	pfizer	pfizer	NOUN
admet-1883	233	28	bnt162b1	bnt162b1	NOUN
admet-1883	233	29	nucleoside	nucleoside	ADV
admet-1883	233	30	-modified	-modified	ADJ
admet-1883	233	31	rna	rna	NOUN
admet-1883	233	32	vaccine	vaccine	NOUN
admet-1883	233	33	p	p	X
admet-1883	233	34	/	/	SYM
admet-1883	233	35	b	b	NOUN
admet-1883	233	36	regimen	regimen	NOUN
admet-1883	233	37	targets	target	VERB
admet-1883	233	38	the	the	DET
admet-1883	233	39	spike	spike	ADJ
admet-1883	233	40	protein	protein	NOUN
admet-1883	233	41	of	of	ADP
admet-1883	233	42	membranebound	membranebound	ADJ
admet-1883	233	43	sars	sar	NOUN
admet-1883	233	44	-	-	PUNCT
admet-1883	233	45	cov-2	cov-2	PUNCT
admet-1883	233	46	and	and	CCONJ
admet-1883	233	47	encodes	encode	NOUN
admet-1883	233	48	for	for	ADP
admet-1883	233	49	its	its	PRON
admet-1883	233	50	prefusion	prefusion	NOUN
admet-1883	233	51	state	state	NOUN
admet-1883	233	52	.	.	PUNCT
admet-1883	234	1	bnt162b2	bnt162b2	NOUN
admet-1883	234	2	or	or	CCONJ
admet-1883	234	3	comirnaty	comirnaty	NOUN
admet-1883	234	4	nucleoside	nucleoside	VERB
admet-1883	234	5	-modified	-modified	ADJ
admet-1883	234	6	rna	rna	NOUN
admet-1883	234	7	vaccine	vaccine	NOUN
admet-1883	234	8	p	p	X
admet-1883	234	9	/	/	SYM
admet-1883	234	10	b	b	NOUN
admet-1883	234	11	regimen	regimen	NOUN
admet-1883	234	12	targets	target	VERB
admet-1883	234	13	the	the	DET
admet-1883	234	14	spike	spike	ADJ
admet-1883	234	15	protein	protein	NOUN
admet-1883	234	16	of	of	ADP
admet-1883	234	17	sars	sar	NOUN
admet-1883	234	18	-	-	PUNCT
admet-1883	234	19	cov-2	cov-2	PUNCT
admet-1883	234	20	and	and	CCONJ
admet-1883	234	21	encodes	encode	VERB
admet-1883	234	22	their	their	PRON
admet-1883	234	23	receptor	receptor	NOUN
admet-1883	234	24	-	-	PUNCT
admet-1883	234	25	binding	bind	VERB
admet-1883	234	26	domain	domain	NOUN
admet-1883	234	27	,	,	PUNCT
admet-1883	234	28	thereby	thereby	ADV
admet-1883	234	29	eliciting	elicit	VERB
admet-1883	234	30	human	human	ADJ
admet-1883	234	31	antibody	antibody	NOUN
admet-1883	234	32	and	and	CCONJ
admet-1883	234	33	th1	th1	PROPN
admet-1883	234	34	t	t	PROPN
admet-1883	234	35	cell	cell	NOUN
admet-1883	234	36	responses	response	VERB
admet-1883	234	37	bnt162b3	bnt162b3	ADJ
admet-1883	234	38	nucleoside	nucleoside	ADJ
admet-1883	234	39	-modified	-modified	ADJ
admet-1883	234	40	rna	rna	NOUN
admet-1883	234	41	vaccine	vaccine	NOUN
admet-1883	234	42	p	p	X
admet-1883	234	43	/	/	SYM
admet-1883	234	44	b	b	NOUN
admet-1883	234	45	regimen	regiman	NOUN
admet-1883	234	46	na	na	X
admet-1883	234	47	bnt162c2	bnt162c2	PROPN
admet-1883	234	48	selfamplifying	selfamplifye	VERB
admet-1883	234	49	mrna	mrna	PROPN
admet-1883	234	50	(	(	PUNCT
admet-1883	234	51	sarna	sarna	PROPN
admet-1883	234	52	)	)	PUNCT
admet-1883	234	53	vaccine	vaccine	NOUN
admet-1883	234	54	p	p	PROPN
admet-1883	234	55	/	/	SYM
admet-1883	234	56	b	b	NOUN
admet-1883	234	57	regimen	regiman	NOUN
admet-1883	234	58	or	or	CCONJ
admet-1883	234	59	single	single	ADJ
admet-1883	234	60	dose	dose	NOUN
admet-1883	234	61	(	(	PUNCT
admet-1883	234	62	sd	sd	NOUN
admet-1883	234	63	)	)	PUNCT
admet-1883	234	64	regimen	regiman	NOUN
admet-1883	234	65	na	na	AUX
admet-1883	234	66	2	2	NUM
admet-1883	234	67	.	.	PUNCT
admet-1883	234	68	lunar	lunar	NOUN
admet-1883	234	69	-	-	PUNCT
admet-1883	234	70	cov19	cov19	NOUN
admet-1883	234	71	self	self	NOUN
admet-1883	234	72	-	-	PUNCT
admet-1883	234	73	transcribing	transcribe	VERB
admet-1883	234	74	and	and	CCONJ
admet-1883	234	75	replicating	replicate	VERB
admet-1883	234	76	mrna	mrna	NOUN
admet-1883	234	77	vaccine	vaccine	NOUN
admet-1883	234	78	p	p	PROPN
admet-1883	234	79	/	/	SYM
admet-1883	234	80	b	b	NOUN
admet-1883	234	81	regimen	regiman	NOUN
admet-1883	234	82	or	or	CCONJ
admet-1883	234	83	sd	sd	NOUN
admet-1883	234	84	regimen	regiman	NOUN
admet-1883	234	85	sarscov-2	sarscov-2	NUM
admet-1883	234	86	covid-19	covid-19	PROPN
admet-1883	234	87	lnp	lnp	PROPN
admet-1883	234	88	encodes	encode	VERB
admet-1883	234	89	the	the	DET
admet-1883	234	90	sarscov-2	sarscov-2	NUM
admet-1883	234	91	spike	spike	ADJ
admet-1883	234	92	protein	protein	NOUN
admet-1883	234	93	and	and	CCONJ
admet-1883	234	94	an	an	DET
admet-1883	234	95	alphavirusbased	alphavirusbased	ADJ
admet-1883	234	96	replicon	replicon	NOUN
admet-1883	234	97	.	.	PUNCT
admet-1883	235	1	arcturus	arcturus	NOUN
admet-1883	235	2	therapeutics	therapeutic	NOUN
admet-1883	235	3	3	3	X
admet-1883	235	4	.	.	PUNCT
admet-1883	236	1	spikevax	spikevax	PROPN
admet-1883	236	2	or	or	CCONJ
admet-1883	236	3	mrna1273	mrna1273	PROPN
admet-1883	236	4	or	or	CCONJ
admet-1883	236	5	elasomeran	elasomeran	VERB
admet-1883	236	6	nucleoside	nucleoside	ADV
admet-1883	236	7	-modified	-modifie	VERB
admet-1883	236	8	rna	rna	NOUN
admet-1883	236	9	vaccine	vaccine	NOUN
admet-1883	236	10	two	two	NUM
admet-1883	236	11	dose	dose	PROPN
admet-1883	236	12	(	(	PUNCT
admet-1883	236	13	td	td	NOUN
admet-1883	236	14	)	)	PUNCT
admet-1883	236	15	regimen	regiman	NOUN
admet-1883	236	16	sarscov-2	sarscov-2	NUM
admet-1883	236	17	covid-19	covid-19	PROPN
admet-1883	236	18	lnp	lnp	PROPN
admet-1883	236	19	targets	target	VERB
admet-1883	236	20	the	the	DET
admet-1883	236	21	spike	spike	ADJ
admet-1883	236	22	glycoprotein	glycoprotein	NOUN
admet-1883	236	23	of	of	ADP
admet-1883	236	24	sarscov-2	sarscov-2	NUM
admet-1883	236	25	and	and	CCONJ
admet-1883	236	26	encodes	encode	NOUN
admet-1883	236	27	for	for	ADP
admet-1883	236	28	its	its	PRON
admet-1883	236	29	prefusion	prefusion	NOUN
admet-1883	236	30	state	state	NOUN
admet-1883	236	31	.	.	PUNCT
admet-1883	237	1	moderna	moderna	PROPN
admet-1883	237	2	the	the	DET
admet-1883	237	3	branch	branch	NOUN
admet-1883	237	4	-	-	PUNCT
admet-1883	237	5	like	like	ADJ
admet-1883	237	6	structure	structure	NOUN
admet-1883	237	7	and	and	CCONJ
admet-1883	237	8	lipophilicity	lipophilicity	NOUN
admet-1883	237	9	of	of	ADP
admet-1883	237	10	dendrimers	dendrimer	NOUN
admet-1883	237	11	enhance	enhance	VERB
admet-1883	237	12	the	the	DET
admet-1883	237	13	solubility	solubility	NOUN
admet-1883	237	14	of	of	ADP
admet-1883	237	15	ps	ps	PROPN
admet-1883	237	16	and	and	CCONJ
admet-1883	237	17	,	,	PUNCT
admet-1883	237	18	at	at	ADP
admet-1883	237	19	the	the	DET
admet-1883	237	20	same	same	ADJ
admet-1883	237	21	time	time	NOUN
admet-1883	237	22	,	,	PUNCT
admet-1883	237	23	help	help	VERB
admet-1883	237	24	in	in	ADP
admet-1883	237	25	the	the	DET
admet-1883	237	26	improvement	improvement	NOUN
admet-1883	237	27	of	of	ADP
admet-1883	237	28	cellular	cellular	ADJ
admet-1883	237	29	uptake	uptake	NOUN
admet-1883	237	30	.	.	PUNCT
admet-1883	238	1	the	the	DET
admet-1883	238	2	other	other	ADJ
admet-1883	238	3	advantages	advantage	NOUN
admet-1883	238	4	include	include	VERB
admet-1883	238	5	the	the	DET
admet-1883	238	6	higher	high	ADJ
admet-1883	238	7	production	production	NOUN
admet-1883	238	8	of	of	ADP
admet-1883	238	9	ros	ros	PROPN
admet-1883	238	10	in	in	ADP
admet-1883	238	11	nanoformulations	nanoformulation	NOUN
admet-1883	238	12	.	.	PUNCT
admet-1883	239	1	ps	ps	NOUN
admet-1883	239	2	molecules	molecule	NOUN
admet-1883	239	3	are	be	AUX
admet-1883	239	4	well	well	ADV
admet-1883	239	5	separated	separate	VERB
admet-1883	239	6	by	by	ADP
admet-1883	239	7	the	the	DET
admet-1883	239	8	nanostructures	nanostructure	NOUN
admet-1883	239	9	like	like	ADP
admet-1883	239	10	liposomes	liposome	NOUN
admet-1883	239	11	,	,	PUNCT
admet-1883	239	12	dendrimers	dendrimer	NOUN
admet-1883	239	13	,	,	PUNCT
admet-1883	239	14	etc	etc	X
admet-1883	239	15	.	.	X
admet-1883	239	16	,	,	PUNCT
admet-1883	239	17	to	to	PART
admet-1883	239	18	stop	stop	VERB
admet-1883	239	19	self	self	NOUN
admet-1883	239	20	-	-	PUNCT
admet-1883	239	21	quenching	quenching	NOUN
admet-1883	240	1	[	[	X
admet-1883	240	2	81	81	NUM
admet-1883	240	3	]	]	PUNCT
admet-1883	240	4	.	.	PUNCT
admet-1883	241	1	recently	recently	ADV
admet-1883	241	2	up	up	ADP
admet-1883	241	3	-	-	PUNCT
admet-1883	241	4	conversion	conversion	NOUN
admet-1883	241	5	nanoparticles	nanoparticle	NOUN
admet-1883	241	6	-	-	PUNCT
admet-1883	241	7	based	base	VERB
admet-1883	241	8	pdt	pdt	NOUN
admet-1883	241	9	has	have	AUX
admet-1883	241	10	gained	gain	VERB
admet-1883	241	11	popularity	popularity	NOUN
admet-1883	241	12	for	for	ADP
admet-1883	241	13	its	its	PRON
admet-1883	241	14	absorption	absorption	NOUN
admet-1883	241	15	band	band	NOUN
admet-1883	241	16	in	in	ADP
admet-1883	241	17	the	the	DET
admet-1883	241	18	nir	nir	ADJ
admet-1883	241	19	zone	zone	NOUN
admet-1883	241	20	.	.	PUNCT
admet-1883	242	1	after	after	ADP
admet-1883	242	2	absorbing	absorb	VERB
admet-1883	242	3	nir	nir	ADJ
admet-1883	242	4	radiation	radiation	NOUN
admet-1883	242	5	,	,	PUNCT
admet-1883	242	6	the	the	DET
admet-1883	242	7	up	up	ADJ
admet-1883	242	8	-	-	PUNCT
admet-1883	242	9	conversion	conversion	NOUN
admet-1883	242	10	nanoparticles	nanoparticle	NOUN
admet-1883	242	11	(	(	PUNCT
admet-1883	242	12	ucnp	ucnp	ADV
admet-1883	242	13	)	)	PUNCT
admet-1883	242	14	emit	emit	VERB
admet-1883	242	15	visible	visible	ADJ
admet-1883	242	16	light	light	NOUN
admet-1883	242	17	,	,	PUNCT
admet-1883	242	18	which	which	PRON
admet-1883	242	19	is	be	AUX
admet-1883	242	20	absorbed	absorb	VERB
admet-1883	242	21	by	by	ADP
admet-1883	242	22	the	the	DET
admet-1883	242	23	ps	ps	PROPN
admet-1883	242	24	molecules	molecule	NOUN
admet-1883	242	25	to	to	PART
admet-1883	242	26	react	react	VERB
admet-1883	242	27	with	with	ADP
admet-1883	242	28	molecular	molecular	ADJ
admet-1883	242	29	oxygen	oxygen	NOUN
admet-1883	242	30	for	for	ADP
admet-1883	242	31	the	the	DET
admet-1883	242	32	generation	generation	NOUN
admet-1883	242	33	of	of	ADP
admet-1883	242	34	ros	ros	PROPN
admet-1883	242	35	[	[	X
admet-1883	242	36	82,83	82,83	NUM
admet-1883	242	37	]	]	PUNCT
admet-1883	242	38	.	.	PUNCT
admet-1883	243	1	lim	lim	PROPN
admet-1883	243	2	et	et	PROPN
admet-1883	243	3	al	al	PROPN
admet-1883	243	4	.	.	PROPN
admet-1883	243	5	showed	show	VERB
admet-1883	243	6	that	that	SCONJ
admet-1883	243	7	the	the	DET
admet-1883	243	8	ucnp	ucnp	ADV
admet-1883	243	9	-	-	PUNCT
admet-1883	243	10	mediated	mediate	VERB
admet-1883	243	11	ros	ros	NOUN
admet-1883	243	12	generation	generation	NOUN
admet-1883	243	13	could	could	AUX
admet-1883	243	14	inactivate	inactivate	VERB
admet-1883	243	15	the	the	DET
admet-1883	243	16	dengue	dengue	NOUN
admet-1883	243	17	virus	virus	NOUN
admet-1883	243	18	serotype	serotype	PROPN
admet-1883	243	19	2	2	NUM
admet-1883	243	20	(	(	PUNCT
admet-1883	243	21	denv2	denv2	PROPN
admet-1883	243	22	)	)	PUNCT
admet-1883	243	23	and	and	CCONJ
admet-1883	243	24	adenovirus	adenovirus	NOUN
admet-1883	243	25	type	type	NOUN
admet-1883	243	26	5	5	NUM
admet-1883	243	27	(	(	PUNCT
admet-1883	243	28	ad5v	ad5v	NOUN
admet-1883	243	29	)	)	PUNCT
admet-1883	244	1	[	[	X
admet-1883	244	2	84	84	NUM
admet-1883	244	3	]	]	PUNCT
admet-1883	244	4	.	.	PUNCT
admet-1883	245	1	this	this	DET
admet-1883	245	2	strategy	strategy	NOUN
admet-1883	245	3	can	can	AUX
admet-1883	245	4	be	be	AUX
admet-1883	245	5	well	well	ADV
admet-1883	245	6	applicable	applicable	ADJ
admet-1883	245	7	to	to	ADP
admet-1883	245	8	the	the	DET
admet-1883	245	9	management	management	NOUN
admet-1883	245	10	of	of	ADP
admet-1883	245	11	sars	sar	NOUN
admet-1883	245	12	-	-	PUNCT
admet-1883	245	13	cov-2	cov-2	NOUN
admet-1883	245	14	infections	infection	NOUN
admet-1883	245	15	.	.	PUNCT
admet-1883	246	1	the	the	DET
admet-1883	246	2	surface	surface	NOUN
admet-1883	246	3	modification	modification	NOUN
admet-1883	246	4	strategy	strategy	NOUN
admet-1883	246	5	of	of	ADP
admet-1883	246	6	nanoformulated	nanoformulated	ADJ
admet-1883	246	7	ps	ps	PROPN
admet-1883	246	8	with	with	ADP
admet-1883	246	9	targeting	target	VERB
admet-1883	246	10	moieties	moiety	NOUN
admet-1883	246	11	as	as	ADP
admet-1883	246	12	specific	specific	ADJ
admet-1883	246	13	ligands	ligand	NOUN
admet-1883	246	14	or	or	CCONJ
admet-1883	246	15	antibodies	antibody	NOUN
admet-1883	246	16	can	can	AUX
admet-1883	246	17	help	help	VERB
admet-1883	246	18	to	to	PART
admet-1883	246	19	increase	increase	VERB
admet-1883	246	20	the	the	DET
admet-1883	246	21	specificity	specificity	NOUN
admet-1883	246	22	of	of	ADP
admet-1883	246	23	apdt	apdt	NOUN
admet-1883	246	24	against	against	ADP
admet-1883	246	25	covid-19	covid-19	PROPN
admet-1883	246	26	protecting	protect	VERB
admet-1883	246	27	healthy	healthy	ADJ
admet-1883	246	28	cells	cell	NOUN
admet-1883	246	29	[	[	X
admet-1883	246	30	85	85	NUM
admet-1883	246	31	]	]	PUNCT
admet-1883	246	32	.	.	PUNCT
admet-1883	247	1	carbon	carbon	NOUN
admet-1883	247	2	nanotubes	nanotube	NOUN
admet-1883	247	3	have	have	AUX
admet-1883	247	4	been	be	AUX
admet-1883	247	5	proposed	propose	VERB
admet-1883	247	6	for	for	ADP
admet-1883	247	7	use	use	NOUN
admet-1883	247	8	as	as	ADP
admet-1883	247	9	novel	novel	ADJ
admet-1883	247	10	photosensitizers	photosensitizer	NOUN
admet-1883	247	11	in	in	ADP
admet-1883	247	12	photodynamic	photodynamic	ADJ
admet-1883	247	13	therapy	therapy	NOUN
admet-1883	247	14	.	.	PUNCT
admet-1883	248	1	carbon	carbon	NOUN
admet-1883	248	2	nanotubes	nanotube	NOUN
admet-1883	248	3	that	that	PRON
admet-1883	248	4	have	have	AUX
admet-1883	248	5	been	be	AUX
admet-1883	248	6	functionalized	functionalize	VERB
admet-1883	248	7	,	,	PUNCT
admet-1883	248	8	conjugated	conjugate	VERB
admet-1883	248	9	,	,	PUNCT
admet-1883	248	10	or	or	CCONJ
admet-1883	248	11	encapsulated	encapsulate	VERB
admet-1883	248	12	with	with	ADP
admet-1883	248	13	other	other	ADJ
admet-1883	248	14	photosensitizers	photosensitizer	NOUN
admet-1883	248	15	are	be	AUX
admet-1883	248	16	powerful	powerful	ADJ
admet-1883	248	17	for	for	ADP
admet-1883	248	18	pdt	pdt	NOUN
admet-1883	248	19	against	against	ADP
admet-1883	248	20	infectious	infectious	ADJ
admet-1883	248	21	diseases	disease	NOUN
admet-1883	248	22	.	.	PUNCT
admet-1883	249	1	banerjee	banerjee	PROPN
admet-1883	249	2	et	et	PROPN
admet-1883	249	3	al	al	PROPN
admet-1883	249	4	.	.	PROPN
admet-1883	249	5	investigated	investigate	VERB
admet-1883	249	6	ppix	ppix	NOUN
admet-1883	249	7	conjugated	conjugate	VERB
admet-1883	249	8	to	to	ADP
admet-1883	249	9	multi	multi	ADJ
admet-1883	249	10	-	-	ADJ
admet-1883	249	11	walled	walled	ADJ
admet-1883	249	12	and	and	CCONJ
admet-1883	249	13	single	single	ADJ
admet-1883	249	14	-	-	PUNCT
admet-1883	249	15	walled	wall	VERB
admet-1883	249	16	carbon	carbon	NOUN
admet-1883	249	17	tubes	tube	NOUN
admet-1883	249	18	,	,	PUNCT
admet-1883	249	19	and	and	CCONJ
admet-1883	249	20	this	this	DET
admet-1883	249	21	conjugation	conjugation	NOUN
admet-1883	249	22	was	be	AUX
admet-1883	249	23	found	find	VERB
admet-1883	249	24	to	to	PART
admet-1883	249	25	inhibit	inhibit	VERB
admet-1883	249	26	the	the	DET
admet-1883	249	27	influenza	influenza	NOUN
admet-1883	249	28	a	a	DET
admet-1883	249	29	virus	virus	NOUN
admet-1883	250	1	[	[	X
admet-1883	250	2	86	86	NUM
admet-1883	250	3	]	]	PUNCT
admet-1883	250	4	.	.	PUNCT
admet-1883	251	1	for	for	ADP
admet-1883	251	2	recently	recently	ADV
admet-1883	251	3	discovered	discover	VERB
admet-1883	251	4	covid-19	covid-19	PROPN
admet-1883	251	5	,	,	PUNCT
admet-1883	251	6	surface	surface	NOUN
admet-1883	251	7	-	-	PUNCT
admet-1883	251	8	modified	modify	VERB
admet-1883	251	9	nanoparticles	nanoparticle	NOUN
admet-1883	251	10	could	could	AUX
admet-1883	251	11	target	target	VERB
admet-1883	251	12	the	the	DET
admet-1883	251	13	receptor	receptor	NOUN
admet-1883	251	14	present	present	ADJ
admet-1883	251	15	on	on	ADP
admet-1883	251	16	the	the	DET
admet-1883	251	17	lung	lung	NOUN
admet-1883	251	18	cell	cell	NOUN
admet-1883	251	19	with	with	ADP
admet-1883	251	20	the	the	DET
admet-1883	251	21	https://doi.org/10.5599/admet.1883	https://doi.org/10.5599/admet.1883	ADJ
admet-1883	251	22	p.	p.	PROPN
admet-1883	251	23	pallavi	pallavi	VERB
admet-1883	251	24	et	et	PROPN
admet-1883	251	25	al	al	PROPN
admet-1883	251	26	.	.	PROPN
admet-1883	251	27	admet	admet	PROPN
admet-1883	251	28	&	&	CCONJ
admet-1883	251	29	dmpk	dmpk	PROPN
admet-1883	251	30	11(4	11(4	NUM
admet-1883	251	31	)	)	PUNCT
admet-1883	251	32	(	(	PUNCT
admet-1883	251	33	2023	2023	NUM
admet-1883	251	34	)	)	PUNCT
admet-1883	251	35	513	513	NUM
admet-1883	251	36	-	-	SYM
admet-1883	251	37	531	531	NUM
admet-1883	251	38	524	524	NUM
admet-1883	251	39	particular	particular	ADJ
admet-1883	251	40	antibodies	antibody	NOUN
admet-1883	251	41	causing	cause	VERB
admet-1883	251	42	the	the	DET
admet-1883	251	43	infected	infected	ADJ
admet-1883	251	44	cells	cell	NOUN
admet-1883	251	45	to	to	PART
admet-1883	251	46	be	be	AUX
admet-1883	251	47	destroyed	destroy	VERB
admet-1883	251	48	by	by	ADP
admet-1883	251	49	apdt	apdt	NOUN
admet-1883	251	50	.	.	PUNCT
admet-1883	252	1	recent	recent	ADJ
admet-1883	252	2	research	research	NOUN
admet-1883	252	3	suggests	suggest	VERB
admet-1883	252	4	that	that	SCONJ
admet-1883	252	5	apdt	apdt	NOUN
admet-1883	252	6	may	may	AUX
admet-1883	252	7	be	be	AUX
admet-1883	252	8	effective	effective	ADJ
admet-1883	252	9	in	in	ADP
admet-1883	252	10	the	the	DET
admet-1883	252	11	treatment	treatment	NOUN
admet-1883	252	12	of	of	ADP
admet-1883	252	13	covid-19	covid-19	PROPN
admet-1883	252	14	with	with	ADP
admet-1883	252	15	lesser	less	ADJ
admet-1883	252	16	side	side	NOUN
admet-1883	252	17	effects	effect	NOUN
admet-1883	252	18	and	and	CCONJ
admet-1883	252	19	pharmacological	pharmacological	ADJ
admet-1883	252	20	interactions	interaction	NOUN
admet-1883	252	21	.	.	PUNCT
admet-1883	253	1	computational	computational	ADJ
admet-1883	253	2	approach	approach	NOUN
admet-1883	253	3	the	the	DET
admet-1883	253	4	computational	computational	ADJ
admet-1883	253	5	approach	approach	NOUN
admet-1883	253	6	of	of	ADP
admet-1883	253	7	the	the	DET
admet-1883	253	8	combination	combination	NOUN
admet-1883	253	9	of	of	ADP
admet-1883	253	10	chemistry	chemistry	NOUN
admet-1883	253	11	and	and	CCONJ
admet-1883	253	12	biology	biology	NOUN
admet-1883	253	13	has	have	AUX
admet-1883	253	14	evolved	evolve	VERB
admet-1883	253	15	as	as	ADP
admet-1883	253	16	one	one	NUM
admet-1883	253	17	of	of	ADP
admet-1883	253	18	the	the	DET
admet-1883	253	19	essential	essential	ADJ
admet-1883	253	20	parts	part	NOUN
admet-1883	253	21	of	of	ADP
admet-1883	253	22	drug	drug	NOUN
admet-1883	253	23	discovery	discovery	NOUN
admet-1883	253	24	.	.	PUNCT
admet-1883	254	1	new	new	ADJ
admet-1883	254	2	lead	lead	NOUN
admet-1883	254	3	molecules	molecule	NOUN
admet-1883	254	4	can	can	AUX
admet-1883	254	5	be	be	AUX
admet-1883	254	6	significantly	significantly	ADV
admet-1883	254	7	develope	develope	VERB
admet-1883	254	8	d	d	X
admet-1883	254	9	by	by	ADP
admet-1883	254	10	computational	computational	ADJ
admet-1883	254	11	approach	approach	NOUN
admet-1883	254	12	at	at	ADP
admet-1883	254	13	minimal	minimal	ADJ
admet-1883	254	14	cost	cost	NOUN
admet-1883	254	15	within	within	ADP
admet-1883	254	16	a	a	DET
admet-1883	254	17	limited	limited	ADJ
admet-1883	254	18	period	period	NOUN
admet-1883	254	19	of	of	ADP
admet-1883	254	20	time	time	NOUN
admet-1883	254	21	.	.	PUNCT
admet-1883	255	1	the	the	DET
admet-1883	255	2	efficacy	efficacy	NOUN
admet-1883	255	3	of	of	ADP
admet-1883	255	4	the	the	DET
admet-1883	255	5	method	method	NOUN
admet-1883	255	6	of	of	ADP
admet-1883	255	7	testing	testing	NOUN
admet-1883	255	8	and	and	CCONJ
admet-1883	255	9	analyzing	analyze	VERB
admet-1883	255	10	the	the	DET
admet-1883	255	11	developed	develop	VERB
admet-1883	255	12	products	product	NOUN
admet-1883	255	13	can	can	AUX
admet-1883	255	14	be	be	AUX
admet-1883	255	15	effectively	effectively	ADV
admet-1883	255	16	improved	improve	VERB
admet-1883	255	17	[	[	X
admet-1883	255	18	87	87	NUM
admet-1883	255	19	]	]	PUNCT
admet-1883	255	20	.	.	PUNCT
admet-1883	256	1	certain	certain	ADJ
admet-1883	256	2	tools	tool	NOUN
admet-1883	256	3	like	like	ADP
admet-1883	256	4	molecular	molecular	ADJ
admet-1883	256	5	docking	docking	NOUN
admet-1883	256	6	,	,	PUNCT
admet-1883	256	7	virtual	virtual	ADJ
admet-1883	256	8	screening	screening	NOUN
admet-1883	256	9	,	,	PUNCT
admet-1883	256	10	protein	protein	NOUN
admet-1883	256	11	modeling	modeling	NOUN
admet-1883	256	12	,	,	PUNCT
admet-1883	256	13	admet	admet	PROPN
admet-1883	256	14	(	(	PUNCT
admet-1883	256	15	adsorption	adsorption	NOUN
admet-1883	256	16	,	,	PUNCT
admet-1883	256	17	distribution	distribution	NOUN
admet-1883	256	18	,	,	PUNCT
admet-1883	256	19	metabolism	metabolism	NOUN
admet-1883	256	20	,	,	PUNCT
admet-1883	256	21	excretion	excretion	NOUN
admet-1883	256	22	,	,	PUNCT
admet-1883	256	23	and	and	CCONJ
admet-1883	256	24	toxicity	toxicity	NOUN
admet-1883	256	25	)	)	PUNCT
admet-1883	256	26	,	,	PUNCT
admet-1883	256	27	molecular	molecular	ADJ
admet-1883	256	28	dynamics	dynamic	NOUN
admet-1883	256	29	,	,	PUNCT
admet-1883	256	30	and	and	CCONJ
admet-1883	256	31	qsar	qsar	NOUN
admet-1883	256	32	(	(	PUNCT
admet-1883	256	33	quantitative	quantitative	ADJ
admet-1883	256	34	structure	structure	NOUN
admet-1883	256	35	-	-	PUNCT
admet-1883	256	36	activity	activity	NOUN
admet-1883	256	37	relationship	relationship	NOUN
admet-1883	256	38	)	)	PUNCT
admet-1883	256	39	are	be	AUX
admet-1883	256	40	capable	capable	ADJ
admet-1883	256	41	of	of	ADP
admet-1883	256	42	providing	provide	VERB
admet-1883	256	43	valid	valid	ADJ
admet-1883	256	44	predictions	prediction	NOUN
admet-1883	256	45	and	and	CCONJ
admet-1883	256	46	has	have	AUX
admet-1883	256	47	raised	raise	VERB
admet-1883	256	48	as	as	ADP
admet-1883	256	49	key	key	ADJ
admet-1883	256	50	part	part	NOUN
admet-1883	256	51	of	of	ADP
admet-1883	256	52	the	the	DET
admet-1883	256	53	computational	computational	ADJ
admet-1883	256	54	approach	approach	NOUN
admet-1883	256	55	.	.	PUNCT
admet-1883	257	1	the	the	DET
admet-1883	257	2	photochemical	photochemical	ADJ
admet-1883	257	3	reactivity	reactivity	NOUN
admet-1883	257	4	of	of	ADP
admet-1883	257	5	ps	ps	PROPN
admet-1883	257	6	needs	need	NOUN
admet-1883	257	7	to	to	PART
admet-1883	257	8	be	be	AUX
admet-1883	257	9	well	well	ADV
admet-1883	257	10	understood	understand	VERB
admet-1883	257	11	for	for	ADP
admet-1883	257	12	an	an	DET
admet-1883	257	13	effective	effective	ADJ
admet-1883	257	14	yield	yield	NOUN
admet-1883	257	15	and	and	CCONJ
admet-1883	257	16	for	for	ADP
admet-1883	257	17	which	which	PRON
admet-1883	257	18	molecular	molecular	ADJ
admet-1883	257	19	orbital	orbital	ADJ
admet-1883	257	20	calculations	calculation	NOUN
admet-1883	257	21	are	be	AUX
admet-1883	257	22	used	use	VERB
admet-1883	257	23	as	as	SCONJ
admet-1883	257	24	they	they	PRON
admet-1883	257	25	can	can	AUX
admet-1883	257	26	predict	predict	VERB
admet-1883	257	27	the	the	DET
admet-1883	257	28	mechanism	mechanism	NOUN
admet-1883	257	29	of	of	ADP
admet-1883	257	30	action	action	NOUN
admet-1883	257	31	and	and	CCONJ
admet-1883	257	32	anticipate	anticipate	VERB
admet-1883	257	33	the	the	DET
admet-1883	257	34	results	result	NOUN
admet-1883	257	35	.	.	PUNCT
admet-1883	258	1	wang	wang	PROPN
admet-1883	258	2	et	et	PROPN
admet-1883	258	3	al	al	PROPN
admet-1883	258	4	.	.	PROPN
admet-1883	259	1	recently	recently	ADV
admet-1883	259	2	designed	design	VERB
admet-1883	259	3	a	a	DET
admet-1883	259	4	ps	ps	NOUN
admet-1883	259	5	for	for	ADP
admet-1883	259	6	pdt	pdt	NOUN
admet-1883	259	7	as	as	ADP
admet-1883	259	8	cancer	cancer	NOUN
admet-1883	259	9	treatment	treatment	NOUN
admet-1883	259	10	using	use	VERB
admet-1883	259	11	computer	computer	NOUN
admet-1883	259	12	-	-	PUNCT
admet-1883	259	13	aided	aid	VERB
admet-1883	259	14	drug	drug	NOUN
admet-1883	259	15	designing	designing	NOUN
admet-1883	259	16	[	[	X
admet-1883	259	17	88	88	NUM
admet-1883	259	18	]	]	PUNCT
admet-1883	259	19	.	.	PUNCT
admet-1883	260	1	the	the	DET
admet-1883	260	2	team	team	NOUN
admet-1883	260	3	used	use	VERB
admet-1883	260	4	two	two	NUM
admet-1883	260	5	drugs	drug	NOUN
admet-1883	260	6	where	where	SCONJ
admet-1883	260	7	the	the	DET
admet-1883	260	8	similarity	similarity	NOUN
admet-1883	260	9	in	in	ADP
admet-1883	260	10	molecular	molecular	ADJ
admet-1883	260	11	properties	property	NOUN
admet-1883	260	12	and	and	CCONJ
admet-1883	260	13	the	the	DET
admet-1883	260	14	intermolecular	intermolecular	ADJ
admet-1883	260	15	interactions	interaction	NOUN
admet-1883	260	16	between	between	ADP
admet-1883	260	17	the	the	DET
admet-1883	260	18	two	two	NUM
admet-1883	260	19	drugs	drug	NOUN
admet-1883	260	20	were	be	AUX
admet-1883	260	21	identified	identify	VERB
admet-1883	260	22	with	with	ADP
admet-1883	260	23	a	a	DET
admet-1883	260	24	dynamic	dynamic	ADJ
admet-1883	260	25	simulation	simulation	NOUN
admet-1883	260	26	model	model	NOUN
admet-1883	260	27	and	and	CCONJ
admet-1883	260	28	molecular	molecular	ADJ
admet-1883	260	29	docking	docking	NOUN
admet-1883	260	30	,	,	PUNCT
admet-1883	260	31	respectively	respectively	ADV
admet-1883	260	32	.	.	PUNCT
admet-1883	261	1	the	the	DET
admet-1883	261	2	efficiency	efficiency	NOUN
admet-1883	261	3	of	of	ADP
admet-1883	261	4	the	the	DET
admet-1883	261	5	particle	particle	NOUN
admet-1883	261	6	for	for	ADP
admet-1883	261	7	cancer	cancer	NOUN
admet-1883	261	8	therapy	therapy	NOUN
admet-1883	261	9	was	be	AUX
admet-1883	261	10	greatly	greatly	ADV
admet-1883	261	11	improved	improve	VERB
admet-1883	261	12	due	due	ADP
admet-1883	261	13	to	to	ADP
admet-1883	261	14	the	the	DET
admet-1883	261	15	screening	screening	NOUN
admet-1883	261	16	test	test	NOUN
admet-1883	261	17	done	do	VERB
admet-1883	261	18	via	via	ADP
admet-1883	261	19	a	a	DET
admet-1883	261	20	computational	computational	ADJ
admet-1883	261	21	approach	approach	NOUN
admet-1883	261	22	[	[	X
admet-1883	261	23	88	88	NUM
admet-1883	261	24	]	]	PUNCT
admet-1883	261	25	.	.	PUNCT
admet-1883	262	1	fedorov	fedorov	PROPN
admet-1883	262	2	et	et	PROPN
admet-1883	262	3	al	al	PROPN
admet-1883	262	4	.	.	PROPN
admet-1883	262	5	utilized	utilize	VERB
admet-1883	262	6	coarse	coarse	ADJ
admet-1883	262	7	graining	grain	VERB
admet-1883	262	8	molecular	molecular	ADJ
admet-1883	262	9	dynamic	dynamic	ADJ
admet-1883	262	10	method	method	NOUN
admet-1883	262	11	to	to	PART
admet-1883	262	12	understand	understand	VERB
admet-1883	262	13	the	the	DET
admet-1883	262	14	molecular	molecular	ADJ
admet-1883	262	15	inte	inte	NOUN
admet-1883	262	16	raction	raction	NOUN
admet-1883	262	17	between	between	ADP
admet-1883	262	18	the	the	DET
admet-1883	262	19	developed	develop	VERB
admet-1883	262	20	ps	ps	PROPN
admet-1883	262	21	and	and	CCONJ
admet-1883	262	22	the	the	DET
admet-1883	262	23	surface	surface	NOUN
admet-1883	262	24	structure	structure	NOUN
admet-1883	262	25	of	of	ADP
admet-1883	262	26	the	the	DET
admet-1883	262	27	virus	virus	NOUN
admet-1883	262	28	,	,	PUNCT
admet-1883	262	29	and	and	CCONJ
admet-1883	262	30	with	with	ADP
admet-1883	262	31	the	the	DET
admet-1883	262	32	same	same	ADJ
admet-1883	262	33	,	,	PUNCT
admet-1883	262	34	the	the	DET
admet-1883	262	35	major	major	ADJ
admet-1883	262	36	and	and	CCONJ
admet-1883	262	37	minor	minor	ADJ
admet-1883	262	38	binding	bind	VERB
admet-1883	262	39	sites	site	NOUN
admet-1883	262	40	were	be	AUX
admet-1883	262	41	also	also	ADV
admet-1883	262	42	studied	study	VERB
admet-1883	262	43	[	[	X
admet-1883	262	44	89	89	NUM
admet-1883	262	45	]	]	PUNCT
admet-1883	262	46	.	.	PUNCT
admet-1883	263	1	similarly	similarly	ADV
admet-1883	263	2	,	,	PUNCT
admet-1883	263	3	sharshov	sharshov	PROPN
admet-1883	263	4	et	et	PROPN
admet-1883	263	5	al	al	PROPN
admet-1883	263	6	.	.	PROPN
admet-1883	263	7	studied	study	VERB
admet-1883	263	8	the	the	DET
admet-1883	263	9	chemistry	chemistry	NOUN
admet-1883	263	10	behind	behind	ADP
admet-1883	263	11	the	the	DET
admet-1883	263	12	interaction	interaction	NOUN
admet-1883	263	13	between	between	ADP
admet-1883	263	14	ps	ps	PROPN
admet-1883	263	15	and	and	CCONJ
admet-1883	263	16	virus	virus	NOUN
admet-1883	263	17	using	use	VERB
admet-1883	263	18	dynamic	dynamic	ADJ
admet-1883	263	19	simulation	simulation	NOUN
admet-1883	263	20	methods	method	NOUN
admet-1883	263	21	[	[	X
admet-1883	263	22	90	90	NUM
admet-1883	263	23	]	]	PUNCT
admet-1883	263	24	.	.	PUNCT
admet-1883	264	1	table	table	NOUN
admet-1883	264	2	4	4	NUM
admet-1883	264	3	summarizes	summarize	NOUN
admet-1883	264	4	the	the	DET
admet-1883	264	5	other	other	ADJ
admet-1883	264	6	computational	computational	ADJ
admet-1883	264	7	approaches	approach	NOUN
admet-1883	264	8	to	to	PART
admet-1883	264	9	formulate	formulate	VERB
admet-1883	264	10	the	the	DET
admet-1883	264	11	ps	ps	PROPN
admet-1883	264	12	.	.	PROPN
admet-1883	264	13	table	table	NOUN
admet-1883	264	14	4	4	NUM
admet-1883	264	15	.	.	PUNCT
admet-1883	265	1	the	the	DET
admet-1883	265	2	summary	summary	NOUN
admet-1883	265	3	of	of	ADP
admet-1883	265	4	the	the	DET
admet-1883	265	5	computer	computer	NOUN
admet-1883	265	6	-	-	PUNCT
admet-1883	265	7	aided	aid	VERB
admet-1883	265	8	designing	designing	NOUN
admet-1883	265	9	and	and	CCONJ
admet-1883	265	10	analysis	analysis	NOUN
admet-1883	265	11	of	of	ADP
admet-1883	265	12	ps	ps	PROPN
admet-1883	265	13	.	.	PUNCT
admet-1883	266	1	no	no	DET
admet-1883	266	2	ps	ps	NOUN
admet-1883	266	3	designed	design	VERB
admet-1883	266	4	method	method	NOUN
admet-1883	266	5	used	use	VERB
admet-1883	266	6	purpose	purpose	NOUN
admet-1883	266	7	ref	ref	NOUN
admet-1883	266	8	.	.	PUNCT
admet-1883	267	1	1	1	X
admet-1883	267	2	.	.	X
admet-1883	267	3	palladium	palladium	NOUN
admet-1883	267	4	-	-	PUNCT
admet-1883	267	5	platinum	platinum	NOUN
admet-1883	267	6	complex	complex	ADJ
admet-1883	267	7	gaussian	gaussian	NOUN
admet-1883	267	8	16	16	NUM
admet-1883	267	9	program	program	NOUN
admet-1883	267	10	two	two	NUM
admet-1883	267	11	-	-	PUNCT
admet-1883	267	12	photon	photon	NOUN
admet-1883	267	13	pdt	pdt	NOUN
admet-1883	267	14	cancer	cancer	NOUN
admet-1883	267	15	therapy	therapy	NOUN
admet-1883	267	16	[	[	X
admet-1883	267	17	91	91	NUM
admet-1883	267	18	]	]	SYM
admet-1883	267	19	2	2	NUM
admet-1883	267	20	.	.	X
admet-1883	267	21	imidazolium	imidazolium	NOUN
admet-1883	267	22	-	-	PUNCT
admet-1883	267	23	based	base	VERB
admet-1883	267	24	porous	porous	ADJ
admet-1883	267	25	organic	organic	ADJ
admet-1883	267	26	polymer	polymer	NOUN
admet-1883	267	27	photosensitizer	photosensitizer	NOUN
admet-1883	267	28	non	non	ADJ
admet-1883	267	29	-	-	ADJ
admet-1883	267	30	adiabatic	adiabatic	ADJ
admet-1883	267	31	molecular	molecular	ADJ
admet-1883	267	32	dynamics	dynamic	NOUN
admet-1883	267	33	simulation	simulation	NOUN
admet-1883	267	34	anticancer	anticancer	NOUN
admet-1883	267	35	pdt	pdt	PROPN
admet-1883	268	1	[	[	X
admet-1883	268	2	92	92	NUM
admet-1883	268	3	]	]	SYM
admet-1883	268	4	3	3	X
admet-1883	268	5	.	.	PUNCT
admet-1883	268	6	benzothiazole	benzothiazole	NOUN
admet-1883	268	7	-	-	PUNCT
admet-1883	268	8	based	base	VERB
admet-1883	268	9	organic	organic	ADJ
admet-1883	268	10	ps	ps	NOUN
admet-1883	268	11	gaussian	gaussian	ADJ
admet-1883	268	12	16	16	NUM
admet-1883	268	13	program	program	NOUN
admet-1883	268	14	novel	novel	NOUN
admet-1883	268	15	design	design	NOUN
admet-1883	268	16	of	of	ADP
admet-1883	268	17	organic	organic	ADJ
admet-1883	268	18	ps	ps	NOUN
admet-1883	268	19	that	that	PRON
admet-1883	268	20	is	be	AUX
admet-1883	268	21	operative	operative	ADJ
admet-1883	268	22	in	in	ADP
admet-1883	268	23	the	the	DET
admet-1883	268	24	nir	nir	ADJ
admet-1883	268	25	region	region	NOUN
admet-1883	269	1	[	[	X
admet-1883	269	2	93	93	NUM
admet-1883	269	3	]	]	SYM
admet-1883	269	4	4	4	NUM
admet-1883	269	5	.	.	X
admet-1883	269	6	halogen	halogen	NOUN
admet-1883	269	7	-	-	PUNCT
admet-1883	269	8	free	free	ADJ
admet-1883	269	9	boron	boron	NOUN
admet-1883	269	10	dipyrromethene	dipyrromethene	NOUN
admet-1883	269	11	photosensitizer	photosensitizer	NOUN
admet-1883	269	12	density	density	NOUN
admet-1883	269	13	functional	functional	ADJ
admet-1883	269	14	theory	theory	NOUN
admet-1883	269	15	(	(	PUNCT
admet-1883	269	16	dft	dft	PROPN
admet-1883	269	17	)	)	PUNCT
admet-1883	269	18	with	with	ADP
admet-1883	269	19	the	the	DET
admet-1883	269	20	dependence	dependence	NOUN
admet-1883	269	21	on	on	ADP
admet-1883	269	22	time	time	NOUN
admet-1883	269	23	(	(	PUNCT
admet-1883	269	24	tddft	tddft	NOUN
admet-1883	269	25	)	)	PUNCT
admet-1883	269	26	bioimaging	bioimaging	NOUN
admet-1883	269	27	and	and	CCONJ
admet-1883	269	28	anticancer	anticancer	NOUN
admet-1883	269	29	pdt	pdt	PROPN
admet-1883	270	1	[	[	X
admet-1883	270	2	94	94	NUM
admet-1883	270	3	]	]	SYM
admet-1883	270	4	5	5	NUM
admet-1883	270	5	.	.	PUNCT
admet-1883	270	6	propolis	propoli	NOUN
admet-1883	270	7	-	-	PUNCT
admet-1883	270	8	benzofuran	benzofuran	VERB
admet-1883	270	9	a	a	DET
admet-1883	270	10	photosensitizer	photosensitizer	NOUN
admet-1883	270	11	swissadme	swissadme	NOUN
admet-1883	270	12	tool	tool	NOUN
admet-1883	270	13	,	,	PUNCT
admet-1883	270	14	osiris	osiris	PROPN
admet-1883	270	15	and	and	CCONJ
admet-1883	270	16	pro	pro	ADJ
admet-1883	270	17	-	-	ADJ
admet-1883	270	18	tox	tox	ADJ
admet-1883	270	19	ii	ii	PROPN
admet-1883	270	20	pdt	pdt	PROPN
admet-1883	270	21	for	for	ADP
admet-1883	270	22	monkeypox	monkeypox	PROPN
admet-1883	270	23	virus	virus	NOUN
admet-1883	270	24	[	[	X
admet-1883	270	25	95	95	NUM
admet-1883	270	26	]	]	SYM
admet-1883	270	27	6	6	NUM
admet-1883	270	28	.	.	PUNCT
admet-1883	271	1	cy7photolabile	cy7photolabile	NOUN
admet-1883	271	2	protecting	protect	VERB
admet-1883	271	3	groups	group	NOUN
admet-1883	271	4	gaussview	gaussview	VERB
admet-1883	271	5	6.0	6.0	NUM
admet-1883	271	6	facile	facile	ADJ
admet-1883	271	7	synthesis	synthesis	NOUN
admet-1883	271	8	for	for	ADP
admet-1883	271	9	biomedical	biomedical	ADJ
admet-1883	271	10	applications	application	NOUN
admet-1883	271	11	[	[	X
admet-1883	271	12	96	96	NUM
admet-1883	271	13	]	]	SYM
admet-1883	271	14	7	7	NUM
admet-1883	271	15	.	.	PUNCT
admet-1883	271	16	meso	meso	PROPN
admet-1883	271	17	-	-	PUNCT
admet-1883	271	18	tetraphenylporphyrin	tetraphenylporphyrin	NOUN
admet-1883	271	19	tddft	tddft	NOUN
admet-1883	271	20	anticancer	anticancer	NOUN
admet-1883	271	21	pdt	pdt	PROPN
admet-1883	272	1	[	[	X
admet-1883	272	2	97	97	NUM
admet-1883	272	3	]	]	SYM
admet-1883	272	4	8	8	NUM
admet-1883	272	5	.	.	PUNCT
admet-1883	273	1	dicyanomethylene-4h	dicyanomethylene-4h	NOUN
admet-1883	273	2	-	-	NOUN
admet-1883	273	3	chromene	chromene	NOUN
admet-1883	273	4	based	base	VERB
admet-1883	273	5	ps	ps	PROPN
admet-1883	273	6	mesra	mesra	PROPN
admet-1883	273	7	software	software	NOUN
admet-1883	273	8	with	with	ADP
admet-1883	273	9	gaussian	gaussian	ADJ
admet-1883	273	10	16	16	NUM
admet-1883	273	11	program	program	NOUN
admet-1883	273	12	image	image	NOUN
admet-1883	273	13	-	-	PUNCT
admet-1883	273	14	guided	guide	VERB
admet-1883	273	15	anticancer	anticancer	NOUN
admet-1883	273	16	pdt	pdt	NOUN
admet-1883	274	1	[	[	X
admet-1883	274	2	98	98	NUM
admet-1883	274	3	]	]	SYM
admet-1883	274	4	9	9	NUM
admet-1883	274	5	.	.	PUNCT
admet-1883	274	6	fucoxanthin	fucoxanthin	NOUN
admet-1883	274	7	/	/	SYM
admet-1883	274	8	graphene	graphene	PROPN
admet-1883	274	9	complex	complex	ADJ
admet-1883	274	10	dft	dft	NOUN
admet-1883	274	11	to	to	PART
admet-1883	274	12	study	study	VERB
admet-1883	274	13	the	the	DET
admet-1883	274	14	photosensitization	photosensitization	NOUN
admet-1883	274	15	features	feature	VERB
admet-1883	274	16	for	for	ADP
admet-1883	274	17	various	various	ADJ
admet-1883	274	18	applications	application	NOUN
admet-1883	274	19	[	[	X
admet-1883	274	20	99	99	NUM
admet-1883	274	21	]	]	SYM
admet-1883	274	22	10	10	NUM
admet-1883	274	23	.	.	PUNCT
admet-1883	274	24	porphyrin	porphyrin	NOUN
admet-1883	274	25	-	-	PUNCT
admet-1883	274	26	based	base	VERB
admet-1883	274	27	ps	ps	NOUN
admet-1883	274	28	with	with	ADP
admet-1883	274	29	two	two	NUM
admet-1883	274	30	ethanethioate	ethanethioate	ADJ
admet-1883	274	31	dft	dft	PROPN
admet-1883	274	32	and	and	CCONJ
admet-1883	274	33	tddft	tddft	NOUN
admet-1883	274	34	calculation	calculation	NOUN
admet-1883	274	35	of	of	ADP
admet-1883	274	36	the	the	DET
admet-1883	274	37	excited	excited	ADJ
admet-1883	274	38	state	state	NOUN
admet-1883	274	39	properties	property	NOUN
admet-1883	274	40	of	of	ADP
admet-1883	274	41	the	the	DET
admet-1883	274	42	novel	novel	ADJ
admet-1883	274	43	design	design	NOUN
admet-1883	274	44	[	[	X
admet-1883	274	45	100	100	NUM
admet-1883	274	46	]	]	X
admet-1883	274	47	admet	admet	PROPN
admet-1883	274	48	&	&	CCONJ
admet-1883	274	49	dmpk	dmpk	PROPN
admet-1883	274	50	11(4	11(4	NUM
admet-1883	274	51	)	)	PUNCT
admet-1883	274	52	(	(	PUNCT
admet-1883	274	53	2023	2023	NUM
admet-1883	274	54	)	)	PUNCT
admet-1883	274	55	513	513	NUM
admet-1883	274	56	-	-	SYM
admet-1883	274	57	531	531	NUM
admet-1883	274	58	infections	infection	NOUN
admet-1883	274	59	associated	associate	VERB
admet-1883	274	60	with	with	ADP
admet-1883	274	61	sars	sar	NOUN
admet-1883	274	62	-	-	PUNCT
admet-1883	274	63	cov-2	cov-2	PART
admet-1883	274	64	exploited	exploit	VERB
admet-1883	274	65	via	via	ADP
admet-1883	274	66	photodynamic	photodynamic	ADJ
admet-1883	274	67	therapy	therapy	NOUN
admet-1883	274	68	doi	doi	NOUN
admet-1883	274	69	:	:	PUNCT
admet-1883	274	70	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-1883	274	71	t.1883	t.1883	VERB
admet-1883	274	72	525	525	NUM
admet-1883	274	73	conclusion	conclusion	NOUN
admet-1883	274	74	and	and	CCONJ
admet-1883	274	75	future	future	ADJ
admet-1883	274	76	perspective	perspective	NOUN
admet-1883	274	77	covid-19	covid-19	PROPN
admet-1883	274	78	is	be	AUX
admet-1883	274	79	rapidly	rapidly	ADV
admet-1883	274	80	spreading	spread	VERB
admet-1883	274	81	around	around	ADP
admet-1883	274	82	the	the	DET
admet-1883	274	83	world	world	NOUN
admet-1883	274	84	,	,	PUNCT
admet-1883	274	85	resulting	result	VERB
admet-1883	274	86	in	in	ADP
admet-1883	274	87	an	an	DET
admet-1883	274	88	increase	increase	NOUN
admet-1883	274	89	in	in	ADP
admet-1883	274	90	affected	affected	ADJ
admet-1883	274	91	cases	case	NOUN
admet-1883	274	92	and	and	CCONJ
admet-1883	274	93	deaths	death	NOUN
admet-1883	274	94	.	.	PUNCT
admet-1883	275	1	we	we	PRON
admet-1883	275	2	are	be	AUX
admet-1883	275	3	confronted	confront	VERB
admet-1883	275	4	with	with	ADP
admet-1883	275	5	many	many	ADJ
admet-1883	275	6	unknowns	unknown	NOUN
admet-1883	275	7	,	,	PUNCT
admet-1883	275	8	and	and	CCONJ
admet-1883	275	9	we	we	PRON
admet-1883	275	10	must	must	AUX
admet-1883	275	11	continue	continue	VERB
admet-1883	275	12	to	to	PART
admet-1883	275	13	monitor	monitor	VERB
admet-1883	275	14	and	and	CCONJ
admet-1883	275	15	research	research	NOUN
admet-1883	275	16	.	.	PUNCT
admet-1883	276	1	until	until	ADP
admet-1883	276	2	now	now	ADV
admet-1883	276	3	,	,	PUNCT
admet-1883	276	4	no	no	DET
admet-1883	276	5	appropriate	appropriate	ADJ
admet-1883	276	6	therapy	therapy	NOUN
admet-1883	276	7	against	against	ADP
admet-1883	276	8	sars	sar	NOUN
admet-1883	276	9	-	-	PUNCT
admet-1883	276	10	cov-2	cov-2	NOUN
admet-1883	276	11	for	for	ADP
admet-1883	276	12	a	a	DET
admet-1883	276	13	complete	complete	ADJ
admet-1883	276	14	cure	cure	NOUN
admet-1883	276	15	is	be	AUX
admet-1883	276	16	available	available	ADJ
admet-1883	276	17	.	.	PUNCT
admet-1883	277	1	to	to	PART
admet-1883	277	2	resolve	resolve	VERB
admet-1883	277	3	this	this	DET
admet-1883	277	4	issue	issue	NOUN
admet-1883	277	5	,	,	PUNCT
admet-1883	277	6	researchers	researcher	NOUN
admet-1883	277	7	are	be	AUX
admet-1883	277	8	focusing	focus	VERB
admet-1883	277	9	on	on	ADP
admet-1883	277	10	developing	develop	VERB
admet-1883	277	11	viable	viable	ADJ
admet-1883	277	12	vaccinations	vaccination	NOUN
admet-1883	277	13	and	and	CCONJ
admet-1883	277	14	treatments	treatment	NOUN
admet-1883	277	15	.	.	PUNCT
admet-1883	278	1	nanotechnology	nanotechnology	NOUN
admet-1883	278	2	is	be	AUX
admet-1883	278	3	now	now	ADV
admet-1883	278	4	emerging	emerge	VERB
admet-1883	278	5	as	as	ADP
admet-1883	278	6	a	a	DET
admet-1883	278	7	potential	potential	ADJ
admet-1883	278	8	field	field	NOUN
admet-1883	278	9	for	for	ADP
admet-1883	278	10	diagnosing	diagnose	VERB
admet-1883	278	11	and	and	CCONJ
admet-1883	278	12	treating	treat	VERB
admet-1883	278	13	several	several	ADJ
admet-1883	278	14	disorders	disorder	NOUN
admet-1883	278	15	.	.	PUNCT
admet-1883	279	1	due	due	ADP
admet-1883	279	2	to	to	ADP
admet-1883	279	3	the	the	DET
admet-1883	279	4	small	small	ADJ
admet-1883	279	5	size	size	NOUN
admet-1883	279	6	and	and	CCONJ
admet-1883	279	7	exponential	exponential	ADJ
admet-1883	279	8	surface	surface	NOUN
admet-1883	279	9	chemistry	chemistry	NOUN
admet-1883	279	10	,	,	PUNCT
admet-1883	279	11	the	the	DET
admet-1883	279	12	nanoparticle	nanoparticle	NOUN
admet-1883	279	13	can	can	AUX
admet-1883	279	14	be	be	AUX
admet-1883	279	15	an	an	DET
admet-1883	279	16	effective	effective	ADJ
admet-1883	279	17	tool	tool	NOUN
admet-1883	279	18	in	in	ADP
admet-1883	279	19	manufacturing	manufacture	VERB
admet-1883	279	20	vaccines	vaccine	NOUN
admet-1883	279	21	and	and	CCONJ
admet-1883	279	22	developing	develop	VERB
admet-1883	279	23	treatment	treatment	NOUN
admet-1883	279	24	strategies	strategy	NOUN
admet-1883	279	25	against	against	ADP
admet-1883	279	26	covid-19	covid-19	PROPN
admet-1883	279	27	infection	infection	NOUN
admet-1883	279	28	.	.	PUNCT
admet-1883	280	1	pdt	pdt	PROPN
admet-1883	280	2	is	be	AUX
admet-1883	280	3	a	a	DET
admet-1883	280	4	non	non	ADJ
admet-1883	280	5	-	-	ADJ
admet-1883	280	6	invasive	invasive	ADJ
admet-1883	280	7	therapeutic	therapeutic	ADJ
admet-1883	280	8	strategy	strategy	NOUN
admet-1883	280	9	based	base	VERB
admet-1883	280	10	on	on	ADP
admet-1883	280	11	the	the	DET
admet-1883	280	12	activation	activation	NOUN
admet-1883	280	13	of	of	ADP
admet-1883	280	14	a	a	DET
admet-1883	280	15	ps	ps	NOUN
admet-1883	280	16	with	with	ADP
admet-1883	280	17	the	the	DET
admet-1883	280	18	help	help	NOUN
admet-1883	280	19	of	of	ADP
admet-1883	280	20	light	light	NOUN
admet-1883	280	21	in	in	ADP
admet-1883	280	22	a	a	DET
admet-1883	280	23	certain	certain	ADJ
admet-1883	280	24	wavelength	wavelength	NOUN
admet-1883	280	25	.	.	PUNCT
admet-1883	281	1	in	in	ADP
admet-1883	281	2	pdt	pdt	PROPN
admet-1883	281	3	,	,	PUNCT
admet-1883	281	4	the	the	DET
admet-1883	281	5	nanoparticle	nanoparticle	NOUN
admet-1883	281	6	can	can	AUX
admet-1883	281	7	act	act	VERB
admet-1883	281	8	as	as	ADP
admet-1883	281	9	a	a	DET
admet-1883	281	10	drug	drug	NOUN
admet-1883	281	11	carrier	carrier	NOUN
admet-1883	281	12	or	or	CCONJ
admet-1883	281	13	a	a	DET
admet-1883	281	14	drug	drug	NOUN
admet-1883	281	15	by	by	ADP
admet-1883	281	16	itself	itself	PRON
admet-1883	281	17	.	.	PUNCT
admet-1883	282	1	in	in	ADP
admet-1883	282	2	order	order	NOUN
admet-1883	282	3	to	to	PART
admet-1883	282	4	overcome	overcome	VERB
admet-1883	282	5	the	the	DET
admet-1883	282	6	drawback	drawback	NOUN
admet-1883	282	7	of	of	ADP
admet-1883	282	8	ps	ps	NOUN
admet-1883	282	9	,	,	PUNCT
admet-1883	282	10	nanoparticles	nanoparticle	NOUN
admet-1883	282	11	can	can	AUX
admet-1883	282	12	be	be	AUX
admet-1883	282	13	used	use	VERB
admet-1883	282	14	as	as	ADP
admet-1883	282	15	a	a	DET
admet-1883	282	16	carrier	carrier	NOUN
admet-1883	282	17	of	of	ADP
admet-1883	282	18	ps	ps	PROPN
admet-1883	282	19	.	.	PUNCT
admet-1883	283	1	studies	study	NOUN
admet-1883	283	2	revealed	reveal	VERB
admet-1883	283	3	nanoparticle	nanoparticle	NOUN
admet-1883	283	4	-	-	PUNCT
admet-1883	283	5	based	base	VERB
admet-1883	283	6	antiviral	antiviral	ADJ
admet-1883	283	7	medicines	medicine	NOUN
admet-1883	283	8	and	and	CCONJ
admet-1883	283	9	nano	nano	NOUN
admet-1883	283	10	-	-	PUNCT
admet-1883	283	11	based	base	VERB
admet-1883	283	12	-	-	PUNCT
admet-1883	283	13	pdt	pdt	NOUN
admet-1883	283	14	would	would	AUX
admet-1883	283	15	sufficiently	sufficiently	ADV
admet-1883	283	16	combat	combat	VERB
admet-1883	283	17	the	the	DET
admet-1883	283	18	covid-19	covid-19	PROPN
admet-1883	283	19	pandemic	pandemic	NOUN
admet-1883	283	20	.	.	PUNCT
admet-1883	284	1	authors	author	NOUN
admet-1883	284	2	contribution	contribution	VERB
admet-1883	284	3	:	:	PUNCT
admet-1883	284	4	pp	pp	PROPN
admet-1883	284	5	&	&	CCONJ
admet-1883	284	6	kh	kh	PROPN
admet-1883	284	7	collected	collect	VERB
admet-1883	284	8	all	all	DET
admet-1883	284	9	required	require	VERB
admet-1883	284	10	data	datum	NOUN
admet-1883	284	11	and	and	CCONJ
admet-1883	284	12	wrote	write	VERB
admet-1883	284	13	the	the	DET
admet-1883	284	14	initial	initial	ADJ
admet-1883	284	15	draft	draft	NOUN
admet-1883	284	16	.	.	PUNCT
admet-1883	285	1	nae	nae	PROPN
admet-1883	285	2	,	,	PUNCT
admet-1883	285	3	pg	pg	PROPN
admet-1883	285	4	,	,	PUNCT
admet-1883	285	5	and	and	CCONJ
admet-1883	285	6	kg	kg	PRON
admet-1883	285	7	compiled	compile	VERB
admet-1883	285	8	it	it	PRON
admet-1883	285	9	with	with	ADP
admet-1883	285	10	additional	additional	ADJ
admet-1883	285	11	data	datum	NOUN
admet-1883	285	12	.	.	PUNCT
admet-1883	286	1	the	the	DET
admet-1883	286	2	concept	concept	NOUN
admet-1883	286	3	,	,	PUNCT
admet-1883	286	4	overall	overall	ADJ
admet-1883	286	5	representation	representation	NOUN
admet-1883	286	6	,	,	PUNCT
admet-1883	286	7	and	and	CCONJ
admet-1883	286	8	final	final	ADJ
admet-1883	286	9	version	version	NOUN
admet-1883	286	10	were	be	AUX
admet-1883	286	11	prepared	prepare	VERB
admet-1883	286	12	by	by	ADP
admet-1883	286	13	ag	ag	PROPN
admet-1883	286	14	.	.	PROPN
admet-1883	286	15	conflict	conflict	NOUN
admet-1883	286	16	of	of	ADP
admet-1883	286	17	interest	interest	NOUN
admet-1883	286	18	:	:	PUNCT
admet-1883	286	19	the	the	DET
admet-1883	286	20	authors	author	NOUN
admet-1883	286	21	declare	declare	VERB
admet-1883	286	22	that	that	SCONJ
admet-1883	286	23	there	there	PRON
admet-1883	286	24	is	be	VERB
admet-1883	286	25	not	not	PART
admet-1883	286	26	any	any	DET
admet-1883	286	27	conflict	conflict	NOUN
admet-1883	286	28	of	of	ADP
admet-1883	286	29	interest	interest	NOUN
admet-1883	286	30	.	.	PUNCT
admet-1883	287	1	acknowledgements	acknowledgement	NOUN
admet-1883	287	2	:	:	PUNCT
admet-1883	288	1	authors	author	NOUN
admet-1883	288	2	acknowledge	acknowledge	VERB
admet-1883	288	3	care	care	VERB
admet-1883	288	4	for	for	ADP
admet-1883	288	5	financial	financial	ADJ
admet-1883	288	6	and	and	CCONJ
admet-1883	288	7	infrastructural	infrastructural	ADJ
admet-1883	288	8	support	support	NOUN
admet-1883	288	9	.	.	PUNCT
admet-1883	289	1	pp	pp	ADV
admet-1883	289	2	,	,	PUNCT
admet-1883	289	3	kr	kr	PROPN
admet-1883	289	4	&	&	CCONJ
admet-1883	289	5	pg	pg	PROPN
admet-1883	289	6	acknowledge	acknowledge	VERB
admet-1883	289	7	care	care	NOUN
admet-1883	289	8	for	for	ADP
admet-1883	289	9	fellowships	fellowship	NOUN
admet-1883	289	10	too	too	ADV
admet-1883	289	11	.	.	PUNCT
admet-1883	290	1	references	reference	NOUN
admet-1883	290	2	[	[	X
admet-1883	290	3	1	1	NUM
admet-1883	290	4	]	]	PUNCT
admet-1883	290	5	a.	a.	NOUN
admet-1883	290	6	valsamatzi	valsamatzi	NOUN
admet-1883	290	7	-	-	PUNCT
admet-1883	290	8	panagiotou	panagiotou	ADJ
admet-1883	290	9	,	,	PUNCT
admet-1883	290	10	r.	r.	PROPN
admet-1883	290	11	penchovsky	penchovsky	PROPN
admet-1883	290	12	.	.	PUNCT
admet-1883	291	1	environmental	environmental	ADJ
admet-1883	291	2	factors	factor	NOUN
admet-1883	291	3	influencing	influence	VERB
admet-1883	291	4	the	the	DET
admet-1883	291	5	transmission	transmission	NOUN
admet-1883	291	6	of	of	ADP
admet-1883	291	7	the	the	DET
admet-1883	291	8	coronavirus	coronavirus	NOUN
admet-1883	291	9	2019	2019	NUM
admet-1883	291	10	:	:	PUNCT
admet-1883	291	11	a	a	DET
admet-1883	291	12	review	review	NOUN
admet-1883	291	13	.	.	PUNCT
admet-1883	292	1	environmental	environmental	ADJ
admet-1883	292	2	chemistry	chemistry	NOUN
admet-1883	292	3	letters	letter	NOUN
admet-1883	292	4	20	20	NUM
admet-1883	292	5	(	(	PUNCT
admet-1883	292	6	2022	2022	NUM
admet-1883	292	7	)	)	PUNCT
admet-1883	292	8	1603	1603	NUM
admet-1883	292	9	-	-	SYM
admet-1883	292	10	1610	1610	NUM
admet-1883	292	11	.	.	PUNCT
admet-1883	293	1	https://doi.org/	https://doi.org/	VERB
admet-1883	293	2	10.1007	10.1007	NUM
admet-1883	293	3	/	/	SYM
admet-1883	293	4	s10311	s10311	NOUN
admet-1883	293	5	-	-	PUNCT
admet-1883	293	6	022	022	NUM
admet-1883	293	7	-	-	PUNCT
admet-1883	293	8	01418	01418	NUM
admet-1883	293	9	-	-	SYM
admet-1883	293	10	9	9	NUM
admet-1883	293	11	.	.	PUNCT
admet-1883	294	1	[	[	X
admet-1883	294	2	2	2	NUM
admet-1883	294	3	]	]	PUNCT
admet-1883	294	4	a.	a.	NOUN
admet-1883	294	5	girigoswami	girigoswami	PROPN
admet-1883	294	6	,	,	PUNCT
admet-1883	294	7	k.	k.	PROPN
admet-1883	294	8	girigoswami	girigoswami	PROPN
admet-1883	294	9	.	.	PUNCT
admet-1883	295	1	versatile	versatile	ADJ
admet-1883	295	2	applications	application	NOUN
admet-1883	295	3	of	of	ADP
admet-1883	295	4	nanosponges	nanosponge	NOUN
admet-1883	295	5	in	in	ADP
admet-1883	295	6	biomedical	biomedical	ADJ
admet-1883	295	7	field	field	NOUN
admet-1883	295	8	:	:	PUNCT
admet-1883	295	9	a	a	DET
admet-1883	295	10	glimpse	glimpse	NOUN
admet-1883	295	11	on	on	ADP
admet-1883	295	12	sars	sar	NOUN
admet-1883	295	13	-	-	PUNCT
admet-1883	295	14	cov-2	cov-2	NOUN
admet-1883	295	15	management	management	NOUN
admet-1883	295	16	.	.	PUNCT
admet-1883	296	1	bionanoscience	bionanoscience	NOUN
admet-1883	296	2	12	12	NUM
admet-1883	296	3	(	(	PUNCT
admet-1883	296	4	2022	2022	NUM
admet-1883	296	5	)	)	PUNCT
admet-1883	296	6	1018	1018	NUM
admet-1883	296	7	-	-	SYM
admet-1883	296	8	1031	1031	NUM
admet-1883	296	9	.	.	PUNCT
admet-1883	297	1	https://doi.org/10.1007/s126	https://doi.org/10.1007/s126	PROPN
admet-1883	297	2	68	68	NUM
admet-1883	297	3	-	-	PUNCT
admet-1883	297	4	022	022	NUM
admet-1883	297	5	-	-	PUNCT
admet-1883	297	6	01000	01000	NUM
admet-1883	297	7	-	-	SYM
admet-1883	297	8	1	1	NUM
admet-1883	297	9	.	.	PUNCT
admet-1883	298	1	[	[	X
admet-1883	298	2	3	3	X
admet-1883	298	3	]	]	X
admet-1883	298	4	g.s	g.s	PROPN
admet-1883	298	5	.	.	PROPN
admet-1883	298	6	el	el	PROPN
admet-1883	298	7	-	-	PUNCT
admet-1883	298	8	sayyad	sayyad	PROPN
admet-1883	298	9	,	,	PUNCT
admet-1883	298	10	d.	d.	PROPN
admet-1883	298	11	elfadil	elfadil	PROPN
admet-1883	298	12	,	,	PUNCT
admet-1883	299	1	m.s	m.s	PROPN
admet-1883	299	2	.	.	PROPN
admet-1883	299	3	gaballah	gaballah	PROPN
admet-1883	299	4	,	,	PUNCT
admet-1883	299	5	d.m	d.m	PROPN
admet-1883	299	6	.	.	PUNCT
admet-1883	300	1	el	el	PROPN
admet-1883	300	2	-	-	PUNCT
admet-1883	300	3	sherif	sherif	PROPN
admet-1883	300	4	,	,	PUNCT
admet-1883	300	5	m.	m.	PROPN
admet-1883	300	6	abouzid	abouzid	PROPN
admet-1883	300	7	,	,	PUNCT
admet-1883	300	8	h.g	h.g	PROPN
admet-1883	300	9	.	.	PROPN
admet-1883	300	10	nada	nada	PROPN
admet-1883	300	11	,	,	PUNCT
admet-1883	300	12	m.s	m.s	PROPN
admet-1883	300	13	.	.	PROPN
admet-1883	300	14	khalil	khalil	PROPN
admet-1883	300	15	,	,	PUNCT
admet-1883	300	16	m.a	m.a	PROPN
admet-1883	300	17	.	.	PROPN
admet-1883	300	18	ghorab	ghorab	PROPN
admet-1883	300	19	.	.	PUNCT
admet-1883	301	1	implication	implication	NOUN
admet-1883	301	2	of	of	ADP
admet-1883	301	3	nanotechnology	nanotechnology	NOUN
admet-1883	301	4	to	to	PART
admet-1883	301	5	reduce	reduce	VERB
admet-1883	301	6	the	the	DET
admet-1883	301	7	environmental	environmental	ADJ
admet-1883	301	8	risks	risk	NOUN
admet-1883	301	9	of	of	ADP
admet-1883	301	10	waste	waste	NOUN
admet-1883	301	11	associated	associate	VERB
admet-1883	301	12	with	with	ADP
admet-1883	301	13	the	the	DET
admet-1883	301	14	covid-19	covid-19	PROPN
admet-1883	301	15	pandemic	pandemic	NOUN
admet-1883	301	16	.	.	PUNCT
admet-1883	302	1	rsc	rsc	PROPN
admet-1883	302	2	advances	advance	VERB
admet-1883	302	3	13	13	NUM
admet-1883	302	4	(	(	PUNCT
admet-1883	302	5	2023	2023	NUM
admet-1883	302	6	)	)	PUNCT
admet-1883	302	7	12438	12438	NUM
admet-1883	302	8	-	-	SYM
admet-1883	302	9	12454	12454	NUM
admet-1883	302	10	.	.	PUNCT
admet-1883	303	1	https://doi.org/10.1039/	https://doi.org/10.1039/	PROPN
admet-1883	303	2	d3ra01052j	d3ra01052j	PROPN
admet-1883	303	3	.	.	PUNCT
admet-1883	304	1	[	[	X
admet-1883	304	2	4	4	NUM
admet-1883	304	3	]	]	PUNCT
admet-1883	304	4	m.	m.	NOUN
admet-1883	304	5	rademaker	rademaker	PROPN
admet-1883	304	6	,	,	PUNCT
admet-1883	304	7	c.	c.	PROPN
admet-1883	304	8	baker	baker	PROPN
admet-1883	304	9	,	,	PUNCT
admet-1883	304	10	p.	p.	PROPN
admet-1883	304	11	foley	foley	PROPN
admet-1883	304	12	,	,	PUNCT
admet-1883	304	13	j.	j.	PROPN
admet-1883	304	14	sullivan	sullivan	PROPN
admet-1883	304	15	,	,	PUNCT
admet-1883	304	16	c.	c.	PROPN
admet-1883	304	17	wang	wang	PROPN
admet-1883	304	18	.	.	PUNCT
admet-1883	305	1	advice	advice	NOUN
admet-1883	305	2	regarding	regard	VERB
admet-1883	305	3	covid‐19	covid‐19	PROPN
admet-1883	305	4	and	and	CCONJ
admet-1883	305	5	use	use	NOUN
admet-1883	305	6	of	of	ADP
admet-1883	305	7	immunomodulators	immunomodulator	NOUN
admet-1883	305	8	,	,	PUNCT
admet-1883	305	9	in	in	ADP
admet-1883	305	10	patients	patient	NOUN
admet-1883	305	11	with	with	ADP
admet-1883	305	12	severe	severe	ADJ
admet-1883	305	13	dermatological	dermatological	ADJ
admet-1883	305	14	diseases	disease	NOUN
admet-1883	305	15	.	.	PUNCT
admet-1883	306	1	the	the	DET
admet-1883	306	2	australasian	australasian	ADJ
admet-1883	306	3	jjournal	jjournal	NOUN
admet-1883	306	4	of	of	ADP
admet-1883	306	5	dermatology	dermatology	NOUN
admet-1883	306	6	(	(	PUNCT
admet-1883	306	7	2020	2020	NUM
admet-1883	306	8	)	)	PUNCT
admet-1883	306	9	.	.	PUNCT
admet-1883	307	1	https://doi.org/10.1111/ajd.13295	https://doi.org/10.1111/ajd.13295	PROPN
admet-1883	307	2	.	.	PUNCT
admet-1883	308	1	[	[	X
admet-1883	308	2	5	5	X
admet-1883	308	3	]	]	PUNCT
admet-1883	308	4	s.	s.	PROPN
admet-1883	308	5	aftab	aftab	PROPN
admet-1883	308	6	,	,	PUNCT
admet-1883	308	7	m.z	m.z	PROPN
admet-1883	308	8	.	.	PROPN
admet-1883	308	9	iqbal	iqbal	PROPN
admet-1883	308	10	,	,	PUNCT
admet-1883	308	11	s.	s.	PROPN
admet-1883	308	12	hussain	hussain	PROPN
admet-1883	308	13	,	,	PUNCT
admet-1883	308	14	h.h	h.h	PROPN
admet-1883	308	15	.	.	PROPN
admet-1883	308	16	hegazy	hegazy	PROPN
admet-1883	308	17	.	.	PUNCT
admet-1883	309	1	recent	recent	ADJ
admet-1883	309	2	advances	advance	NOUN
admet-1883	309	3	in	in	ADP
admet-1883	309	4	nanomaterials‐based	nanomaterials‐base	VERB
admet-1883	309	5	fets	fet	NOUN
admet-1883	309	6	for	for	ADP
admet-1883	309	7	sars‐	sars‐	PROPN
admet-1883	309	8	cov‐2	cov‐2	PROPN
admet-1883	309	9	(	(	PUNCT
admet-1883	309	10	covid‐19	covid‐19	PROPN
admet-1883	309	11	virus	virus	NOUN
admet-1883	309	12	)	)	PUNCT
admet-1883	309	13	diagnosis	diagnosis	NOUN
admet-1883	309	14	.	.	PUNCT
admet-1883	310	1	advanced	advanced	ADJ
admet-1883	310	2	functional	functional	ADJ
admet-1883	310	3	materials	material	NOUN
admet-1883	310	4	(	(	PUNCT
admet-1883	310	5	2023	2023	NUM
admet-1883	310	6	)	)	PUNCT
admet-1883	310	7	2301007	2301007	NUM
admet-1883	310	8	.	.	PUNCT
admet-1883	311	1	https://doi.org/10.1002/adfm.202301007	https://doi.org/10.1002/adfm.202301007	PROPN
admet-1883	311	2	.	.	PUNCT
admet-1883	312	1	[	[	X
admet-1883	312	2	6	6	NUM
admet-1883	312	3	]	]	PUNCT
admet-1883	312	4	n.	n.	NOUN
admet-1883	312	5	agharezaei	agharezaei	NOUN
admet-1883	312	6	,	,	PUNCT
admet-1883	312	7	f.	f.	PROPN
admet-1883	312	8	forouzesh	forouzesh	PROPN
admet-1883	312	9	.	.	PUNCT
admet-1883	313	1	sars	sar	NOUN
admet-1883	313	2	-	-	PUNCT
admet-1883	313	3	cov-2	cov-2	NOUN
admet-1883	313	4	:	:	PUNCT
admet-1883	313	5	history	history	NOUN
admet-1883	313	6	,	,	PUNCT
admet-1883	313	7	genetics	genetic	NOUN
admet-1883	313	8	,	,	PUNCT
admet-1883	313	9	and	and	CCONJ
admet-1883	313	10	treatment	treatment	NOUN
admet-1883	313	11	.	.	PUNCT
admet-1883	314	1	journal	journal	PROPN
admet-1883	314	2	of	of	ADP
admet-1883	314	3	arak	arak	PROPN
admet-1883	314	4	university	university	PROPN
admet-1883	314	5	of	of	ADP
admet-1883	314	6	medical	medical	PROPN
admet-1883	314	7	sciences	science	NOUN
admet-1883	314	8	23	23	NUM
admet-1883	314	9	(	(	PUNCT
admet-1883	314	10	2020	2020	NUM
admet-1883	314	11	)	)	PUNCT
admet-1883	314	12	666	666	NUM
admet-1883	314	13	-	-	SYM
admet-1883	314	14	685	685	NUM
admet-1883	314	15	.	.	PUNCT
admet-1883	315	1	https://doi.org/10.32598/jams.23.cov.5712.2	https://doi.org/10.32598/jams.23.cov.5712.2	NUM
admet-1883	315	2	.	.	PUNCT
admet-1883	316	1	[	[	X
admet-1883	316	2	7	7	NUM
admet-1883	316	3	]	]	PUNCT
admet-1883	316	4	a.	a.	NOUN
admet-1883	316	5	tharayil	tharayil	PROPN
admet-1883	316	6	,	,	PUNCT
admet-1883	316	7	r.	r.	PROPN
admet-1883	316	8	rajakumari	rajakumari	PROPN
admet-1883	316	9	,	,	PUNCT
admet-1883	316	10	a.	a.	PROPN
admet-1883	316	11	kumar	kumar	PROPN
admet-1883	316	12	,	,	PUNCT
admet-1883	316	13	m.d	m.d	PROPN
admet-1883	316	14	.	.	PROPN
admet-1883	316	15	choudhary	choudhary	PROPN
admet-1883	316	16	,	,	PUNCT
admet-1883	316	17	p.	p.	PROPN
admet-1883	316	18	palit	palit	NOUN
admet-1883	316	19	,	,	PUNCT
admet-1883	316	20	s.	s.	PROPN
admet-1883	316	21	thomas	thomas	PROPN
admet-1883	316	22	.	.	PUNCT
admet-1883	317	1	new	new	ADJ
admet-1883	317	2	insights	insight	NOUN
admet-1883	317	3	into	into	ADP
admet-1883	317	4	application	application	NOUN
admet-1883	317	5	of	of	ADP
admet-1883	317	6	nanoparticles	nanoparticle	NOUN
admet-1883	317	7	in	in	ADP
admet-1883	317	8	the	the	DET
admet-1883	317	9	diagnosis	diagnosis	NOUN
admet-1883	317	10	and	and	CCONJ
admet-1883	317	11	screening	screening	NOUN
admet-1883	317	12	of	of	ADP
admet-1883	317	13	novel	novel	ADJ
admet-1883	317	14	coronavirus	coronavirus	NOUN
admet-1883	317	15	(	(	PUNCT
admet-1883	317	16	sars	sar	NOUN
admet-1883	317	17	-	-	PUNCT
admet-1883	317	18	cov-2	cov-2	NOUN
admet-1883	317	19	)	)	PUNCT
admet-1883	317	20	.	.	PUNCT
admet-1883	318	1	emergent	emergent	ADJ
admet-1883	318	2	materials	material	NOUN
admet-1883	318	3	4	4	NUM
admet-1883	318	4	(	(	PUNCT
admet-1883	318	5	2021	2021	NUM
admet-1883	318	6	)	)	PUNCT
admet-1883	318	7	101	101	NUM
admet-1883	318	8	-	-	SYM
admet-1883	318	9	117	117	NUM
admet-1883	318	10	.	.	PUNCT
admet-1883	319	1	https://doi.org/10.1007/s42247-021-00182-w	https://doi.org/10.1007/s42247-021-00182-w	NOUN
admet-1883	319	2	.	.	PUNCT
admet-1883	320	1	[	[	X
admet-1883	320	2	8	8	NUM
admet-1883	320	3	]	]	X
admet-1883	320	4	p.	p.	NOUN
admet-1883	320	5	parthasarathy	parthasarathy	PROPN
admet-1883	320	6	,	,	PUNCT
admet-1883	320	7	s.	s.	PROPN
admet-1883	320	8	vivekanandan	vivekanandan	PROPN
admet-1883	320	9	.	.	PUNCT
admet-1883	321	1	an	an	DET
admet-1883	321	2	extensive	extensive	ADJ
admet-1883	321	3	study	study	NOUN
admet-1883	321	4	on	on	ADP
admet-1883	321	5	the	the	DET
admet-1883	321	6	covid-19	covid-19	PROPN
admet-1883	321	7	pandemic	pandemic	NOUN
admet-1883	321	8	,	,	PUNCT
admet-1883	321	9	an	an	DET
admet-1883	321	10	emerging	emerge	VERB
admet-1883	321	11	global	global	ADJ
admet-1883	321	12	crisis	crisis	NOUN
admet-1883	321	13	:	:	PUNCT
admet-1883	321	14	risks	risk	NOUN
admet-1883	321	15	,	,	PUNCT
admet-1883	321	16	transmission	transmission	NOUN
admet-1883	321	17	,	,	PUNCT
admet-1883	321	18	impacts	impact	NOUN
admet-1883	321	19	and	and	CCONJ
admet-1883	321	20	mitigation	mitigation	NOUN
admet-1883	321	21	.	.	PUNCT
admet-1883	322	1	journal	journal	NOUN
admet-1883	322	2	of	of	ADP
admet-1883	322	3	infection	infection	NOUN
admet-1883	322	4	and	and	CCONJ
admet-1883	322	5	public	public	ADJ
admet-1883	322	6	health	health	NOUN
admet-1883	322	7	14	14	NUM
admet-1883	322	8	(	(	PUNCT
admet-1883	322	9	2021	2021	NUM
admet-1883	322	10	)	)	PUNCT
admet-1883	322	11	249	249	NUM
admet-1883	322	12	-	-	SYM
admet-1883	322	13	259	259	NUM
admet-1883	322	14	.	.	PUNCT
admet-1883	323	1	https://doi.org/10.1016/j.jiph.2020.12.020	https://doi.org/10.1016/j.jiph.2020.12.020	NOUN
admet-1883	323	2	.	.	PUNCT
admet-1883	324	1	[	[	X
admet-1883	324	2	9	9	NUM
admet-1883	324	3	]	]	X
admet-1883	324	4	y.	y.	PROPN
admet-1883	324	5	fan	fan	PROPN
admet-1883	324	6	,	,	PUNCT
admet-1883	324	7	k.	k.	PROPN
admet-1883	324	8	zhao	zhao	PROPN
admet-1883	324	9	,	,	PUNCT
admet-1883	324	10	z.-l	z.-l	PROPN
admet-1883	324	11	.	.	PUNCT
admet-1883	325	1	shi	shi	PROPN
admet-1883	325	2	,	,	PUNCT
admet-1883	325	3	p.	p.	PROPN
admet-1883	325	4	zhou	zhou	PROPN
admet-1883	325	5	.	.	PUNCT
admet-1883	326	1	bat	bat	NOUN
admet-1883	326	2	coronaviruses	coronaviruse	NOUN
admet-1883	326	3	in	in	ADP
admet-1883	326	4	china	china	PROPN
admet-1883	326	5	.	.	PUNCT
admet-1883	327	1	viruses	virus	NOUN
admet-1883	327	2	11	11	NUM
admet-1883	327	3	(	(	PUNCT
admet-1883	327	4	2019	2019	NUM
admet-1883	327	5	)	)	PUNCT
admet-1883	327	6	210	210	NUM
admet-1883	327	7	.	.	PUNCT
admet-1883	328	1	https://doi.org/	https://doi.org/	VERB
admet-1883	328	2	10.3390	10.3390	NUM
admet-1883	328	3	/	/	SYM
admet-1883	328	4	v11030210	v11030210	NOUN
admet-1883	328	5	.	.	PUNCT
admet-1883	329	1	https://doi.org/10.5599/admet.1883	https://doi.org/10.5599/admet.1883	PROPN
admet-1883	329	2	https://doi.org/‌10.1007/s10311-022-01418-9	https://doi.org/‌10.1007/s10311-022-01418-9	PRON
admet-1883	329	3	https://doi.org/‌10.1007/s10311-022-01418-9	https://doi.org/‌10.1007/s10311-022-01418-9	ADJ
admet-1883	329	4	https://doi.org/10.1007/s126‌68-022-01000-1	https://doi.org/10.1007/s126‌68-022-01000-1	PROPN
admet-1883	329	5	https://doi.org/10.1007/s126‌68-022-01000-1	https://doi.org/10.1007/s126‌68-022-01000-1	PROPN
admet-1883	329	6	https://doi.org/10.1039/‌d3ra01052j	https://doi.org/10.1039/‌d3ra01052j	PROPN
admet-1883	329	7	https://doi.org/10.1039/‌d3ra01052j	https://doi.org/10.1039/‌d3ra01052j	VERB
admet-1883	329	8	https://doi.org/10.1111/ajd.13295	https://doi.org/10.1111/ajd.13295	ADJ
admet-1883	329	9	https://doi.org/10.1002/adfm.202301007	https://doi.org/10.1002/adfm.202301007	ADJ
admet-1883	329	10	https://doi.org/10.32598/jams.23.cov.5712.2	https://doi.org/10.32598/jams.23.cov.5712.2	NUM
admet-1883	329	11	https://doi.org/10.1007/s42247-021-00182-w	https://doi.org/10.1007/s42247-021-00182-w	NOUN
admet-1883	329	12	https://doi.org/10.1016/j.jiph.2020.12.020	https://doi.org/10.1016/j.jiph.2020.12.020	PRON
admet-1883	329	13	https://doi.org/‌10.3390/v11030210	https://doi.org/‌10.3390/v11030210	PROPN
admet-1883	329	14	https://doi.org/‌10.3390/v11030210	https://doi.org/‌10.3390/v11030210	PROPN
admet-1883	329	15	p.	p.	PROPN
admet-1883	329	16	pallavi	pallavi	VERB
admet-1883	329	17	et	et	PROPN
admet-1883	329	18	al	al	PROPN
admet-1883	329	19	.	.	PROPN
admet-1883	329	20	admet	admet	PROPN
admet-1883	329	21	&	&	CCONJ
admet-1883	329	22	dmpk	dmpk	PROPN
admet-1883	329	23	11(4	11(4	NUM
admet-1883	329	24	)	)	PUNCT
admet-1883	329	25	(	(	PUNCT
admet-1883	329	26	2023	2023	NUM
admet-1883	329	27	)	)	PUNCT
admet-1883	329	28	513	513	NUM
admet-1883	329	29	-	-	SYM
admet-1883	329	30	531	531	NUM
admet-1883	329	31	526	526	NUM
admet-1883	330	1	[	[	SYM
admet-1883	330	2	10	10	NUM
admet-1883	330	3	]	]	PUNCT
admet-1883	330	4	ss	ss	NOUN
admet-1883	330	5	bandyopadhyay	bandyopadhyay	NOUN
admet-1883	330	6	,	,	PUNCT
admet-1883	330	7	a.k	a.k	PROPN
admet-1883	330	8	.	.	PROPN
admet-1883	330	9	halder	halder	PROPN
admet-1883	330	10	,	,	PUNCT
admet-1883	330	11	s.	s.	PROPN
admet-1883	330	12	saha	saha	PROPN
admet-1883	330	13	,	,	PUNCT
admet-1883	330	14	p.	p.	PROPN
admet-1883	330	15	chatterjee	chatterjee	PROPN
admet-1883	330	16	,	,	PUNCT
admet-1883	330	17	m.	m.	NOUN
admet-1883	330	18	nasipuri	nasipuri	PROPN
admet-1883	330	19	,	,	PUNCT
admet-1883	330	20	s.	s.	PROPN
admet-1883	330	21	basu	basu	PROPN
admet-1883	330	22	.	.	PROPN
admet-1883	331	1	assessment	assessment	NOUN
admet-1883	331	2	of	of	ADP
admet-1883	331	3	go	go	NOUN
admet-1883	331	4	-	-	PUNCT
admet-1883	331	5	based	base	VERB
admet-1883	331	6	protein	protein	NOUN
admet-1883	331	7	interaction	interaction	NOUN
admet-1883	331	8	affinities	affinity	NOUN
admet-1883	331	9	in	in	ADP
admet-1883	331	10	the	the	DET
admet-1883	331	11	large	large	ADJ
admet-1883	331	12	-	-	PUNCT
admet-1883	331	13	scale	scale	NOUN
admet-1883	331	14	human	human	ADJ
admet-1883	331	15	–	–	PUNCT
admet-1883	331	16	coronavirus	coronavirus	NOUN
admet-1883	331	17	family	family	NOUN
admet-1883	331	18	interactome	interactome	NOUN
admet-1883	331	19	.	.	PUNCT
admet-1883	332	1	vaccines	vaccine	NOUN
admet-1883	332	2	11	11	NUM
admet-1883	332	3	(	(	PUNCT
admet-1883	332	4	2023	2023	NUM
admet-1883	332	5	)	)	PUNCT
admet-1883	332	6	549	549	NUM
admet-1883	332	7	.	.	PUNCT
admet-1883	332	8	https://doi.org/10.3390/vaccines11030549	https://doi.org/10.3390/vaccines11030549	PROPN
admet-1883	332	9	.	.	PUNCT
admet-1883	333	1	[	[	X
admet-1883	333	2	11	11	NUM
admet-1883	333	3	]	]	X
admet-1883	333	4	a.s	a.s	PROPN
admet-1883	333	5	.	.	PROPN
admet-1883	333	6	ray	ray	PROPN
admet-1883	333	7	,	,	PUNCT
admet-1883	333	8	k.	k.	PROPN
admet-1883	333	9	bhattacharya	bhattacharya	PROPN
admet-1883	333	10	.	.	PUNCT
admet-1883	334	1	an	an	DET
admet-1883	334	2	overview	overview	NOUN
admet-1883	334	3	on	on	ADP
admet-1883	334	4	the	the	DET
admet-1883	334	5	zoonotic	zoonotic	ADJ
admet-1883	334	6	aspects	aspect	NOUN
admet-1883	334	7	of	of	ADP
admet-1883	334	8	covid-19	covid-19	PROPN
admet-1883	334	9	.	.	PUNCT
admet-1883	335	1	proceedings	proceeding	NOUN
admet-1883	335	2	of	of	ADP
admet-1883	335	3	the	the	DET
admet-1883	335	4	national	national	PROPN
admet-1883	335	5	academy	academy	PROPN
admet-1883	335	6	of	of	ADP
admet-1883	335	7	sciences	sciences	PROPN
admet-1883	335	8	,	,	PUNCT
admet-1883	335	9	india	india	PROPN
admet-1883	335	10	section	section	PROPN
admet-1883	335	11	b	b	PROPN
admet-1883	335	12	:	:	PUNCT
admet-1883	335	13	biological	biological	ADJ
admet-1883	335	14	sciences	science	NOUN
admet-1883	335	15	(	(	PUNCT
admet-1883	335	16	2023	2023	NUM
admet-1883	335	17	)	)	PUNCT
admet-1883	335	18	1	1	NUM
admet-1883	335	19	-	-	SYM
admet-1883	335	20	5	5	NUM
admet-1883	335	21	.	.	PUNCT
admet-1883	335	22	https://doi.org/	https://doi.org/	VERB
admet-1883	335	23	10.1007	10.1007	NUM
admet-1883	335	24	/	/	SYM
admet-1883	335	25	s40011	s40011	NOUN
admet-1883	335	26	-	-	PUNCT
admet-1883	335	27	023	023	NUM
admet-1883	335	28	-	-	PUNCT
admet-1883	335	29	01445	01445	NUM
admet-1883	335	30	-	-	SYM
admet-1883	335	31	8	8	NUM
admet-1883	335	32	.	.	PUNCT
admet-1883	336	1	[	[	X
admet-1883	336	2	12	12	NUM
admet-1883	336	3	]	]	X
admet-1883	336	4	b.	b.	PROPN
admet-1883	336	5	lou	lou	PROPN
admet-1883	336	6	,	,	PUNCT
admet-1883	336	7	t.-d	t.-d	PROPN
admet-1883	336	8	.	.	PUNCT
admet-1883	337	1	li	li	PROPN
admet-1883	337	2	,	,	PUNCT
admet-1883	337	3	s.-f	s.-f	PROPN
admet-1883	337	4	.	.	PUNCT
admet-1883	338	1	zheng	zheng	PROPN
admet-1883	338	2	,	,	PUNCT
admet-1883	338	3	y.-y	y.-y	PROPN
admet-1883	338	4	.	.	PUNCT
admet-1883	339	1	su	su	PROPN
admet-1883	339	2	,	,	PUNCT
admet-1883	339	3	z.-y	z.-y	NOUN
admet-1883	339	4	.	.	PUNCT
admet-1883	340	1	li	li	PROPN
admet-1883	340	2	,	,	PUNCT
admet-1883	340	3	w.	w.	PROPN
admet-1883	340	4	liu	liu	PROPN
admet-1883	340	5	,	,	PUNCT
admet-1883	340	6	f.	f.	PROPN
admet-1883	340	7	yu	yu	PROPN
admet-1883	340	8	,	,	PUNCT
admet-1883	340	9	s.-x	s.-x	NOUN
admet-1883	340	10	.	.	PUNCT
admet-1883	341	1	ge	ge	PROPN
admet-1883	341	2	,	,	PUNCT
admet-1883	341	3	q.-d	q.-d	PROPN
admet-1883	341	4	.	.	PUNCT
admet-1883	342	1	zou	zou	PROPN
admet-1883	342	2	,	,	PUNCT
admet-1883	342	3	q.	q.	PROPN
admet-1883	342	4	yuan	yuan	PROPN
admet-1883	342	5	.	.	PUNCT
admet-1883	343	1	serology	serology	NOUN
admet-1883	343	2	characteristics	characteristic	NOUN
admet-1883	343	3	of	of	ADP
admet-1883	343	4	sars	sar	NOUN
admet-1883	343	5	-	-	PUNCT
admet-1883	343	6	cov-2	cov-2	NOUN
admet-1883	343	7	infection	infection	NOUN
admet-1883	343	8	after	after	ADP
admet-1883	343	9	exposure	exposure	NOUN
admet-1883	343	10	and	and	CCONJ
admet-1883	343	11	post	post	ADJ
admet-1883	343	12	-	-	ADJ
admet-1883	343	13	symptom	symptom	ADJ
admet-1883	343	14	onset	onset	NOUN
admet-1883	343	15	.	.	PUNCT
admet-1883	344	1	european	european	ADJ
admet-1883	344	2	respiratory	respiratory	ADJ
admet-1883	344	3	journal	journal	NOUN
admet-1883	344	4	56	56	NUM
admet-1883	344	5	(	(	PUNCT
admet-1883	344	6	2020	2020	NUM
admet-1883	344	7	)	)	PUNCT
admet-1883	344	8	.	.	PUNCT
admet-1883	345	1	https://doi.org/10.1183/13993003.00763-2020	https://doi.org/10.1183/13993003.00763-2020	X
admet-1883	345	2	.	.	PUNCT
admet-1883	346	1	[	[	X
admet-1883	346	2	13	13	NUM
admet-1883	346	3	]	]	SYM
admet-1883	346	4	g.m	g.m	PROPN
admet-1883	346	5	.	.	PROPN
admet-1883	346	6	vahey	vahey	PROPN
admet-1883	346	7	,	,	PUNCT
admet-1883	346	8	k.e	k.e	PROPN
admet-1883	346	9	.	.	PROPN
admet-1883	346	10	marshall	marshall	PROPN
admet-1883	346	11	,	,	PUNCT
admet-1883	346	12	e.	e.	PROPN
admet-1883	346	13	mcdonald	mcdonald	PROPN
admet-1883	346	14	,	,	PUNCT
admet-1883	346	15	s.w	s.w	PROPN
admet-1883	346	16	.	.	PROPN
admet-1883	346	17	martin	martin	PROPN
admet-1883	346	18	,	,	PUNCT
admet-1883	346	19	j.e	j.e	PROPN
admet-1883	346	20	.	.	PROPN
admet-1883	346	21	tate	tate	PROPN
admet-1883	346	22	,	,	PUNCT
admet-1883	346	23	c.m	c.m	PROPN
admet-1883	346	24	.	.	PROPN
admet-1883	346	25	midgley	midgley	PROPN
admet-1883	346	26	,	,	PUNCT
admet-1883	346	27	m.e	m.e	PROPN
admet-1883	346	28	.	.	PROPN
admet-1883	346	29	killerby	killerby	PROPN
admet-1883	346	30	,	,	PUNCT
admet-1883	346	31	b.	b.	PROPN
admet-1883	346	32	kawasaki	kawasaki	PROPN
admet-1883	346	33	,	,	PUNCT
admet-1883	346	34	r.k	r.k	PROPN
admet-1883	346	35	.	.	PROPN
admet-1883	346	36	herlihy	herlihy	PROPN
admet-1883	346	37	,	,	PUNCT
admet-1883	346	38	n.b	n.b	PROPN
admet-1883	346	39	.	.	PROPN
admet-1883	346	40	alden	alden	PROPN
admet-1883	346	41	.	.	PUNCT
admet-1883	347	1	symptom	symptom	NOUN
admet-1883	347	2	profiles	profile	NOUN
admet-1883	347	3	and	and	CCONJ
admet-1883	347	4	progression	progression	NOUN
admet-1883	347	5	in	in	ADP
admet-1883	347	6	hospitalized	hospitalize	VERB
admet-1883	347	7	and	and	CCONJ
admet-1883	347	8	nonhospitalized	nonhospitalize	VERB
admet-1883	347	9	patients	patient	NOUN
admet-1883	347	10	with	with	ADP
admet-1883	347	11	coronavirus	coronavirus	NOUN
admet-1883	347	12	disease	disease	NOUN
admet-1883	347	13	,	,	PUNCT
admet-1883	347	14	colorado	colorado	PROPN
admet-1883	347	15	,	,	PUNCT
admet-1883	347	16	usa	usa	PROPN
admet-1883	347	17	,	,	PUNCT
admet-1883	347	18	2020	2020	NUM
admet-1883	347	19	.	.	PUNCT
admet-1883	348	1	emerging	emerge	VERB
admet-1883	348	2	infectious	infectious	ADJ
admet-1883	348	3	diseases	disease	NOUN
admet-1883	348	4	27	27	NUM
admet-1883	348	5	(	(	PUNCT
admet-1883	348	6	2021	2021	NUM
admet-1883	348	7	)	)	PUNCT
admet-1883	348	8	385	385	NUM
admet-1883	348	9	.	.	PUNCT
admet-1883	349	1	https://doi.org/10.3201/eid2702.203729	https://doi.org/10.3201/eid2702.203729	X
admet-1883	349	2	.	.	PUNCT
admet-1883	350	1	[	[	X
admet-1883	350	2	14	14	NUM
admet-1883	350	3	]	]	X
admet-1883	350	4	e.a	e.a	PROPN
admet-1883	350	5	.	.	PROPN
admet-1883	350	6	meyerowitz	meyerowitz	PROPN
admet-1883	350	7	,	,	PUNCT
admet-1883	350	8	a.	a.	NOUN
admet-1883	350	9	richterman	richterman	PROPN
admet-1883	350	10	,	,	PUNCT
admet-1883	350	11	i.i	i.i	PROPN
admet-1883	350	12	.	.	PROPN
admet-1883	350	13	bogoch	bogoch	PROPN
admet-1883	350	14	,	,	PUNCT
admet-1883	350	15	n.	n.	NOUN
admet-1883	350	16	low	low	PROPN
admet-1883	350	17	,	,	PUNCT
admet-1883	350	18	m.	m.	NOUN
admet-1883	350	19	cevik	cevik	NOUN
admet-1883	350	20	.	.	PUNCT
admet-1883	351	1	towards	towards	ADP
admet-1883	351	2	an	an	DET
admet-1883	351	3	accurate	accurate	ADJ
admet-1883	351	4	and	and	CCONJ
admet-1883	351	5	systematic	systematic	ADJ
admet-1883	351	6	characterisation	characterisation	NOUN
admet-1883	351	7	of	of	ADP
admet-1883	351	8	persistently	persistently	ADV
admet-1883	351	9	asymptomatic	asymptomatic	ADJ
admet-1883	351	10	infection	infection	NOUN
admet-1883	351	11	with	with	ADP
admet-1883	351	12	sars	sar	NOUN
admet-1883	351	13	-	-	PUNCT
admet-1883	351	14	cov-2	cov-2	NOUN
admet-1883	351	15	.	.	PUNCT
admet-1883	352	1	the	the	DET
admet-1883	352	2	lancet	lancet	ADJ
admet-1883	352	3	infectious	infectious	ADJ
admet-1883	352	4	diseases	disease	NOUN
admet-1883	352	5	21	21	NUM
admet-1883	352	6	(	(	PUNCT
admet-1883	352	7	2021	2021	NUM
admet-1883	352	8	)	)	PUNCT
admet-1883	352	9	e163	e163	PROPN
admet-1883	352	10	-	-	PUNCT
admet-1883	352	11	e169	e169	PROPN
admet-1883	352	12	.	.	PUNCT
admet-1883	352	13	https://doi.org/10.1016/s1473-3099(20)30837-9	https://doi.org/10.1016/s1473-3099(20)30837-9	NOUN
admet-1883	352	14	.	.	PUNCT
admet-1883	353	1	[	[	X
admet-1883	353	2	15	15	NUM
admet-1883	353	3	]	]	X
admet-1883	353	4	j.a	j.a	PROPN
admet-1883	353	5	.	.	PROPN
admet-1883	353	6	siordia	siordia	PROPN
admet-1883	353	7	,	,	PUNCT
admet-1883	353	8	m.	m.	NOUN
admet-1883	353	9	bernaba	bernaba	PROPN
admet-1883	353	10	,	,	PUNCT
admet-1883	353	11	k.	k.	PROPN
admet-1883	353	12	yoshino	yoshino	PROPN
admet-1883	353	13	,	,	PUNCT
admet-1883	353	14	a.	a.	NOUN
admet-1883	353	15	ulhaque	ulhaque	NOUN
admet-1883	353	16	,	,	PUNCT
admet-1883	353	17	s.	s.	PROPN
admet-1883	353	18	kumar	kumar	PROPN
admet-1883	353	19	,	,	PUNCT
admet-1883	353	20	m.	m.	PROPN
admet-1883	353	21	bernaba	bernaba	PROPN
admet-1883	353	22	,	,	PUNCT
admet-1883	353	23	e.	e.	PROPN
admet-1883	353	24	bergin	bergin	PROPN
admet-1883	353	25	.	.	PUNCT
admet-1883	354	1	systematic	systematic	ADJ
admet-1883	354	2	and	and	CCONJ
admet-1883	354	3	statistical	statistical	ADJ
admet-1883	354	4	review	review	NOUN
admet-1883	354	5	of	of	ADP
admet-1883	354	6	coronavirus	coronavirus	NOUN
admet-1883	354	7	disease	disease	NOUN
admet-1883	354	8	19	19	NUM
admet-1883	354	9	treatment	treatment	NOUN
admet-1883	354	10	trials	trial	NOUN
admet-1883	354	11	.	.	PUNCT
admet-1883	355	1	sn	sn	PROPN
admet-1883	355	2	comprehensive	comprehensive	ADJ
admet-1883	355	3	clinical	clinical	ADJ
admet-1883	355	4	medicine	medicine	NOUN
admet-1883	355	5	2	2	NUM
admet-1883	355	6	(	(	PUNCT
admet-1883	355	7	2020	2020	NUM
admet-1883	355	8	)	)	PUNCT
admet-1883	355	9	1120	1120	NUM
admet-1883	355	10	-	-	SYM
admet-1883	355	11	1131	1131	NUM
admet-1883	355	12	.	.	PUNCT
admet-1883	355	13	https://doi.org/10.1007/s42399-020-00399-6	https://doi.org/10.1007/s42399-020-00399-6	NUM
admet-1883	355	14	.	.	PUNCT
admet-1883	356	1	[	[	X
admet-1883	356	2	16	16	NUM
admet-1883	356	3	]	]	PUNCT
admet-1883	356	4	m.	m.	NOUN
admet-1883	356	5	hossen	hossen	PROPN
admet-1883	356	6	,	,	PUNCT
admet-1883	356	7	m.a	m.a	PROPN
admet-1883	356	8	.	.	PROPN
admet-1883	356	9	barek	barek	PROPN
admet-1883	356	10	,	,	PUNCT
admet-1883	356	11	n.	n.	PROPN
admet-1883	356	12	jahan	jahan	PROPN
admet-1883	356	13	,	,	PUNCT
admet-1883	356	14	m.	m.	PROPN
admet-1883	356	15	safiqul	safiqul	PROPN
admet-1883	356	16	islam	islam	PROPN
admet-1883	356	17	.	.	PUNCT
admet-1883	357	1	a	a	DET
admet-1883	357	2	review	review	NOUN
admet-1883	357	3	on	on	ADP
admet-1883	357	4	current	current	ADJ
admet-1883	357	5	repurposing	repurpose	VERB
admet-1883	357	6	drugs	drug	NOUN
admet-1883	357	7	for	for	ADP
admet-1883	357	8	the	the	DET
admet-1883	357	9	treatment	treatment	NOUN
admet-1883	357	10	of	of	ADP
admet-1883	357	11	covid-19	covid-19	PROPN
admet-1883	357	12	:	:	PUNCT
admet-1883	357	13	reality	reality	NOUN
admet-1883	357	14	and	and	CCONJ
admet-1883	357	15	challenges	challenge	NOUN
admet-1883	357	16	.	.	PUNCT
admet-1883	358	1	sn	sn	PROPN
admet-1883	358	2	comprehensive	comprehensive	ADJ
admet-1883	358	3	clinical	clinical	ADJ
admet-1883	358	4	medicine	medicine	NOUN
admet-1883	358	5	2	2	NUM
admet-1883	358	6	(	(	PUNCT
admet-1883	358	7	2020	2020	NUM
admet-1883	358	8	)	)	PUNCT
admet-1883	358	9	17771789	17771789	NUM
admet-1883	358	10	.	.	PUNCT
admet-1883	359	1	https://doi.org/10.1007/s42399-020-00485-9	https://doi.org/10.1007/s42399-020-00485-9	X
admet-1883	359	2	.	.	PUNCT
admet-1883	360	1	[	[	X
admet-1883	360	2	17	17	NUM
admet-1883	360	3	]	]	PUNCT
admet-1883	360	4	p.	p.	NOUN
admet-1883	360	5	pagliano	pagliano	PROPN
admet-1883	360	6	,	,	PUNCT
admet-1883	360	7	g.	g.	PROPN
admet-1883	360	8	scarpati	scarpati	PROPN
admet-1883	360	9	,	,	PUNCT
admet-1883	360	10	c.	c.	PROPN
admet-1883	360	11	sellitto	sellitto	PROPN
admet-1883	360	12	,	,	PUNCT
admet-1883	360	13	v.	v.	PROPN
admet-1883	360	14	conti	conti	PROPN
admet-1883	360	15	,	,	PUNCT
admet-1883	360	16	a.m.	a.m.	PROPN
admet-1883	360	17	spera	spera	PROPN
admet-1883	360	18	,	,	PUNCT
admet-1883	360	19	t.	t.	NOUN
admet-1883	360	20	ascione	ascione	NOUN
admet-1883	360	21	,	,	PUNCT
admet-1883	360	22	o.	o.	PROPN
admet-1883	360	23	piazza	piazza	NOUN
admet-1883	360	24	,	,	PUNCT
admet-1883	360	25	a.	a.	PROPN
admet-1883	360	26	filippelli	filippelli	PROPN
admet-1883	360	27	.	.	PUNCT
admet-1883	361	1	experimental	experimental	ADJ
admet-1883	361	2	pharmacotherapy	pharmacotherapy	NOUN
admet-1883	361	3	for	for	ADP
admet-1883	361	4	covid-19	covid-19	PROPN
admet-1883	361	5	:	:	PUNCT
admet-1883	361	6	the	the	DET
admet-1883	361	7	latest	late	ADJ
admet-1883	361	8	advances	advance	NOUN
admet-1883	361	9	.	.	PUNCT
admet-1883	362	1	journal	journal	NOUN
admet-1883	362	2	of	of	ADP
admet-1883	362	3	experimental	experimental	ADJ
admet-1883	362	4	pharmacology	pharmacology	NOUN
admet-1883	362	5	13	13	NUM
admet-1883	362	6	(	(	PUNCT
admet-1883	362	7	2021	2021	NUM
admet-1883	362	8	)	)	PUNCT
admet-1883	362	9	1	1	NUM
admet-1883	362	10	.	.	PUNCT
admet-1883	363	1	https://doi.org/10.2147/jep.s255209	https://doi.org/10.2147/jep.s255209	NOUN
admet-1883	363	2	.	.	PUNCT
admet-1883	364	1	[	[	X
admet-1883	364	2	18	18	NUM
admet-1883	364	3	]	]	X
admet-1883	364	4	g.j	g.j	PROPN
admet-1883	364	5	.	.	PROPN
admet-1883	364	6	soufi	soufi	PROPN
admet-1883	364	7	,	,	PUNCT
admet-1883	364	8	a.	a.	NOUN
admet-1883	364	9	hekmatnia	hekmatnia	NOUN
admet-1883	364	10	,	,	PUNCT
admet-1883	364	11	m.	m.	NOUN
admet-1883	364	12	nasrollahzadeh	nasrollahzadeh	PROPN
admet-1883	364	13	,	,	PUNCT
admet-1883	364	14	n.	n.	PROPN
admet-1883	364	15	shafiei	shafiei	PROPN
admet-1883	364	16	,	,	PUNCT
admet-1883	364	17	m.	m.	NOUN
admet-1883	364	18	sajjadi	sajjadi	NOUN
admet-1883	364	19	,	,	PUNCT
admet-1883	364	20	p.	p.	NOUN
admet-1883	364	21	iravani	iravani	PROPN
admet-1883	364	22	,	,	PUNCT
admet-1883	364	23	s.	s.	PROPN
admet-1883	364	24	fallah	fallah	PROPN
admet-1883	364	25	,	,	PUNCT
admet-1883	364	26	s.	s.	PROPN
admet-1883	364	27	iravani	iravani	PROPN
admet-1883	364	28	,	,	PUNCT
admet-1883	364	29	r.s	r.s	PROPN
admet-1883	364	30	.	.	PROPN
admet-1883	364	31	varma	varma	PROPN
admet-1883	364	32	.	.	PUNCT
admet-1883	365	1	sars	sars	PROPN
admet-1883	365	2	-	-	PUNCT
admet-1883	365	3	cov-2	cov-2	PART
admet-1883	365	4	(	(	PUNCT
admet-1883	365	5	covid-19	covid-19	PROPN
admet-1883	365	6	):	):	PUNCT
admet-1883	365	7	new	new	ADJ
admet-1883	365	8	discoveries	discovery	NOUN
admet-1883	365	9	and	and	CCONJ
admet-1883	365	10	current	current	ADJ
admet-1883	365	11	challenges	challenge	NOUN
admet-1883	365	12	.	.	PUNCT
admet-1883	366	1	applied	apply	VERB
admet-1883	366	2	sciences	science	NOUN
admet-1883	366	3	10	10	NUM
admet-1883	366	4	(	(	PUNCT
admet-1883	366	5	2020	2020	NUM
admet-1883	366	6	)	)	PUNCT
admet-1883	366	7	3641	3641	NUM
admet-1883	366	8	.	.	PUNCT
admet-1883	367	1	https://doi.org/10.3390/app10103641	https://doi.org/10.3390/app10103641	PROPN
admet-1883	367	2	.	.	PUNCT
admet-1883	368	1	[	[	X
admet-1883	368	2	19	19	NUM
admet-1883	368	3	]	]	X
admet-1883	368	4	r.	r.	PROPN
admet-1883	368	5	ranjbar	ranjbar	PROPN
admet-1883	368	6	,	,	PUNCT
admet-1883	368	7	h.	h.	PROPN
admet-1883	368	8	mahmoodzadeh	mahmoodzadeh	PROPN
admet-1883	368	9	hosseini	hosseini	PROPN
admet-1883	368	10	,	,	PUNCT
admet-1883	368	11	f.	f.	PROPN
admet-1883	368	12	safarpoor	safarpoor	PROPN
admet-1883	368	13	dehkordi	dehkordi	PROPN
admet-1883	368	14	.	.	PUNCT
admet-1883	369	1	a	a	DET
admet-1883	369	2	review	review	NOUN
admet-1883	369	3	on	on	ADP
admet-1883	369	4	biochemical	biochemical	ADJ
admet-1883	369	5	and	and	CCONJ
admet-1883	369	6	immunological	immunological	ADJ
admet-1883	369	7	biomarkers	biomarker	NOUN
admet-1883	369	8	used	use	VERB
admet-1883	369	9	for	for	ADP
admet-1883	369	10	laboratory	laboratory	NOUN
admet-1883	369	11	diagnosis	diagnosis	NOUN
admet-1883	369	12	of	of	ADP
admet-1883	369	13	sars	sar	NOUN
admet-1883	369	14	-	-	PUNCT
admet-1883	369	15	cov-2	cov-2	PART
admet-1883	369	16	(	(	PUNCT
admet-1883	369	17	covid-19	covid-19	PROPN
admet-1883	369	18	)	)	PUNCT
admet-1883	369	19	.	.	PUNCT
admet-1883	370	1	the	the	DET
admet-1883	370	2	open	open	ADJ
admet-1883	370	3	microbiology	microbiology	NOUN
admet-1883	370	4	journal	journal	NOUN
admet-1883	370	5	14	14	NUM
admet-1883	370	6	(	(	PUNCT
admet-1883	370	7	2020	2020	NUM
admet-1883	370	8	)	)	PUNCT
admet-1883	370	9	.	.	PUNCT
admet-1883	371	1	https://doi.org/10.2174/1874434602014010290	https://doi.org/10.2174/1874434602014010290	X
admet-1883	371	2	.	.	PUNCT
admet-1883	372	1	[	[	X
admet-1883	372	2	20	20	NUM
admet-1883	372	3	]	]	X
admet-1883	372	4	y.	y.	PROPN
admet-1883	372	5	huang	huang	PROPN
admet-1883	372	6	,	,	PUNCT
admet-1883	372	7	c.	c.	PROPN
admet-1883	372	8	yang	yang	PROPN
admet-1883	372	9	,	,	PUNCT
admet-1883	372	10	x.-f	x.-f	PROPN
admet-1883	372	11	.	.	PUNCT
admet-1883	373	1	xu	xu	PROPN
admet-1883	373	2	,	,	PUNCT
admet-1883	373	3	w.	w.	PROPN
admet-1883	373	4	xu	xu	PROPN
admet-1883	373	5	,	,	PUNCT
admet-1883	373	6	s.-w	s.-w	PROPN
admet-1883	373	7	.	.	PUNCT
admet-1883	374	1	liu	liu	PROPN
admet-1883	374	2	.	.	PROPN
admet-1883	375	1	structural	structural	ADJ
admet-1883	375	2	and	and	CCONJ
admet-1883	375	3	functional	functional	ADJ
admet-1883	375	4	properties	property	NOUN
admet-1883	375	5	of	of	ADP
admet-1883	375	6	sars	sar	NOUN
admet-1883	375	7	-	-	PUNCT
admet-1883	375	8	cov-2	cov-2	NOUN
admet-1883	375	9	spike	spike	ADJ
admet-1883	375	10	protein	protein	NOUN
admet-1883	375	11	:	:	PUNCT
admet-1883	375	12	potential	potential	ADJ
admet-1883	375	13	antivirus	antivirus	NOUN
admet-1883	375	14	drug	drug	NOUN
admet-1883	375	15	development	development	NOUN
admet-1883	375	16	for	for	ADP
admet-1883	375	17	covid-19	covid-19	PROPN
admet-1883	375	18	.	.	PUNCT
admet-1883	375	19	acta	acta	PROPN
admet-1883	375	20	pharmacologica	pharmacologica	PROPN
admet-1883	375	21	sinica	sinica	PROPN
admet-1883	375	22	41	41	NUM
admet-1883	375	23	(	(	PUNCT
admet-1883	375	24	2020	2020	NUM
admet-1883	375	25	)	)	PUNCT
admet-1883	375	26	1141	1141	NUM
admet-1883	375	27	-	-	SYM
admet-1883	375	28	1149	1149	NUM
admet-1883	375	29	.	.	PUNCT
admet-1883	376	1	https://doi.org/10.1038/s41401-020-0485-4	https://doi.org/10.1038/s41401-020-0485-4	NUM
admet-1883	376	2	.	.	PUNCT
admet-1883	377	1	[	[	X
admet-1883	377	2	21	21	NUM
admet-1883	377	3	]	]	X
admet-1883	377	4	c.r	c.r	PROPN
admet-1883	377	5	.	.	PROPN
admet-1883	377	6	carlson	carlson	PROPN
admet-1883	377	7	,	,	PUNCT
admet-1883	377	8	j.b	j.b	PROPN
admet-1883	377	9	.	.	PROPN
admet-1883	377	10	asfaha	asfaha	PROPN
admet-1883	377	11	,	,	PUNCT
admet-1883	377	12	c.m	c.m	PROPN
admet-1883	377	13	.	.	PROPN
admet-1883	377	14	ghent	ghent	PROPN
admet-1883	377	15	,	,	PUNCT
admet-1883	377	16	c.j	c.j	PROPN
admet-1883	377	17	.	.	PROPN
admet-1883	377	18	howard	howard	PROPN
admet-1883	377	19	,	,	PUNCT
admet-1883	377	20	n.	n.	PROPN
admet-1883	377	21	hartooni	hartooni	PROPN
admet-1883	377	22	,	,	PUNCT
admet-1883	377	23	m.	m.	NOUN
admet-1883	377	24	safari	safari	NOUN
admet-1883	377	25	,	,	PUNCT
admet-1883	377	26	a.d	a.d	PROPN
admet-1883	377	27	.	.	PROPN
admet-1883	377	28	frankel	frankel	PROPN
admet-1883	377	29	,	,	PUNCT
admet-1883	377	30	d.o	d.o	PROPN
admet-1883	377	31	.	.	PROPN
admet-1883	377	32	morgan	morgan	PROPN
admet-1883	377	33	.	.	PROPN
admet-1883	378	1	phosphoregulation	phosphoregulation	NOUN
admet-1883	378	2	of	of	ADP
admet-1883	378	3	phase	phase	NOUN
admet-1883	378	4	separation	separation	NOUN
admet-1883	378	5	by	by	ADP
admet-1883	378	6	the	the	DET
admet-1883	378	7	sars	sar	NOUN
admet-1883	378	8	-	-	PUNCT
admet-1883	378	9	cov-2	cov-2	NOUN
admet-1883	378	10	n	n	PRON
admet-1883	378	11	protein	protein	NOUN
admet-1883	378	12	suggests	suggest	VERB
admet-1883	378	13	a	a	DET
admet-1883	378	14	biophysical	biophysical	ADJ
admet-1883	378	15	basis	basis	NOUN
admet-1883	378	16	for	for	ADP
admet-1883	378	17	its	its	PRON
admet-1883	378	18	dual	dual	ADJ
admet-1883	378	19	functions	function	NOUN
admet-1883	378	20	.	.	PUNCT
admet-1883	379	1	molecular	molecular	ADJ
admet-1883	379	2	cell	cell	NOUN
admet-1883	379	3	80	80	NUM
admet-1883	379	4	(	(	PUNCT
admet-1883	379	5	2020	2020	NUM
admet-1883	379	6	)	)	PUNCT
admet-1883	379	7	1092	1092	NUM
admet-1883	379	8	-	-	SYM
admet-1883	379	9	1103	1103	NUM
admet-1883	379	10	.	.	PUNCT
admet-1883	380	1	e1094	e1094	ADJ
admet-1883	380	2	.	.	PUNCT
admet-1883	381	1	https://doi.org/10.1016/j.mol	https://doi.org/10.1016/j.mol	PROPN
admet-1883	381	2	cel.2020.11.025	cel.2020.11.025	PROPN
admet-1883	381	3	.	.	PUNCT
admet-1883	382	1	[	[	X
admet-1883	382	2	22	22	NUM
admet-1883	382	3	]	]	X
admet-1883	382	4	j.	j.	PROPN
admet-1883	382	5	w	w	PROPN
admet-1883	382	6	schott	schott	PROPN
admet-1883	382	7	,	,	PUNCT
admet-1883	382	8	m.	m.	NOUN
admet-1883	382	9	galla	galla	PROPN
admet-1883	382	10	,	,	PUNCT
admet-1883	382	11	t.	t.	PROPN
admet-1883	382	12	godinho	godinho	PROPN
admet-1883	382	13	,	,	PUNCT
admet-1883	382	14	c.	c.	PROPN
admet-1883	382	15	baum	baum	PROPN
admet-1883	382	16	,	,	PUNCT
admet-1883	382	17	a.	a.	PROPN
admet-1883	382	18	schambach	schambach	PROPN
admet-1883	382	19	.	.	PUNCT
admet-1883	383	1	viral	viral	ADJ
admet-1883	383	2	and	and	CCONJ
admet-1883	383	3	non	non	ADJ
admet-1883	383	4	-	-	ADJ
admet-1883	383	5	viral	viral	ADJ
admet-1883	383	6	approaches	approach	NOUN
admet-1883	383	7	for	for	ADP
admet-1883	383	8	transient	transient	ADJ
admet-1883	383	9	delivery	delivery	NOUN
admet-1883	383	10	of	of	ADP
admet-1883	383	11	mrna	mrna	NOUN
admet-1883	383	12	and	and	CCONJ
admet-1883	383	13	proteins	protein	NOUN
admet-1883	383	14	.	.	PUNCT
admet-1883	384	1	current	current	ADJ
admet-1883	384	2	gene	gene	NOUN
admet-1883	384	3	therapy	therapy	NOUN
admet-1883	384	4	11	11	NUM
admet-1883	384	5	(	(	PUNCT
admet-1883	384	6	2011	2011	NUM
admet-1883	384	7	)	)	PUNCT
admet-1883	384	8	382	382	NUM
admet-1883	384	9	-	-	SYM
admet-1883	384	10	398	398	NUM
admet-1883	384	11	.	.	PUNCT
admet-1883	385	1	https://doi.org/10.2174/	https://doi.org/10.2174/	PROPN
admet-1883	385	2	156652311797415872	156652311797415872	NUM
admet-1883	385	3	.	.	PUNCT
admet-1883	386	1	[	[	X
admet-1883	386	2	23	23	NUM
admet-1883	386	3	]	]	PUNCT
admet-1883	386	4	t.	t.	PROPN
admet-1883	386	5	velikova	velikova	PROPN
admet-1883	386	6	,	,	PUNCT
admet-1883	386	7	t.	t.	PROPN
admet-1883	386	8	georgiev	georgiev	PROPN
admet-1883	386	9	.	.	PUNCT
admet-1883	387	1	sars	sars	PROPN
admet-1883	387	2	-	-	PUNCT
admet-1883	387	3	cov-2	cov-2	NOUN
admet-1883	387	4	vaccines	vaccine	NOUN
admet-1883	387	5	and	and	CCONJ
admet-1883	387	6	autoimmune	autoimmune	ADJ
admet-1883	387	7	diseases	disease	NOUN
admet-1883	387	8	amidst	amidst	ADP
admet-1883	387	9	the	the	DET
admet-1883	387	10	covid-19	covid-19	PROPN
admet-1883	387	11	crisis	crisis	NOUN
admet-1883	387	12	.	.	PUNCT
admet-1883	388	1	rheumatology	rheumatology	NOUN
admet-1883	388	2	international	international	PROPN
admet-1883	388	3	41	41	NUM
admet-1883	388	4	(	(	PUNCT
admet-1883	388	5	2021	2021	NUM
admet-1883	388	6	)	)	PUNCT
admet-1883	388	7	509	509	NUM
admet-1883	388	8	-	-	SYM
admet-1883	388	9	518	518	NUM
admet-1883	388	10	.	.	PUNCT
admet-1883	389	1	https://doi.org/10.1007/s00296-021-04792-9	https://doi.org/10.1007/s00296-021-04792-9	NOUN
admet-1883	389	2	.	.	PUNCT
admet-1883	390	1	[	[	X
admet-1883	390	2	24	24	NUM
admet-1883	390	3	]	]	PUNCT
admet-1883	390	4	y.-f	y.-f	PROPN
admet-1883	390	5	.	.	PUNCT
admet-1883	391	1	tu	tu	PROPN
admet-1883	391	2	,	,	PUNCT
admet-1883	391	3	c.-s	c.-	NOUN
admet-1883	391	4	.	.	PUNCT
admet-1883	392	1	chien	chien	PROPN
admet-1883	392	2	,	,	PUNCT
admet-1883	392	3	a.a	a.a	PROPN
admet-1883	392	4	.	.	PROPN
admet-1883	392	5	yarmishyn	yarmishyn	PROPN
admet-1883	392	6	,	,	PUNCT
admet-1883	392	7	y.-y	y.-y	NOUN
admet-1883	392	8	.	.	PUNCT
admet-1883	393	1	lin	lin	PROPN
admet-1883	393	2	,	,	PUNCT
admet-1883	393	3	y.-h	y.-h	PROPN
admet-1883	393	4	.	.	PUNCT
admet-1883	394	1	luo	luo	PROPN
admet-1883	394	2	,	,	PUNCT
admet-1883	394	3	y.-t	y.-t	NOUN
admet-1883	394	4	.	.	PUNCT
admet-1883	395	1	lin	lin	PROPN
admet-1883	395	2	,	,	PUNCT
admet-1883	395	3	w.-y	w.-y	NOUN
admet-1883	395	4	.	.	PUNCT
admet-1883	396	1	lai	lai	PROPN
admet-1883	396	2	,	,	PUNCT
admet-1883	396	3	d.-m	d.-m	PROPN
admet-1883	396	4	.	.	PUNCT
admet-1883	397	1	yang	yang	PROPN
admet-1883	397	2	,	,	PUNCT
admet-1883	397	3	s.-j	s.-j	PROPN
admet-1883	397	4	.	.	PUNCT
admet-1883	398	1	chou	chou	PROPN
admet-1883	398	2	,	,	PUNCT
admet-1883	398	3	y.p	y.p	PROPN
admet-1883	398	4	.	.	PROPN
admet-1883	398	5	yang	yang	PROPN
admet-1883	398	6	.	.	PUNCT
admet-1883	399	1	a	a	DET
admet-1883	399	2	review	review	NOUN
admet-1883	399	3	of	of	ADP
admet-1883	399	4	sars	sar	NOUN
admet-1883	399	5	-	-	PUNCT
admet-1883	399	6	cov-2	cov-2	NOUN
admet-1883	399	7	and	and	CCONJ
admet-1883	399	8	the	the	DET
admet-1883	399	9	ongoing	ongoing	ADJ
admet-1883	399	10	clinical	clinical	ADJ
admet-1883	399	11	trials	trial	NOUN
admet-1883	399	12	.	.	PUNCT
admet-1883	400	1	international	international	ADJ
admet-1883	400	2	journal	journal	NOUN
admet-1883	400	3	of	of	ADP
admet-1883	400	4	molecular	molecular	ADJ
admet-1883	400	5	sciences	science	NOUN
admet-1883	400	6	21	21	NUM
admet-1883	400	7	(	(	PUNCT
admet-1883	400	8	2020	2020	NUM
admet-1883	400	9	)	)	PUNCT
admet-1883	400	10	2657	2657	NUM
admet-1883	400	11	.	.	PUNCT
admet-1883	401	1	https://doi.org/10.3390/ijms21072657	https://doi.org/10.3390/ijms21072657	PROPN
admet-1883	401	2	.	.	PUNCT
admet-1883	402	1	[	[	X
admet-1883	402	2	25	25	NUM
admet-1883	402	3	]	]	X
admet-1883	402	4	f.	f.	PROPN
admet-1883	402	5	oroojalian	oroojalian	PROPN
admet-1883	402	6	,	,	PUNCT
admet-1883	402	7	a.	a.	NOUN
admet-1883	402	8	haghbin	haghbin	PROPN
admet-1883	402	9	,	,	PUNCT
admet-1883	402	10	b.	b.	PROPN
admet-1883	402	11	baradaran	baradaran	PROPN
admet-1883	402	12	,	,	PUNCT
admet-1883	402	13	n.	n.	PROPN
admet-1883	402	14	hemmat	hemmat	PROPN
admet-1883	402	15	,	,	PUNCT
admet-1883	402	16	m.-a	m.-a	NOUN
admet-1883	402	17	.	.	PUNCT
admet-1883	403	1	shahbazi	shahbazi	PROPN
admet-1883	403	2	,	,	PUNCT
admet-1883	403	3	h.b	h.b	PROPN
admet-1883	403	4	.	.	PROPN
admet-1883	403	5	baghi	baghi	PROPN
admet-1883	403	6	,	,	PUNCT
admet-1883	403	7	a.	a.	NOUN
admet-1883	403	8	mokhtarzadeh	mokhtarzadeh	PROPN
admet-1883	403	9	,	,	PUNCT
admet-1883	403	10	m.r	m.r	PROPN
admet-1883	403	11	.	.	PROPN
admet-1883	403	12	hamblin	hamblin	PROPN
admet-1883	403	13	.	.	PUNCT
admet-1883	404	1	novel	novel	ADJ
admet-1883	404	2	insights	insight	NOUN
admet-1883	404	3	into	into	ADP
admet-1883	404	4	the	the	DET
admet-1883	404	5	treatment	treatment	NOUN
admet-1883	404	6	of	of	ADP
admet-1883	404	7	sars	sar	NOUN
admet-1883	404	8	-	-	PUNCT
admet-1883	404	9	cov-2	cov-2	PART
admet-1883	404	10	infection	infection	NOUN
admet-1883	404	11	:	:	PUNCT
admet-1883	404	12	an	an	DET
admet-1883	404	13	overview	overview	NOUN
admet-1883	404	14	of	of	ADP
admet-1883	404	15	current	current	ADJ
admet-1883	404	16	clinical	clinical	ADJ
admet-1883	404	17	trials	trial	NOUN
admet-1883	404	18	.	.	PUNCT
admet-1883	405	1	international	international	ADJ
admet-1883	405	2	journal	journal	NOUN
admet-1883	405	3	of	of	ADP
admet-1883	405	4	biological	biological	ADJ
admet-1883	405	5	macromolecules	macromolecule	NOUN
admet-1883	405	6	165	165	NUM
admet-1883	405	7	(	(	PUNCT
admet-1883	405	8	2020	2020	NUM
admet-1883	405	9	)	)	PUNCT
admet-1883	405	10	18	18	NUM
admet-1883	405	11	-	-	SYM
admet-1883	405	12	43	43	NUM
admet-1883	405	13	.	.	PUNCT
admet-1883	406	1	https://doi.org/10.1016/j.ijbiomac.2020.09.204	https://doi.org/10.1016/j.ijbiomac.2020.09.204	NUM
admet-1883	406	2	.	.	PUNCT
admet-1883	407	1	https://doi.org/10.3390/vaccines11030549	https://doi.org/10.3390/vaccines11030549	VERB
admet-1883	407	2	https://doi.org/‌10.1007/s40011-023-01445-8	https://doi.org/‌10.1007/s40011-023-01445-8	ADV
admet-1883	407	3	https://doi.org/‌10.1007/s40011-023-01445-8	https://doi.org/‌10.1007/s40011-023-01445-8	ADJ
admet-1883	407	4	https://doi.org/10.1183/13993003.00763-2020	https://doi.org/10.1183/13993003.00763-2020	X
admet-1883	407	5	https://doi.org/10.3201/eid2702.203729	https://doi.org/10.3201/eid2702.203729	VERB
admet-1883	407	6	https://doi.org/10.1016/s1473-3099(20)30837-9	https://doi.org/10.1016/s1473-3099(20)30837-9	NOUN
admet-1883	407	7	https://doi.org/10.1007/s42399-020-00399-6	https://doi.org/10.1007/s42399-020-00399-6	NUM
admet-1883	407	8	https://doi.org/10.1007/s42399-020-00485-9	https://doi.org/10.1007/s42399-020-00485-9	NUM
admet-1883	407	9	https://doi.org/10.2147/jep.s255209	https://doi.org/10.2147/jep.s255209	NUM
admet-1883	407	10	https://doi.org/10.3390/app10103641	https://doi.org/10.3390/app10103641	PROPN
admet-1883	407	11	https://doi.org/10.2174/1874434602014010290	https://doi.org/10.2174/1874434602014010290	X
admet-1883	407	12	https://doi.org/10.1038/s41401-020-0485-4	https://doi.org/10.1038/s41401-020-0485-4	NUM
admet-1883	407	13	https://doi.org/10.1016/j.mol‌cel.2020.11.025	https://doi.org/10.1016/j.mol‌cel.2020.11.025	PRON
admet-1883	407	14	https://doi.org/10.1016/j.mol‌cel.2020.11.025	https://doi.org/10.1016/j.mol‌cel.2020.11.025	X
admet-1883	407	15	https://doi.org/10.2174/‌156652311797415872	https://doi.org/10.2174/‌156652311797415872	VERB
admet-1883	407	16	https://doi.org/10.2174/‌156652311797415872	https://doi.org/10.2174/‌156652311797415872	PRON
admet-1883	407	17	https://doi.org/10.1007/s00296-021-04792-9	https://doi.org/10.1007/s00296-021-04792-9	PROPN
admet-1883	407	18	https://doi.org/10.3390/ijms21072657	https://doi.org/10.3390/ijms21072657	PROPN
admet-1883	407	19	https://doi.org/10.1016/j.ijbiomac.2020.09.204	https://doi.org/10.1016/j.ijbiomac.2020.09.204	NUM
admet-1883	407	20	admet	admet	NOUN
admet-1883	407	21	&	&	CCONJ
admet-1883	407	22	dmpk	dmpk	PROPN
admet-1883	407	23	11(4	11(4	NUM
admet-1883	407	24	)	)	PUNCT
admet-1883	407	25	(	(	PUNCT
admet-1883	407	26	2023	2023	NUM
admet-1883	407	27	)	)	PUNCT
admet-1883	407	28	513	513	NUM
admet-1883	407	29	-	-	SYM
admet-1883	407	30	531	531	NUM
admet-1883	407	31	infections	infection	NOUN
admet-1883	407	32	associated	associate	VERB
admet-1883	407	33	with	with	ADP
admet-1883	407	34	sars	sar	NOUN
admet-1883	407	35	-	-	PUNCT
admet-1883	407	36	cov-2	cov-2	PART
admet-1883	407	37	exploited	exploit	VERB
admet-1883	407	38	via	via	ADP
admet-1883	407	39	photodynamic	photodynamic	ADJ
admet-1883	407	40	therapy	therapy	NOUN
admet-1883	407	41	doi	doi	NOUN
admet-1883	407	42	:	:	PUNCT
admet-1883	407	43	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-1883	407	44	t.1883	t.1883	VERB
admet-1883	407	45	527	527	NUM
admet-1883	408	1	[	[	X
admet-1883	408	2	26	26	NUM
admet-1883	408	3	]	]	PUNCT
admet-1883	408	4	l.	l.	PROPN
admet-1883	408	5	yan	yan	PROPN
admet-1883	408	6	,	,	PUNCT
admet-1883	408	7	y.	y.	PROPN
admet-1883	408	8	yang	yang	PROPN
admet-1883	408	9	,	,	PUNCT
admet-1883	408	10	m.	m.	PROPN
admet-1883	408	11	li	li	PROPN
admet-1883	408	12	,	,	PUNCT
admet-1883	408	13	y.	y.	PROPN
admet-1883	408	14	zhang	zhang	PROPN
admet-1883	408	15	,	,	PUNCT
admet-1883	408	16	l.	l.	PROPN
admet-1883	408	17	zheng	zheng	PROPN
admet-1883	408	18	,	,	PUNCT
admet-1883	408	19	j.	j.	PROPN
admet-1883	408	20	ge	ge	PROPN
admet-1883	408	21	,	,	PUNCT
admet-1883	408	22	y.c	y.c	PROPN
admet-1883	408	23	.	.	PROPN
admet-1883	408	24	huang	huang	PROPN
admet-1883	408	25	,	,	PUNCT
admet-1883	408	26	z.	z.	PROPN
admet-1883	408	27	liu	liu	PROPN
admet-1883	408	28	,	,	PUNCT
admet-1883	408	29	t.	t.	PROPN
admet-1883	408	30	wang	wang	PROPN
admet-1883	408	31	,	,	PUNCT
admet-1883	408	32	s.	s.	PROPN
admet-1883	408	33	gao	gao	PROPN
admet-1883	408	34	.	.	PUNCT
admet-1883	409	1	coupling	coupling	NOUN
admet-1883	409	2	of	of	ADP
admet-1883	409	3	n7methyltransferase	n7methyltransferase	NOUN
admet-1883	409	4	and	and	CCONJ
admet-1883	409	5	3′-5′	3′-5′	NUM
admet-1883	409	6	exoribonuclease	exoribonuclease	NOUN
admet-1883	409	7	with	with	ADP
admet-1883	409	8	sars	sar	NOUN
admet-1883	409	9	-	-	PUNCT
admet-1883	409	10	cov-2	cov-2	PART
admet-1883	409	11	polymerase	polymerase	NOUN
admet-1883	409	12	reveals	reveal	VERB
admet-1883	409	13	mechanisms	mechanism	NOUN
admet-1883	409	14	for	for	ADP
admet-1883	409	15	capping	capping	NOUN
admet-1883	409	16	and	and	CCONJ
admet-1883	409	17	proofreading	proofreading	NOUN
admet-1883	409	18	.	.	PUNCT
admet-1883	410	1	cell	cell	NOUN
admet-1883	410	2	184	184	NUM
admet-1883	410	3	(	(	PUNCT
admet-1883	410	4	2021	2021	NUM
admet-1883	410	5	)	)	PUNCT
admet-1883	410	6	3474	3474	NUM
admet-1883	410	7	-	-	SYM
admet-1883	410	8	3485	3485	NUM
admet-1883	410	9	.	.	PUNCT
admet-1883	411	1	e3411	e3411	VERB
admet-1883	411	2	.	.	PUNCT
admet-1883	412	1	https://doi.org/10.1016/j.cell.20	https://doi.org/10.1016/j.cell.20	PROPN
admet-1883	412	2	21.05.033	21.05.033	NUM
admet-1883	412	3	.	.	PUNCT
admet-1883	413	1	[	[	X
admet-1883	413	2	27	27	NUM
admet-1883	413	3	]	]	X
admet-1883	413	4	g.	g.	PROPN
admet-1883	413	5	freer	free	ADJ
admet-1883	413	6	,	,	PUNCT
admet-1883	413	7	m.	m.	NOUN
admet-1883	413	8	lai	lai	PROPN
admet-1883	413	9	,	,	PUNCT
admet-1883	413	10	p.	p.	PROPN
admet-1883	413	11	quaranta	quaranta	PROPN
admet-1883	413	12	,	,	PUNCT
admet-1883	413	13	p.g	p.g	PROPN
admet-1883	413	14	.	.	PROPN
admet-1883	413	15	spezia	spezia	PROPN
admet-1883	413	16	,	,	PUNCT
admet-1883	413	17	m.	m.	NOUN
admet-1883	413	18	pistello	pistello	PROPN
admet-1883	413	19	.	.	PUNCT
admet-1883	414	1	evolution	evolution	NOUN
admet-1883	414	2	of	of	ADP
admet-1883	414	3	viruses	virus	NOUN
admet-1883	414	4	and	and	CCONJ
admet-1883	414	5	the	the	DET
admet-1883	414	6	emergence	emergence	NOUN
admet-1883	414	7	of	of	ADP
admet-1883	414	8	sarscov-2	sarscov-2	NUM
admet-1883	414	9	variants	variant	NOUN
admet-1883	414	10	.	.	PUNCT
admet-1883	415	1	new	new	ADJ
admet-1883	415	2	microbiologica	microbiologica	PROPN
admet-1883	415	3	44	44	NUM
admet-1883	415	4	(	(	PUNCT
admet-1883	415	5	2021	2021	NUM
admet-1883	415	6	)	)	PUNCT
admet-1883	415	7	191	191	NUM
admet-1883	415	8	-	-	SYM
admet-1883	415	9	204	204	NUM
admet-1883	415	10	.	.	PUNCT
admet-1883	416	1	https://doi.org/europepmc.org/article/med/	https://doi.org/europepmc.org/article/med/	NUM
admet-1883	416	2	34942015	34942015	NUM
admet-1883	416	3	.	.	PUNCT
admet-1883	417	1	[	[	X
admet-1883	417	2	28	28	NUM
admet-1883	417	3	]	]	X
admet-1883	417	4	s.	s.	PROPN
admet-1883	417	5	qiu	qiu	PROPN
admet-1883	417	6	,	,	PUNCT
admet-1883	417	7	y.	y.	PROPN
admet-1883	417	8	hu	hu	PROPN
admet-1883	417	9	.	.	PROPN
admet-1883	417	10	are	be	AUX
admet-1883	417	11	covid-19	covid-19	PROPN
admet-1883	417	12	susceptibility	susceptibility	NOUN
admet-1883	417	13	genes	gene	NOUN
admet-1883	417	14	related	relate	VERB
admet-1883	417	15	to	to	ADP
admet-1883	417	16	lung	lung	NOUN
admet-1883	417	17	cancer	cancer	NOUN
admet-1883	417	18	?	?	PUNCT
admet-1883	418	1	journal	journal	NOUN
admet-1883	418	2	of	of	ADP
admet-1883	418	3	infection	infection	NOUN
admet-1883	418	4	83	83	NUM
admet-1883	418	5	(	(	PUNCT
admet-1883	418	6	2021	2021	NUM
admet-1883	418	7	)	)	PUNCT
admet-1883	418	8	607	607	NUM
admet-1883	418	9	-	-	SYM
admet-1883	418	10	635	635	NUM
admet-1883	418	11	.	.	PUNCT
admet-1883	419	1	https://doi.org/10.1016/j.jinf.2021.08.032	https://doi.org/10.1016/j.jinf.2021.08.032	NOUN
admet-1883	419	2	.	.	PUNCT
admet-1883	420	1	[	[	X
admet-1883	420	2	29	29	NUM
admet-1883	420	3	]	]	X
admet-1883	420	4	c.	c.	PROPN
admet-1883	420	5	karthika	karthika	PROPN
admet-1883	420	6	,	,	PUNCT
admet-1883	420	7	r.	r.	PROPN
admet-1883	420	8	swathy	swathy	PROPN
admet-1883	420	9	krishna	krishna	PROPN
admet-1883	420	10	,	,	PUNCT
admet-1883	420	11	m.	m.	PROPN
admet-1883	420	12	rahman	rahman	PROPN
admet-1883	420	13	,	,	PUNCT
admet-1883	420	14	r.	r.	PROPN
admet-1883	420	15	akter	akter	PROPN
admet-1883	420	16	,	,	PUNCT
admet-1883	420	17	d.	d.	PROPN
admet-1883	420	18	kaushik	kaushik	PROPN
admet-1883	420	19	.	.	PUNCT
admet-1883	421	1	covid-19	covid-19	PROPN
admet-1883	421	2	,	,	PUNCT
admet-1883	421	3	the	the	DET
admet-1883	421	4	firestone	firestone	PROPN
admet-1883	421	5	in	in	ADP
admet-1883	421	6	21st	21st	ADJ
admet-1883	421	7	century	century	NOUN
admet-1883	421	8	:	:	PUNCT
admet-1883	421	9	a	a	DET
admet-1883	421	10	review	review	NOUN
admet-1883	421	11	on	on	ADP
admet-1883	421	12	coronavirus	coronavirus	NOUN
admet-1883	421	13	disease	disease	NOUN
admet-1883	421	14	and	and	CCONJ
admet-1883	421	15	its	its	PRON
admet-1883	421	16	clinical	clinical	ADJ
admet-1883	421	17	perspectives	perspective	NOUN
admet-1883	421	18	.	.	PUNCT
admet-1883	422	1	environmental	environmental	ADJ
admet-1883	422	2	science	science	NOUN
admet-1883	422	3	and	and	CCONJ
admet-1883	422	4	pollution	pollution	NOUN
admet-1883	422	5	research	research	NOUN
admet-1883	422	6	28	28	NUM
admet-1883	422	7	(	(	PUNCT
admet-1883	422	8	2021	2021	NUM
admet-1883	422	9	)	)	PUNCT
admet-1883	422	10	64951	64951	NUM
admet-1883	422	11	-	-	SYM
admet-1883	422	12	64966	64966	NUM
admet-1883	422	13	.	.	PUNCT
admet-1883	423	1	https://doi.org/10.1007/s11356-021-16654-9	https://doi.org/10.1007/s11356-021-16654-9	NUM
admet-1883	423	2	.	.	PUNCT
admet-1883	424	1	[	[	X
admet-1883	424	2	30	30	NUM
admet-1883	424	3	]	]	PUNCT
admet-1883	424	4	m.	m.	NOUN
admet-1883	424	5	verdecia	verdecia	PROPN
admet-1883	424	6	,	,	PUNCT
admet-1883	424	7	j.f	j.f	PROPN
admet-1883	424	8	.	.	PROPN
admet-1883	424	9	kokai	kokai	PROPN
admet-1883	424	10	-	-	PUNCT
admet-1883	424	11	kun	kun	PROPN
admet-1883	424	12	,	,	PUNCT
admet-1883	424	13	m.	m.	NOUN
admet-1883	424	14	kibbey	kibbey	PROPN
admet-1883	424	15	,	,	PUNCT
admet-1883	424	16	s.	s.	PROPN
admet-1883	424	17	acharya	acharya	PROPN
admet-1883	424	18	,	,	PUNCT
admet-1883	424	19	j.	j.	PROPN
admet-1883	424	20	venema	venema	PROPN
admet-1883	424	21	,	,	PUNCT
admet-1883	424	22	f.	f.	PROPN
admet-1883	424	23	atouf	atouf	PROPN
admet-1883	424	24	.	.	PUNCT
admet-1883	425	1	covid-19	covid-19	PROPN
admet-1883	425	2	vaccine	vaccine	NOUN
admet-1883	425	3	platforms	platform	NOUN
admet-1883	425	4	:	:	PUNCT
admet-1883	425	5	delivering	deliver	VERB
admet-1883	425	6	on	on	ADP
admet-1883	425	7	a	a	DET
admet-1883	425	8	promise	promise	NOUN
admet-1883	425	9	?	?	PUNCT
admet-1883	426	1	human	human	ADJ
admet-1883	426	2	vaccines	vaccine	NOUN
admet-1883	426	3	&	&	CCONJ
admet-1883	426	4	immunotherapeutics	immunotherapeutics	PROPN
admet-1883	426	5	17	17	NUM
admet-1883	426	6	(	(	PUNCT
admet-1883	426	7	2021	2021	NUM
admet-1883	426	8	)	)	PUNCT
admet-1883	426	9	2873	2873	NUM
admet-1883	426	10	-	-	SYM
admet-1883	426	11	2893	2893	NUM
admet-1883	426	12	.	.	PUNCT
admet-1883	427	1	https://doi.org/10.1080/21645515.2021.1911204	https://doi.org/10.1080/21645515.2021.1911204	X
admet-1883	427	2	.	.	PUNCT
admet-1883	428	1	[	[	X
admet-1883	428	2	31	31	NUM
admet-1883	428	3	]	]	X
admet-1883	428	4	y.	y.	PROPN
admet-1883	428	5	li	li	PROPN
admet-1883	428	6	,	,	PUNCT
admet-1883	428	7	y.	y.	PROPN
admet-1883	428	8	bi	bi	PROPN
admet-1883	428	9	,	,	PUNCT
admet-1883	428	10	h.	h.	PROPN
admet-1883	428	11	xiao	xiao	PROPN
admet-1883	428	12	,	,	PUNCT
admet-1883	428	13	y.	y.	PROPN
admet-1883	428	14	yao	yao	PROPN
admet-1883	428	15	,	,	PUNCT
admet-1883	428	16	x.	x.	PROPN
admet-1883	428	17	liu	liu	PROPN
admet-1883	428	18	,	,	PUNCT
admet-1883	428	19	z.	z.	PROPN
admet-1883	428	20	hu	hu	PROPN
admet-1883	428	21	,	,	PUNCT
admet-1883	428	22	j.	j.	PROPN
admet-1883	428	23	duan	duan	PROPN
admet-1883	428	24	,	,	PUNCT
admet-1883	428	25	y.	y.	PROPN
admet-1883	428	26	yang	yang	PROPN
admet-1883	428	27	,	,	PUNCT
admet-1883	428	28	z.	z.	PROPN
admet-1883	428	29	li	li	PROPN
admet-1883	428	30	,	,	PUNCT
admet-1883	428	31	y.	y.	PROPN
admet-1883	428	32	li	li	PROPN
admet-1883	428	33	.	.	PUNCT
admet-1883	429	1	a	a	DET
admet-1883	429	2	novel	novel	ADJ
admet-1883	429	3	dna	dna	NOUN
admet-1883	429	4	and	and	CCONJ
admet-1883	429	5	protein	protein	NOUN
admet-1883	429	6	combination	combination	NOUN
admet-1883	429	7	covid-19	covid-19	PROPN
admet-1883	429	8	vaccine	vaccine	NOUN
admet-1883	429	9	formulation	formulation	NOUN
admet-1883	429	10	provides	provide	VERB
admet-1883	429	11	full	full	ADJ
admet-1883	429	12	protection	protection	NOUN
admet-1883	429	13	against	against	ADP
admet-1883	429	14	sars	sar	NOUN
admet-1883	429	15	-	-	PUNCT
admet-1883	429	16	cov-2	cov-2	NOUN
admet-1883	429	17	in	in	ADP
admet-1883	429	18	rhesus	rhesus	NOUN
admet-1883	429	19	macaques	macaque	NOUN
admet-1883	429	20	.	.	PUNCT
admet-1883	430	1	emerging	emerge	VERB
admet-1883	430	2	microbes	microbe	NOUN
admet-1883	430	3	&	&	CCONJ
admet-1883	430	4	infections	infection	NOUN
admet-1883	430	5	10	10	NUM
admet-1883	430	6	(	(	PUNCT
admet-1883	430	7	2021	2021	NUM
admet-1883	430	8	)	)	PUNCT
admet-1883	430	9	342	342	NUM
admet-1883	430	10	-	-	SYM
admet-1883	430	11	355	355	NUM
admet-1883	430	12	.	.	PUNCT
admet-1883	431	1	https://doi.org/10.1080/222217	https://doi.org/10.1080/222217	PROPN
admet-1883	431	2	51.2021.1887767	51.2021.1887767	NUM
admet-1883	431	3	.	.	PUNCT
admet-1883	432	1	[	[	X
admet-1883	432	2	32	32	NUM
admet-1883	432	3	]	]	X
admet-1883	432	4	y.b	y.b	PROPN
admet-1883	432	5	.	.	PROPN
admet-1883	432	6	seo	seo	PROPN
admet-1883	432	7	,	,	PUNCT
admet-1883	432	8	y.s	y.s	PROPN
admet-1883	432	9	.	.	PROPN
admet-1883	432	10	suh	suh	PROPN
admet-1883	432	11	,	,	PUNCT
admet-1883	432	12	j.i	j.i	PROPN
admet-1883	432	13	.	.	PROPN
admet-1883	432	14	ryu	ryu	PROPN
admet-1883	432	15	,	,	PUNCT
admet-1883	432	16	h.	h.	PROPN
admet-1883	432	17	jang	jang	PROPN
admet-1883	432	18	,	,	PUNCT
admet-1883	432	19	h.	h.	PROPN
admet-1883	432	20	oh	oh	INTJ
admet-1883	432	21	,	,	PUNCT
admet-1883	432	22	b.-s	b.-s	PROPN
admet-1883	432	23	.	.	PUNCT
admet-1883	432	24	koo	koo	NOUN
admet-1883	432	25	,	,	PUNCT
admet-1883	432	26	s.-h	s.-h	NOUN
admet-1883	432	27	.	.	PUNCT
admet-1883	433	1	seo	seo	PROPN
admet-1883	433	2	,	,	PUNCT
admet-1883	433	3	j.j	j.j	PROPN
admet-1883	433	4	.	.	PROPN
admet-1883	433	5	hong	hong	PROPN
admet-1883	433	6	,	,	PUNCT
admet-1883	433	7	m.	m.	NOUN
admet-1883	433	8	song	song	NOUN
admet-1883	433	9	,	,	PUNCT
admet-1883	433	10	s.-j	s.-j	PROPN
admet-1883	433	11	.	.	PUNCT
admet-1883	434	1	kim	kim	PROPN
admet-1883	434	2	.	.	PUNCT
admet-1883	435	1	soluble	soluble	ADJ
admet-1883	435	2	spike	spike	ADJ
admet-1883	435	3	dna	dna	NOUN
admet-1883	435	4	vaccine	vaccine	NOUN
admet-1883	435	5	provides	provide	VERB
admet-1883	435	6	long	long	ADJ
admet-1883	435	7	-	-	PUNCT
admet-1883	435	8	term	term	NOUN
admet-1883	435	9	protective	protective	ADJ
admet-1883	435	10	immunity	immunity	NOUN
admet-1883	435	11	against	against	ADP
admet-1883	435	12	sars	sar	NOUN
admet-1883	435	13	-	-	PUNCT
admet-1883	435	14	cov-2	cov-2	NOUN
admet-1883	435	15	in	in	ADP
admet-1883	435	16	mice	mouse	NOUN
admet-1883	435	17	and	and	CCONJ
admet-1883	435	18	nonhuman	nonhuman	ADJ
admet-1883	435	19	primates	primate	NOUN
admet-1883	435	20	.	.	PUNCT
admet-1883	436	1	vaccines	vaccine	NOUN
admet-1883	436	2	9	9	NUM
admet-1883	436	3	(	(	PUNCT
admet-1883	436	4	2021	2021	NUM
admet-1883	436	5	)	)	PUNCT
admet-1883	436	6	307	307	NUM
admet-1883	436	7	.	.	PUNCT
admet-1883	437	1	https://doi.org/10.3390/vaccines9040307	https://doi.org/10.3390/vaccines9040307	PROPN
admet-1883	437	2	.	.	PUNCT
admet-1883	438	1	[	[	X
admet-1883	438	2	33	33	NUM
admet-1883	438	3	]	]	PUNCT
admet-1883	438	4	b.	b.	PROPN
admet-1883	438	5	doroftei	doroftei	PROPN
admet-1883	438	6	,	,	PUNCT
admet-1883	438	7	a.	a.	NOUN
admet-1883	438	8	ciobica	ciobica	PROPN
admet-1883	438	9	,	,	PUNCT
admet-1883	438	10	o.-d	o.-d	PROPN
admet-1883	438	11	.	.	PUNCT
admet-1883	439	1	ilie	ilie	PROPN
admet-1883	439	2	,	,	PUNCT
admet-1883	439	3	r.	r.	PROPN
admet-1883	439	4	maftei	maftei	PROPN
admet-1883	439	5	,	,	PUNCT
admet-1883	439	6	c.	c.	PROPN
admet-1883	439	7	ilea	ilea	PROPN
admet-1883	439	8	.	.	PUNCT
admet-1883	440	1	mini	mini	NOUN
admet-1883	440	2	-	-	NOUN
admet-1883	440	3	review	review	NOUN
admet-1883	440	4	discussing	discuss	VERB
admet-1883	440	5	the	the	DET
admet-1883	440	6	reliability	reliability	NOUN
admet-1883	440	7	and	and	CCONJ
admet-1883	440	8	efficiency	efficiency	NOUN
admet-1883	440	9	of	of	ADP
admet-1883	440	10	covid-19	covid-19	PROPN
admet-1883	440	11	vaccines	vaccine	NOUN
admet-1883	440	12	.	.	PUNCT
admet-1883	441	1	diagnostics	diagnostic	NOUN
admet-1883	441	2	11	11	NUM
admet-1883	441	3	(	(	PUNCT
admet-1883	441	4	2021	2021	NUM
admet-1883	441	5	)	)	PUNCT
admet-1883	441	6	579	579	NUM
admet-1883	441	7	.	.	PUNCT
admet-1883	441	8	https://doi.org/10.3390/diagnostics11040579	https://doi.org/10.3390/diagnostics11040579	NOUN
admet-1883	441	9	.	.	PUNCT
admet-1883	442	1	[	[	X
admet-1883	442	2	34	34	NUM
admet-1883	442	3	]	]	X
admet-1883	442	4	p.	p.	NOUN
admet-1883	442	5	intapiboon	intapiboon	NOUN
admet-1883	442	6	,	,	PUNCT
admet-1883	442	7	p.	p.	PROPN
admet-1883	442	8	seepathomnarong	seepathomnarong	PROPN
admet-1883	442	9	,	,	PUNCT
admet-1883	442	10	j.	j.	PROPN
admet-1883	442	11	ongarj	ongarj	PROPN
admet-1883	442	12	,	,	PUNCT
admet-1883	442	13	s.	s.	PROPN
admet-1883	442	14	surasombatpattana	surasombatpattana	PROPN
admet-1883	442	15	,	,	PUNCT
admet-1883	442	16	s.	s.	PROPN
admet-1883	442	17	uppanisakorn	uppanisakorn	VERB
admet-1883	442	18	,	,	PUNCT
admet-1883	442	19	s.	s.	PROPN
admet-1883	442	20	mahasirimongkol	mahasirimongkol	PROPN
admet-1883	442	21	,	,	PUNCT
admet-1883	442	22	w.	w.	PROPN
admet-1883	442	23	sawaengdee	sawaengdee	PROPN
admet-1883	442	24	,	,	PUNCT
admet-1883	442	25	s.	s.	PROPN
admet-1883	442	26	phumiamorn	phumiamorn	PROPN
admet-1883	442	27	,	,	PUNCT
admet-1883	442	28	s.	s.	PROPN
admet-1883	442	29	sapsutthipas	sapsutthipas	PROPN
admet-1883	442	30	,	,	PUNCT
admet-1883	442	31	p.	p.	NOUN
admet-1883	442	32	sangsupawanich	sangsupawanich	PROPN
admet-1883	442	33	.	.	PUNCT
admet-1883	443	1	immunogenicity	immunogenicity	NOUN
admet-1883	443	2	and	and	CCONJ
admet-1883	443	3	safety	safety	NOUN
admet-1883	443	4	of	of	ADP
admet-1883	443	5	an	an	DET
admet-1883	443	6	intradermal	intradermal	ADJ
admet-1883	443	7	bnt162b2	bnt162b2	PROPN
admet-1883	443	8	mrna	mrna	PROPN
admet-1883	443	9	vaccine	vaccine	NOUN
admet-1883	443	10	booster	booster	NOUN
admet-1883	443	11	after	after	ADP
admet-1883	443	12	two	two	NUM
admet-1883	443	13	doses	dose	NOUN
admet-1883	443	14	of	of	ADP
admet-1883	443	15	inactivated	inactivated	ADJ
admet-1883	443	16	sars	sar	NOUN
admet-1883	443	17	-	-	PUNCT
admet-1883	443	18	cov-2	cov-2	NOUN
admet-1883	443	19	vaccine	vaccine	NOUN
admet-1883	443	20	in	in	ADP
admet-1883	443	21	healthy	healthy	ADJ
admet-1883	443	22	population	population	NOUN
admet-1883	443	23	.	.	PUNCT
admet-1883	444	1	vaccines	vaccine	NOUN
admet-1883	444	2	9	9	NUM
admet-1883	444	3	(	(	PUNCT
admet-1883	444	4	2021	2021	NUM
admet-1883	444	5	)	)	PUNCT
admet-1883	444	6	1375	1375	NUM
admet-1883	444	7	.	.	PUNCT
admet-1883	445	1	https://doi.org/10.3390/	https://doi.org/10.3390/	PROPN
admet-1883	445	2	vaccines9121375	vaccines9121375	PROPN
admet-1883	445	3	.	.	PUNCT
admet-1883	446	1	[	[	X
admet-1883	446	2	35	35	NUM
admet-1883	446	3	]	]	X
admet-1883	446	4	w.	w.	PROPN
admet-1883	446	5	ho	ho	PROPN
admet-1883	446	6	,	,	PUNCT
admet-1883	446	7	m.	m.	NOUN
admet-1883	446	8	gao	gao	PROPN
admet-1883	446	9	,	,	PUNCT
admet-1883	446	10	f.	f.	PROPN
admet-1883	446	11	li	li	PROPN
admet-1883	446	12	,	,	PUNCT
admet-1883	446	13	z.	z.	PROPN
admet-1883	446	14	li	li	PROPN
admet-1883	446	15	,	,	PUNCT
admet-1883	446	16	x.q	x.q	PROPN
admet-1883	446	17	.	.	PROPN
admet-1883	446	18	zhang	zhang	PROPN
admet-1883	446	19	,	,	PUNCT
admet-1883	446	20	x.	x.	PROPN
admet-1883	446	21	xu	xu	PROPN
admet-1883	446	22	.	.	PUNCT
admet-1883	447	1	next‐generation	next‐generation	NOUN
admet-1883	447	2	vaccines	vaccine	NOUN
admet-1883	447	3	:	:	PUNCT
admet-1883	447	4	nanoparticle‐mediated	nanoparticle‐mediate	VERB
admet-1883	447	5	dna	dna	PROPN
admet-1883	447	6	and	and	CCONJ
admet-1883	447	7	mrna	mrna	PROPN
admet-1883	447	8	delivery	delivery	NOUN
admet-1883	447	9	.	.	PUNCT
admet-1883	448	1	advanced	advanced	ADJ
admet-1883	448	2	healthcare	healthcare	NOUN
admet-1883	448	3	materials	material	NOUN
admet-1883	448	4	10	10	NUM
admet-1883	448	5	(	(	PUNCT
admet-1883	448	6	2021	2021	NUM
admet-1883	448	7	)	)	PUNCT
admet-1883	448	8	2001812	2001812	NUM
admet-1883	448	9	.	.	PUNCT
admet-1883	449	1	https://doi.org/	https://doi.org/	VERB
admet-1883	449	2	10.1002	10.1002	NUM
admet-1883	449	3	/	/	SYM
admet-1883	449	4	adhm.202001812	adhm.202001812	PROPN
admet-1883	449	5	.	.	PUNCT
admet-1883	450	1	[	[	X
admet-1883	450	2	36	36	NUM
admet-1883	450	3	]	]	X
admet-1883	450	4	s.s	s.s	PROPN
admet-1883	450	5	.	.	PROPN
admet-1883	450	6	rosa	rosa	PROPN
admet-1883	450	7	,	,	PUNCT
admet-1883	450	8	d.m	d.m	PROPN
admet-1883	450	9	.	.	PUNCT
admet-1883	450	10	prazeres	prazere	NOUN
admet-1883	450	11	,	,	PUNCT
admet-1883	450	12	a.m.	a.m.	PROPN
admet-1883	450	13	azevedo	azevedo	PROPN
admet-1883	450	14	,	,	PUNCT
admet-1883	450	15	m.p	m.p	PROPN
admet-1883	450	16	.	.	PROPN
admet-1883	450	17	marques	marques	PROPN
admet-1883	450	18	.	.	PUNCT
admet-1883	451	1	mrna	mrna	PROPN
admet-1883	451	2	vaccines	vaccine	NOUN
admet-1883	451	3	manufacturing	manufacturing	NOUN
admet-1883	451	4	:	:	PUNCT
admet-1883	451	5	challenges	challenge	NOUN
admet-1883	451	6	and	and	CCONJ
admet-1883	451	7	bottlenecks	bottleneck	NOUN
admet-1883	451	8	.	.	PUNCT
admet-1883	452	1	vaccine	vaccine	NOUN
admet-1883	452	2	39	39	NUM
admet-1883	452	3	(	(	PUNCT
admet-1883	452	4	2021	2021	NUM
admet-1883	452	5	)	)	PUNCT
admet-1883	452	6	2190	2190	NUM
admet-1883	452	7	-	-	SYM
admet-1883	452	8	2200	2200	NUM
admet-1883	452	9	.	.	PUNCT
admet-1883	453	1	https://doi.org/10.1016/j.vaccine.2021.03.038	https://doi.org/10.1016/j.vaccine.2021.03.038	PROPN
admet-1883	453	2	.	.	PUNCT
admet-1883	454	1	[	[	X
admet-1883	454	2	37	37	NUM
admet-1883	454	3	]	]	PUNCT
admet-1883	454	4	r.	r.	PROPN
admet-1883	454	5	yadav	yadav	PROPN
admet-1883	454	6	,	,	PUNCT
admet-1883	454	7	j.k	j.k	PROPN
admet-1883	454	8	.	.	PROPN
admet-1883	454	9	chaudhary	chaudhary	PROPN
admet-1883	454	10	,	,	PUNCT
admet-1883	454	11	n.	n.	PROPN
admet-1883	454	12	jain	jain	PROPN
admet-1883	454	13	,	,	PUNCT
admet-1883	454	14	p.k	p.k	PROPN
admet-1883	454	15	.	.	PROPN
admet-1883	454	16	chaudhary	chaudhary	PROPN
admet-1883	454	17	,	,	PUNCT
admet-1883	454	18	s.	s.	PROPN
admet-1883	454	19	khanra	khanra	PROPN
admet-1883	454	20	,	,	PUNCT
admet-1883	454	21	p.	p.	PROPN
admet-1883	454	22	dhamija	dhamija	PROPN
admet-1883	454	23	,	,	PUNCT
admet-1883	454	24	a.	a.	NOUN
admet-1883	454	25	sharma	sharma	PROPN
admet-1883	454	26	,	,	PUNCT
admet-1883	454	27	a.	a.	PROPN
admet-1883	454	28	kumar	kumar	PROPN
admet-1883	454	29	,	,	PUNCT
admet-1883	454	30	s.	s.	PROPN
admet-1883	454	31	handu	handu	PROPN
admet-1883	454	32	.	.	PUNCT
admet-1883	455	1	role	role	NOUN
admet-1883	455	2	of	of	ADP
admet-1883	455	3	structural	structural	ADJ
admet-1883	455	4	and	and	CCONJ
admet-1883	455	5	non	non	ADJ
admet-1883	455	6	-	-	ADJ
admet-1883	455	7	structural	structural	ADJ
admet-1883	455	8	proteins	protein	NOUN
admet-1883	455	9	and	and	CCONJ
admet-1883	455	10	therapeutic	therapeutic	ADJ
admet-1883	455	11	targets	target	NOUN
admet-1883	455	12	of	of	ADP
admet-1883	455	13	sars	sar	NOUN
admet-1883	455	14	-	-	PUNCT
admet-1883	455	15	cov-2	cov-2	NOUN
admet-1883	455	16	for	for	ADP
admet-1883	455	17	covid-19	covid-19	PROPN
admet-1883	455	18	.	.	PUNCT
admet-1883	456	1	cells	cell	NOUN
admet-1883	456	2	10	10	NUM
admet-1883	456	3	(	(	PUNCT
admet-1883	456	4	2021	2021	NUM
admet-1883	456	5	)	)	PUNCT
admet-1883	456	6	821	821	NUM
admet-1883	456	7	.	.	PUNCT
admet-1883	456	8	https://doi.org/10.3390/cells10040821	https://doi.org/10.3390/cells10040821	PROPN
admet-1883	456	9	.	.	PUNCT
admet-1883	457	1	[	[	X
admet-1883	457	2	38	38	NUM
admet-1883	457	3	]	]	X
admet-1883	457	4	y.	y.	PROPN
admet-1883	457	5	valdes	valde	NOUN
admet-1883	457	6	-	-	PUNCT
admet-1883	457	7	balbin	balbin	NOUN
admet-1883	457	8	,	,	PUNCT
admet-1883	457	9	d.	d.	PROPN
admet-1883	457	10	santana	santana	PROPN
admet-1883	457	11	-	-	PUNCT
admet-1883	457	12	mederos	medero	NOUN
admet-1883	457	13	,	,	PUNCT
admet-1883	457	14	f.	f.	PROPN
admet-1883	457	15	paquet	paquet	PROPN
admet-1883	457	16	,	,	PUNCT
admet-1883	457	17	s.	s.	PROPN
admet-1883	457	18	fernandez	fernandez	PROPN
admet-1883	457	19	,	,	PUNCT
admet-1883	457	20	y.	y.	PROPN
admet-1883	457	21	climent	climent	PROPN
admet-1883	457	22	,	,	PUNCT
admet-1883	457	23	f.	f.	PROPN
admet-1883	457	24	chiodo	chiodo	PROPN
admet-1883	457	25	,	,	PUNCT
admet-1883	457	26	l.	l.	PROPN
admet-1883	457	27	rodríguez	rodríguez	PROPN
admet-1883	457	28	,	,	PUNCT
admet-1883	457	29	b.	b.	PROPN
admet-1883	457	30	sanchez	sanchez	PROPN
admet-1883	457	31	ramirez	ramirez	PROPN
admet-1883	457	32	,	,	PUNCT
admet-1883	457	33	k.	k.	PROPN
admet-1883	457	34	leon	leon	PROPN
admet-1883	457	35	,	,	PUNCT
admet-1883	457	36	t.	t.	PROPN
admet-1883	457	37	hernandez	hernandez	PROPN
admet-1883	457	38	.	.	PUNCT
admet-1883	458	1	molecular	molecular	ADJ
admet-1883	458	2	aspects	aspect	NOUN
admet-1883	458	3	concerning	concern	VERB
admet-1883	458	4	the	the	DET
admet-1883	458	5	use	use	NOUN
admet-1883	458	6	of	of	ADP
admet-1883	458	7	the	the	DET
admet-1883	458	8	sars	sar	NOUN
admet-1883	458	9	-	-	PUNCT
admet-1883	458	10	cov-2	cov-2	NOUN
admet-1883	458	11	receptor	receptor	NOUN
admet-1883	458	12	binding	bind	VERB
admet-1883	458	13	domain	domain	NOUN
admet-1883	458	14	as	as	ADP
admet-1883	458	15	a	a	DET
admet-1883	458	16	target	target	NOUN
admet-1883	458	17	for	for	ADP
admet-1883	458	18	preventive	preventive	ADJ
admet-1883	458	19	vaccines	vaccine	NOUN
admet-1883	458	20	.	.	PUNCT
admet-1883	459	1	acs	acs	PROPN
admet-1883	459	2	central	central	ADJ
admet-1883	459	3	science	science	PROPN
admet-1883	459	4	7	7	NUM
admet-1883	459	5	(	(	PUNCT
admet-1883	459	6	2021	2021	NUM
admet-1883	459	7	)	)	PUNCT
admet-1883	459	8	757	757	PROPN
admet-1883	459	9	-	-	SYM
admet-1883	459	10	767	767	NUM
admet-1883	459	11	.	.	PUNCT
admet-1883	460	1	https://doi.org/10.1021/acscentsci.1c00216	https://doi.org/10.1021/acscentsci.1c00216	VERB
admet-1883	460	2	.	.	PUNCT
admet-1883	461	1	[	[	X
admet-1883	461	2	39	39	NUM
admet-1883	461	3	]	]	PUNCT
admet-1883	461	4	t.	t.	PROPN
admet-1883	461	5	li	li	PROPN
admet-1883	461	6	,	,	PUNCT
admet-1883	461	7	w.	w.	PROPN
admet-1883	461	8	xue	xue	PROPN
admet-1883	461	9	,	,	PUNCT
admet-1883	461	10	q.	q.	PROPN
admet-1883	461	11	zheng	zheng	PROPN
admet-1883	461	12	,	,	PUNCT
admet-1883	461	13	s.	s.	PROPN
admet-1883	461	14	song	song	PROPN
admet-1883	461	15	,	,	PUNCT
admet-1883	461	16	c.	c.	PROPN
admet-1883	461	17	yang	yang	PROPN
admet-1883	461	18	,	,	PUNCT
admet-1883	461	19	h.	h.	PROPN
admet-1883	461	20	xiong	xiong	PROPN
admet-1883	461	21	,	,	PUNCT
admet-1883	461	22	s.	s.	PROPN
admet-1883	461	23	zhang	zhang	PROPN
admet-1883	461	24	,	,	PUNCT
admet-1883	461	25	m.	m.	PROPN
admet-1883	461	26	hong	hong	PROPN
admet-1883	461	27	,	,	PUNCT
admet-1883	461	28	y.	y.	PROPN
admet-1883	461	29	zhang	zhang	PROPN
admet-1883	461	30	,	,	PUNCT
admet-1883	461	31	h.	h.	PROPN
admet-1883	461	32	yu	yu	PROPN
admet-1883	461	33	.	.	PUNCT
admet-1883	461	34	crossneutralizing	crossneutralize	VERB
admet-1883	461	35	antibodies	antibody	NOUN
admet-1883	461	36	bind	bind	VERB
admet-1883	461	37	a	a	DET
admet-1883	461	38	sars	sar	NOUN
admet-1883	461	39	-	-	PUNCT
admet-1883	461	40	cov-2	cov-2	NOUN
admet-1883	461	41	cryptic	cryptic	ADJ
admet-1883	461	42	site	site	NOUN
admet-1883	461	43	and	and	CCONJ
admet-1883	461	44	resist	resist	VERB
admet-1883	461	45	circulating	circulate	VERB
admet-1883	461	46	variants	variant	NOUN
admet-1883	461	47	.	.	PUNCT
admet-1883	462	1	nature	nature	NOUN
admet-1883	462	2	communications	communication	NOUN
admet-1883	462	3	12	12	NUM
admet-1883	462	4	(	(	PUNCT
admet-1883	462	5	2021	2021	NUM
admet-1883	462	6	)	)	PUNCT
admet-1883	462	7	1	1	NUM
admet-1883	462	8	-	-	SYM
admet-1883	462	9	12	12	NUM
admet-1883	462	10	.	.	PUNCT
admet-1883	463	1	https://doi.org/10.1038/s41467-021-25997-3	https://doi.org/10.1038/s41467-021-25997-3	NUM
admet-1883	463	2	.	.	PUNCT
admet-1883	464	1	[	[	X
admet-1883	464	2	40	40	NUM
admet-1883	464	3	]	]	X
admet-1883	464	4	n.	n.	PROPN
admet-1883	464	5	wang	wang	PROPN
admet-1883	464	6	,	,	PUNCT
admet-1883	464	7	y.	y.	PROPN
admet-1883	464	8	sun	sun	PROPN
admet-1883	464	9	,	,	PUNCT
admet-1883	464	10	r.	r.	PROPN
admet-1883	464	11	feng	feng	PROPN
admet-1883	464	12	,	,	PUNCT
admet-1883	464	13	y.	y.	PROPN
admet-1883	464	14	wang	wang	PROPN
admet-1883	464	15	,	,	PUNCT
admet-1883	464	16	y.	y.	PROPN
admet-1883	464	17	guo	guo	PROPN
admet-1883	464	18	,	,	PUNCT
admet-1883	464	19	l.	l.	PROPN
admet-1883	464	20	zhang	zhang	PROPN
admet-1883	464	21	,	,	PUNCT
admet-1883	464	22	y.-q	y.-q	PROPN
admet-1883	464	23	.	.	PUNCT
admet-1883	464	24	deng	deng	PROPN
admet-1883	464	25	,	,	PUNCT
admet-1883	464	26	l.	l.	PROPN
admet-1883	464	27	wang	wang	PROPN
admet-1883	464	28	,	,	PUNCT
admet-1883	464	29	z.	z.	PROPN
admet-1883	464	30	cui	cui	PROPN
admet-1883	464	31	,	,	PUNCT
admet-1883	464	32	l.	l.	PROPN
admet-1883	464	33	cao	cao	PROPN
admet-1883	464	34	.	.	PROPN
admet-1883	464	35	structurebased	structurebase	VERB
admet-1883	464	36	development	development	NOUN
admet-1883	464	37	of	of	ADP
admet-1883	464	38	human	human	ADJ
admet-1883	464	39	antibody	antibody	NOUN
admet-1883	464	40	cocktails	cocktail	NOUN
admet-1883	464	41	against	against	ADP
admet-1883	464	42	sars	sar	NOUN
admet-1883	464	43	-	-	PUNCT
admet-1883	464	44	cov-2	cov-2	NOUN
admet-1883	464	45	.	.	PUNCT
admet-1883	465	1	cell	cell	NOUN
admet-1883	465	2	research	research	NOUN
admet-1883	465	3	31	31	NUM
admet-1883	465	4	(	(	PUNCT
admet-1883	465	5	2021	2021	NUM
admet-1883	465	6	)	)	PUNCT
admet-1883	465	7	101103	101103	NUM
admet-1883	465	8	.	.	PUNCT
admet-1883	466	1	https://doi.org/10.1038/s41422-020-00446-w	https://doi.org/10.1038/s41422-020-00446-w	NOUN
admet-1883	466	2	.	.	PUNCT
admet-1883	467	1	[	[	X
admet-1883	467	2	41	41	NUM
admet-1883	467	3	]	]	PUNCT
admet-1883	467	4	z.	z.	PROPN
admet-1883	467	5	wu	wu	PROPN
admet-1883	467	6	,	,	PUNCT
admet-1883	467	7	t.	t.	PROPN
admet-1883	467	8	li	li	PROPN
admet-1883	467	9	.	.	PROPN
admet-1883	467	10	nanoparticle	nanoparticle	NOUN
admet-1883	467	11	-	-	PUNCT
admet-1883	467	12	mediated	mediate	VERB
admet-1883	467	13	cytoplasmic	cytoplasmic	ADJ
admet-1883	467	14	delivery	delivery	NOUN
admet-1883	467	15	of	of	ADP
admet-1883	467	16	messenger	messenger	NOUN
admet-1883	467	17	rna	rna	NOUN
admet-1883	467	18	vaccines	vaccine	NOUN
admet-1883	467	19	:	:	PUNCT
admet-1883	467	20	challenges	challenge	NOUN
admet-1883	467	21	and	and	CCONJ
admet-1883	467	22	future	future	ADJ
admet-1883	467	23	perspectives	perspective	NOUN
admet-1883	467	24	.	.	PUNCT
admet-1883	468	1	pharmaceutical	pharmaceutical	ADJ
admet-1883	468	2	research	research	NOUN
admet-1883	468	3	38	38	NUM
admet-1883	468	4	(	(	PUNCT
admet-1883	468	5	2021	2021	NUM
admet-1883	468	6	)	)	PUNCT
admet-1883	468	7	473	473	NUM
admet-1883	468	8	-	-	SYM
admet-1883	468	9	478	478	NUM
admet-1883	468	10	.	.	PUNCT
admet-1883	469	1	https://doi.org/10.1007/s11095021-03015-x	https://doi.org/10.1007/s11095021-03015-x	PROPN
admet-1883	469	2	.	.	PUNCT
admet-1883	470	1	https://doi.org/10.5599/admet.1883	https://doi.org/10.5599/admet.1883	PROPN
admet-1883	470	2	https://doi.org/10.1016/j.cell.20‌21.05.033	https://doi.org/10.1016/j.cell.20‌21.05.033	PROPN
admet-1883	470	3	https://doi.org/10.1016/j.cell.20‌21.05.033	https://doi.org/10.1016/j.cell.20‌21.05.033	PROPN
admet-1883	470	4	https://doi.org/europepmc.org/article/med/‌34942015	https://doi.org/europepmc.org/article/med/‌34942015	PROPN
admet-1883	470	5	https://doi.org/europepmc.org/article/med/‌34942015	https://doi.org/europepmc.org/article/med/‌34942015	PROPN
admet-1883	471	1	https://doi.org/10.1016/j.jinf.2021.08.032	https://doi.org/10.1016/j.jinf.2021.08.032	VERB
admet-1883	471	2	https://doi.org/10.1007/s11356-021-16654-9	https://doi.org/10.1007/s11356-021-16654-9	ADJ
admet-1883	471	3	https://doi.org/10.1080/21645515.2021.1911204	https://doi.org/10.1080/21645515.2021.1911204	PROPN
admet-1883	471	4	https://doi.org/10.1080/222217‌51.2021.1887767	https://doi.org/10.1080/222217‌51.2021.1887767	VERB
admet-1883	471	5	https://doi.org/10.1080/222217‌51.2021.1887767	https://doi.org/10.1080/222217‌51.2021.1887767	VERB
admet-1883	471	6	https://doi.org/10.3390/vaccines9040307	https://doi.org/10.3390/vaccines9040307	PROPN
admet-1883	471	7	https://doi.org/10.3390/diagnostics11040579	https://doi.org/10.3390/diagnostics11040579	PROPN
admet-1883	471	8	https://doi.org/10.3390/‌vaccines9121375	https://doi.org/10.3390/‌vaccines9121375	PROPN
admet-1883	471	9	https://doi.org/10.3390/‌vaccines9121375	https://doi.org/10.3390/‌vaccines9121375	PROPN
admet-1883	472	1	https://doi.org/‌10.1002/adhm.202001812	https://doi.org/‌10.1002/adhm.202001812	PROPN
admet-1883	472	2	https://doi.org/‌10.1002/adhm.202001812	https://doi.org/‌10.1002/adhm.202001812	PROPN
admet-1883	472	3	https://doi.org/10.1016/j.vaccine.2021.03.038	https://doi.org/10.1016/j.vaccine.2021.03.038	PROPN
admet-1883	472	4	https://doi.org/10.3390/cells10040821	https://doi.org/10.3390/cells10040821	NOUN
admet-1883	472	5	https://doi.org/10.1021/acscentsci.1c00216	https://doi.org/10.1021/acscentsci.1c00216	NOUN
admet-1883	472	6	https://doi.org/10.1038/s41467-021-25997-3	https://doi.org/10.1038/s41467-021-25997-3	NUM
admet-1883	472	7	https://doi.org/10.1038/s41422-020-00446-w	https://doi.org/10.1038/s41422-020-00446-w	NOUN
admet-1883	472	8	https://doi.org/10.1007/s11095-021-03015-x	https://doi.org/10.1007/s11095-021-03015-x	PROPN
admet-1883	472	9	https://doi.org/10.1007/s11095-021-03015-x	https://doi.org/10.1007/s11095-021-03015-x	PROPN
admet-1883	473	1	p.	p.	PROPN
admet-1883	473	2	pallavi	pallavi	VERB
admet-1883	473	3	et	et	PROPN
admet-1883	473	4	al	al	PROPN
admet-1883	473	5	.	.	PROPN
admet-1883	473	6	admet	admet	PROPN
admet-1883	473	7	&	&	CCONJ
admet-1883	473	8	dmpk	dmpk	PROPN
admet-1883	473	9	11(4	11(4	NUM
admet-1883	473	10	)	)	PUNCT
admet-1883	473	11	(	(	PUNCT
admet-1883	473	12	2023	2023	NUM
admet-1883	473	13	)	)	PUNCT
admet-1883	474	1	513	513	NUM
admet-1883	474	2	-	-	SYM
admet-1883	474	3	531	531	NUM
admet-1883	474	4	528	528	NUM
admet-1883	474	5	[	[	SYM
admet-1883	474	6	42	42	NUM
admet-1883	474	7	]	]	PUNCT
admet-1883	474	8	a.	a.	NOUN
admet-1883	474	9	girigoswami	girigoswami	PROPN
admet-1883	474	10	,	,	PUNCT
admet-1883	474	11	w.	w.	PROPN
admet-1883	474	12	yassine	yassine	PROPN
admet-1883	474	13	,	,	PUNCT
admet-1883	474	14	p.	p.	PROPN
admet-1883	474	15	sharmiladevi	sharmiladevi	NOUN
admet-1883	474	16	,	,	PUNCT
admet-1883	474	17	v.	v.	PROPN
admet-1883	474	18	haribabu	haribabu	PROPN
admet-1883	474	19	,	,	PUNCT
admet-1883	474	20	k.	k.	PROPN
admet-1883	474	21	girigoswami	girigoswami	PROPN
admet-1883	474	22	.	.	PUNCT
admet-1883	475	1	camouflaged	camouflage	VERB
admet-1883	475	2	nanosilver	nanosilver	ADV
admet-1883	475	3	with	with	ADP
admet-1883	475	4	excitation	excitation	NOUN
admet-1883	475	5	wavelength	wavelength	NOUN
admet-1883	475	6	dependent	dependent	ADJ
admet-1883	475	7	high	high	ADJ
admet-1883	475	8	quantum	quantum	NOUN
admet-1883	475	9	yield	yield	NOUN
admet-1883	475	10	for	for	ADP
admet-1883	475	11	targeted	target	VERB
admet-1883	475	12	theranostic	theranostic	ADJ
admet-1883	475	13	.	.	PUNCT
admet-1883	476	1	scientific	scientific	ADJ
admet-1883	476	2	reports	report	NOUN
admet-1883	476	3	8	8	NUM
admet-1883	476	4	(	(	PUNCT
admet-1883	476	5	2018	2018	NUM
admet-1883	476	6	)	)	PUNCT
admet-1883	476	7	1	1	NUM
admet-1883	476	8	-	-	SYM
admet-1883	476	9	7	7	NUM
admet-1883	476	10	.	.	PUNCT
admet-1883	476	11	https://doi.org/10.1038/s41598-018-34843-4	https://doi.org/10.1038/s41598-018-34843-4	NUM
admet-1883	476	12	.	.	PUNCT
admet-1883	477	1	[	[	X
admet-1883	477	2	43	43	NUM
admet-1883	477	3	]	]	X
admet-1883	477	4	v.	v.	CCONJ
admet-1883	477	5	haribabu	haribabu	PROPN
admet-1883	477	6	,	,	PUNCT
admet-1883	477	7	p.	p.	PROPN
admet-1883	477	8	sharmiladevi	sharmiladevi	NOUN
admet-1883	477	9	,	,	PUNCT
admet-1883	477	10	n.	n.	PROPN
admet-1883	477	11	akhtar	akhtar	PROPN
admet-1883	477	12	,	,	PUNCT
admet-1883	477	13	as	as	SCONJ
admet-1883	477	14	farook	farook	NOUN
admet-1883	477	15	,	,	PUNCT
admet-1883	477	16	k.	k.	PROPN
admet-1883	477	17	girigoswami	girigoswami	PROPN
admet-1883	477	18	,	,	PUNCT
admet-1883	477	19	a.	a.	PROPN
admet-1883	477	20	girigoswami	girigoswami	PROPN
admet-1883	477	21	.	.	PUNCT
admet-1883	478	1	label	label	NOUN
admet-1883	478	2	free	free	ADJ
admet-1883	478	3	ultrasmall	ultrasmall	ADJ
admet-1883	478	4	fluoromagnetic	fluoromagnetic	ADJ
admet-1883	478	5	ferrite	ferrite	NOUN
admet-1883	478	6	-	-	PUNCT
admet-1883	478	7	clusters	cluster	NOUN
admet-1883	478	8	for	for	ADP
admet-1883	478	9	targeted	target	VERB
admet-1883	478	10	cancer	cancer	NOUN
admet-1883	478	11	imaging	imaging	NOUN
admet-1883	478	12	and	and	CCONJ
admet-1883	478	13	drug	drug	NOUN
admet-1883	478	14	delivery	delivery	NOUN
admet-1883	478	15	.	.	PUNCT
admet-1883	479	1	current	current	ADJ
admet-1883	479	2	drug	drug	NOUN
admet-1883	479	3	delivery	delivery	NOUN
admet-1883	479	4	16	16	NUM
admet-1883	479	5	(	(	PUNCT
admet-1883	479	6	2019	2019	NUM
admet-1883	479	7	)	)	PUNCT
admet-1883	479	8	233	233	NUM
admet-1883	479	9	-	-	SYM
admet-1883	479	10	241	241	NUM
admet-1883	479	11	.	.	PUNCT
admet-1883	480	1	https://doi.org/10.2174/1567201816666181119112410	https://doi.org/10.2174/1567201816666181119112410	PROPN
admet-1883	480	2	.	.	PUNCT
admet-1883	481	1	[	[	X
admet-1883	481	2	44	44	NUM
admet-1883	481	3	]	]	PUNCT
admet-1883	481	4	p.	p.	NOUN
admet-1883	481	5	sharmiladevi	sharmiladevi	NOUN
admet-1883	481	6	,	,	PUNCT
admet-1883	481	7	m.	m.	NOUN
admet-1883	481	8	breghatha	breghatha	PROPN
admet-1883	481	9	,	,	PUNCT
admet-1883	481	10	k.	k.	PROPN
admet-1883	481	11	dhanavardhini	dhanavardhini	PROPN
admet-1883	481	12	,	,	PUNCT
admet-1883	481	13	r.	r.	PROPN
admet-1883	481	14	priya	priya	PROPN
admet-1883	481	15	,	,	PUNCT
admet-1883	481	16	k.	k.	PROPN
admet-1883	481	17	girigoswami	girigoswami	PROPN
admet-1883	481	18	,	,	PUNCT
admet-1883	481	19	a.	a.	PROPN
admet-1883	481	20	girigoswami	girigoswami	PROPN
admet-1883	481	21	.	.	PUNCT
admet-1883	482	1	efficient	efficient	ADJ
admet-1883	482	2	wormlike	wormlike	ADJ
admet-1883	482	3	micelles	micelle	NOUN
admet-1883	482	4	for	for	ADP
admet-1883	482	5	the	the	DET
admet-1883	482	6	controlled	control	VERB
admet-1883	482	7	delivery	delivery	NOUN
admet-1883	482	8	of	of	ADP
admet-1883	482	9	anticancer	anticancer	NOUN
admet-1883	482	10	drugs	drug	NOUN
admet-1883	482	11	.	.	PUNCT
admet-1883	483	1	nanoscience	nanoscience	PROPN
admet-1883	483	2	&	&	CCONJ
admet-1883	483	3	nanotechnologyasia	nanotechnologyasia	PROPN
admet-1883	483	4	11	11	NUM
admet-1883	483	5	(	(	PUNCT
admet-1883	483	6	2021	2021	NUM
admet-1883	483	7	)	)	PUNCT
admet-1883	483	8	350	350	NUM
admet-1883	483	9	-	-	SYM
admet-1883	483	10	356	356	NUM
admet-1883	483	11	.	.	PUNCT
admet-1883	484	1	https://doi.org/10.2174/2210681210999200728115601	https://doi.org/10.2174/2210681210999200728115601	NOUN
admet-1883	484	2	.	.	PUNCT
admet-1883	485	1	[	[	X
admet-1883	485	2	45	45	NUM
admet-1883	485	3	]	]	PUNCT
admet-1883	485	4	p.	p.	NOUN
admet-1883	485	5	sharmiladevi	sharmiladevi	NOUN
admet-1883	485	6	,	,	PUNCT
admet-1883	485	7	k.	k.	PROPN
admet-1883	485	8	girigoswami	girigoswami	PROPN
admet-1883	485	9	,	,	PUNCT
admet-1883	485	10	v.	v.	PROPN
admet-1883	485	11	haribabu	haribabu	PROPN
admet-1883	485	12	,	,	PUNCT
admet-1883	485	13	a.	a.	PROPN
admet-1883	485	14	girigoswami	girigoswami	PROPN
admet-1883	485	15	.	.	PUNCT
admet-1883	486	1	nano	nano	NOUN
admet-1883	486	2	-	-	PUNCT
admet-1883	486	3	enabled	enable	VERB
admet-1883	486	4	theranostics	theranostic	NOUN
admet-1883	486	5	for	for	ADP
admet-1883	486	6	cancer	cancer	NOUN
admet-1883	486	7	.	.	PUNCT
admet-1883	487	1	materials	material	NOUN
admet-1883	487	2	advances	advance	VERB
admet-1883	487	3	2	2	NUM
admet-1883	487	4	(	(	PUNCT
admet-1883	487	5	2021	2021	NUM
admet-1883	487	6	)	)	PUNCT
admet-1883	487	7	2876	2876	NUM
admet-1883	487	8	-	-	SYM
admet-1883	487	9	2891	2891	NUM
admet-1883	487	10	.	.	PUNCT
admet-1883	488	1	https://doi.org/10.1039/d1ma00069a	https://doi.org/10.1039/d1ma00069a	PROPN
admet-1883	488	2	.	.	PUNCT
admet-1883	489	1	[	[	X
admet-1883	489	2	46	46	NUM
admet-1883	489	3	]	]	X
admet-1883	489	4	s.w	s.w	PROPN
admet-1883	489	5	.	.	PROPN
admet-1883	489	6	vedakumari	vedakumari	PROPN
admet-1883	489	7	,	,	PUNCT
admet-1883	489	8	r.	r.	PROPN
admet-1883	489	9	senthil	senthil	PROPN
admet-1883	489	10	,	,	PUNCT
admet-1883	489	11	s.	s.	PROPN
admet-1883	489	12	sekar	sekar	PROPN
admet-1883	489	13	,	,	PUNCT
admet-1883	489	14	c.s	c.s	PROPN
admet-1883	489	15	.	.	PROPN
admet-1883	489	16	babu	babu	PROPN
admet-1883	489	17	,	,	PUNCT
admet-1883	489	18	t.p	t.p	PROPN
admet-1883	489	19	.	.	PROPN
admet-1883	489	20	sastry	sastry	PROPN
admet-1883	489	21	.	.	PUNCT
admet-1883	490	1	enhancing	enhance	VERB
admet-1883	490	2	anti	anti	ADJ
admet-1883	490	3	-	-	ADJ
admet-1883	490	4	cancer	cancer	ADJ
admet-1883	490	5	activity	activity	NOUN
admet-1883	490	6	of	of	ADP
admet-1883	490	7	erlotinib	erlotinib	NOUN
admet-1883	490	8	by	by	ADP
admet-1883	490	9	antibody	antibody	NOUN
admet-1883	490	10	conjugated	conjugate	VERB
admet-1883	490	11	nanofibrin	nanofibrin	NOUN
admet-1883	490	12	-	-	PUNCT
admet-1883	490	13	in	in	ADV
admet-1883	490	14	vitro	vitro	X
admet-1883	490	15	studies	study	NOUN
admet-1883	490	16	on	on	ADP
admet-1883	490	17	lung	lung	NOUN
admet-1883	490	18	adenocarcinoma	adenocarcinoma	NOUN
admet-1883	490	19	cell	cell	NOUN
admet-1883	490	20	lines	line	NOUN
admet-1883	490	21	.	.	PUNCT
admet-1883	491	1	materials	material	NOUN
admet-1883	491	2	chemistry	chemistry	NOUN
admet-1883	491	3	and	and	CCONJ
admet-1883	491	4	physics	physics	NOUN
admet-1883	491	5	224	224	NUM
admet-1883	491	6	(	(	PUNCT
admet-1883	491	7	2019	2019	NUM
admet-1883	491	8	)	)	PUNCT
admet-1883	491	9	328	328	NUM
admet-1883	491	10	-	-	SYM
admet-1883	491	11	333	333	NUM
admet-1883	491	12	.	.	PUNCT
admet-1883	492	1	https://doi.org/10.1016/j.matchemphys.2018.11.061	https://doi.org/10.1016/j.matchemphys.2018.11.061	PROPN
admet-1883	492	2	.	.	PUNCT
admet-1883	493	1	[	[	X
admet-1883	493	2	47	47	NUM
admet-1883	493	3	]	]	PUNCT
admet-1883	493	4	lm	lm	ADJ
admet-1883	493	5	lazer	lazer	NOUN
admet-1883	493	6	,	,	PUNCT
admet-1883	493	7	b.	b.	PROPN
admet-1883	493	8	sadhasivam	sadhasivam	PROPN
admet-1883	493	9	,	,	PUNCT
admet-1883	493	10	k.	k.	PROPN
admet-1883	493	11	palaniyandi	palaniyandi	PROPN
admet-1883	493	12	,	,	PUNCT
admet-1883	493	13	t.	t.	NOUN
admet-1883	493	14	muthuswamy	muthuswamy	NOUN
admet-1883	493	15	,	,	PUNCT
admet-1883	493	16	i.	i.	PROPN
admet-1883	493	17	ramachandran	ramachandran	PROPN
admet-1883	493	18	,	,	PUNCT
admet-1883	493	19	a.	a.	PROPN
admet-1883	493	20	balakrishnan	balakrishnan	PROPN
admet-1883	493	21	,	,	PUNCT
admet-1883	493	22	s.	s.	PROPN
admet-1883	493	23	pathak	pathak	PROPN
admet-1883	493	24	,	,	PUNCT
admet-1883	493	25	s.	s.	PROPN
admet-1883	493	26	narayan	narayan	PROPN
admet-1883	493	27	,	,	PUNCT
admet-1883	493	28	s.	s.	PROPN
admet-1883	493	29	ramalingam	ramalingam	PROPN
admet-1883	493	30	.	.	PUNCT
admet-1883	494	1	chitosan	chitosan	NOUN
admet-1883	494	2	-	-	PUNCT
admet-1883	494	3	based	base	VERB
admet-1883	494	4	nano	nano	NOUN
admet-1883	494	5	-	-	PUNCT
admet-1883	494	6	formulation	formulation	NOUN
admet-1883	494	7	enhances	enhance	VERB
admet-1883	494	8	the	the	DET
admet-1883	494	9	anticancer	anticancer	NOUN
admet-1883	494	10	efficacy	efficacy	NOUN
admet-1883	494	11	of	of	ADP
admet-1883	494	12	hesperetin	hesperetin	PROPN
admet-1883	494	13	.	.	PUNCT
admet-1883	495	1	international	international	ADJ
admet-1883	495	2	journal	journal	NOUN
admet-1883	495	3	of	of	ADP
admet-1883	495	4	biological	biological	ADJ
admet-1883	495	5	macromolecules	macromolecule	NOUN
admet-1883	495	6	107	107	NUM
admet-1883	495	7	(	(	PUNCT
admet-1883	495	8	2018	2018	NUM
admet-1883	495	9	)	)	PUNCT
admet-1883	495	10	1988	1988	NUM
admet-1883	495	11	-	-	SYM
admet-1883	495	12	1998	1998	NUM
admet-1883	495	13	.	.	PUNCT
admet-1883	496	1	https://doi.org/10.1016/j.ijbiomac.2017.10.064	https://doi.org/10.1016/j.ijbiomac.2017.10.064	ADJ
admet-1883	496	2	.	.	PUNCT
admet-1883	497	1	[	[	X
admet-1883	497	2	48	48	NUM
admet-1883	497	3	]	]	PUNCT
admet-1883	497	4	f.	f.	PROPN
admet-1883	497	5	hou	hou	PROPN
admet-1883	497	6	,	,	PUNCT
admet-1883	497	7	z.	z.	PROPN
admet-1883	497	8	teng	teng	PROPN
admet-1883	497	9	,	,	PUNCT
admet-1883	497	10	j.	j.	PROPN
admet-1883	497	11	ru	ru	PROPN
admet-1883	497	12	,	,	PUNCT
admet-1883	497	13	h.	h.	PROPN
admet-1883	497	14	liu	liu	PROPN
admet-1883	497	15	,	,	PUNCT
admet-1883	497	16	j.	j.	PROPN
admet-1883	497	17	li	li	PROPN
admet-1883	497	18	,	,	PUNCT
admet-1883	497	19	y.	y.	PROPN
admet-1883	497	20	zhang	zhang	PROPN
admet-1883	497	21	,	,	PUNCT
admet-1883	497	22	s.	s.	PROPN
admet-1883	497	23	sun	sun	PROPN
admet-1883	497	24	,	,	PUNCT
admet-1883	497	25	h.	h.	PROPN
admet-1883	497	26	guo	guo	PROPN
admet-1883	497	27	.	.	PUNCT
admet-1883	498	1	flower	flower	NOUN
admet-1883	498	2	-	-	PUNCT
admet-1883	498	3	like	like	ADJ
admet-1883	498	4	mesoporous	mesoporous	ADJ
admet-1883	498	5	silica	silica	NOUN
admet-1883	498	6	nanoparticles	nanoparticle	NOUN
admet-1883	498	7	as	as	ADP
admet-1883	498	8	an	an	DET
admet-1883	498	9	antigen	antigen	ADJ
admet-1883	498	10	delivery	delivery	NOUN
admet-1883	498	11	platform	platform	NOUN
admet-1883	498	12	to	to	PART
admet-1883	498	13	promote	promote	VERB
admet-1883	498	14	systemic	systemic	ADJ
admet-1883	498	15	immune	immune	ADJ
admet-1883	498	16	response	response	NOUN
admet-1883	498	17	.	.	PUNCT
admet-1883	499	1	nanomedicine	nanomedicine	NOUN
admet-1883	499	2	:	:	PUNCT
admet-1883	499	3	nanotechnology	nanotechnology	NOUN
admet-1883	499	4	,	,	PUNCT
admet-1883	499	5	biology	biology	NOUN
admet-1883	499	6	and	and	CCONJ
admet-1883	499	7	medicine	medicine	NOUN
admet-1883	499	8	42	42	NUM
admet-1883	499	9	(	(	PUNCT
admet-1883	499	10	2022	2022	NUM
admet-1883	499	11	)	)	PUNCT
admet-1883	499	12	102541	102541	NUM
admet-1883	499	13	.	.	PUNCT
admet-1883	500	1	https://doi.org/10.1016/j.nano.20	https://doi.org/10.1016/j.nano.20	NOUN
admet-1883	500	2	22.102541	22.102541	NUM
admet-1883	500	3	.	.	PUNCT
admet-1883	501	1	[	[	X
admet-1883	501	2	49	49	NUM
admet-1883	501	3	]	]	X
admet-1883	501	4	c.t	c.t	PROPN
admet-1883	501	5	.	.	PROPN
admet-1883	501	6	perciani	perciani	PROPN
admet-1883	501	7	,	,	PUNCT
admet-1883	501	8	l.y	l.y	PROPN
admet-1883	501	9	.	.	PROPN
admet-1883	501	10	liu	liu	PROPN
admet-1883	501	11	,	,	PUNCT
admet-1883	501	12	l.	l.	PROPN
admet-1883	501	13	wood	wood	PROPN
admet-1883	501	14	,	,	PUNCT
admet-1883	501	15	s.a	s.a	PROPN
admet-1883	501	16	.	.	PROPN
admet-1883	501	17	macparland	macparland	PROPN
admet-1883	501	18	.	.	PUNCT
admet-1883	502	1	enhancing	enhance	VERB
admet-1883	502	2	immunity	immunity	NOUN
admet-1883	502	3	with	with	ADP
admet-1883	502	4	nanomedicine	nanomedicine	NOUN
admet-1883	502	5	:	:	PUNCT
admet-1883	502	6	employing	employ	VERB
admet-1883	502	7	nanoparticles	nanoparticle	NOUN
admet-1883	502	8	to	to	PART
admet-1883	502	9	harness	harness	VERB
admet-1883	502	10	the	the	DET
admet-1883	502	11	immune	immune	ADJ
admet-1883	502	12	system	system	NOUN
admet-1883	502	13	.	.	PUNCT
admet-1883	503	1	acs	acs	PROPN
admet-1883	503	2	nano	nano	VERB
admet-1883	503	3	15	15	NUM
admet-1883	503	4	(	(	PUNCT
admet-1883	503	5	2020	2020	NUM
admet-1883	503	6	)	)	PUNCT
admet-1883	503	7	7	7	NUM
admet-1883	503	8	-	-	SYM
admet-1883	503	9	20	20	NUM
admet-1883	503	10	.	.	PUNCT
admet-1883	504	1	https://doi.org/10.1021/acsnano.0c08913	https://doi.org/10.1021/acsnano.0c08913	NOUN
admet-1883	504	2	.	.	PUNCT
admet-1883	505	1	[	[	X
admet-1883	505	2	50	50	NUM
admet-1883	505	3	]	]	PUNCT
admet-1883	505	4	l.	l.	PROPN
admet-1883	505	5	schoenmaker	schoenmaker	PROPN
admet-1883	505	6	,	,	PUNCT
admet-1883	505	7	d.	d.	PROPN
admet-1883	505	8	witzigmann	witzigmann	PROPN
admet-1883	505	9	,	,	PUNCT
admet-1883	505	10	j.a	j.a	PROPN
admet-1883	505	11	.	.	PROPN
admet-1883	505	12	kulkarni	kulkarni	PROPN
admet-1883	505	13	,	,	PUNCT
admet-1883	505	14	r.	r.	PROPN
admet-1883	505	15	verbeke	verbeke	PROPN
admet-1883	505	16	,	,	PUNCT
admet-1883	505	17	g.	g.	PROPN
admet-1883	505	18	kersten	kersten	PROPN
admet-1883	505	19	,	,	PUNCT
admet-1883	505	20	w.	w.	PROPN
admet-1883	505	21	jiskoot	jiskoot	PROPN
admet-1883	505	22	,	,	PUNCT
admet-1883	505	23	d.j	d.j	PROPN
admet-1883	505	24	.	.	PROPN
admet-1883	505	25	crommelin	crommelin	PROPN
admet-1883	505	26	.	.	PUNCT
admet-1883	506	1	mrna	mrna	PROPN
admet-1883	506	2	-	-	PUNCT
admet-1883	506	3	lipid	lipid	NOUN
admet-1883	506	4	nanoparticle	nanoparticle	NOUN
admet-1883	506	5	covid-19	covid-19	PROPN
admet-1883	506	6	vaccines	vaccine	NOUN
admet-1883	506	7	:	:	PUNCT
admet-1883	506	8	structure	structure	NOUN
admet-1883	506	9	and	and	CCONJ
admet-1883	506	10	stability	stability	NOUN
admet-1883	506	11	.	.	PUNCT
admet-1883	507	1	international	international	ADJ
admet-1883	507	2	journal	journal	PROPN
admet-1883	507	3	of	of	ADP
admet-1883	507	4	pharmaceutics	pharmaceutic	NOUN
admet-1883	507	5	601	601	NUM
admet-1883	507	6	(	(	PUNCT
admet-1883	507	7	2021	2021	NUM
admet-1883	507	8	)	)	PUNCT
admet-1883	507	9	120586	120586	NUM
admet-1883	507	10	.	.	PUNCT
admet-1883	508	1	https://doi.org/10.1016/j.ijpharm.2021.120586	https://doi.org/10.1016/j.ijpharm.2021.120586	ADJ
admet-1883	508	2	.	.	PUNCT
admet-1883	509	1	[	[	X
admet-1883	509	2	51	51	NUM
admet-1883	509	3	]	]	PUNCT
admet-1883	509	4	j.	j.	PROPN
admet-1883	509	5	van	van	PROPN
admet-1883	509	6	praet	praet	NOUN
admet-1883	509	7	,	,	PUNCT
admet-1883	509	8	m.	m.	NOUN
admet-1883	509	9	reynders	reynder	NOUN
admet-1883	509	10	,	,	PUNCT
admet-1883	509	11	d.	d.	PROPN
admet-1883	509	12	de	de	PROPN
admet-1883	509	13	bacquer	bacquer	PROPN
admet-1883	509	14	,	,	PUNCT
admet-1883	509	15	l.	l.	PROPN
admet-1883	509	16	viaene	viaene	PROPN
admet-1883	509	17	,	,	PUNCT
admet-1883	509	18	m.k	m.k	PROPN
admet-1883	509	19	.	.	PROPN
admet-1883	509	20	schoutteten	schoutteten	PROPN
admet-1883	509	21	,	,	PUNCT
admet-1883	509	22	r.	r.	PROPN
admet-1883	509	23	caluwé	caluwé	PROPN
admet-1883	509	24	,	,	PUNCT
admet-1883	509	25	p.	p.	PROPN
admet-1883	509	26	doubel	doubel	NOUN
admet-1883	509	27	,	,	PUNCT
admet-1883	509	28	l.	l.	PROPN
admet-1883	509	29	heylen	heylen	PROPN
admet-1883	509	30	,	,	PUNCT
admet-1883	509	31	a.v	a.v	PROPN
admet-1883	509	32	.	.	PROPN
admet-1883	509	33	de	de	PROPN
admet-1883	509	34	bel	bel	PROPN
admet-1883	509	35	,	,	PUNCT
admet-1883	509	36	b.	b.	PROPN
admet-1883	509	37	van	van	PROPN
admet-1883	509	38	vlem	vlem	PROPN
admet-1883	509	39	.	.	PUNCT
admet-1883	510	1	predictors	predictor	NOUN
admet-1883	510	2	and	and	CCONJ
admet-1883	510	3	dynamics	dynamic	NOUN
admet-1883	510	4	of	of	ADP
admet-1883	510	5	the	the	DET
admet-1883	510	6	humoral	humoral	ADJ
admet-1883	510	7	and	and	CCONJ
admet-1883	510	8	cellular	cellular	ADJ
admet-1883	510	9	immune	immune	ADJ
admet-1883	510	10	response	response	NOUN
admet-1883	510	11	to	to	ADP
admet-1883	510	12	sars	sars	PROPN
admet-1883	510	13	-	-	PUNCT
admet-1883	510	14	cov-2	cov-2	NOUN
admet-1883	510	15	mrna	mrna	NOUN
admet-1883	510	16	vaccines	vaccine	NOUN
admet-1883	510	17	in	in	ADP
admet-1883	510	18	hemodialysis	hemodialysis	NOUN
admet-1883	510	19	patients	patient	NOUN
admet-1883	510	20	:	:	PUNCT
admet-1883	510	21	a	a	DET
admet-1883	510	22	multicenter	multicenter	ADJ
admet-1883	510	23	observational	observational	ADJ
admet-1883	510	24	study	study	NOUN
admet-1883	510	25	.	.	PUNCT
admet-1883	511	1	journal	journal	NOUN
admet-1883	511	2	of	of	ADP
admet-1883	511	3	the	the	DET
admet-1883	511	4	american	american	ADJ
admet-1883	511	5	society	society	NOUN
admet-1883	511	6	of	of	ADP
admet-1883	511	7	nephrology	nephrology	NOUN
admet-1883	511	8	32	32	NUM
admet-1883	511	9	(	(	PUNCT
admet-1883	511	10	2021	2021	NUM
admet-1883	511	11	)	)	PUNCT
admet-1883	511	12	3208	3208	NUM
admet-1883	511	13	-	-	SYM
admet-1883	511	14	3220	3220	NUM
admet-1883	511	15	.	.	PUNCT
admet-1883	512	1	https://doi.org/10.1681/	https://doi.org/10.1681/	NOUN
admet-1883	512	2	asn.2021070908	asn.2021070908	X
admet-1883	512	3	.	.	PUNCT
admet-1883	513	1	[	[	X
admet-1883	513	2	52	52	NUM
admet-1883	513	3	]	]	PUNCT
admet-1883	513	4	e.	e.	PROPN
admet-1883	513	5	hamidi	hamidi	PROPN
admet-1883	513	6	-	-	PUNCT
admet-1883	513	7	asl	asl	PROPN
admet-1883	513	8	,	,	PUNCT
admet-1883	513	9	l.	l.	PROPN
admet-1883	513	10	heidari	heidari	PROPN
admet-1883	513	11	,	,	PUNCT
admet-1883	513	12	j.b	j.b	PROPN
admet-1883	513	13	.	.	PUNCT
admet-1883	513	14	raoof	raoof	PROPN
admet-1883	513	15	,	,	PUNCT
admet-1883	513	16	t.p	t.p	PROPN
admet-1883	513	17	.	.	PROPN
admet-1883	513	18	richard	richard	PROPN
admet-1883	513	19	,	,	PUNCT
admet-1883	513	20	s.	s.	PROPN
admet-1883	513	21	farhad	farhad	PROPN
admet-1883	513	22	,	,	PUNCT
admet-1883	513	23	m.	m.	NOUN
admet-1883	513	24	ghani	ghani	PROPN
admet-1883	513	25	.	.	PUNCT
admet-1883	514	1	a	a	DET
admet-1883	514	2	review	review	NOUN
admet-1883	514	3	on	on	ADP
admet-1883	514	4	the	the	DET
admet-1883	514	5	recent	recent	ADJ
admet-1883	514	6	achievements	achievement	NOUN
admet-1883	514	7	on	on	ADP
admet-1883	514	8	coronaviruses	coronaviruse	NOUN
admet-1883	514	9	recognition	recognition	NOUN
admet-1883	514	10	using	use	VERB
admet-1883	514	11	electrochemical	electrochemical	ADJ
admet-1883	514	12	detection	detection	NOUN
admet-1883	514	13	me	i	PRON
admet-1883	514	14	thods	thod	NOUN
admet-1883	514	15	.	.	PUNCT
admet-1883	514	16	microchemical	microchemical	ADJ
admet-1883	514	17	journal	journal	PROPN
admet-1883	514	18	(	(	PUNCT
admet-1883	514	19	2022	2022	NUM
admet-1883	514	20	)	)	PUNCT
admet-1883	514	21	107322	107322	NUM
admet-1883	514	22	.	.	PUNCT
admet-1883	515	1	https://doi.org/10.1016/j.microc.2022.107322	https://doi.org/10.1016/j.microc.2022.107322	PROPN
admet-1883	515	2	.	.	PUNCT
admet-1883	516	1	[	[	X
admet-1883	516	2	53	53	NUM
admet-1883	516	3	]	]	X
admet-1883	516	4	c.o	c.o	PROPN
admet-1883	516	5	.	.	PROPN
admet-1883	516	6	priyanka	priyanka	PROPN
admet-1883	516	7	,	,	PUNCT
admet-1883	516	8	i.	i.	PROPN
admet-1883	516	9	singh	singh	PROPN
admet-1883	516	10	.	.	PUNCT
admet-1883	517	1	diagnosis	diagnosis	NOUN
admet-1883	517	2	of	of	ADP
admet-1883	517	3	sars	sar	NOUN
admet-1883	517	4	-	-	PUNCT
admet-1883	517	5	cov-2	cov-2	NOUN
admet-1883	517	6	:	:	PUNCT
admet-1883	517	7	a	a	DET
admet-1883	517	8	review	review	NOUN
admet-1883	517	9	on	on	ADP
admet-1883	517	10	the	the	DET
admet-1883	517	11	current	current	ADJ
admet-1883	517	12	scenario	scenario	NOUN
admet-1883	517	13	and	and	CCONJ
admet-1883	517	14	future	future	ADJ
admet-1883	517	15	outlook	outlook	NOUN
admet-1883	517	16	.	.	PUNCT
admet-1883	518	1	acta	acta	PROPN
admet-1883	518	2	virologica	virologica	PROPN
admet-1883	518	3	64	64	NUM
admet-1883	518	4	(	(	PUNCT
admet-1883	518	5	2020	2020	NUM
admet-1883	518	6	)	)	PUNCT
admet-1883	518	7	396	396	NUM
admet-1883	518	8	-	-	SYM
admet-1883	518	9	408	408	NUM
admet-1883	518	10	.	.	PUNCT
admet-1883	519	1	https://doi.org/10.4149/av_2020_402	https://doi.org/10.4149/av_2020_402	NOUN
admet-1883	519	2	.	.	PUNCT
admet-1883	520	1	[	[	X
admet-1883	520	2	54	54	NUM
admet-1883	520	3	]	]	PUNCT
admet-1883	520	4	s.	s.	PROPN
admet-1883	520	5	yadav	yadav	PROPN
admet-1883	520	6	,	,	PUNCT
admet-1883	520	7	m.a	m.a	PROPN
admet-1883	520	8	.	.	PROPN
admet-1883	520	9	sadique	sadique	PROPN
admet-1883	520	10	,	,	PUNCT
admet-1883	520	11	p.	p.	PROPN
admet-1883	520	12	ranjan	ranjan	PROPN
admet-1883	520	13	,	,	PUNCT
admet-1883	520	14	n.	n.	PROPN
admet-1883	520	15	kumar	kumar	PROPN
admet-1883	520	16	,	,	PUNCT
admet-1883	520	17	a.	a.	NOUN
admet-1883	520	18	singhal	singhal	PROPN
admet-1883	520	19	,	,	PUNCT
admet-1883	520	20	a.k	a.k	PROPN
admet-1883	520	21	.	.	PROPN
admet-1883	520	22	srivastava	srivastava	PROPN
admet-1883	520	23	,	,	PUNCT
admet-1883	520	24	r.	r.	PROPN
admet-1883	520	25	khan	khan	PROPN
admet-1883	520	26	.	.	PUNCT
admet-1883	521	1	sers	ser	NOUN
admet-1883	521	2	based	base	VERB
admet-1883	521	3	lateral	lateral	ADJ
admet-1883	521	4	flow	flow	NOUN
admet-1883	521	5	immunoassay	immunoassay	NOUN
admet-1883	521	6	for	for	ADP
admet-1883	521	7	point	point	NOUN
admet-1883	521	8	-	-	PUNCT
admet-1883	521	9	of	of	ADP
admet-1883	521	10	-	-	PUNCT
admet-1883	521	11	care	care	NOUN
admet-1883	521	12	detection	detection	NOUN
admet-1883	521	13	of	of	ADP
admet-1883	521	14	sars	sar	NOUN
admet-1883	521	15	-	-	PUNCT
admet-1883	521	16	cov-2	cov-2	NOUN
admet-1883	521	17	in	in	ADP
admet-1883	521	18	clinical	clinical	ADJ
admet-1883	521	19	samples	sample	NOUN
admet-1883	521	20	.	.	PUNCT
admet-1883	522	1	acs	acs	PROPN
admet-1883	522	2	applied	apply	VERB
admet-1883	522	3	bio	bio	NOUN
admet-1883	522	4	materials	material	NOUN
admet-1883	522	5	4	4	NUM
admet-1883	522	6	(	(	PUNCT
admet-1883	522	7	2021	2021	NUM
admet-1883	522	8	)	)	PUNCT
admet-1883	522	9	2974	2974	NUM
admet-1883	522	10	-	-	SYM
admet-1883	522	11	2995	2995	NUM
admet-1883	522	12	.	.	PUNCT
admet-1883	523	1	https://doi.org/10.1021/acsabm.1c00102	https://doi.org/10.1021/acsabm.1c00102	NOUN
admet-1883	523	2	.	.	PUNCT
admet-1883	524	1	[	[	X
admet-1883	524	2	55	55	NUM
admet-1883	524	3	]	]	X
admet-1883	524	4	d.	d.	PROPN
admet-1883	524	5	thompson	thompson	PROPN
admet-1883	524	6	,	,	PUNCT
admet-1883	524	7	y.	y.	PROPN
admet-1883	524	8	lei	lei	PROPN
admet-1883	524	9	.	.	PUNCT
admet-1883	524	10	mini	mini	ADJ
admet-1883	524	11	review	review	NOUN
admet-1883	524	12	:	:	PUNCT
admet-1883	524	13	recent	recent	ADJ
admet-1883	524	14	progress	progress	NOUN
admet-1883	524	15	in	in	ADP
admet-1883	524	16	rt	rt	PROPN
admet-1883	524	17	-	-	PUNCT
admet-1883	524	18	lamp	lamp	NOUN
admet-1883	524	19	enabled	enable	VERB
admet-1883	524	20	covid-19	covid-19	PROPN
admet-1883	524	21	detection	detection	NOUN
admet-1883	524	22	.	.	PUNCT
admet-1883	525	1	sensors	sensor	NOUN
admet-1883	525	2	and	and	CCONJ
admet-1883	525	3	actuators	actuator	NOUN
admet-1883	525	4	reports	report	VERB
admet-1883	525	5	2	2	NUM
admet-1883	525	6	(	(	PUNCT
admet-1883	525	7	2020	2020	NUM
admet-1883	525	8	)	)	PUNCT
admet-1883	525	9	100017	100017	NUM
admet-1883	525	10	.	.	PUNCT
admet-1883	526	1	https://doi.org/10.1016/j.snr.2020.100017	https://doi.org/10.1016/j.snr.2020.100017	X
admet-1883	526	2	.	.	PUNCT
admet-1883	527	1	[	[	X
admet-1883	527	2	56	56	NUM
admet-1883	527	3	]	]	X
admet-1883	527	4	j.	j.	PROPN
admet-1883	527	5	lukose	lukose	PROPN
admet-1883	527	6	,	,	PUNCT
admet-1883	527	7	s.	s.	PROPN
admet-1883	527	8	chidangil	chidangil	PROPN
admet-1883	527	9	,	,	PUNCT
admet-1883	527	10	s.d	s.d	PROPN
admet-1883	527	11	.	.	PROPN
admet-1883	527	12	george	george	PROPN
admet-1883	527	13	.	.	PUNCT
admet-1883	528	1	optical	optical	ADJ
admet-1883	528	2	technologies	technology	NOUN
admet-1883	528	3	for	for	ADP
admet-1883	528	4	the	the	DET
admet-1883	528	5	detection	detection	NOUN
admet-1883	528	6	of	of	ADP
admet-1883	528	7	viruses	virus	NOUN
admet-1883	528	8	like	like	ADP
admet-1883	528	9	covid-19	covid-19	PROPN
admet-1883	528	10	:	:	PUNCT
admet-1883	528	11	progress	progress	NOUN
admet-1883	528	12	and	and	CCONJ
admet-1883	528	13	prospects	prospect	NOUN
admet-1883	528	14	.	.	PUNCT
admet-1883	529	1	biosensors	biosensor	NOUN
admet-1883	529	2	and	and	CCONJ
admet-1883	529	3	bioelectronics	bioelectronic	NOUN
admet-1883	529	4	178	178	NUM
admet-1883	529	5	(	(	PUNCT
admet-1883	529	6	2021	2021	NUM
admet-1883	529	7	)	)	PUNCT
admet-1883	529	8	113004	113004	NUM
admet-1883	529	9	.	.	PUNCT
admet-1883	530	1	https://doi.org/10.1016/j.bios.2021.113004	https://doi.org/10.1016/j.bios.2021.113004	NOUN
admet-1883	530	2	.	.	PUNCT
admet-1883	531	1	[	[	X
admet-1883	531	2	57	57	NUM
admet-1883	531	3	]	]	X
admet-1883	531	4	y.	y.	PROPN
admet-1883	531	5	duan	duan	PROPN
admet-1883	531	6	,	,	PUNCT
admet-1883	531	7	w.	w.	PROPN
admet-1883	531	8	wu	wu	PROPN
admet-1883	531	9	,	,	PUNCT
admet-1883	531	10	q.	q.	PROPN
admet-1883	531	11	zhao	zhao	PROPN
admet-1883	531	12	,	,	PUNCT
admet-1883	531	13	s.	s.	PROPN
admet-1883	531	14	liu	liu	PROPN
admet-1883	531	15	,	,	PUNCT
admet-1883	531	16	h.	h.	PROPN
admet-1883	531	17	liu	liu	PROPN
admet-1883	531	18	,	,	PUNCT
admet-1883	531	19	m.	m.	PROPN
admet-1883	531	20	huang	huang	PROPN
admet-1883	531	21	,	,	PUNCT
admet-1883	531	22	t.	t.	PROPN
admet-1883	531	23	wang	wang	PROPN
admet-1883	531	24	,	,	PUNCT
admet-1883	531	25	m.	m.	PROPN
admet-1883	531	26	liang	liang	PROPN
admet-1883	531	27	,	,	PUNCT
admet-1883	531	28	z.	z.	PROPN
admet-1883	531	29	wang	wang	PROPN
admet-1883	531	30	.	.	PUNCT
admet-1883	532	1	enzyme	enzyme	NOUN
admet-1883	532	2	-	-	PUNCT
admet-1883	532	3	antibodymodified	antibodymodifie	VERB
admet-1883	532	4	gold	gold	NOUN
admet-1883	532	5	nanoparticle	nanoparticle	NOUN
admet-1883	532	6	probes	probe	NOUN
admet-1883	532	7	for	for	ADP
admet-1883	532	8	the	the	DET
admet-1883	532	9	ultrasensitive	ultrasensitive	ADJ
admet-1883	532	10	detection	detection	NOUN
admet-1883	532	11	of	of	ADP
admet-1883	532	12	nucleocapsid	nucleocapsid	ADJ
admet-1883	532	13	protein	protein	NOUN
admet-1883	532	14	in	in	ADP
admet-1883	532	15	sftsv	sftsv	NOUN
admet-1883	532	16	.	.	PUNCT
admet-1883	533	1	international	international	ADJ
admet-1883	533	2	journal	journal	PROPN
admet-1883	533	3	of	of	ADP
admet-1883	533	4	environmental	environmental	ADJ
admet-1883	533	5	research	research	NOUN
admet-1883	533	6	and	and	CCONJ
admet-1883	533	7	public	public	ADJ
admet-1883	533	8	health	health	NOUN
admet-1883	533	9	17	17	NUM
admet-1883	533	10	(	(	PUNCT
admet-1883	533	11	2020	2020	NUM
admet-1883	533	12	)	)	PUNCT
admet-1883	533	13	4427	4427	NUM
admet-1883	533	14	.	.	PUNCT
admet-1883	534	1	https://doi.org/10.3390/ijerph17124427	https://doi.org/10.3390/ijerph17124427	PROPN
admet-1883	534	2	.	.	PUNCT
admet-1883	535	1	https://doi.org/10.1038/s41598-018-34843-4	https://doi.org/10.1038/s41598-018-34843-4	PROPN
admet-1883	536	1	https://doi.org/10.2174/1567201816666181119112410	https://doi.org/10.2174/1567201816666181119112410	PROPN
admet-1883	536	2	https://doi.org/10.2174/2210681210999200728115601	https://doi.org/10.2174/2210681210999200728115601	PRON
admet-1883	537	1	https://doi.org/10.1039/d1ma00069a	https://doi.org/10.1039/d1ma00069a	PROPN
admet-1883	537	2	https://doi.org/10.1016/j.matchemphys.2018.11.061	https://doi.org/10.1016/j.matchemphys.2018.11.061	PROPN
admet-1883	537	3	https://doi.org/10.1016/j.ijbiomac.2017.10.064	https://doi.org/10.1016/j.ijbiomac.2017.10.064	NOUN
admet-1883	537	4	https://doi.org/10.1016/j.nano.20‌22.102541	https://doi.org/10.1016/j.nano.20‌22.102541	X
admet-1883	537	5	https://doi.org/10.1016/j.nano.20‌22.102541	https://doi.org/10.1016/j.nano.20‌22.102541	PUNCT
admet-1883	537	6	https://doi.org/10.1021/acsnano.0c08913	https://doi.org/10.1021/acsnano.0c08913	PROPN
admet-1883	537	7	https://doi.org/10.1016/j.ijpharm.2021.120586	https://doi.org/10.1016/j.ijpharm.2021.120586	ADJ
admet-1883	537	8	https://doi.org/10.1681/‌asn.2021070908	https://doi.org/10.1681/‌asn.2021070908	PROPN
admet-1883	537	9	https://doi.org/10.1681/‌asn.2021070908	https://doi.org/10.1681/‌asn.2021070908	PROPN
admet-1883	537	10	https://doi.org/10.1016/j.microc.2022.107322	https://doi.org/10.1016/j.microc.2022.107322	PROPN
admet-1883	537	11	https://doi.org/10.4149/av_2020_402	https://doi.org/10.4149/av_2020_402	PROPN
admet-1883	537	12	https://doi.org/10.1021/acsabm.1c00102	https://doi.org/10.1021/acsabm.1c00102	NOUN
admet-1883	537	13	https://doi.org/10.1016/j.snr.2020.100017	https://doi.org/10.1016/j.snr.2020.100017	PROPN
admet-1883	537	14	https://doi.org/10.1016/j.bios.2021.113004	https://doi.org/10.1016/j.bios.2021.113004	VERB
admet-1883	537	15	https://doi.org/10.3390/ijerph17124427	https://doi.org/10.3390/ijerph17124427	NOUN
admet-1883	537	16	admet	admet	PROPN
admet-1883	537	17	&	&	CCONJ
admet-1883	537	18	dmpk	dmpk	PROPN
admet-1883	537	19	11(4	11(4	NUM
admet-1883	537	20	)	)	PUNCT
admet-1883	537	21	(	(	PUNCT
admet-1883	537	22	2023	2023	NUM
admet-1883	537	23	)	)	PUNCT
admet-1883	537	24	513	513	NUM
admet-1883	537	25	-	-	SYM
admet-1883	537	26	531	531	NUM
admet-1883	537	27	infections	infection	NOUN
admet-1883	537	28	associated	associate	VERB
admet-1883	537	29	with	with	ADP
admet-1883	537	30	sars	sar	NOUN
admet-1883	537	31	-	-	PUNCT
admet-1883	537	32	cov-2	cov-2	PART
admet-1883	537	33	exploited	exploit	VERB
admet-1883	537	34	via	via	ADP
admet-1883	537	35	photodynamic	photodynamic	ADJ
admet-1883	537	36	therapy	therapy	NOUN
admet-1883	537	37	doi	doi	NOUN
admet-1883	537	38	:	:	PUNCT
admet-1883	537	39	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-1883	537	40	t.1883	t.1883	NOUN
admet-1883	537	41	529	529	NUM
admet-1883	538	1	[	[	X
admet-1883	538	2	58	58	NUM
admet-1883	538	3	]	]	SYM
admet-1883	538	4	h.k	h.k	PROPN
admet-1883	538	5	.	.	PROPN
admet-1883	538	6	choi	choi	PROPN
admet-1883	538	7	,	,	PUNCT
admet-1883	538	8	m.-j	m.-j	PROPN
admet-1883	538	9	.	.	PUNCT
admet-1883	539	1	lee	lee	PROPN
admet-1883	539	2	,	,	PUNCT
admet-1883	539	3	s.n	s.n	PROPN
admet-1883	539	4	.	.	PROPN
admet-1883	539	5	lee	lee	PROPN
admet-1883	539	6	,	,	PUNCT
admet-1883	539	7	t.-h	t.-h	PROPN
admet-1883	539	8	.	.	PUNCT
admet-1883	540	1	kim	kim	PROPN
admet-1883	540	2	,	,	PUNCT
admet-1883	540	3	b.-k	b.-k	PROPN
admet-1883	540	4	.	.	PUNCT
admet-1883	541	1	oh	oh	INTJ
admet-1883	541	2	.	.	PUNCT
admet-1883	542	1	noble	noble	ADJ
admet-1883	542	2	metal	metal	NOUN
admet-1883	542	3	nanomaterial	nanomaterial	NOUN
admet-1883	542	4	-	-	PUNCT
admet-1883	542	5	based	base	VERB
admet-1883	542	6	biosensors	biosensor	NOUN
admet-1883	542	7	for	for	ADP
admet-1883	542	8	electrochemical	electrochemical	ADJ
admet-1883	542	9	and	and	CCONJ
admet-1883	542	10	optical	optical	ADJ
admet-1883	542	11	detection	detection	NOUN
admet-1883	542	12	of	of	ADP
admet-1883	542	13	viruses	virus	NOUN
admet-1883	542	14	causing	cause	VERB
admet-1883	542	15	respiratory	respiratory	ADJ
admet-1883	542	16	illnesses	illness	NOUN
admet-1883	542	17	.	.	PUNCT
admet-1883	543	1	frontiers	frontier	NOUN
admet-1883	543	2	in	in	ADP
admet-1883	543	3	chemistry	chemistry	NOUN
admet-1883	543	4	9	9	NUM
admet-1883	543	5	(	(	PUNCT
admet-1883	543	6	2021	2021	NUM
admet-1883	543	7	)	)	PUNCT
admet-1883	543	8	.	.	PUNCT
admet-1883	544	1	https://doi.org/10.3389/fchem.2021.672739	https://doi.org/10.3389/fchem.2021.672739	PROPN
admet-1883	544	2	.	.	PUNCT
admet-1883	545	1	[	[	X
admet-1883	545	2	59	59	NUM
admet-1883	545	3	]	]	PUNCT
admet-1883	545	4	s.	s.	PROPN
admet-1883	545	5	ghosh	ghosh	PROPN
admet-1883	545	6	,	,	PUNCT
admet-1883	545	7	k.	k.	PROPN
admet-1883	545	8	girigoswami	girigoswami	PROPN
admet-1883	545	9	,	,	PUNCT
admet-1883	545	10	a.	a.	PROPN
admet-1883	545	11	girigoswami	girigoswami	PROPN
admet-1883	545	12	.	.	PUNCT
admet-1883	546	1	membrane	membrane	NOUN
admet-1883	546	2	-	-	PUNCT
admet-1883	546	3	encapsulated	encapsulate	VERB
admet-1883	546	4	camouflaged	camouflage	VERB
admet-1883	546	5	nanomedicines	nanomedicine	NOUN
admet-1883	546	6	in	in	ADP
admet-1883	546	7	drug	drug	NOUN
admet-1883	546	8	delivery	delivery	NOUN
admet-1883	546	9	.	.	PUNCT
admet-1883	547	1	nanomedicine	nanomedicine	NOUN
admet-1883	547	2	:	:	PUNCT
admet-1883	547	3	nanotechnology	nanotechnology	NOUN
admet-1883	547	4	,	,	PUNCT
admet-1883	547	5	biology	biology	NOUN
admet-1883	547	6	,	,	PUNCT
admet-1883	547	7	and	and	CCONJ
admet-1883	547	8	medicine	medicine	NOUN
admet-1883	547	9	14	14	NUM
admet-1883	547	10	(	(	PUNCT
admet-1883	547	11	2019	2019	NUM
admet-1883	547	12	)	)	PUNCT
admet-1883	547	13	2067	2067	NUM
admet-1883	547	14	-	-	SYM
admet-1883	547	15	2082	2082	NUM
admet-1883	547	16	.	.	PUNCT
admet-1883	548	1	https://doi.org/10.2217/nnm-2019-0155	https://doi.org/10.2217/nnm-2019-0155	PROPN
admet-1883	548	2	.	.	PUNCT
admet-1883	549	1	[	[	X
admet-1883	549	2	60	60	NUM
admet-1883	549	3	]	]	X
admet-1883	549	4	v.	v.	CCONJ
admet-1883	549	5	haribabu	haribabu	PROPN
admet-1883	549	6	,	,	PUNCT
admet-1883	549	7	k.	k.	PROPN
admet-1883	549	8	girigoswami	girigoswami	PROPN
admet-1883	549	9	,	,	PUNCT
admet-1883	549	10	a.	a.	PROPN
admet-1883	549	11	girigoswami	girigoswami	PROPN
admet-1883	549	12	.	.	PUNCT
admet-1883	550	1	magneto	magneto	NOUN
admet-1883	550	2	-	-	PUNCT
admet-1883	550	3	silver	silver	NOUN
admet-1883	550	4	core	core	NOUN
admet-1883	550	5	–	–	PUNCT
admet-1883	550	6	shell	shell	ADJ
admet-1883	550	7	nanohybrids	nanohybrid	NOUN
admet-1883	550	8	for	for	ADP
admet-1883	550	9	theragnosis	theragnosis	NOUN
admet-1883	550	10	.	.	PUNCT
admet-1883	551	1	nano	nano	NOUN
admet-1883	551	2	-	-	PUNCT
admet-1883	551	3	structures	structure	NOUN
admet-1883	551	4	&	&	CCONJ
admet-1883	551	5	nano	nano	NOUN
admet-1883	551	6	-	-	PUNCT
admet-1883	551	7	objects	object	VERB
admet-1883	551	8	25	25	NUM
admet-1883	551	9	(	(	PUNCT
admet-1883	551	10	2021	2021	NUM
admet-1883	551	11	)	)	PUNCT
admet-1883	551	12	100636	100636	NUM
admet-1883	551	13	.	.	PUNCT
admet-1883	552	1	https://doi.org/10.1016/j.nanoso.2020.100636	https://doi.org/10.1016/j.nanoso.2020.100636	NOUN
admet-1883	552	2	.	.	PUNCT
admet-1883	553	1	[	[	X
admet-1883	553	2	61	61	NUM
admet-1883	553	3	]	]	X
admet-1883	553	4	g.	g.	PROPN
admet-1883	553	5	agraharam	agraharam	PROPN
admet-1883	553	6	,	,	PUNCT
admet-1883	553	7	a.	a.	PROPN
admet-1883	553	8	girigoswami	girigoswami	PROPN
admet-1883	553	9	,	,	PUNCT
admet-1883	553	10	k.	k.	PROPN
admet-1883	553	11	girigoswami	girigoswami	PROPN
admet-1883	553	12	.	.	PUNCT
admet-1883	554	1	nanoencapsulated	nanoencapsulate	VERB
admet-1883	554	2	myricetin	myricetin	NOUN
admet-1883	554	3	to	to	PART
admet-1883	554	4	improve	improve	VERB
admet-1883	554	5	antioxidant	antioxidant	ADJ
admet-1883	554	6	activity	activity	NOUN
admet-1883	554	7	and	and	CCONJ
admet-1883	554	8	bioavailability	bioavailability	NOUN
admet-1883	554	9	:	:	PUNCT
admet-1883	554	10	a	a	DET
admet-1883	554	11	study	study	NOUN
admet-1883	554	12	on	on	ADP
admet-1883	554	13	zebrafish	zebrafish	ADJ
admet-1883	554	14	embryos	embryo	NOUN
admet-1883	554	15	.	.	PUNCT
admet-1883	555	1	chemistry	chemistry	NOUN
admet-1883	555	2	4	4	NUM
admet-1883	555	3	(	(	PUNCT
admet-1883	555	4	2021	2021	NUM
admet-1883	555	5	)	)	PUNCT
admet-1883	555	6	1	1	NUM
admet-1883	555	7	-	-	SYM
admet-1883	555	8	17	17	NUM
admet-1883	555	9	.	.	PUNCT
admet-1883	555	10	https://doi.org/10.3390/chemistry4010001	https://doi.org/10.3390/chemistry4010001	PROPN
admet-1883	555	11	.	.	PUNCT
admet-1883	556	1	[	[	X
admet-1883	556	2	62	62	NUM
admet-1883	556	3	]	]	PUNCT
admet-1883	556	4	r.	r.	PROPN
admet-1883	556	5	medhi	medhi	PROPN
admet-1883	556	6	,	,	PUNCT
admet-1883	556	7	p.	p.	PROPN
admet-1883	556	8	srinoi	srinoi	PROPN
admet-1883	556	9	,	,	PUNCT
admet-1883	556	10	n.	n.	PROPN
admet-1883	556	11	ngo	ngo	PROPN
admet-1883	556	12	,	,	PUNCT
admet-1883	556	13	h.-v	h.-v	PROPN
admet-1883	556	14	.	.	PUNCT
admet-1883	557	1	tran	tran	PROPN
admet-1883	557	2	,	,	PUNCT
admet-1883	557	3	t.r	t.r	PROPN
admet-1883	557	4	.	.	PROPN
admet-1883	557	5	lee	lee	PROPN
admet-1883	557	6	.	.	PROPN
admet-1883	557	7	nanoparticle	nanoparticle	NOUN
admet-1883	557	8	-	-	PUNCT
admet-1883	557	9	based	base	VERB
admet-1883	557	10	strategies	strategy	NOUN
admet-1883	557	11	to	to	PART
admet-1883	557	12	combat	combat	VERB
admet-1883	557	13	covid-19	covid-19	PROPN
admet-1883	557	14	.	.	PUNCT
admet-1883	558	1	acs	acs	PROPN
admet-1883	558	2	applied	apply	VERB
admet-1883	558	3	nano	nano	NOUN
admet-1883	558	4	materials	material	NOUN
admet-1883	558	5	3	3	NUM
admet-1883	558	6	(	(	PUNCT
admet-1883	558	7	2020	2020	NUM
admet-1883	558	8	)	)	PUNCT
admet-1883	558	9	8557	8557	NUM
admet-1883	558	10	-	-	SYM
admet-1883	558	11	8580	8580	NUM
admet-1883	558	12	.	.	PUNCT
admet-1883	559	1	https://doi.org/10.1021/acsanm.0c01978	https://doi.org/10.1021/acsanm.0c01978	NOUN
admet-1883	559	2	.	.	PUNCT
admet-1883	560	1	[	[	X
admet-1883	560	2	63	63	NUM
admet-1883	560	3	]	]	PUNCT
admet-1883	560	4	c.	c.	PROPN
admet-1883	560	5	durmus	durmus	PROPN
admet-1883	560	6	,	,	PUNCT
admet-1883	560	7	s.b	s.b	PROPN
admet-1883	560	8	.	.	PROPN
admet-1883	560	9	hanoglu	hanoglu	PROPN
admet-1883	560	10	,	,	PUNCT
admet-1883	560	11	d.	d.	PROPN
admet-1883	560	12	harmanci	harmanci	PROPN
admet-1883	560	13	,	,	PUNCT
admet-1883	560	14	h.	h.	PROPN
admet-1883	560	15	moulahoum	moulahoum	PROPN
admet-1883	560	16	,	,	PUNCT
admet-1883	560	17	k.	k.	PROPN
admet-1883	560	18	tok	tok	PROPN
admet-1883	560	19	,	,	PUNCT
admet-1883	560	20	f.	f.	PROPN
admet-1883	560	21	ghorbanizamani	ghorbanizamani	PROPN
admet-1883	560	22	,	,	PUNCT
admet-1883	560	23	s.	s.	PROPN
admet-1883	560	24	sanli	sanli	PROPN
admet-1883	560	25	,	,	PUNCT
admet-1883	560	26	f.	f.	PROPN
admet-1883	560	27	zihnioglu	zihnioglu	PROPN
admet-1883	560	28	,	,	PUNCT
admet-1883	560	29	s.	s.	PROPN
admet-1883	560	30	evran	evran	PROPN
admet-1883	560	31	,	,	PUNCT
admet-1883	560	32	c.	c.	PROPN
admet-1883	560	33	cicek	cicek	PROPN
admet-1883	560	34	.	.	PUNCT
admet-1883	561	1	indiscriminate	indiscriminate	ADJ
admet-1883	561	2	sars	sar	NOUN
admet-1883	561	3	-	-	PUNCT
admet-1883	561	4	cov-2	cov-2	PART
admet-1883	561	5	multivariant	multivariant	NOUN
admet-1883	561	6	detection	detection	NOUN
admet-1883	561	7	using	use	VERB
admet-1883	561	8	magnetic	magnetic	ADJ
admet-1883	561	9	nanoparticle	nanoparticle	NOUN
admet-1883	561	10	-	-	PUNCT
admet-1883	561	11	based	base	VERB
admet-1883	561	12	electrochemical	electrochemical	ADJ
admet-1883	561	13	immunosensing	immunosensing	NOUN
admet-1883	561	14	.	.	PUNCT
admet-1883	562	1	talanta	talanta	PROPN
admet-1883	562	2	(	(	PUNCT
admet-1883	562	3	2022	2022	NUM
admet-1883	562	4	)	)	PUNCT
admet-1883	562	5	123356	123356	NUM
admet-1883	562	6	.	.	PUNCT
admet-1883	563	1	https://doi.org/	https://doi.org/	VERB
admet-1883	563	2	10.1016	10.1016	NUM
admet-1883	563	3	/	/	SYM
admet-1883	563	4	j.talanta.2022.123356	j.talanta.2022.123356	NOUN
admet-1883	563	5	.	.	PUNCT
admet-1883	564	1	[	[	X
admet-1883	564	2	64	64	NUM
admet-1883	564	3	]	]	PUNCT
admet-1883	564	4	t.	t.	PROPN
admet-1883	564	5	dube	dube	PROPN
admet-1883	564	6	,	,	PUNCT
admet-1883	564	7	a.	a.	PROPN
admet-1883	564	8	ghosh	ghosh	PROPN
admet-1883	564	9	,	,	PUNCT
admet-1883	564	10	j.	j.	PROPN
admet-1883	564	11	mishra	mishra	PROPN
admet-1883	564	12	,	,	PUNCT
admet-1883	564	13	u.b	u.b	PROPN
admet-1883	564	14	.	.	PROPN
admet-1883	564	15	kompella	kompella	PROPN
admet-1883	564	16	,	,	PUNCT
admet-1883	564	17	j.j	j.j	PROPN
admet-1883	564	18	.	.	PROPN
admet-1883	564	19	panda	panda	NOUN
admet-1883	564	20	.	.	PUNCT
admet-1883	565	1	repurposed	repurpose	VERB
admet-1883	565	2	drugs	drug	NOUN
admet-1883	565	3	,	,	PUNCT
admet-1883	565	4	molecular	molecular	ADJ
admet-1883	565	5	vaccines	vaccine	NOUN
admet-1883	565	6	,	,	PUNCT
admet-1883	565	7	immune‐modulators	immune‐modulator	NOUN
admet-1883	565	8	,	,	PUNCT
admet-1883	565	9	and	and	CCONJ
admet-1883	565	10	nanotherapeutics	nanotherapeutic	VERB
admet-1883	565	11	to	to	PART
admet-1883	565	12	treat	treat	VERB
admet-1883	565	13	and	and	CCONJ
admet-1883	565	14	prevent	prevent	VERB
admet-1883	565	15	covid‐19	covid‐19	PROPN
admet-1883	565	16	associated	associate	VERB
admet-1883	565	17	with	with	ADP
admet-1883	565	18	sars‐	sars‐	PROPN
admet-1883	565	19	cov‐2	cov‐2	PROPN
admet-1883	565	20	,	,	PUNCT
admet-1883	565	21	a	a	DET
admet-1883	565	22	deadly	deadly	ADJ
admet-1883	565	23	nanovector	nanovector	NOUN
admet-1883	565	24	.	.	PUNCT
admet-1883	566	1	advanced	advanced	ADJ
admet-1883	566	2	therapeutics	therapeutic	NOUN
admet-1883	566	3	4	4	NUM
admet-1883	566	4	(	(	PUNCT
admet-1883	566	5	2021	2021	NUM
admet-1883	566	6	)	)	PUNCT
admet-1883	566	7	2000172	2000172	NUM
admet-1883	566	8	.	.	PUNCT
admet-1883	567	1	https://doi.org/10.1002/	https://doi.org/10.1002/	PROPN
admet-1883	567	2	adtp.202000172	adtp.202000172	PROPN
admet-1883	567	3	.	.	PUNCT
admet-1883	568	1	[	[	X
admet-1883	568	2	65	65	NUM
admet-1883	568	3	]	]	X
admet-1883	568	4	s.	s.	PROPN
admet-1883	568	5	mouffak	mouffak	PROPN
admet-1883	568	6	,	,	PUNCT
admet-1883	568	7	q.	q.	PROPN
admet-1883	568	8	shubbar	shubbar	PROPN
admet-1883	568	9	,	,	PUNCT
admet-1883	568	10	e.	e.	PROPN
admet-1883	568	11	saleh	saleh	PROPN
admet-1883	568	12	,	,	PUNCT
admet-1883	568	13	r.	r.	PROPN
admet-1883	568	14	el	el	PROPN
admet-1883	568	15	-	-	PUNCT
admet-1883	568	16	awady	awady	PROPN
admet-1883	568	17	.	.	PUNCT
admet-1883	569	1	recent	recent	ADJ
admet-1883	569	2	advances	advance	NOUN
admet-1883	569	3	in	in	ADP
admet-1883	569	4	management	management	NOUN
admet-1883	569	5	of	of	ADP
admet-1883	569	6	covid-19	covid-19	PROPN
admet-1883	569	7	:	:	PUNCT
admet-1883	569	8	a	a	DET
admet-1883	569	9	review	review	NOUN
admet-1883	569	10	.	.	PUNCT
admet-1883	570	1	biomedicine	biomedicine	NOUN
admet-1883	570	2	and	and	CCONJ
admet-1883	570	3	pharmacotherapy	pharmacotherapy	NOUN
admet-1883	570	4	143	143	NUM
admet-1883	570	5	(	(	PUNCT
admet-1883	570	6	2021	2021	NUM
admet-1883	570	7	)	)	PUNCT
admet-1883	570	8	112107	112107	NUM
admet-1883	570	9	.	.	PUNCT
admet-1883	571	1	https://doi.org/10.1016/j.bio	https://doi.org/10.1016/j.bio	PUNCT
admet-1883	571	2	pha.2021.112107	pha.2021.112107	NOUN
admet-1883	571	3	.	.	PUNCT
admet-1883	572	1	[	[	X
admet-1883	572	2	66	66	NUM
admet-1883	572	3	]	]	PUNCT
admet-1883	572	4	k.	k.	PROPN
admet-1883	572	5	girigoswami	girigoswami	PROPN
admet-1883	572	6	,	,	PUNCT
admet-1883	572	7	p.	p.	PROPN
admet-1883	572	8	pallavi	pallavi	PROPN
admet-1883	572	9	,	,	PUNCT
admet-1883	572	10	a.	a.	NOUN
admet-1883	572	11	girigoswami	girigoswami	PROPN
admet-1883	572	12	,	,	PUNCT
admet-1883	572	13	targeting	target	VERB
admet-1883	572	14	cancer	cancer	NOUN
admet-1883	572	15	stem	stem	NOUN
admet-1883	572	16	cells	cell	NOUN
admet-1883	572	17	by	by	ADP
admet-1883	572	18	nanoenabled	nanoenable	VERB
admet-1883	572	19	drug	drug	NOUN
admet-1883	572	20	delivery	delivery	NOUN
admet-1883	572	21	,	,	PUNCT
admet-1883	572	22	in	in	ADP
admet-1883	572	23	cancer	cancer	NOUN
admet-1883	572	24	stem	stem	NOUN
admet-1883	572	25	cells	cell	NOUN
admet-1883	572	26	:	:	PUNCT
admet-1883	572	27	new	new	ADJ
admet-1883	572	28	horizons	horizon	NOUN
admet-1883	572	29	in	in	ADP
admet-1883	572	30	cancer	cancer	NOUN
admet-1883	572	31	therapies	therapy	NOUN
admet-1883	572	32	,	,	PUNCT
admet-1883	572	33	springer2020	springer2020	PROPN
admet-1883	572	34	,	,	PUNCT
admet-1883	572	35	p.	p.	NOUN
admet-1883	572	36	313	313	NUM
admet-1883	572	37	-	-	SYM
admet-1883	572	38	337	337	NUM
admet-1883	572	39	.	.	PUNCT
admet-1883	573	1	https://doi.org/10.1007/978-981-15-5120-8_17	https://doi.org/10.1007/978-981-15-5120-8_17	X
admet-1883	573	2	.	.	PUNCT
admet-1883	574	1	[	[	X
admet-1883	574	2	67	67	NUM
admet-1883	574	3	]	]	PUNCT
admet-1883	574	4	m.	m.	NOUN
admet-1883	574	5	vimaladevi	vimaladevi	PROPN
admet-1883	574	6	,	,	PUNCT
admet-1883	574	7	k.c	k.c	PROPN
admet-1883	574	8	.	.	PROPN
admet-1883	574	9	divya	divya	PROPN
admet-1883	574	10	,	,	PUNCT
admet-1883	574	11	a.	a.	PROPN
admet-1883	574	12	girigoswami	girigoswami	PROPN
admet-1883	574	13	.	.	PUNCT
admet-1883	575	1	liposomal	liposomal	PROPN
admet-1883	575	2	nanoformulations	nanoformulation	NOUN
admet-1883	575	3	of	of	ADP
admet-1883	575	4	rhodamine	rhodamine	NOUN
admet-1883	575	5	for	for	ADP
admet-1883	575	6	targeted	target	VERB
admet-1883	575	7	photodynamic	photodynamic	ADJ
admet-1883	575	8	inactivation	inactivation	NOUN
admet-1883	575	9	of	of	ADP
admet-1883	575	10	multidrug	multidrug	NOUN
admet-1883	575	11	resistant	resistant	ADJ
admet-1883	575	12	gram	gram	NOUN
admet-1883	575	13	negative	negative	ADJ
admet-1883	575	14	bacteria	bacteria	NOUN
admet-1883	575	15	in	in	ADP
admet-1883	575	16	sewage	sewage	NOUN
admet-1883	575	17	treatment	treatment	NOUN
admet-1883	575	18	plant	plant	NOUN
admet-1883	575	19	.	.	PUNCT
admet-1883	576	1	journal	journal	NOUN
admet-1883	576	2	of	of	ADP
admet-1883	576	3	photochemistry	photochemistry	NOUN
admet-1883	576	4	and	and	CCONJ
admet-1883	576	5	photobiology	photobiology	NOUN
admet-1883	576	6	b	b	NOUN
admet-1883	576	7	:	:	PUNCT
admet-1883	576	8	biology	biology	NOUN
admet-1883	576	9	162	162	NUM
admet-1883	576	10	(	(	PUNCT
admet-1883	576	11	2016	2016	NUM
admet-1883	576	12	)	)	PUNCT
admet-1883	576	13	146	146	NUM
admet-1883	576	14	-	-	SYM
admet-1883	576	15	152	152	NUM
admet-1883	576	16	.	.	PUNCT
admet-1883	577	1	https://doi.org/	https://doi.org/	VERB
admet-1883	577	2	10.1016	10.1016	NUM
admet-1883	577	3	/	/	SYM
admet-1883	577	4	j.jphotobiol.2016.06.034	j.jphotobiol.2016.06.034	NOUN
admet-1883	577	5	.	.	PUNCT
admet-1883	578	1	[	[	X
admet-1883	578	2	68	68	NUM
admet-1883	578	3	]	]	X
admet-1883	578	4	l.v	l.v	PROPN
admet-1883	578	5	.	.	PROPN
admet-1883	578	6	chekulayeva	chekulayeva	PROPN
admet-1883	578	7	,	,	PUNCT
admet-1883	578	8	i.n	i.n	PROPN
admet-1883	578	9	.	.	PROPN
admet-1883	578	10	shevchuk	shevchuk	PROPN
admet-1883	578	11	,	,	PUNCT
admet-1883	578	12	v.a	v.a	PROPN
admet-1883	578	13	.	.	PROPN
admet-1883	578	14	chekulayev	chekulayev	PROPN
admet-1883	578	15	,	,	PUNCT
admet-1883	578	16	k.	k.	PROPN
admet-1883	578	17	ilmarinen	ilmarinen	PROPN
admet-1883	578	18	.	.	PUNCT
admet-1883	579	1	hydrogen	hydrogen	NOUN
admet-1883	579	2	peroxide	peroxide	NOUN
admet-1883	579	3	,	,	PUNCT
admet-1883	579	4	superoxide	superoxide	NOUN
admet-1883	579	5	,	,	PUNCT
admet-1883	579	6	and	and	CCONJ
admet-1883	579	7	hydroxyl	hydroxyl	NOUN
admet-1883	579	8	radicals	radical	NOUN
admet-1883	579	9	are	be	AUX
admet-1883	579	10	involved	involve	VERB
admet-1883	579	11	in	in	ADP
admet-1883	579	12	the	the	DET
admet-1883	579	13	phototoxic	phototoxic	ADJ
admet-1883	579	14	action	action	NOUN
admet-1883	579	15	of	of	ADP
admet-1883	579	16	hematoporphyrin	hematoporphyrin	NOUN
admet-1883	579	17	derivative	derivative	ADJ
admet-1883	579	18	against	against	ADP
admet-1883	579	19	tumor	tumor	NOUN
admet-1883	579	20	cells	cell	NOUN
admet-1883	579	21	.	.	PUNCT
admet-1883	580	1	journal	journal	PROPN
admet-1883	580	2	of	of	ADP
admet-1883	580	3	environmental	environmental	ADJ
admet-1883	580	4	pathology	pathology	NOUN
admet-1883	580	5	,	,	PUNCT
admet-1883	580	6	toxicology	toxicology	NOUN
admet-1883	580	7	and	and	CCONJ
admet-1883	580	8	oncology	oncology	NOUN
admet-1883	580	9	25	25	NUM
admet-1883	580	10	(	(	PUNCT
admet-1883	580	11	2006	2006	NUM
admet-1883	580	12	)	)	PUNCT
admet-1883	580	13	.	.	PUNCT
admet-1883	581	1	https://doi.org/10.1615/jenvironpatholtoxicoloncol.v25.i1-2.40	https://doi.org/10.1615/jenvironpatholtoxicoloncol.v25.i1-2.40	PROPN
admet-1883	581	2	.	.	PUNCT
admet-1883	582	1	[	[	X
admet-1883	582	2	69	69	NUM
admet-1883	582	3	]	]	PUNCT
admet-1883	582	4	m.	m.	NOUN
admet-1883	582	5	price	price	NOUN
admet-1883	582	6	,	,	PUNCT
admet-1883	582	7	j.j	j.j	PROPN
admet-1883	582	8	.	.	PROPN
admet-1883	582	9	reiners	reiner	NOUN
admet-1883	582	10	,	,	PUNCT
admet-1883	582	11	a.m.	a.m.	PROPN
admet-1883	582	12	santiago	santiago	PROPN
admet-1883	582	13	,	,	PUNCT
admet-1883	582	14	d.	d.	PROPN
admet-1883	582	15	kessel	kessel	PROPN
admet-1883	582	16	.	.	PUNCT
admet-1883	583	1	monitoring	monitor	VERB
admet-1883	583	2	singlet	singlet	ADJ
admet-1883	583	3	oxygen	oxygen	NOUN
admet-1883	583	4	and	and	CCONJ
admet-1883	583	5	hydroxyl	hydroxyl	NOUN
admet-1883	583	6	radical	radical	ADJ
admet-1883	583	7	formation	formation	NOUN
admet-1883	583	8	with	with	ADP
admet-1883	583	9	fluorescent	fluorescent	ADJ
admet-1883	583	10	probes	probe	NOUN
admet-1883	583	11	during	during	ADP
admet-1883	583	12	photodynamic	photodynamic	ADJ
admet-1883	583	13	therapy	therapy	NOUN
admet-1883	583	14	.	.	PUNCT
admet-1883	584	1	photochemistry	photochemistry	NOUN
admet-1883	584	2	and	and	CCONJ
admet-1883	584	3	photobiology	photobiology	NOUN
admet-1883	584	4	85	85	NUM
admet-1883	584	5	(	(	PUNCT
admet-1883	584	6	2009	2009	NUM
admet-1883	584	7	)	)	PUNCT
admet-1883	584	8	1177	1177	NUM
admet-1883	584	9	-	-	SYM
admet-1883	584	10	1181	1181	NUM
admet-1883	584	11	.	.	PUNCT
admet-1883	585	1	https://doi.org/10.1111/j.1751-1097.2009.00555.x	https://doi.org/10.1111/j.1751-1097.2009.00555.x	NOUN
admet-1883	585	2	.	.	PUNCT
admet-1883	586	1	[	[	X
admet-1883	586	2	70	70	NUM
admet-1883	586	3	]	]	X
admet-1883	586	4	e.s	e.s	PROPN
admet-1883	586	5	.	.	PROPN
admet-1883	586	6	shibu	shibu	PROPN
admet-1883	586	7	,	,	PUNCT
admet-1883	586	8	m.	m.	PROPN
admet-1883	586	9	hamada	hamada	PROPN
admet-1883	586	10	,	,	PUNCT
admet-1883	586	11	n.	n.	PROPN
admet-1883	586	12	murase	murase	PROPN
admet-1883	586	13	,	,	PUNCT
admet-1883	586	14	v.	v.	PROPN
admet-1883	586	15	biju	biju	PROPN
admet-1883	586	16	.	.	PUNCT
admet-1883	586	17	nanomaterials	nanomaterial	NOUN
admet-1883	586	18	formulations	formulation	NOUN
admet-1883	586	19	for	for	ADP
admet-1883	586	20	photothermal	photothermal	ADJ
admet-1883	586	21	and	and	CCONJ
admet-1883	586	22	photodynamic	photodynamic	ADJ
admet-1883	586	23	therapy	therapy	NOUN
admet-1883	586	24	of	of	ADP
admet-1883	586	25	cancer	cancer	NOUN
admet-1883	586	26	.	.	PUNCT
admet-1883	587	1	journal	journal	NOUN
admet-1883	587	2	of	of	ADP
admet-1883	587	3	photochemistry	photochemistry	NOUN
admet-1883	587	4	and	and	CCONJ
admet-1883	587	5	photobiology	photobiology	NOUN
admet-1883	587	6	c	c	NOUN
admet-1883	587	7	:	:	PUNCT
admet-1883	587	8	photochemistry	photochemistry	NOUN
admet-1883	587	9	reviews	review	NOUN
admet-1883	587	10	15	15	NUM
admet-1883	587	11	(	(	PUNCT
admet-1883	587	12	2013	2013	NUM
admet-1883	587	13	)	)	PUNCT
admet-1883	587	14	53	53	NUM
admet-1883	587	15	-	-	SYM
admet-1883	587	16	72	72	NUM
admet-1883	587	17	.	.	PUNCT
admet-1883	588	1	https://doi.org/10.1016/j.jphotochemrev.2012.09.004	https://doi.org/10.1016/j.jphotochemrev.2012.09.004	NOUN
admet-1883	588	2	.	.	PUNCT
admet-1883	589	1	[	[	X
admet-1883	589	2	71	71	NUM
admet-1883	589	3	]	]	X
admet-1883	589	4	a.p	a.p	PROPN
admet-1883	589	5	.	.	PROPN
admet-1883	589	6	castano	castano	PROPN
admet-1883	589	7	,	,	PUNCT
admet-1883	589	8	t.n	t.n	PROPN
admet-1883	589	9	.	.	PROPN
admet-1883	589	10	demidova	demidova	PROPN
admet-1883	589	11	,	,	PUNCT
admet-1883	589	12	m.r	m.r	PROPN
admet-1883	589	13	.	.	PROPN
admet-1883	589	14	hamblin	hamblin	PROPN
admet-1883	589	15	.	.	PUNCT
admet-1883	590	1	mechanisms	mechanism	NOUN
admet-1883	590	2	in	in	ADP
admet-1883	590	3	photodynamic	photodynamic	ADJ
admet-1883	590	4	therapy	therapy	NOUN
admet-1883	590	5	:	:	PUNCT
admet-1883	590	6	part	part	NOUN
admet-1883	590	7	three	three	NUM
admet-1883	590	8	—	—	PUNCT
admet-1883	590	9	photosensitizer	photosensitizer	NOUN
admet-1883	590	10	pharmacokinetics	pharmacokinetic	NOUN
admet-1883	590	11	,	,	PUNCT
admet-1883	590	12	biodistribution	biodistribution	NOUN
admet-1883	590	13	,	,	PUNCT
admet-1883	590	14	tumor	tumor	NOUN
admet-1883	590	15	localization	localization	NOUN
admet-1883	590	16	and	and	CCONJ
admet-1883	590	17	modes	mode	NOUN
admet-1883	590	18	of	of	ADP
admet-1883	590	19	tumor	tumor	NOUN
admet-1883	590	20	destruction	destruction	NOUN
admet-1883	590	21	.	.	PUNCT
admet-1883	591	1	photodiagnosis	photodiagnosis	NOUN
admet-1883	591	2	and	and	CCONJ
admet-1883	591	3	photodynamic	photodynamic	ADJ
admet-1883	591	4	therapy	therapy	NOUN
admet-1883	591	5	2	2	NUM
admet-1883	591	6	(	(	PUNCT
admet-1883	591	7	2005	2005	NUM
admet-1883	591	8	)	)	PUNCT
admet-1883	591	9	91	91	NUM
admet-1883	591	10	-	-	SYM
admet-1883	591	11	106	106	NUM
admet-1883	591	12	.	.	PUNCT
admet-1883	592	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
admet-1883	592	2	s1572	s1572	NOUN
admet-1883	592	3	-	-	PUNCT
admet-1883	592	4	1000(05)00060	1000(05)00060	NUM
admet-1883	592	5	-	-	PUNCT
admet-1883	592	6	8	8	NUM
admet-1883	592	7	.	.	PUNCT
admet-1883	593	1	[	[	X
admet-1883	593	2	72	72	NUM
admet-1883	593	3	]	]	X
admet-1883	593	4	j.m	j.m	PROPN
admet-1883	593	5	.	.	PROPN
admet-1883	593	6	dąbrowski	dąbrowski	PROPN
admet-1883	593	7	,	,	PUNCT
admet-1883	593	8	l.g	l.g	PROPN
admet-1883	593	9	.	.	PROPN
admet-1883	593	10	arnaut	arnaut	PROPN
admet-1883	593	11	.	.	PUNCT
admet-1883	594	1	photodynamic	photodynamic	ADJ
admet-1883	594	2	therapy	therapy	NOUN
admet-1883	594	3	(	(	PUNCT
admet-1883	594	4	pdt	pdt	PROPN
admet-1883	594	5	)	)	PUNCT
admet-1883	594	6	of	of	ADP
admet-1883	594	7	cancer	cancer	NOUN
admet-1883	594	8	:	:	PUNCT
admet-1883	594	9	from	from	ADP
admet-1883	594	10	local	local	ADJ
admet-1883	594	11	to	to	ADP
admet-1883	594	12	systemic	systemic	ADJ
admet-1883	594	13	treatment	treatment	NOUN
admet-1883	594	14	.	.	PUNCT
admet-1883	595	1	photochemical	photochemical	PROPN
admet-1883	595	2	&	&	CCONJ
admet-1883	595	3	photobiological	photobiological	ADJ
admet-1883	595	4	sciences	science	NOUN
admet-1883	595	5	14	14	NUM
admet-1883	595	6	(	(	PUNCT
admet-1883	595	7	2015	2015	NUM
admet-1883	595	8	)	)	PUNCT
admet-1883	595	9	1765	1765	NUM
admet-1883	595	10	-	-	SYM
admet-1883	595	11	1780	1780	NUM
admet-1883	595	12	.	.	PUNCT
admet-1883	596	1	https://doi.org/	https://doi.org/	VERB
admet-1883	596	2	10.1039	10.1039	NUM
admet-1883	596	3	/	/	SYM
admet-1883	596	4	c5pp00132c	c5pp00132c	PROPN
admet-1883	596	5	.	.	PUNCT
admet-1883	597	1	[	[	X
admet-1883	597	2	73	73	NUM
admet-1883	597	3	]	]	PUNCT
admet-1883	597	4	p.	p.	NOUN
admet-1883	597	5	hillemanns	hillemanns	PROPN
admet-1883	597	6	,	,	PUNCT
admet-1883	597	7	m.h	m.h	PROPN
admet-1883	597	8	.	.	PROPN
admet-1883	597	9	einstein	einstein	PROPN
admet-1883	597	10	,	,	PUNCT
admet-1883	597	11	o.e	o.e	PROPN
admet-1883	597	12	.	.	PROPN
admet-1883	597	13	iversen	iversen	PROPN
admet-1883	597	14	.	.	PUNCT
admet-1883	598	1	topical	topical	ADJ
admet-1883	598	2	hexaminolevulinate	hexaminolevulinate	ADJ
admet-1883	598	3	photodynamic	photodynamic	ADJ
admet-1883	598	4	therapy	therapy	NOUN
admet-1883	598	5	for	for	ADP
admet-1883	598	6	the	the	DET
admet-1883	598	7	treatment	treatment	NOUN
admet-1883	598	8	of	of	ADP
admet-1883	598	9	persistent	persistent	ADJ
admet-1883	598	10	human	human	ADJ
admet-1883	598	11	papilloma	papilloma	NOUN
admet-1883	598	12	virus	virus	NOUN
admet-1883	598	13	infections	infection	NOUN
admet-1883	598	14	and	and	CCONJ
admet-1883	598	15	cervical	cervical	ADJ
admet-1883	598	16	intraepithelial	intraepithelial	ADJ
admet-1883	598	17	neoplasia	neoplasia	NOUN
admet-1883	598	18	.	.	PUNCT
admet-1883	599	1	https://doi.org/10.5599/admet.1883	https://doi.org/10.5599/admet.1883	PROPN
admet-1883	599	2	https://doi.org/10.3389/fchem.2021.672739	https://doi.org/10.3389/fchem.2021.672739	PROPN
admet-1883	599	3	https://doi.org/10.2217/nnm-2019-0155	https://doi.org/10.2217/nnm-2019-0155	PROPN
admet-1883	599	4	https://doi.org/10.1016/j.nanoso.2020.100636	https://doi.org/10.1016/j.nanoso.2020.100636	PROPN
admet-1883	599	5	https://doi.org/10.3390/chemistry4010001	https://doi.org/10.3390/chemistry4010001	PROPN
admet-1883	599	6	https://doi.org/10.1021/acsanm.0c01978	https://doi.org/10.1021/acsanm.0c01978	NOUN
admet-1883	599	7	https://doi.org/‌10.1016/‌j.talanta.2022.123356	https://doi.org/‌10.1016/‌j.talanta.2022.123356	NOUN
admet-1883	599	8	https://doi.org/‌10.1016/‌j.talanta.2022.123356	https://doi.org/‌10.1016/‌j.talanta.2022.123356	NOUN
admet-1883	599	9	https://doi.org/10.1002/‌adtp.202000172	https://doi.org/10.1002/‌adtp.202000172	PROPN
admet-1883	599	10	https://doi.org/10.1002/‌adtp.202000172	https://doi.org/10.1002/‌adtp.202000172	VERB
admet-1883	599	11	https://doi.org/10.1016/j.bio‌pha.2021.112107	https://doi.org/10.1016/j.bio‌pha.2021.112107	INTJ
admet-1883	600	1	https://doi.org/10.1016/j.bio‌pha.2021.112107	https://doi.org/10.1016/j.bio‌pha.2021.112107	INTJ
admet-1883	600	2	https://doi.org/10.1007/978-981-15-5120-8_17	https://doi.org/10.1007/978-981-15-5120-8_17	NOUN
admet-1883	600	3	https://doi.org/‌10.1016/j.jphotobiol.2016.06.034	https://doi.org/‌10.1016/j.jphotobiol.2016.06.034	NOUN
admet-1883	600	4	https://doi.org/‌10.1016/j.jphotobiol.2016.06.034	https://doi.org/‌10.1016/j.jphotobiol.2016.06.034	NOUN
admet-1883	601	1	https://doi.org/10.1615/jenvironpatholtoxicoloncol.v25.i1-2.40	https://doi.org/10.1615/jenvironpatholtoxicoloncol.v25.i1-2.40	NOUN
admet-1883	601	2	https://doi.org/10.1111/j.1751-1097.2009.00555.x	https://doi.org/10.1111/j.1751-1097.2009.00555.x	NOUN
admet-1883	601	3	https://doi.org/10.1016/j.jphotochemrev.2012.09.004	https://doi.org/10.1016/j.jphotochemrev.2012.09.004	NOUN
admet-1883	601	4	https://doi.org/10.1016/‌s1572-1000(05)00060-8	https://doi.org/10.1016/‌s1572-1000(05)00060-8	NUM
admet-1883	601	5	https://doi.org/10.1016/‌s1572-1000(05)00060-8	https://doi.org/10.1016/‌s1572-1000(05)00060-8	NUM
admet-1883	601	6	https://doi.org/‌10.1039/c5pp00132c	https://doi.org/‌10.1039/c5pp00132c	PROPN
admet-1883	601	7	https://doi.org/‌10.1039/c5pp00132c	https://doi.org/‌10.1039/c5pp00132c	PROPN
admet-1883	601	8	p.	p.	PROPN
admet-1883	601	9	pallavi	pallavi	VERB
admet-1883	601	10	et	et	PROPN
admet-1883	601	11	al	al	PROPN
admet-1883	601	12	.	.	PROPN
admet-1883	601	13	admet	admet	PROPN
admet-1883	601	14	&	&	CCONJ
admet-1883	601	15	dmpk	dmpk	PROPN
admet-1883	601	16	11(4	11(4	NUM
admet-1883	601	17	)	)	PUNCT
admet-1883	601	18	(	(	PUNCT
admet-1883	601	19	2023	2023	NUM
admet-1883	601	20	)	)	PUNCT
admet-1883	602	1	513	513	NUM
admet-1883	602	2	-	-	SYM
admet-1883	602	3	531	531	NUM
admet-1883	602	4	530	530	NUM
admet-1883	602	5	expert	expert	NOUN
admet-1883	602	6	opinion	opinion	NOUN
admet-1883	602	7	on	on	ADP
admet-1883	602	8	investigational	investigational	ADJ
admet-1883	602	9	drugs	drug	NOUN
admet-1883	602	10	24	24	NUM
admet-1883	602	11	(	(	PUNCT
admet-1883	602	12	2015	2015	NUM
admet-1883	602	13	)	)	PUNCT
admet-1883	602	14	273	273	NUM
admet-1883	602	15	-	-	SYM
admet-1883	602	16	281	281	NUM
admet-1883	602	17	.	.	PUNCT
admet-1883	602	18	https://doi.org/10.1517/13543784.20	https://doi.org/10.1517/13543784.20	NOUN
admet-1883	602	19	15.990150	15.990150	NUM
admet-1883	602	20	.	.	PUNCT
admet-1883	603	1	[	[	X
admet-1883	603	2	74	74	NUM
admet-1883	603	3	]	]	X
admet-1883	603	4	ld	ld	PROPN
admet-1883	603	5	.	.	PUNCT
admet-1883	603	6	dias	dias	PROPN
admet-1883	603	7	,	,	PUNCT
admet-1883	603	8	v.s.	v.s.	ADJ
admet-1883	603	9	bagnato	bagnato	NOUN
admet-1883	603	10	.	.	PUNCT
admet-1883	604	1	an	an	DET
admet-1883	604	2	update	update	NOUN
admet-1883	604	3	on	on	ADP
admet-1883	604	4	clinical	clinical	ADJ
admet-1883	604	5	photodynamic	photodynamic	ADJ
admet-1883	604	6	therapy	therapy	NOUN
admet-1883	604	7	for	for	ADP
admet-1883	604	8	fighting	fight	VERB
admet-1883	604	9	respiratory	respiratory	ADJ
admet-1883	604	10	tract	tract	NOUN
admet-1883	604	11	infections	infection	NOUN
admet-1883	604	12	:	:	PUNCT
admet-1883	604	13	a	a	DET
admet-1883	604	14	promising	promising	ADJ
admet-1883	604	15	tool	tool	NOUN
admet-1883	604	16	against	against	ADP
admet-1883	604	17	covid-19	covid-19	PROPN
admet-1883	604	18	and	and	CCONJ
admet-1883	604	19	its	its	PRON
admet-1883	604	20	co	co	NOUN
admet-1883	604	21	-	-	NOUN
admet-1883	604	22	infections	infection	NOUN
admet-1883	604	23	.	.	PUNCT
admet-1883	605	1	laser	laser	NOUN
admet-1883	605	2	physics	physics	NOUN
admet-1883	605	3	letters	letter	NOUN
admet-1883	605	4	17	17	NUM
admet-1883	605	5	(	(	PUNCT
admet-1883	605	6	2020	2020	NUM
admet-1883	605	7	)	)	PUNCT
admet-1883	605	8	083001	083001	NUM
admet-1883	605	9	.	.	PUNCT
admet-1883	606	1	https://doi.org/10.1088/1612-202x/ab95a9	https://doi.org/10.1088/1612-202x/ab95a9	X
admet-1883	606	2	.	.	PUNCT
admet-1883	607	1	[	[	X
admet-1883	607	2	75	75	NUM
admet-1883	607	3	]	]	X
admet-1883	607	4	v.a	v.a	PROPN
admet-1883	607	5	.	.	PROPN
admet-1883	607	6	svyatchenko	svyatchenko	PROPN
admet-1883	607	7	,	,	PUNCT
admet-1883	607	8	s.d	s.d	PROPN
admet-1883	607	9	.	.	PROPN
admet-1883	607	10	nikonov	nikonov	PROPN
admet-1883	607	11	,	,	PUNCT
admet-1883	607	12	a.p	a.p	PROPN
admet-1883	607	13	.	.	PROPN
admet-1883	607	14	mayorov	mayorov	PROPN
admet-1883	607	15	,	,	PUNCT
admet-1883	607	16	m.l	m.l	PROPN
admet-1883	607	17	.	.	PROPN
admet-1883	607	18	gelfond	gelfond	PROPN
admet-1883	607	19	,	,	PUNCT
admet-1883	607	20	v.b	v.b	PROPN
admet-1883	607	21	.	.	PROPN
admet-1883	607	22	loktev	loktev	PROPN
admet-1883	607	23	.	.	PUNCT
admet-1883	608	1	antiviral	antiviral	ADJ
admet-1883	608	2	photodynamic	photodynamic	ADJ
admet-1883	608	3	therapy	therapy	NOUN
admet-1883	608	4	:	:	PUNCT
admet-1883	608	5	inactivation	inactivation	NOUN
admet-1883	608	6	and	and	CCONJ
admet-1883	608	7	inhibition	inhibition	NOUN
admet-1883	608	8	of	of	ADP
admet-1883	608	9	sars	sar	NOUN
admet-1883	608	10	-	-	PUNCT
admet-1883	608	11	cov-2	cov-2	NOUN
admet-1883	608	12	in	in	ADP
admet-1883	608	13	vitro	vitro	X
admet-1883	608	14	using	use	VERB
admet-1883	608	15	methylene	methylene	ADJ
admet-1883	608	16	blue	blue	NOUN
admet-1883	608	17	and	and	CCONJ
admet-1883	608	18	radachlorin	radachlorin	NOUN
admet-1883	608	19	.	.	PUNCT
admet-1883	609	1	photodiagnosis	photodiagnosis	NOUN
admet-1883	609	2	and	and	CCONJ
admet-1883	609	3	photodynamic	photodynamic	ADJ
admet-1883	609	4	therapy	therapy	NOUN
admet-1883	609	5	33	33	NUM
admet-1883	609	6	(	(	PUNCT
admet-1883	609	7	2021	2021	NUM
admet-1883	609	8	)	)	PUNCT
admet-1883	609	9	102112	102112	NUM
admet-1883	609	10	.	.	PUNCT
admet-1883	610	1	https://doi.org/10.1016/j.pdpdt.20	https://doi.org/10.1016/j.pdpdt.20	X
admet-1883	610	2	20.102112	20.102112	NUM
admet-1883	610	3	.	.	PUNCT
admet-1883	611	1	[	[	X
admet-1883	611	2	76	76	NUM
admet-1883	611	3	]	]	X
admet-1883	611	4	k.	k.	PROPN
admet-1883	611	5	khorsandi	khorsandi	PROPN
admet-1883	611	6	,	,	PUNCT
admet-1883	611	7	s.	s.	PROPN
admet-1883	611	8	fekrazad	fekrazad	PROPN
admet-1883	611	9	,	,	PUNCT
admet-1883	611	10	f.	f.	PROPN
admet-1883	611	11	vahdatinia	vahdatinia	PROPN
admet-1883	611	12	,	,	PUNCT
admet-1883	611	13	a.	a.	NOUN
admet-1883	611	14	farmany	farmany	PROPN
admet-1883	611	15	,	,	PUNCT
admet-1883	611	16	r.	r.	PROPN
admet-1883	611	17	fekrazad	fekrazad	PROPN
admet-1883	611	18	.	.	PUNCT
admet-1883	612	1	nano	nano	ADJ
admet-1883	612	2	antiviral	antiviral	ADJ
admet-1883	612	3	photodynamic	photodynamic	ADJ
admet-1883	612	4	therapy	therapy	NOUN
admet-1883	612	5	:	:	PUNCT
admet-1883	612	6	a	a	DET
admet-1883	612	7	probable	probable	ADJ
admet-1883	612	8	biophysicochemical	biophysicochemical	ADJ
admet-1883	612	9	management	management	NOUN
admet-1883	612	10	modality	modality	NOUN
admet-1883	612	11	in	in	ADP
admet-1883	612	12	sars	sar	NOUN
admet-1883	612	13	-	-	PUNCT
admet-1883	612	14	cov-2	cov-2	NOUN
admet-1883	612	15	.	.	PUNCT
admet-1883	613	1	expert	expert	ADJ
admet-1883	613	2	opinion	opinion	NOUN
admet-1883	613	3	on	on	ADP
admet-1883	613	4	drug	drug	NOUN
admet-1883	613	5	delivery	delivery	NOUN
admet-1883	613	6	18	18	NUM
admet-1883	613	7	(	(	PUNCT
admet-1883	613	8	2021	2021	NUM
admet-1883	613	9	)	)	PUNCT
admet-1883	613	10	265	265	NUM
admet-1883	613	11	-	-	SYM
admet-1883	613	12	272	272	NUM
admet-1883	613	13	.	.	PUNCT
admet-1883	614	1	https://doi.org/10.1080/17425247.2021.1829591	https://doi.org/10.1080/17425247.2021.1829591	VERB
admet-1883	614	2	.	.	PUNCT
admet-1883	615	1	[	[	X
admet-1883	615	2	77	77	NUM
admet-1883	615	3	]	]	X
admet-1883	615	4	c.p	c.p	PROPN
admet-1883	615	5	.	.	PROPN
admet-1883	615	6	sabino	sabino	PROPN
admet-1883	615	7	,	,	PUNCT
admet-1883	615	8	a.r	a.r	PROPN
admet-1883	615	9	.	.	PROPN
admet-1883	615	10	ball	ball	PROPN
admet-1883	615	11	,	,	PUNCT
admet-1883	615	12	m.s	m.s	PROPN
admet-1883	615	13	.	.	PROPN
admet-1883	615	14	baptista	baptista	PROPN
admet-1883	615	15	,	,	PUNCT
admet-1883	615	16	t.	t.	PROPN
admet-1883	615	17	dai	dai	PROPN
admet-1883	615	18	,	,	PUNCT
admet-1883	615	19	m.r	m.r	PROPN
admet-1883	615	20	.	.	PROPN
admet-1883	615	21	hamblin	hamblin	PROPN
admet-1883	615	22	,	,	PUNCT
admet-1883	615	23	m.s	m.s	PROPN
admet-1883	615	24	.	.	PROPN
admet-1883	615	25	ribeiro	ribeiro	PROPN
admet-1883	615	26	,	,	PUNCT
admet-1883	615	27	a.l	a.l	PROPN
admet-1883	615	28	.	.	PROPN
admet-1883	615	29	santos	santos	PROPN
admet-1883	615	30	,	,	PUNCT
admet-1883	615	31	f.p	f.p	PROPN
admet-1883	615	32	.	.	PROPN
admet-1883	615	33	sellera	sellera	PROPN
admet-1883	615	34	,	,	PUNCT
admet-1883	615	35	g.p	g.p	PROPN
admet-1883	615	36	.	.	PROPN
admet-1883	615	37	tegos	tegos	PROPN
admet-1883	615	38	,	,	PUNCT
admet-1883	615	39	m.	m.	NOUN
admet-1883	615	40	wainwright	wainwright	PROPN
admet-1883	615	41	.	.	PUNCT
admet-1883	616	1	light	light	NOUN
admet-1883	616	2	-	-	PUNCT
admet-1883	616	3	based	base	VERB
admet-1883	616	4	technologies	technology	NOUN
admet-1883	616	5	for	for	ADP
admet-1883	616	6	management	management	NOUN
admet-1883	616	7	of	of	ADP
admet-1883	616	8	covid-19	covid-19	PROPN
admet-1883	616	9	pandemic	pandemic	ADJ
admet-1883	616	10	crisis	crisis	NOUN
admet-1883	616	11	.	.	PUNCT
admet-1883	617	1	journal	journal	NOUN
admet-1883	617	2	of	of	ADP
admet-1883	617	3	photochemistry	photochemistry	NOUN
admet-1883	617	4	and	and	CCONJ
admet-1883	617	5	photobiology	photobiology	NOUN
admet-1883	617	6	b	b	NOUN
admet-1883	617	7	:	:	PUNCT
admet-1883	617	8	biology	biology	NOUN
admet-1883	617	9	212	212	NUM
admet-1883	617	10	(	(	PUNCT
admet-1883	617	11	2020	2020	NUM
admet-1883	617	12	)	)	PUNCT
admet-1883	617	13	111999	111999	NUM
admet-1883	617	14	.	.	PUNCT
admet-1883	618	1	https://doi.org/	https://doi.org/	VERB
admet-1883	618	2	10.1016	10.1016	NUM
admet-1883	618	3	/	/	SYM
admet-1883	618	4	j.jphotobiol.2020.111999	j.jphotobiol.2020.111999	NOUN
admet-1883	618	5	.	.	PUNCT
admet-1883	619	1	[	[	X
admet-1883	619	2	78	78	NUM
admet-1883	619	3	]	]	PUNCT
admet-1883	619	4	h.	h.	NOUN
admet-1883	619	5	mahmoudi	mahmoudi	PROPN
admet-1883	619	6	,	,	PUNCT
admet-1883	619	7	a.	a.	NOUN
admet-1883	619	8	bahador	bahador	NOUN
admet-1883	619	9	,	,	PUNCT
admet-1883	619	10	m.	m.	NOUN
admet-1883	619	11	pourhajibagher	pourhajibagher	NOUN
admet-1883	619	12	,	,	PUNCT
admet-1883	619	13	m.y	m.y	PROPN
admet-1883	619	14	.	.	PROPN
admet-1883	619	15	alikhani	alikhani	PROPN
admet-1883	619	16	.	.	PUNCT
admet-1883	620	1	antimicrobial	antimicrobial	ADJ
admet-1883	620	2	photodynamic	photodynamic	ADJ
admet-1883	620	3	therapy	therapy	NOUN
admet-1883	620	4	:	:	PUNCT
admet-1883	620	5	an	an	DET
admet-1883	620	6	effective	effective	ADJ
admet-1883	620	7	alternative	alternative	ADJ
admet-1883	620	8	approach	approach	NOUN
admet-1883	620	9	to	to	PART
admet-1883	620	10	control	control	VERB
admet-1883	620	11	bacterial	bacterial	ADJ
admet-1883	620	12	infections	infection	NOUN
admet-1883	620	13	.	.	PUNCT
admet-1883	621	1	journal	journal	PROPN
admet-1883	621	2	of	of	ADP
admet-1883	621	3	lasers	laser	NOUN
admet-1883	621	4	in	in	ADP
admet-1883	621	5	medical	medical	ADJ
admet-1883	621	6	sciences	science	NOUN
admet-1883	621	7	9	9	NUM
admet-1883	621	8	(	(	PUNCT
admet-1883	621	9	2018	2018	NUM
admet-1883	621	10	)	)	PUNCT
admet-1883	621	11	154	154	NUM
admet-1883	621	12	.	.	PUNCT
admet-1883	622	1	https://doi.org/10.15171/jlms.2018.29	https://doi.org/10.15171/jlms.2018.29	NOUN
admet-1883	622	2	.	.	PUNCT
admet-1883	623	1	[	[	X
admet-1883	623	2	79	79	NUM
admet-1883	623	3	]	]	X
admet-1883	623	4	m.	m.	NOUN
admet-1883	623	5	gheblawi	gheblawi	PROPN
admet-1883	623	6	,	,	PUNCT
admet-1883	623	7	k.	k.	PROPN
admet-1883	623	8	wang	wang	PROPN
admet-1883	623	9	,	,	PUNCT
admet-1883	623	10	a.	a.	NOUN
admet-1883	623	11	viveiros	viveiros	PROPN
admet-1883	623	12	,	,	PUNCT
admet-1883	623	13	q.	q.	NOUN
admet-1883	623	14	nguyen	nguyen	PROPN
admet-1883	623	15	,	,	PUNCT
admet-1883	623	16	j.-c	j.-c	PROPN
admet-1883	623	17	.	.	PUNCT
admet-1883	624	1	zhong	zhong	PROPN
admet-1883	624	2	,	,	PUNCT
admet-1883	624	3	a.j	a.j	PROPN
admet-1883	624	4	.	.	PROPN
admet-1883	624	5	turner	turner	PROPN
admet-1883	624	6	,	,	PUNCT
admet-1883	624	7	m.k	m.k	PROPN
admet-1883	624	8	.	.	PROPN
admet-1883	624	9	raizada	raizada	PROPN
admet-1883	624	10	,	,	PUNCT
admet-1883	624	11	m.b	m.b	PROPN
admet-1883	624	12	.	.	PROPN
admet-1883	624	13	grant	grant	PROPN
admet-1883	624	14	,	,	PUNCT
admet-1883	624	15	g.y	g.y	PROPN
admet-1883	624	16	.	.	PUNCT
admet-1883	624	17	oudit	oudit	PROPN
admet-1883	624	18	.	.	PUNCT
admet-1883	625	1	angiotensin	angiotensin	NOUN
admet-1883	625	2	-	-	PUNCT
admet-1883	625	3	converting	convert	VERB
admet-1883	625	4	enzyme	enzyme	NOUN
admet-1883	625	5	2	2	NUM
admet-1883	625	6	:	:	PUNCT
admet-1883	625	7	sars	sar	NOUN
admet-1883	625	8	-	-	PUNCT
admet-1883	625	9	cov-2	cov-2	NOUN
admet-1883	625	10	receptor	receptor	NOUN
admet-1883	625	11	and	and	CCONJ
admet-1883	625	12	regulator	regulator	NOUN
admet-1883	625	13	of	of	ADP
admet-1883	625	14	the	the	DET
admet-1883	625	15	renin	renin	ADJ
admet-1883	625	16	-	-	PUNCT
admet-1883	625	17	angiotensin	angiotensin	NOUN
admet-1883	625	18	system	system	NOUN
admet-1883	625	19	:	:	PUNCT
admet-1883	625	20	celebrating	celebrate	VERB
admet-1883	625	21	the	the	DET
admet-1883	625	22	20th	20th	ADJ
admet-1883	625	23	anniversary	anniversary	NOUN
admet-1883	625	24	of	of	ADP
admet-1883	625	25	the	the	DET
admet-1883	625	26	discovery	discovery	NOUN
admet-1883	625	27	of	of	ADP
admet-1883	625	28	ace2	ace2	PROPN
admet-1883	625	29	.	.	PUNCT
admet-1883	626	1	circulation	circulation	NOUN
admet-1883	626	2	research	research	NOUN
admet-1883	626	3	126	126	NUM
admet-1883	626	4	(	(	PUNCT
admet-1883	626	5	2020	2020	NUM
admet-1883	626	6	)	)	PUNCT
admet-1883	626	7	1456	1456	NUM
admet-1883	626	8	-	-	SYM
admet-1883	626	9	1474	1474	NUM
admet-1883	626	10	.	.	PUNCT
admet-1883	627	1	https://doi.org/10.1161/circresaha.120.317015	https://doi.org/10.1161/circresaha.120.317015	PROPN
admet-1883	627	2	.	.	PUNCT
admet-1883	628	1	[	[	X
admet-1883	628	2	80	80	NUM
admet-1883	628	3	]	]	PUNCT
admet-1883	628	4	m.	m.	NOUN
admet-1883	628	5	klausen	klausen	PROPN
admet-1883	628	6	,	,	PUNCT
admet-1883	628	7	m.	m.	NOUN
admet-1883	628	8	ucuncu	ucuncu	PROPN
admet-1883	628	9	,	,	PUNCT
admet-1883	628	10	m.	m.	NOUN
admet-1883	628	11	bradley	bradley	PROPN
admet-1883	628	12	.	.	PUNCT
admet-1883	629	1	design	design	NOUN
admet-1883	629	2	of	of	ADP
admet-1883	629	3	photosensitizing	photosensitize	VERB
admet-1883	629	4	agents	agent	NOUN
admet-1883	629	5	for	for	ADP
admet-1883	629	6	targeted	target	VERB
admet-1883	629	7	antimicrobial	antimicrobial	ADJ
admet-1883	629	8	photodynamic	photodynamic	ADJ
admet-1883	629	9	therapy	therapy	NOUN
admet-1883	629	10	.	.	PUNCT
admet-1883	630	1	molecules	molecule	NOUN
admet-1883	630	2	25	25	NUM
admet-1883	630	3	(	(	PUNCT
admet-1883	630	4	2020	2020	NUM
admet-1883	630	5	)	)	PUNCT
admet-1883	630	6	5239	5239	NUM
admet-1883	630	7	.	.	PUNCT
admet-1883	631	1	https://doi.org/10.3390/molecules25225239	https://doi.org/10.3390/molecules25225239	NOUN
admet-1883	631	2	.	.	PUNCT
admet-1883	632	1	[	[	X
admet-1883	632	2	81	81	NUM
admet-1883	632	3	]	]	PUNCT
admet-1883	632	4	s.	s.	PROPN
admet-1883	632	5	sansaloni	sansaloni	PROPN
admet-1883	632	6	-	-	PUNCT
admet-1883	632	7	pastor	pastor	PROPN
admet-1883	632	8	,	,	PUNCT
admet-1883	632	9	j.	j.	PROPN
admet-1883	632	10	bouilloux	bouilloux	PROPN
admet-1883	632	11	,	,	PUNCT
admet-1883	632	12	n.	n.	NOUN
admet-1883	632	13	lange	lange	NOUN
admet-1883	632	14	.	.	PUNCT
admet-1883	633	1	the	the	DET
admet-1883	633	2	dark	dark	ADJ
admet-1883	633	3	side	side	NOUN
admet-1883	633	4	:	:	PUNCT
admet-1883	633	5	photosensitizer	photosensitizer	NOUN
admet-1883	633	6	prodrugs	prodrug	NOUN
admet-1883	633	7	.	.	PUNCT
admet-1883	634	1	pharmaceuticals	pharmaceutical	NOUN
admet-1883	634	2	12	12	NUM
admet-1883	634	3	(	(	PUNCT
admet-1883	634	4	2019	2019	NUM
admet-1883	634	5	)	)	PUNCT
admet-1883	634	6	148	148	NUM
admet-1883	634	7	.	.	PUNCT
admet-1883	634	8	https://doi.org/10.3390/ph12040148	https://doi.org/10.3390/ph12040148	NOUN
admet-1883	634	9	.	.	PUNCT
admet-1883	635	1	[	[	X
admet-1883	635	2	82	82	NUM
admet-1883	635	3	]	]	X
admet-1883	635	4	p.c.a	p.c.a	NOUN
admet-1883	635	5	.	.	PUNCT
admet-1883	635	6	swamy	swamy	PROPN
admet-1883	635	7	,	,	PUNCT
admet-1883	635	8	g.	g.	PROPN
admet-1883	635	9	sivaraman	sivaraman	PROPN
admet-1883	635	10	,	,	PUNCT
admet-1883	635	11	r.n	r.n	PROPN
admet-1883	635	12	.	.	PROPN
admet-1883	635	13	priyanka	priyanka	PROPN
admet-1883	635	14	,	,	PUNCT
admet-1883	635	15	s.o	s.o	PROPN
admet-1883	635	16	.	.	PROPN
admet-1883	635	17	raja	raja	PROPN
admet-1883	635	18	,	,	PUNCT
admet-1883	635	19	k.	k.	PROPN
admet-1883	635	20	ponnuvel	ponnuvel	PROPN
admet-1883	635	21	,	,	PUNCT
admet-1883	635	22	j.	j.	PROPN
admet-1883	635	23	shanmugpriya	shanmugpriya	PROPN
admet-1883	635	24	,	,	PUNCT
admet-1883	635	25	a.	a.	NOUN
admet-1883	635	26	gulyani	gulyani	PROPN
admet-1883	635	27	.	.	PUNCT
admet-1883	636	1	near	near	ADP
admet-1883	636	2	infrared	infrared	PROPN
admet-1883	636	3	(	(	PUNCT
admet-1883	636	4	nir	nir	NOUN
admet-1883	636	5	)	)	PUNCT
admet-1883	636	6	absorbing	absorb	VERB
admet-1883	636	7	dyes	dye	NOUN
admet-1883	636	8	as	as	ADP
admet-1883	636	9	promising	promise	VERB
admet-1883	636	10	photosensitizer	photosensitizer	NOUN
admet-1883	636	11	for	for	ADP
admet-1883	636	12	photo	photo	NOUN
admet-1883	636	13	dynamic	dynamic	ADJ
admet-1883	636	14	therapy	therapy	NOUN
admet-1883	636	15	.	.	PUNCT
admet-1883	637	1	coordination	coordination	NOUN
admet-1883	637	2	chemistry	chemistry	NOUN
admet-1883	637	3	reviews	review	VERB
admet-1883	637	4	411	411	NUM
admet-1883	637	5	(	(	PUNCT
admet-1883	637	6	2020	2020	NUM
admet-1883	637	7	)	)	PUNCT
admet-1883	637	8	213233	213233	NUM
admet-1883	637	9	.	.	PUNCT
admet-1883	638	1	https://doi.org/10.1016/j.ccr.2020.213233	https://doi.org/10.1016/j.ccr.2020.213233	PUNCT
admet-1883	638	2	.	.	PUNCT
admet-1883	639	1	[	[	X
admet-1883	639	2	83	83	NUM
admet-1883	639	3	]	]	PUNCT
admet-1883	639	4	a.	a.	NOUN
admet-1883	639	5	mavridi	mavridi	PROPN
admet-1883	639	6	-	-	PUNCT
admet-1883	639	7	printezi	printezi	NOUN
admet-1883	639	8	,	,	PUNCT
admet-1883	639	9	m.	m.	NOUN
admet-1883	639	10	guernelli	guernelli	PROPN
admet-1883	639	11	,	,	PUNCT
admet-1883	639	12	a.	a.	NOUN
admet-1883	639	13	menichetti	menichetti	PROPN
admet-1883	639	14	,	,	PUNCT
admet-1883	639	15	m.	m.	PROPN
admet-1883	639	16	montalti	montalti	PROPN
admet-1883	639	17	.	.	PUNCT
admet-1883	639	18	bio	bio	PROPN
admet-1883	639	19	-	-	PUNCT
admet-1883	639	20	applications	application	NOUN
admet-1883	639	21	of	of	ADP
admet-1883	639	22	multifunctional	multifunctional	ADJ
admet-1883	639	23	melanin	melanin	NOUN
admet-1883	639	24	nanoparticles	nanoparticle	NOUN
admet-1883	639	25	:	:	PUNCT
admet-1883	639	26	from	from	ADP
admet-1883	639	27	nanomedicine	nanomedicine	NOUN
admet-1883	639	28	to	to	ADP
admet-1883	639	29	nanocosmetics	nanocosmetic	NOUN
admet-1883	639	30	.	.	PUNCT
admet-1883	640	1	nanomaterials	nanomaterial	NOUN
admet-1883	640	2	10	10	NUM
admet-1883	640	3	(	(	PUNCT
admet-1883	640	4	2020	2020	NUM
admet-1883	640	5	)	)	PUNCT
admet-1883	640	6	2276	2276	NUM
admet-1883	640	7	.	.	PUNCT
admet-1883	641	1	https://doi.org/10.3390/nano10112276	https://doi.org/10.3390/nano10112276	NOUN
admet-1883	641	2	.	.	PUNCT
admet-1883	642	1	[	[	X
admet-1883	642	2	84	84	NUM
admet-1883	642	3	]	]	X
admet-1883	642	4	m.e	m.e	PROPN
admet-1883	642	5	.	.	PROPN
admet-1883	642	6	lim	lim	PROPN
admet-1883	642	7	,	,	PUNCT
admet-1883	642	8	y.-l	y.-l	PROPN
admet-1883	642	9	.	.	PUNCT
admet-1883	643	1	lee	lee	PROPN
admet-1883	643	2	,	,	PUNCT
admet-1883	643	3	y.	y.	PROPN
admet-1883	643	4	zhang	zhang	PROPN
admet-1883	643	5	,	,	PUNCT
admet-1883	643	6	j.j.h	j.j.h	NOUN
admet-1883	643	7	.	.	PUNCT
admet-1883	644	1	chu	chu	PROPN
admet-1883	644	2	.	.	PUNCT
admet-1883	645	1	photodynamic	photodynamic	ADJ
admet-1883	645	2	inactivation	inactivation	NOUN
admet-1883	645	3	of	of	ADP
admet-1883	645	4	viruses	virus	NOUN
admet-1883	645	5	using	use	VERB
admet-1883	645	6	upconversion	upconversion	NOUN
admet-1883	645	7	nanoparticles	nanoparticle	NOUN
admet-1883	645	8	.	.	PUNCT
admet-1883	646	1	biomaterials	biomaterial	NOUN
admet-1883	646	2	33	33	NUM
admet-1883	646	3	(	(	PUNCT
admet-1883	646	4	2012	2012	NUM
admet-1883	646	5	)	)	PUNCT
admet-1883	646	6	1912	1912	NUM
admet-1883	646	7	-	-	SYM
admet-1883	646	8	1920	1920	NUM
admet-1883	646	9	.	.	PUNCT
admet-1883	647	1	https://doi.org/10.1016/j.biomaterials.20	https://doi.org/10.1016/j.biomaterials.20	PRON
admet-1883	648	1	11.11.033	11.11.033	PROPN
admet-1883	648	2	.	.	PUNCT
admet-1883	649	1	[	[	X
admet-1883	649	2	85	85	NUM
admet-1883	649	3	]	]	X
admet-1883	649	4	r.	r.	PROPN
admet-1883	649	5	youf	youf	PROPN
admet-1883	649	6	,	,	PUNCT
admet-1883	649	7	m.	m.	NOUN
admet-1883	649	8	müller	müller	PROPN
admet-1883	649	9	,	,	PUNCT
admet-1883	649	10	a.	a.	PROPN
admet-1883	649	11	balasini	balasini	PROPN
admet-1883	649	12	,	,	PUNCT
admet-1883	649	13	f.	f.	PROPN
admet-1883	649	14	thétiot	thétiot	PROPN
admet-1883	649	15	,	,	PUNCT
admet-1883	649	16	m.	m.	NOUN
admet-1883	649	17	müller	müller	PROPN
admet-1883	649	18	,	,	PUNCT
admet-1883	649	19	a.	a.	PROPN
admet-1883	649	20	hascoët	hascoët	PROPN
admet-1883	649	21	,	,	PUNCT
admet-1883	649	22	u.	u.	PROPN
admet-1883	649	23	jonas	jonas	PROPN
admet-1883	649	24	,	,	PUNCT
admet-1883	649	25	h.	h.	PROPN
admet-1883	649	26	schönherr	schönherr	PROPN
admet-1883	649	27	,	,	PUNCT
admet-1883	649	28	g.	g.	PROPN
admet-1883	649	29	lemercier	lemercier	PROPN
admet-1883	649	30	,	,	PUNCT
admet-1883	649	31	t.	t.	PROPN
admet-1883	649	32	montier	montier	NOUN
admet-1883	649	33	.	.	PUNCT
admet-1883	649	34	antimicrobial	antimicrobial	ADJ
admet-1883	649	35	photodynamic	photodynamic	ADJ
admet-1883	649	36	therapy	therapy	NOUN
admet-1883	649	37	:	:	PUNCT
admet-1883	649	38	latest	late	ADJ
admet-1883	649	39	developments	development	NOUN
admet-1883	649	40	with	with	ADP
admet-1883	649	41	a	a	DET
admet-1883	649	42	focus	focus	NOUN
admet-1883	649	43	on	on	ADP
admet-1883	649	44	combinatory	combinatory	ADJ
admet-1883	649	45	strategies	strategy	NOUN
admet-1883	649	46	.	.	PUNCT
admet-1883	650	1	pharmaceutics	pharmaceutic	NOUN
admet-1883	650	2	13	13	NUM
admet-1883	650	3	(	(	PUNCT
admet-1883	650	4	2021	2021	NUM
admet-1883	650	5	)	)	PUNCT
admet-1883	650	6	1995	1995	NUM
admet-1883	650	7	.	.	PUNCT
admet-1883	651	1	https://doi.org/10.3390/pharmaceutics13121995	https://doi.org/10.3390/pharmaceutics13121995	PROPN
admet-1883	651	2	.	.	PUNCT
admet-1883	652	1	[	[	X
admet-1883	652	2	86	86	NUM
admet-1883	652	3	]	]	PUNCT
admet-1883	652	4	i.	i.	PROPN
admet-1883	652	5	banerjee	banerjee	PROPN
admet-1883	652	6	,	,	PUNCT
admet-1883	652	7	m.p	m.p	PROPN
admet-1883	652	8	.	.	PROPN
admet-1883	652	9	douaisi	douaisi	PROPN
admet-1883	652	10	,	,	PUNCT
admet-1883	652	11	d.	d.	PROPN
admet-1883	652	12	mondal	mondal	PROPN
admet-1883	652	13	,	,	PUNCT
admet-1883	652	14	r.s	r.s	PROPN
admet-1883	652	15	.	.	PROPN
admet-1883	652	16	kane	kane	PROPN
admet-1883	652	17	.	.	PUNCT
admet-1883	653	1	light	light	ADJ
admet-1883	653	2	-	-	PUNCT
admet-1883	653	3	activated	activate	VERB
admet-1883	653	4	nanotube	nanotube	NOUN
admet-1883	653	5	–	–	PUNCT
admet-1883	653	6	porphyrin	porphyrin	NOUN
admet-1883	653	7	conjugates	conjugate	NOUN
admet-1883	653	8	as	as	ADP
admet-1883	653	9	effective	effective	ADJ
admet-1883	653	10	antiviral	antiviral	ADJ
admet-1883	653	11	agents	agent	NOUN
admet-1883	653	12	.	.	PUNCT
admet-1883	654	1	nanotechnology	nanotechnology	NOUN
admet-1883	654	2	23	23	NUM
admet-1883	654	3	(	(	PUNCT
admet-1883	654	4	2012	2012	NUM
admet-1883	654	5	)	)	PUNCT
admet-1883	654	6	105101	105101	NUM
admet-1883	654	7	.	.	PUNCT
admet-1883	655	1	https://doi.org/10.1088/09574484/23/10/105101	https://doi.org/10.1088/09574484/23/10/105101	PROPN
admet-1883	655	2	.	.	PUNCT
admet-1883	656	1	[	[	X
admet-1883	656	2	87	87	NUM
admet-1883	656	3	]	]	SYM
admet-1883	656	4	i.j.d.s	i.j.d.s	PROPN
admet-1883	656	5	.	.	PROPN
admet-1883	656	6	nascimento	nascimento	PROPN
admet-1883	656	7	,	,	PUNCT
admet-1883	656	8	t.m	t.m	PROPN
admet-1883	656	9	.	.	PROPN
admet-1883	656	10	de	de	X
admet-1883	656	11	aquino	aquino	PROPN
admet-1883	656	12	,	,	PUNCT
admet-1883	656	13	e.f	e.f	PROPN
admet-1883	656	14	.	.	PROPN
admet-1883	656	15	da	da	PROPN
admet-1883	656	16	silva	silva	PROPN
admet-1883	656	17	-	-	PUNCT
admet-1883	656	18	júnior	júnior	NOUN
admet-1883	656	19	.	.	PUNCT
admet-1883	657	1	the	the	DET
admet-1883	657	2	new	new	ADJ
admet-1883	657	3	era	era	NOUN
admet-1883	657	4	of	of	ADP
admet-1883	657	5	drug	drug	NOUN
admet-1883	657	6	discovery	discovery	NOUN
admet-1883	657	7	:	:	PUNCT
admet-1883	657	8	the	the	DET
admet-1883	657	9	power	power	NOUN
admet-1883	657	10	of	of	ADP
admet-1883	657	11	computer	computer	NOUN
admet-1883	657	12	-	-	PUNCT
admet-1883	657	13	aided	aid	VERB
admet-1883	657	14	drug	drug	NOUN
admet-1883	657	15	design	design	NOUN
admet-1883	657	16	(	(	PUNCT
admet-1883	657	17	cadd	cadd	NOUN
admet-1883	657	18	)	)	PUNCT
admet-1883	657	19	.	.	PUNCT
admet-1883	658	1	letters	letter	NOUN
admet-1883	658	2	in	in	ADP
admet-1883	658	3	drug	drug	NOUN
admet-1883	658	4	design	design	NOUN
admet-1883	658	5	&	&	CCONJ
admet-1883	658	6	discovery	discovery	PROPN
admet-1883	658	7	19	19	NUM
admet-1883	658	8	(	(	PUNCT
admet-1883	658	9	2022	2022	NUM
admet-1883	658	10	)	)	PUNCT
admet-1883	658	11	951	951	NUM
admet-1883	658	12	-	-	SYM
admet-1883	658	13	955	955	NUM
admet-1883	658	14	.	.	PUNCT
admet-1883	659	1	https://doi.org/10.2174/1570180819666220405225817	https://doi.org/10.2174/1570180819666220405225817	NOUN
admet-1883	659	2	.	.	PUNCT
admet-1883	660	1	[	[	X
admet-1883	660	2	88	88	NUM
admet-1883	660	3	]	]	PUNCT
admet-1883	660	4	q.	q.	PROPN
admet-1883	660	5	wang	wang	PROPN
admet-1883	660	6	,	,	PUNCT
admet-1883	660	7	m.	m.	NOUN
admet-1883	660	8	sun	sun	PROPN
admet-1883	660	9	,	,	PUNCT
admet-1883	660	10	c.	c.	PROPN
admet-1883	660	11	li	li	PROPN
admet-1883	660	12	,	,	PUNCT
admet-1883	660	13	d.	d.	PROPN
admet-1883	660	14	li	li	PROPN
admet-1883	660	15	,	,	PUNCT
admet-1883	660	16	z.	z.	PROPN
admet-1883	660	17	yang	yang	PROPN
admet-1883	660	18	,	,	PUNCT
admet-1883	660	19	q.	q.	PROPN
admet-1883	660	20	jiang	jiang	PROPN
admet-1883	660	21	,	,	PUNCT
admet-1883	660	22	z.	z.	PROPN
admet-1883	660	23	he	he	PRON
admet-1883	660	24	,	,	PUNCT
admet-1883	660	25	h.	h.	PROPN
admet-1883	660	26	ding	ding	PROPN
admet-1883	660	27	,	,	PUNCT
admet-1883	660	28	j.	j.	PROPN
admet-1883	660	29	sun	sun	PROPN
admet-1883	660	30	.	.	PUNCT
admet-1883	661	1	a	a	DET
admet-1883	661	2	computer	computer	NOUN
admet-1883	661	3	-	-	PUNCT
admet-1883	661	4	aided	aid	VERB
admet-1883	661	5	chemphotodynamic	chemphotodynamic	ADJ
admet-1883	661	6	drugs	drug	NOUN
admet-1883	661	7	self	self	NOUN
admet-1883	661	8	-	-	PUNCT
admet-1883	661	9	delivery	delivery	NOUN
admet-1883	661	10	system	system	NOUN
admet-1883	661	11	for	for	ADP
admet-1883	661	12	synergistically	synergistically	ADV
admet-1883	661	13	enhanced	enhance	VERB
admet-1883	661	14	cancer	cancer	NOUN
admet-1883	661	15	therapy	therapy	NOUN
admet-1883	661	16	.	.	PUNCT
admet-1883	662	1	asian	asian	ADJ
admet-1883	662	2	journal	journal	PROPN
admet-1883	662	3	of	of	ADP
admet-1883	662	4	pharmaceutical	pharmaceutical	ADJ
admet-1883	662	5	sciences	science	NOUN
admet-1883	662	6	16	16	NUM
admet-1883	662	7	(	(	PUNCT
admet-1883	662	8	2021	2021	NUM
admet-1883	662	9	)	)	PUNCT
admet-1883	662	10	203	203	NUM
admet-1883	662	11	-	-	SYM
admet-1883	662	12	212	212	NUM
admet-1883	662	13	.	.	PUNCT
admet-1883	663	1	https://doi.org/10.1016/j.ajps.2020.04.002	https://doi.org/10.1016/j.ajps.2020.04.002	NOUN
admet-1883	663	2	.	.	PUNCT
admet-1883	664	1	https://doi.org/10.1517/13543784.20‌15.990150	https://doi.org/10.1517/13543784.20‌15.990150	PROPN
admet-1883	665	1	https://doi.org/10.1517/13543784.20‌15.990150	https://doi.org/10.1517/13543784.20‌15.990150	PROPN
admet-1883	665	2	https://doi.org/10.1088/1612-202x/ab95a9	https://doi.org/10.1088/1612-202x/ab95a9	VERB
admet-1883	665	3	https://doi.org/10.1016/j.pdpdt.20‌20.102112	https://doi.org/10.1016/j.pdpdt.20‌20.102112	PROPN
admet-1883	665	4	https://doi.org/10.1016/j.pdpdt.20‌20.102112	https://doi.org/10.1016/j.pdpdt.20‌20.102112	PROPN
admet-1883	666	1	https://doi.org/10.1080/17425247.2021.1829591	https://doi.org/10.1080/17425247.2021.1829591	PROPN
admet-1883	666	2	https://doi.org/‌10.1016/j.jphotobiol.2020.111999	https://doi.org/‌10.1016/j.jphotobiol.2020.111999	NOUN
admet-1883	666	3	https://doi.org/‌10.1016/j.jphotobiol.2020.111999	https://doi.org/‌10.1016/j.jphotobiol.2020.111999	PROPN
admet-1883	666	4	https://doi.org/10.15171/jlms.2018.29	https://doi.org/10.15171/jlms.2018.29	PROPN
admet-1883	666	5	https://doi.org/10.1161/circresaha.120.317015	https://doi.org/10.1161/circresaha.120.317015	PROPN
admet-1883	666	6	https://doi.org/10.3390/molecules25225239	https://doi.org/10.3390/molecules25225239	PROPN
admet-1883	666	7	https://doi.org/10.3390/ph12040148	https://doi.org/10.3390/ph12040148	NOUN
admet-1883	666	8	https://doi.org/10.1016/j.ccr.2020.213233	https://doi.org/10.1016/j.ccr.2020.213233	PUNCT
admet-1883	666	9	https://doi.org/10.3390/nano10112276	https://doi.org/10.3390/nano10112276	NOUN
admet-1883	667	1	https://doi.org/10.1016/j.bioma‌terials.20‌11.11.033	https://doi.org/10.1016/j.bioma‌terials.20‌11.11.033	PROPN
admet-1883	667	2	https://doi.org/10.1016/j.bioma‌terials.20‌11.11.033	https://doi.org/10.1016/j.bioma‌terials.20‌11.11.033	PROPN
admet-1883	667	3	https://doi.org/10.3390/pharmaceutics13121995	https://doi.org/10.3390/pharmaceutics13121995	AUX
admet-1883	667	4	https://doi.org/10.1088/0957-4484/23/10/105101	https://doi.org/10.1088/0957-4484/23/10/105101	PROPN
admet-1883	667	5	https://doi.org/10.1088/0957-4484/23/10/105101	https://doi.org/10.1088/0957-4484/23/10/105101	PROPN
admet-1883	667	6	https://doi.org/10.2174/1570180819666220405225817	https://doi.org/10.2174/1570180819666220405225817	PROPN
admet-1883	667	7	https://doi.org/10.1016/j.ajps.2020.04.002	https://doi.org/10.1016/j.ajps.2020.04.002	PROPN
admet-1883	667	8	admet	admet	NOUN
admet-1883	667	9	&	&	CCONJ
admet-1883	667	10	dmpk	dmpk	PROPN
admet-1883	667	11	11(4	11(4	NUM
admet-1883	667	12	)	)	PUNCT
admet-1883	667	13	(	(	PUNCT
admet-1883	667	14	2023	2023	NUM
admet-1883	667	15	)	)	PUNCT
admet-1883	667	16	513	513	NUM
admet-1883	667	17	-	-	SYM
admet-1883	667	18	531	531	NUM
admet-1883	667	19	infections	infection	NOUN
admet-1883	667	20	associated	associate	VERB
admet-1883	667	21	with	with	ADP
admet-1883	667	22	sars	sar	NOUN
admet-1883	667	23	-	-	PUNCT
admet-1883	667	24	cov-2	cov-2	PART
admet-1883	667	25	exploited	exploit	VERB
admet-1883	667	26	via	via	ADP
admet-1883	667	27	photodynamic	photodynamic	ADJ
admet-1883	667	28	therapy	therapy	NOUN
admet-1883	667	29	doi	doi	NOUN
admet-1883	667	30	:	:	PUNCT
admet-1883	667	31	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-1883	667	32	t.1883	t.1883	VERB
admet-1883	667	33	531	531	NUM
admet-1883	668	1	[	[	X
admet-1883	668	2	89	89	NUM
admet-1883	668	3	]	]	X
admet-1883	668	4	v.	v.	CCONJ
admet-1883	668	5	fedorov	fedorov	PROPN
admet-1883	668	6	,	,	PUNCT
admet-1883	668	7	e.	e.	PROPN
admet-1883	668	8	kholina	kholina	PROPN
admet-1883	668	9	,	,	PUNCT
admet-1883	668	10	s.	s.	PROPN
admet-1883	668	11	khruschev	khruschev	PROPN
admet-1883	668	12	,	,	PUNCT
admet-1883	668	13	i.	i.	PROPN
admet-1883	668	14	kovalenko	kovalenko	PROPN
admet-1883	668	15	,	,	PUNCT
admet-1883	668	16	a.	a.	PROPN
admet-1883	668	17	rubin	rubin	PROPN
admet-1883	668	18	,	,	PUNCT
admet-1883	668	19	m.	m.	PROPN
admet-1883	668	20	strakhovskaya	strakhovskaya	PROPN
admet-1883	668	21	.	.	PUNCT
admet-1883	669	1	electrostatic	electrostatic	ADJ
admet-1883	669	2	map	map	NOUN
admet-1883	669	3	of	of	ADP
admet-1883	669	4	the	the	DET
admet-1883	669	5	sars	sar	NOUN
admet-1883	669	6	-	-	PUNCT
admet-1883	669	7	cov-2	cov-2	NOUN
admet-1883	669	8	virion	virion	NOUN
admet-1883	669	9	specifies	specifie	NOUN
admet-1883	669	10	binding	bind	VERB
admet-1883	669	11	sites	site	NOUN
admet-1883	669	12	of	of	ADP
admet-1883	669	13	the	the	DET
admet-1883	669	14	antiviral	antiviral	ADJ
admet-1883	669	15	cationic	cationic	ADJ
admet-1883	669	16	photosensitizer	photosensitizer	NOUN
admet-1883	669	17	.	.	PUNCT
admet-1883	670	1	international	international	ADJ
admet-1883	670	2	journal	journal	NOUN
admet-1883	670	3	of	of	ADP
admet-1883	670	4	molecular	molecular	ADJ
admet-1883	670	5	sciences	science	NOUN
admet-1883	670	6	23	23	NUM
admet-1883	670	7	(	(	PUNCT
admet-1883	670	8	2022	2022	NUM
admet-1883	670	9	)	)	PUNCT
admet-1883	670	10	7304	7304	NUM
admet-1883	670	11	.	.	PUNCT
admet-1883	671	1	https://doi.org/10.3390/ijms23137304	https://doi.org/10.3390/ijms23137304	PROPN
admet-1883	671	2	.	.	PUNCT
admet-1883	672	1	[	[	X
admet-1883	672	2	90	90	NUM
admet-1883	672	3	]	]	PUNCT
admet-1883	672	4	k.	k.	PROPN
admet-1883	672	5	sharshov	sharshov	PROPN
admet-1883	672	6	,	,	PUNCT
admet-1883	672	7	m.	m.	PROPN
admet-1883	672	8	solomatina	solomatina	PROPN
admet-1883	672	9	,	,	PUNCT
admet-1883	672	10	o.	o.	PROPN
admet-1883	672	11	kurskaya	kurskaya	PROPN
admet-1883	672	12	,	,	PUNCT
admet-1883	672	13	i.	i.	PROPN
admet-1883	672	14	kovalenko	kovalenko	PROPN
admet-1883	672	15	,	,	PUNCT
admet-1883	672	16	e.	e.	PROPN
admet-1883	672	17	kholina	kholina	PROPN
admet-1883	672	18	,	,	PUNCT
admet-1883	672	19	v.	v.	PROPN
admet-1883	672	20	fedorov	fedorov	PROPN
admet-1883	672	21	,	,	PUNCT
admet-1883	672	22	g.	g.	PROPN
admet-1883	672	23	meerovich	meerovich	PROPN
admet-1883	672	24	,	,	PUNCT
admet-1883	672	25	a.	a.	PROPN
admet-1883	672	26	rubin	rubin	PROPN
admet-1883	672	27	,	,	PUNCT
admet-1883	672	28	m.	m.	PROPN
admet-1883	672	29	strakhovskaya	strakhovskaya	PROPN
admet-1883	672	30	.	.	PUNCT
admet-1883	673	1	the	the	DET
admet-1883	673	2	photosensitizer	photosensitizer	NOUN
admet-1883	673	3	octakis	octaki	VERB
admet-1883	673	4	(	(	PUNCT
admet-1883	673	5	cholinyl	cholinyl	NOUN
admet-1883	673	6	)	)	PUNCT
admet-1883	673	7	zinc	zinc	NOUN
admet-1883	673	8	phthalocyanine	phthalocyanine	NOUN
admet-1883	673	9	with	with	ADP
admet-1883	673	10	ability	ability	NOUN
admet-1883	673	11	to	to	PART
admet-1883	673	12	bind	bind	VERB
admet-1883	673	13	to	to	ADP
admet-1883	673	14	a	a	DET
admet-1883	673	15	model	model	NOUN
admet-1883	673	16	spike	spike	ADJ
admet-1883	673	17	protein	protein	NOUN
admet-1883	673	18	leads	lead	VERB
admet-1883	673	19	to	to	ADP
admet-1883	673	20	a	a	DET
admet-1883	673	21	loss	loss	NOUN
admet-1883	673	22	of	of	ADP
admet-1883	673	23	sars	sar	NOUN
admet-1883	673	24	-	-	PUNCT
admet-1883	673	25	cov-2	cov-2	NOUN
admet-1883	673	26	infectivity	infectivity	NOUN
admet-1883	673	27	in	in	ADP
admet-1883	673	28	vitro	vitro	NOUN
admet-1883	673	29	when	when	SCONJ
admet-1883	673	30	exposed	expose	VERB
admet-1883	673	31	to	to	ADP
admet-1883	673	32	far	far	ADV
admet-1883	673	33	-	-	PUNCT
admet-1883	673	34	red	red	NOUN
admet-1883	673	35	led	lead	VERB
admet-1883	673	36	.	.	PUNCT
admet-1883	674	1	viruses	virus	NOUN
admet-1883	674	2	13	13	NUM
admet-1883	674	3	(	(	PUNCT
admet-1883	674	4	2021	2021	NUM
admet-1883	674	5	)	)	PUNCT
admet-1883	674	6	643	643	NUM
admet-1883	674	7	.	.	PUNCT
admet-1883	675	1	https://doi.org/10.3390/v13040643	https://doi.org/10.3390/v13040643	X
admet-1883	675	2	.	.	PUNCT
admet-1883	676	1	[	[	X
admet-1883	676	2	91	91	NUM
admet-1883	676	3	]	]	PUNCT
admet-1883	676	4	x.	x.	PROPN
admet-1883	676	5	wei	wei	PROPN
admet-1883	676	6	,	,	PUNCT
admet-1883	676	7	w.-b	w.-b	PROPN
admet-1883	676	8	.	.	PUNCT
admet-1883	676	9	cui	cui	PROPN
admet-1883	676	10	,	,	PUNCT
admet-1883	676	11	f.-y	f.-y	NOUN
admet-1883	676	12	.	.	PUNCT
admet-1883	677	1	sun	sun	PROPN
admet-1883	677	2	,	,	PUNCT
admet-1883	677	3	h.	h.	PROPN
admet-1883	677	4	li	li	PROPN
admet-1883	677	5	,	,	PUNCT
admet-1883	677	6	j.-f	j.-f	PROPN
admet-1883	677	7	.	.	PUNCT
admet-1883	678	1	guo	guo	PROPN
admet-1883	678	2	,	,	PUNCT
admet-1883	678	3	x.-l	x.-l	PROPN
admet-1883	678	4	.	.	PUNCT
admet-1883	679	1	hao	hao	PROPN
admet-1883	679	2	,	,	PUNCT
admet-1883	679	3	a.-m	a.-m	PROPN
admet-1883	679	4	.	.	PUNCT
admet-1883	680	1	ren	ren	PROPN
admet-1883	680	2	.	.	PUNCT
admet-1883	681	1	photophysical	photophysical	ADJ
admet-1883	681	2	properties	property	NOUN
admet-1883	681	3	of	of	ADP
admet-1883	681	4	pt	pt	X
admet-1883	681	5	(	(	PUNCT
admet-1883	681	6	ii	ii	NOUN
admet-1883	681	7	)	)	PUNCT
admet-1883	681	8	and	and	CCONJ
admet-1883	681	9	pd	pd	PROPN
admet-1883	681	10	(	(	PUNCT
admet-1883	681	11	ii	ii	NOUN
admet-1883	681	12	)	)	PUNCT
admet-1883	681	13	complexes	complex	NOUN
admet-1883	681	14	for	for	ADP
admet-1883	681	15	two	two	NUM
admet-1883	681	16	-	-	PUNCT
admet-1883	681	17	photon	photon	NOUN
admet-1883	681	18	photodynamic	photodynamic	ADJ
admet-1883	681	19	therapy	therapy	NOUN
admet-1883	681	20	:	:	PUNCT
admet-1883	681	21	a	a	DET
admet-1883	681	22	computational	computational	ADJ
admet-1883	681	23	investigation	investigation	NOUN
admet-1883	681	24	.	.	PUNCT
admet-1883	682	1	dyes	dye	NOUN
admet-1883	682	2	and	and	CCONJ
admet-1883	682	3	pigments	pigment	NOUN
admet-1883	682	4	215	215	NUM
admet-1883	682	5	(	(	PUNCT
admet-1883	682	6	2023	2023	NUM
admet-1883	682	7	)	)	PUNCT
admet-1883	682	8	111283	111283	NUM
admet-1883	682	9	.	.	PUNCT
admet-1883	683	1	https://doi.org/10.1016/j.dyepig.2023.111283	https://doi.org/10.1016/j.dyepig.2023.111283	NOUN
admet-1883	683	2	.	.	PUNCT
admet-1883	684	1	[	[	X
admet-1883	684	2	92	92	NUM
admet-1883	684	3	]	]	PUNCT
admet-1883	684	4	j.	j.	PROPN
admet-1883	684	5	shin	shin	PROPN
admet-1883	684	6	,	,	PUNCT
admet-1883	684	7	d.w	d.w	PROPN
admet-1883	684	8	.	.	PROPN
admet-1883	684	9	kang	kang	PROPN
admet-1883	684	10	,	,	PUNCT
admet-1883	684	11	j.h	j.h	PROPN
admet-1883	684	12	.	.	PROPN
admet-1883	684	13	lim	lim	PROPN
admet-1883	684	14	,	,	PUNCT
admet-1883	684	15	j.m	j.m	PROPN
admet-1883	684	16	.	.	PROPN
admet-1883	684	17	an	an	PRON
admet-1883	684	18	,	,	PUNCT
admet-1883	684	19	y.	y.	PROPN
admet-1883	684	20	kim	kim	PROPN
admet-1883	684	21	,	,	PUNCT
admet-1883	684	22	j.h	j.h	PROPN
admet-1883	684	23	.	.	PROPN
admet-1883	684	24	kim	kim	PROPN
admet-1883	684	25	,	,	PUNCT
admet-1883	684	26	m.s	m.s	PROPN
admet-1883	684	27	.	.	PUNCT
admet-1883	685	1	ji	ji	PROPN
admet-1883	685	2	,	,	PUNCT
admet-1883	685	3	s.	s.	PROPN
admet-1883	685	4	park	park	PROPN
admet-1883	685	5	,	,	PUNCT
admet-1883	685	6	d.	d.	PROPN
admet-1883	685	7	kim	kim	PROPN
admet-1883	685	8	,	,	PUNCT
admet-1883	685	9	j.y	j.y	PROPN
admet-1883	685	10	.	.	PROPN
admet-1883	685	11	lee	lee	PROPN
admet-1883	685	12	.	.	PROPN
admet-1883	685	13	wavelength	wavelength	VERB
admet-1883	685	14	engineerable	engineerable	ADJ
admet-1883	685	15	porous	porous	ADJ
admet-1883	685	16	organic	organic	ADJ
admet-1883	685	17	polymer	polymer	NOUN
admet-1883	685	18	photosensitizers	photosensitizer	NOUN
admet-1883	685	19	with	with	ADP
admet-1883	685	20	protonation	protonation	NOUN
admet-1883	685	21	triggered	trigger	VERB
admet-1883	685	22	ros	ros	PROPN
admet-1883	685	23	generation	generation	NOUN
admet-1883	685	24	.	.	PUNCT
admet-1883	686	1	nature	nature	NOUN
admet-1883	686	2	communications	communication	NOUN
admet-1883	686	3	14	14	NUM
admet-1883	686	4	(	(	PUNCT
admet-1883	686	5	2023	2023	NUM
admet-1883	686	6	)	)	PUNCT
admet-1883	686	7	1498	1498	NUM
admet-1883	686	8	.	.	PUNCT
admet-1883	687	1	https://doi.org/10.1038/s41467-023-37156-x	https://doi.org/10.1038/s41467-023-37156-x	NOUN
admet-1883	687	2	.	.	PUNCT
admet-1883	688	1	[	[	X
admet-1883	688	2	93	93	NUM
admet-1883	688	3	]	]	PUNCT
admet-1883	688	4	bk	bk	PROPN
admet-1883	688	5	.	.	PUNCT
admet-1883	688	6	kundu	kundu	NOUN
admet-1883	688	7	,	,	PUNCT
admet-1883	688	8	g.	g.	PROPN
admet-1883	688	9	han	han	PROPN
admet-1883	688	10	,	,	PUNCT
admet-1883	688	11	y.	y.	PROPN
admet-1883	688	12	sun	sun	PROPN
admet-1883	688	13	.	.	PROPN
admet-1883	688	14	derivatized	derivatize	VERB
admet-1883	688	15	benzothiazoles	benzothiazole	NOUN
admet-1883	688	16	as	as	ADP
admet-1883	688	17	two	two	NUM
admet-1883	688	18	-	-	PUNCT
admet-1883	688	19	photon	photon	NOUN
admet-1883	688	20	-	-	PUNCT
admet-1883	688	21	absorbing	absorb	VERB
admet-1883	688	22	organic	organic	ADJ
admet-1883	688	23	photosensitizers	photosensitizer	NOUN
admet-1883	688	24	active	active	ADJ
admet-1883	688	25	under	under	ADP
admet-1883	688	26	near	near	ADP
admet-1883	688	27	infrared	infrared	ADJ
admet-1883	688	28	light	light	ADJ
admet-1883	688	29	irradiation	irradiation	NOUN
admet-1883	688	30	.	.	PUNCT
admet-1883	689	1	journal	journal	NOUN
admet-1883	689	2	of	of	ADP
admet-1883	689	3	the	the	DET
admet-1883	689	4	american	american	PROPN
admet-1883	689	5	chemical	chemical	PROPN
admet-1883	689	6	society	society	PROPN
admet-1883	689	7	145	145	NUM
admet-1883	689	8	(	(	PUNCT
admet-1883	689	9	2023	2023	NUM
admet-1883	689	10	)	)	PUNCT
admet-1883	689	11	3535	3535	NUM
admet-1883	689	12	-	-	SYM
admet-1883	689	13	3542	3542	NUM
admet-1883	689	14	.	.	PUNCT
admet-1883	690	1	https://doi.org/10.1021/jacs.2c12244	https://doi.org/10.1021/jacs.2c12244	NOUN
admet-1883	690	2	.	.	PUNCT
admet-1883	691	1	[	[	X
admet-1883	691	2	94	94	NUM
admet-1883	691	3	]	]	X
admet-1883	691	4	r.	r.	PROPN
admet-1883	691	5	prieto	prieto	PROPN
admet-1883	691	6	-	-	PUNCT
admet-1883	691	7	montero	montero	PROPN
admet-1883	691	8	,	,	PUNCT
admet-1883	691	9	a.d	a.d	PROPN
admet-1883	691	10	.	.	PROPN
admet-1883	691	11	andres	andres	PROPN
admet-1883	691	12	,	,	PUNCT
admet-1883	691	13	a.	a.	PROPN
admet-1883	691	14	prieto	prieto	PROPN
admet-1883	691	15	-	-	PUNCT
admet-1883	691	16	castañeda	castañeda	NOUN
admet-1883	691	17	,	,	PUNCT
admet-1883	691	18	a.	a.	NOUN
admet-1883	691	19	tabero	tabero	NOUN
admet-1883	691	20	,	,	PUNCT
admet-1883	691	21	a.	a.	PROPN
admet-1883	691	22	longarte	longarte	PROPN
admet-1883	691	23	,	,	PUNCT
admet-1883	691	24	a.r	a.r	PROPN
admet-1883	691	25	.	.	PROPN
admet-1883	691	26	agarrabeitia	agarrabeitia	PROPN
admet-1883	691	27	,	,	PUNCT
admet-1883	691	28	a.	a.	PROPN
admet-1883	691	29	villanueva	villanueva	PROPN
admet-1883	691	30	,	,	PUNCT
admet-1883	691	31	m.j	m.j	PROPN
admet-1883	691	32	.	.	PROPN
admet-1883	691	33	ortiz	ortiz	PROPN
admet-1883	691	34	,	,	PUNCT
admet-1883	691	35	r.	r.	PROPN
admet-1883	691	36	montero	montero	PROPN
admet-1883	691	37	,	,	PUNCT
admet-1883	691	38	d.	d.	PROPN
admet-1883	691	39	casanova	casanova	PROPN
admet-1883	691	40	.	.	PUNCT
admet-1883	692	1	halogen	halogen	NOUN
admet-1883	692	2	-	-	PUNCT
admet-1883	692	3	free	free	ADJ
admet-1883	692	4	photosensitizers	photosensitizer	NOUN
admet-1883	692	5	based	base	VERB
admet-1883	692	6	on	on	ADP
admet-1883	692	7	mesoenamine	mesoenamine	PROPN
admet-1883	692	8	-	-	PUNCT
admet-1883	692	9	bodipys	bodipys	NOUN
admet-1883	692	10	for	for	ADP
admet-1883	692	11	bioimaging	bioimaging	NOUN
admet-1883	692	12	and	and	CCONJ
admet-1883	692	13	photodynamic	photodynamic	ADJ
admet-1883	692	14	therapy	therapy	NOUN
admet-1883	692	15	.	.	PUNCT
admet-1883	693	1	journal	journal	NOUN
admet-1883	693	2	of	of	ADP
admet-1883	693	3	materials	material	NOUN
admet-1883	693	4	chemistry	chemistry	NOUN
admet-1883	693	5	b	b	NOUN
admet-1883	693	6	11	11	NUM
admet-1883	693	7	(	(	PUNCT
admet-1883	693	8	2023	2023	NUM
admet-1883	693	9	)	)	PUNCT
admet-1883	693	10	169	169	NUM
admet-1883	693	11	-	-	SYM
admet-1883	693	12	179	179	NUM
admet-1883	693	13	.	.	PUNCT
admet-1883	694	1	https://doi.org/10.1039/d2tb01515c	https://doi.org/10.1039/d2tb01515c	NUM
admet-1883	694	2	.	.	PUNCT
admet-1883	695	1	[	[	X
admet-1883	695	2	95	95	NUM
admet-1883	695	3	]	]	PUNCT
admet-1883	695	4	m.	m.	NOUN
admet-1883	695	5	pourhajibagher	pourhajibagher	NOUN
admet-1883	695	6	,	,	PUNCT
admet-1883	695	7	a.	a.	NOUN
admet-1883	695	8	bahador	bahador	NOUN
admet-1883	695	9	.	.	PUNCT
admet-1883	696	1	virtual	virtual	ADJ
admet-1883	696	2	screening	screening	NOUN
admet-1883	696	3	and	and	CCONJ
admet-1883	696	4	computational	computational	ADJ
admet-1883	696	5	simulation	simulation	NOUN
admet-1883	696	6	analysis	analysis	NOUN
admet-1883	696	7	of	of	ADP
admet-1883	696	8	antimicrobial	antimicrobial	ADJ
admet-1883	696	9	photodynamic	photodynamic	ADJ
admet-1883	696	10	therapy	therapy	NOUN
admet-1883	696	11	using	use	VERB
admet-1883	696	12	propolis	propoli	NOUN
admet-1883	696	13	-	-	PUNCT
admet-1883	696	14	benzofuran	benzofuran	VERB
admet-1883	696	15	a	a	PRON
admet-1883	696	16	to	to	ADP
admet-1883	696	17	control	control	NOUN
admet-1883	696	18	of	of	ADP
admet-1883	696	19	monkeypox	monkeypox	NOUN
admet-1883	696	20	.	.	PUNCT
admet-1883	697	1	photodiagnosis	photodiagnosis	NOUN
admet-1883	697	2	and	and	CCONJ
admet-1883	697	3	photodynamic	photodynamic	ADJ
admet-1883	697	4	therapy	therapy	NOUN
admet-1883	697	5	41	41	NUM
admet-1883	697	6	(	(	PUNCT
admet-1883	697	7	2023	2023	NUM
admet-1883	697	8	)	)	PUNCT
admet-1883	697	9	103208	103208	NUM
admet-1883	697	10	.	.	PUNCT
admet-1883	698	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
admet-1883	698	2	j.pdpdt.2022.103208	j.pdpdt.2022.103208	NOUN
admet-1883	698	3	.	.	PUNCT
admet-1883	699	1	[	[	X
admet-1883	699	2	96	96	NUM
admet-1883	699	3	]	]	X
admet-1883	699	4	g.	g.	PROPN
admet-1883	699	5	alachouzos	alachouzos	PROPN
admet-1883	699	6	,	,	PUNCT
admet-1883	699	7	a.m.	a.m.	PROPN
admet-1883	699	8	schulte	schulte	PROPN
admet-1883	699	9	,	,	PUNCT
admet-1883	699	10	a.	a.	NOUN
admet-1883	699	11	mondal	mondal	PROPN
admet-1883	699	12	,	,	PUNCT
admet-1883	699	13	w.	w.	PROPN
admet-1883	699	14	szymanski	szymanski	PROPN
admet-1883	699	15	,	,	PUNCT
admet-1883	699	16	b.l	b.l	PROPN
admet-1883	699	17	.	.	PROPN
admet-1883	699	18	feringa	feringa	NOUN
admet-1883	699	19	.	.	PUNCT
admet-1883	700	1	computational	computational	ADJ
admet-1883	700	2	design	design	NOUN
admet-1883	700	3	,	,	PUNCT
admet-1883	700	4	synthesis	synthesis	NOUN
admet-1883	700	5	,	,	PUNCT
admet-1883	700	6	and	and	CCONJ
admet-1883	700	7	photochemistry	photochemistry	NOUN
admet-1883	700	8	of	of	ADP
admet-1883	700	9	cy7‐ppg	cy7‐ppg	PROPN
admet-1883	700	10	,	,	PUNCT
admet-1883	700	11	an	an	DET
admet-1883	700	12	efficient	efficient	ADJ
admet-1883	700	13	nir‐activated	nir‐activated	ADJ
admet-1883	700	14	photolabile	photolabile	ADJ
admet-1883	700	15	protecting	protect	VERB
admet-1883	700	16	group	group	NOUN
admet-1883	700	17	for	for	ADP
admet-1883	700	18	therapeutic	therapeutic	ADJ
admet-1883	700	19	applications	application	NOUN
admet-1883	700	20	.	.	PUNCT
admet-1883	701	1	angewandte	angewandte	PROPN
admet-1883	701	2	chemie	chemie	PROPN
admet-1883	701	3	134	134	NUM
admet-1883	701	4	(	(	PUNCT
admet-1883	701	5	2022	2022	NUM
admet-1883	701	6	)	)	PUNCT
admet-1883	701	7	e202201308	e202201308	NOUN
admet-1883	701	8	.	.	PUNCT
admet-1883	702	1	https://doi.org/10.1002/	https://doi.org/10.1002/	PROPN
admet-1883	702	2	ange.202201308	ange.202201308	PROPN
admet-1883	702	3	.	.	PUNCT
admet-1883	703	1	[	[	X
admet-1883	703	2	97	97	NUM
admet-1883	703	3	]	]	SYM
admet-1883	703	4	ns	ns	PROPN
admet-1883	703	5	.	.	PROPN
admet-1883	703	6	kuzmina	kuzmina	PROPN
admet-1883	703	7	,	,	PUNCT
admet-1883	703	8	v.f	v.f	PROPN
admet-1883	703	9	.	.	PROPN
admet-1883	703	10	otvagin	otvagin	PROPN
admet-1883	703	11	,	,	PUNCT
admet-1883	703	12	a.a	a.a	PROPN
admet-1883	703	13	.	.	PROPN
admet-1883	703	14	maleev	maleev	PROPN
admet-1883	703	15	,	,	PUNCT
admet-1883	703	16	m.a	m.a	PROPN
admet-1883	703	17	.	.	PROPN
admet-1883	703	18	urazaeva	urazaeva	PROPN
admet-1883	703	19	,	,	PUNCT
admet-1883	703	20	a.v	a.v	PROPN
admet-1883	703	21	.	.	PROPN
admet-1883	703	22	nyuchev	nyuchev	PROPN
admet-1883	703	23	,	,	PUNCT
admet-1883	703	24	s.k	s.k	PROPN
admet-1883	703	25	.	.	PROPN
admet-1883	703	26	ignatov	ignatov	PROPN
admet-1883	703	27	,	,	PUNCT
admet-1883	703	28	a.e	a.e	PROPN
admet-1883	703	29	.	.	PROPN
admet-1883	703	30	gavryushin	gavryushin	PROPN
admet-1883	703	31	,	,	PUNCT
admet-1883	703	32	a.y	a.y	PROPN
admet-1883	703	33	.	.	PROPN
admet-1883	703	34	fedorov	fedorov	PROPN
admet-1883	703	35	.	.	PUNCT
admet-1883	704	1	development	development	NOUN
admet-1883	704	2	of	of	ADP
admet-1883	704	3	novel	novel	ADJ
admet-1883	704	4	porphyrin	porphyrin	NOUN
admet-1883	704	5	/	/	SYM
admet-1883	704	6	combretastatin	combretastatin	NOUN
admet-1883	704	7	a-4	a-4	NOUN
admet-1883	704	8	conjugates	conjugate	NOUN
admet-1883	704	9	for	for	ADP
admet-1883	704	10	bimodal	bimodal	NOUN
admet-1883	704	11	chemo	chemo	NOUN
admet-1883	704	12	and	and	CCONJ
admet-1883	704	13	photodynamic	photodynamic	ADJ
admet-1883	704	14	therapy	therapy	NOUN
admet-1883	704	15	:	:	PUNCT
admet-1883	704	16	synthesis	synthesis	NOUN
admet-1883	704	17	,	,	PUNCT
admet-1883	704	18	photophysical	photophysical	ADJ
admet-1883	704	19	and	and	CCONJ
admet-1883	704	20	tddft	tddft	NOUN
admet-1883	704	21	computational	computational	ADJ
admet-1883	704	22	studies	study	NOUN
admet-1883	704	23	.	.	PUNCT
admet-1883	705	1	journal	journal	PROPN
admet-1883	705	2	of	of	ADP
admet-1883	705	3	photochemistry	photochemistry	NOUN
admet-1883	705	4	and	and	CCONJ
admet-1883	705	5	photobiology	photobiology	NOUN
admet-1883	705	6	a	a	DET
admet-1883	705	7	:	:	PUNCT
admet-1883	705	8	chemistry	chemistry	NOUN
admet-1883	705	9	433	433	NUM
admet-1883	705	10	(	(	PUNCT
admet-1883	705	11	2022	2022	NUM
admet-1883	705	12	)	)	PUNCT
admet-1883	705	13	114138	114138	NUM
admet-1883	705	14	.	.	PUNCT
admet-1883	706	1	https://doi.org/10.1016/j.jphoto	https://doi.org/10.1016/j.jphoto	X
admet-1883	706	2	chem.2022.114138	chem.2022.114138	NOUN
admet-1883	706	3	.	.	PUNCT
admet-1883	707	1	[	[	X
admet-1883	707	2	98	98	NUM
admet-1883	707	3	]	]	X
admet-1883	707	4	e.	e.	PROPN
admet-1883	707	5	kilic	kilic	PROPN
admet-1883	707	6	,	,	PUNCT
admet-1883	707	7	z.	z.	PROPN
admet-1883	707	8	elmazoglu	elmazoglu	PROPN
admet-1883	707	9	,	,	PUNCT
admet-1883	707	10	t.	t.	PROPN
admet-1883	707	11	almammadov	almammadov	PROPN
admet-1883	707	12	,	,	PUNCT
admet-1883	707	13	d.	d.	PROPN
admet-1883	707	14	kepil	kepil	PROPN
admet-1883	707	15	,	,	PUNCT
admet-1883	707	16	t.	t.	PROPN
admet-1883	707	17	etienne	etienne	PROPN
admet-1883	707	18	,	,	PUNCT
admet-1883	707	19	a.	a.	NOUN
admet-1883	707	20	marion	marion	PROPN
admet-1883	707	21	,	,	PUNCT
admet-1883	707	22	g.	g.	PROPN
admet-1883	707	23	gunbas	gunbas	PROPN
admet-1883	707	24	,	,	PUNCT
admet-1883	707	25	s.	s.	PROPN
admet-1883	707	26	kolemen	kolemen	PROPN
admet-1883	707	27	.	.	PUNCT
admet-1883	708	1	activitybased	activitybase	VERB
admet-1883	708	2	photosensitizers	photosensitizer	NOUN
admet-1883	708	3	with	with	ADP
admet-1883	708	4	optimized	optimize	VERB
admet-1883	708	5	triplet	triplet	NOUN
admet-1883	708	6	state	state	NOUN
admet-1883	708	7	characteristics	characteristic	NOUN
admet-1883	708	8	toward	toward	ADP
admet-1883	708	9	cancer	cancer	NOUN
admet-1883	708	10	cell	cell	NOUN
admet-1883	708	11	selective	selective	ADJ
admet-1883	708	12	and	and	CCONJ
admet-1883	708	13	image	image	NOUN
admet-1883	708	14	guided	guide	VERB
admet-1883	708	15	photodynamic	photodynamic	ADJ
admet-1883	708	16	therapy	therapy	NOUN
admet-1883	708	17	.	.	PUNCT
admet-1883	709	1	acs	acs	PROPN
admet-1883	709	2	applied	apply	VERB
admet-1883	709	3	bio	bio	NOUN
admet-1883	709	4	materials	material	NOUN
admet-1883	709	5	5	5	NUM
admet-1883	709	6	(	(	PUNCT
admet-1883	709	7	2022	2022	NUM
admet-1883	709	8	)	)	PUNCT
admet-1883	709	9	2754	2754	NUM
admet-1883	709	10	-	-	SYM
admet-1883	709	11	2767	2767	NUM
admet-1883	709	12	.	.	PUNCT
admet-1883	710	1	https://doi.org/10.1021/acsabm.2c00202	https://doi.org/10.1021/acsabm.2c00202	NOUN
admet-1883	710	2	.	.	PUNCT
admet-1883	711	1	[	[	X
admet-1883	711	2	99	99	NUM
admet-1883	711	3	]	]	PUNCT
admet-1883	711	4	a.	a.	NOUN
admet-1883	711	5	saedi	saedi	PROPN
admet-1883	711	6	,	,	PUNCT
admet-1883	711	7	a.	a.	NOUN
admet-1883	711	8	mashinchian	mashinchian	PROPN
admet-1883	711	9	moradi	moradi	NOUN
admet-1883	711	10	,	,	PUNCT
admet-1883	711	11	s.	s.	PROPN
admet-1883	711	12	kimiagar	kimiagar	PROPN
admet-1883	711	13	,	,	PUNCT
admet-1883	711	14	h.a	h.a	PROPN
admet-1883	711	15	.	.	PROPN
admet-1883	711	16	panahi	panahi	PROPN
admet-1883	711	17	.	.	PUNCT
admet-1883	712	1	photosensitization	photosensitization	NOUN
admet-1883	712	2	of	of	ADP
admet-1883	712	3	fucoxanthingraphene	fucoxanthingraphene	NOUN
admet-1883	712	4	complexes	complex	NOUN
admet-1883	712	5	:	:	PUNCT
admet-1883	712	6	a	a	DET
admet-1883	712	7	computational	computational	ADJ
admet-1883	712	8	approach	approach	NOUN
admet-1883	712	9	.	.	PUNCT
admet-1883	713	1	main	main	ADJ
admet-1883	713	2	group	group	NOUN
admet-1883	713	3	chemistry	chemistry	NOUN
admet-1883	713	4	21	21	NUM
admet-1883	713	5	(	(	PUNCT
admet-1883	713	6	2022	2022	NUM
admet-1883	713	7	)	)	PUNCT
admet-1883	713	8	1065	1065	NUM
admet-1883	713	9	-	-	SYM
admet-1883	713	10	1075	1075	NUM
admet-1883	713	11	.	.	PUNCT
admet-1883	714	1	https://doi.org/10.3233/mgc-210188	https://doi.org/10.3233/mgc-210188	X
admet-1883	714	2	.	.	PUNCT
admet-1883	715	1	[	[	X
admet-1883	715	2	100	100	NUM
admet-1883	715	3	]	]	PUNCT
admet-1883	715	4	x.	x.	NOUN
admet-1883	715	5	wang	wang	PROPN
admet-1883	715	6	,	,	PUNCT
admet-1883	715	7	h.	h.	PROPN
admet-1883	715	8	lv	lv	PROPN
admet-1883	715	9	,	,	PUNCT
admet-1883	715	10	y.	y.	PROPN
admet-1883	715	11	sun	sun	PROPN
admet-1883	715	12	,	,	PUNCT
admet-1883	715	13	g.	g.	PROPN
admet-1883	715	14	zu	zu	PROPN
admet-1883	715	15	,	,	PUNCT
admet-1883	715	16	x.	x.	PROPN
admet-1883	715	17	zhang	zhang	PROPN
admet-1883	715	18	,	,	PUNCT
admet-1883	715	19	y.	y.	PROPN
admet-1883	715	20	song	song	PROPN
admet-1883	715	21	,	,	PUNCT
admet-1883	715	22	f.	f.	PROPN
admet-1883	715	23	zhao	zhao	PROPN
admet-1883	715	24	,	,	PUNCT
admet-1883	715	25	j.	j.	PROPN
admet-1883	715	26	wang	wang	PROPN
admet-1883	715	27	.	.	PUNCT
admet-1883	716	1	new	new	ADJ
admet-1883	716	2	porphyrin	porphyrin	NOUN
admet-1883	716	3	photosensitizers	photosensitizer	NOUN
admet-1883	716	4	—	—	PUNCT
admet-1883	716	5	synthesis	synthesis	NOUN
admet-1883	716	6	,	,	PUNCT
admet-1883	716	7	singlet	singlet	ADJ
admet-1883	716	8	oxygen	oxygen	NOUN
admet-1883	716	9	yield	yield	NOUN
admet-1883	716	10	,	,	PUNCT
admet-1883	716	11	photophysical	photophysical	ADJ
admet-1883	716	12	properties	property	NOUN
admet-1883	716	13	and	and	CCONJ
admet-1883	716	14	application	application	NOUN
admet-1883	716	15	in	in	ADP
admet-1883	716	16	pdt	pdt	PROPN
admet-1883	716	17	.	.	PROPN
admet-1883	717	1	spectrochimica	spectrochimica	PROPN
admet-1883	717	2	acta	acta	PROPN
admet-1883	717	3	part	part	PROPN
admet-1883	717	4	a	a	DET
admet-1883	717	5	:	:	PUNCT
admet-1883	717	6	molecular	molecular	ADJ
admet-1883	717	7	and	and	CCONJ
admet-1883	717	8	biomolecular	biomolecular	ADJ
admet-1883	717	9	spectroscopy	spectroscopy	VERB
admet-1883	717	10	279	279	NUM
admet-1883	717	11	(	(	PUNCT
admet-1883	717	12	2022	2022	NUM
admet-1883	717	13	)	)	PUNCT
admet-1883	717	14	121447	121447	NUM
admet-1883	717	15	.	.	PUNCT
admet-1883	718	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
admet-1883	718	2	j.saa.2022.121447	j.saa.2022.121447	PROPN
admet-1883	718	3	.	.	PUNCT
admet-1883	719	1	©	©	PROPN
admet-1883	719	2	2023	2023	NUM
admet-1883	719	3	by	by	ADP
admet-1883	719	4	the	the	DET
admet-1883	719	5	authors	author	NOUN
admet-1883	719	6	;	;	PUNCT
admet-1883	719	7	licensee	licensee	PROPN
admet-1883	719	8	iapc	iapc	PROPN
admet-1883	719	9	,	,	PUNCT
admet-1883	719	10	zagreb	zagreb	PROPN
admet-1883	719	11	,	,	PUNCT
admet-1883	719	12	croatia	croatia	PROPN
admet-1883	719	13	.	.	PUNCT
admet-1883	720	1	this	this	DET
admet-1883	720	2	article	article	NOUN
admet-1883	720	3	is	be	AUX
admet-1883	720	4	an	an	DET
admet-1883	720	5	open	open	ADJ
admet-1883	720	6	-	-	PUNCT
admet-1883	720	7	access	access	NOUN
admet-1883	720	8	article	article	NOUN
admet-1883	720	9	distributed	distribute	VERB
admet-1883	720	10	under	under	ADP
admet-1883	720	11	the	the	DET
admet-1883	720	12	terms	term	NOUN
admet-1883	720	13	and	and	CCONJ
admet-1883	720	14	conditions	condition	NOUN
admet-1883	720	15	of	of	ADP
admet-1883	720	16	the	the	DET
admet-1883	720	17	creative	creative	ADJ
admet-1883	720	18	commons	common	NOUN
admet-1883	720	19	attribution	attribution	NOUN
admet-1883	720	20	license	license	NOUN
admet-1883	720	21	(	(	PUNCT
admet-1883	720	22	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
admet-1883	720	23	)	)	PUNCT
admet-1883	720	24	https://doi.org/10.5599/admet.1883	https://doi.org/10.5599/admet.1883	PROPN
admet-1883	720	25	https://doi.org/10.3390/ijms23137304	https://doi.org/10.3390/ijms23137304	PROPN
admet-1883	720	26	https://doi.org/10.3390/v13040643	https://doi.org/10.3390/v13040643	PROPN
admet-1883	721	1	https://doi.org/10.1016/j.dyepig.2023.111283	https://doi.org/10.1016/j.dyepig.2023.111283	PROPN
admet-1883	721	2	https://doi.org/10.1038/s41467-023-37156-x	https://doi.org/10.1038/s41467-023-37156-x	PROPN
admet-1883	721	3	https://doi.org/10.1021/jacs.2c12244	https://doi.org/10.1021/jacs.2c12244	PROPN
admet-1883	721	4	https://doi.org/10.1039/d2tb01515c	https://doi.org/10.1039/d2tb01515c	PROPN
admet-1883	721	5	https://doi.org/10.1016/j.pdpdt.2022.103208	https://doi.org/10.1016/j.pdpdt.2022.103208	PROPN
admet-1883	721	6	https://doi.org/10.1016/j.pdpdt.2022.103208	https://doi.org/10.1016/j.pdpdt.2022.103208	PROPN
admet-1883	721	7	https://doi.org/10.1002/‌ange.202201308	https://doi.org/10.1002/‌ange.202201308	PROPN
admet-1883	721	8	https://doi.org/10.1002/‌ange.202201308	https://doi.org/10.1002/‌ange.202201308	PROPN
admet-1883	721	9	https://doi.org/10.1016/‌j.jphoto‌chem.2022.114138	https://doi.org/10.1016/‌j.jphoto‌chem.2022.114138	PROPN
admet-1883	721	10	https://doi.org/10.1016/‌j.jphoto‌chem.2022.114138	https://doi.org/10.1016/‌j.jphoto‌chem.2022.114138	PROPN
admet-1883	721	11	https://doi.org/10.1021/acsabm.2c00202	https://doi.org/10.1021/acsabm.2c00202	PROPN
admet-1883	721	12	https://doi.org/10.3233/mgc-210188	https://doi.org/10.3233/mgc-210188	NUM
admet-1883	721	13	https://doi.org/10.1016/‌j.saa.2022.121447	https://doi.org/10.1016/‌j.saa.2022.121447	PROPN
admet-1883	721	14	https://doi.org/10.1016/‌j.saa.2022.121447	https://doi.org/10.1016/‌j.saa.2022.121447	PROPN
admet-1883	721	15	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN